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Abstract  
 
Whole cell biosensors have been extensively used for monitoring toxicity 
and contamination of compounds in environmental biology and microbial 
ecology. However, their application in the pharmaceutical and cosmetics 
industries for preservative efficacy testing (PET) has been limited. 
According to several pharmacopoeias, preservatives should be tested for 
microbial activity using traditional viable count techniques; the use of 
whole cell microbial biosensors potentially provides an alternative, fast, 
and efficient method. The aim of the study was to construct and develop 
whole cell microbial biosensors with Pseudomonas aeruginosa ATCC 
9027. Constitutive promoters: PlysS, Pspc, Ptat, Plpp and PldcC and the lux-
cassette were inserted into plasmid pME4510 and transformed into P. 
aeruginosa ATCC 9027 cells to produce bioluminescent strains. Plasmids 
were found to be maintained stably (~50 copies per cell) throughout the 
growth and death cycle.  
The novel bioluminescent strains were validated in accordance with the 
pharmacopoeia using bioluminescence detection and quantification 
followed by comparison with the traditional plate counting method. The 
bioluminescent method was found to be accurate, precise and equivalent 
at a range of 103 – 107 CFU/mL, as compared with plate counting. 
Recovery of bacterial cells was quantified using bioluminescence; this 
method proved to be accurate with percentage recoveries between 70-
130% for all bioluminescent strains. The method was also more precise 
(relative standard deviation less than 15%) than the traditional plate 
counting method or the ATP bioluminescent method. Therefore, the 
bioluminescent constructs passed/exceeded pharmacopoeial specified 
criteria for range, limit of detection, accuracy, precision and equivalence. 
Physiology of the validated bioluminescent strains was studied by 
assessing the growth and death patterns using constitutive gene 
expression linked with bacterial replication. Promoter strengths were 
evaluated at various stages of the growth and death pattern and related to 
promoter sequences. PlysS, Ptat and Plpp were relatively strong promoters 
whilst PldcC and Pspc were relatively weak promoters. Relative promoter 
strength decreased in the order of Plpp>Ptat>PlysS>PldcC>Pspc during the 
exponential phase whilst Ptat was stronger than Plpp during the stationary 
phase of growth. Plpp had its highest level of expression during the 
exponential phase, while Ptat had relatively stable lux expression during 
the stationary phase. Correlations between relative bioluminescence and 
CFU at 24 hours were greater than 0.9 indicating a strong relationship for 
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all bioluminescent strains. Reduction in correlation coefficients to 
approximately 0.6 between relative bioluminescence and CFU and 
between relative fluorescence and CFU beyond 24 hours indicated that a 
certain proportion of cells were viable but non-culturable. Tat-pME-lux 
showed steady bioluminescence compared to CFU count (R>0.9) 
throughout 28 days of growth. Equivalence analysis showed no significant 
difference between the bioluminescence and plate count method 
throughout 28 days of growth for all five bioluminescent strains.  
Applicability of these novel bioluminescent strains was evaluated for 
preservative efficacy tests (PET) using bacterial replication and 
bioluminescence as a measure of constitutive gene expression. PET using 
benzalkonium chloride and benzyl alcohol showed no significant 
difference between the bioluminescent method and the plate count 
method. Good correlations between bioluminescence, CFU count and 
fluorescence were obtained for benzalkonium chloride (BKC) 
concentrations (R>0.9) between 0.0003% and 0.0025% against strains 
lysR25, lppR4 and tatH5. Similarly, good correlations (R>0.9) between the 
three parameters were obtained for benzyl alcohol (BA) concentrations 
between 0.125% and 2% against strains lysR25, lppR4 and tatH5. The 
bioluminescent method and traditional plate counting method were 
equivalent for concentrations of BKC (0.0003 - 0.02%) and BA (0.25 - 2%) 
during preservative efficacy tests. These bioluminescent constructs 
therefore are good candidates for selection for preservative efficacy 
testing. The bioluminescent method and traditional plate counting method 
were also found to be equivalent for construct tatH5 at a concentration of 
0.125% BA.  
PET testing with BKC and BA showed that tatH5-pMElux (R>0.9) had 
consistently high correlation coefficients between CFU and relative 
bioluminescence. Together with the results from growth and death 
kinetics, where tatH5 showed the greatest constitutive expression, it can 
be concluded that P. aeruginosa ATCC 9027 tatH5-pMElux is the best 
construct for testing various antimicrobial agents. This study has shown 
that according to the pharmacopoeial requirements, the bioluminescent 
method is more accurate, precise and equivalent to the traditional plate 
counting method and therefore can be utilised instead of the traditional 
plate counting method for the purpose of preservative efficacy testing. 
 
 
Page VII 
 
Table of Contents 
Dedication II 
Acknowledgements III 
Declaration by candidate IV 
Abstract V 
Table of Contents VII 
List of Figures XIII 
List of Tables XV 
Abbreviations XVII 
Chapter 1: General introduction 1 
1.1 Antimicrobial preservatives 2 
1.1.1 Pharmacopoieal requirements 2 
1.1.2 Preservative efficacy failures 5 
1.2. Biosensors 7 
1.2.1 General introduction to biosensors 7 
1.2.2 Whole cell biosensors 10 
1.2.3 Applications of biosensors 11 
1.2.4 The Microtox system 13 
1.2.5 Bioreporter genes 14 
1.2.5.1 -galactosidase 14 
1.2.5.2 Green fluorescent protein (GFP) 15 
1.2.5.3 Uroporphyrinogen III methyltransferase and DsRed 16 
1.2.5.4 Luciferases 17 
1.2.5.4.1 lux CDABE cassette 17 
1.2.5.4.2 Mechanism of action of the lux cassette 19 
1.2.6 Bioluminescence 22 
1.2.6.1 Regulation of bioluminescence 23 
1.3. Pseudomonas aeruginosa 26 
1.3.1 Pseudomonas aeruginosa susceptibility to aminoglycosides 27 
1.3.2 Antibiotic resistance in Pseudomonas aeruginosa 29 
1.3.2.1 Aminoglycoside resistance by enzymatic inactivation 30 
1.3.2.2 Impermeability resistance 30 
Page VIII 
 
1.3.2.3 Acquired resistance 31 
1.3.2.4 Adaptive resistance 32 
1.4. Gene expression 33 
1.4.1 Promoter regions 33 
1.4.2 RNA polymerase 35 
1.4.3 Sigma factors 36 
1.4.4 Upstream elements 39 
1.4.5 Constitutive and induced gene expression 39 
1.4.5.1 Lysyl-tRNA synthetase (LysS) gene 41 
1.4.5.2 Spc ribosomal operon (spc) 41 
1.4.5.3 Outer membrane lipoprotein (lpp) 42 
1.4.5.4 Twin-arginine translocase (tat) 43 
1.4.5.5 Lysine decarboxylase (ldcC) 44 
1.5. Rationale, aim and objectives of this project 46 
Chapter 2: Genetic cloning 47 
2.1 Introduction 48 
2.1.1 Plasmid vectors 48 
2.1.2 Recombinant DNA technology 50 
2.1.3 Transformation 51 
2.2 Aim and objectives 52 
2.3 Materials and methods 54 
2.3.1 Bacterial strains 54 
2.3.2 Bioinformatics 55 
2.3.3 Gram staining and microscopy 55 
2.3.4 Antibiotic testing 56 
2.3.5 Genomic DNA extraction 57 
2.3.6 Polymerase Chain Reaction (PCR) 57 
2.3.7 Purification of DNA 60 
2.3.8 Agarose gel electrophoresis 61 
2.3.9 Plasmid isolation 62 
2.3.10 Restriction 62 
2.3.11 Ligation 64 
2.3.12 Preparation of electro-competent cells 64 
2.3.13 Electroporation 65 
2.3.14 Screening of transformants 66 
2.3.15 Bioluminescence measurement 67 
2.3.16 DNA sequencing 67 
2.3.17 Long-term storage of all strains 68 
2.3.18 Data analysis 68 
2.4 Results 69 
2.4.1 Gram staining 69 
Page IX 
 
2.4.2 Antibiotic susceptibility 69 
2.4.3 Bioinformatics 70 
2.4.4 Genomic DNA extraction 72 
2.4.5 Polymerase Chain Reaction (PCR) 74 
2.4.6 Purification of PCR products 77 
2.4.7 Plasmid isolation 79 
2.4.8 Restriction of plasmids pBR322, pSB417, 322-lux and pME4510 80 
2.4.9 Ligation of lux cassette into pME4510. 83 
2.4.10 Transformation and screening of pME-lux 84 
2.4.11 Restriction of pME-lux plasmids 85 
2.4.12 PCR with new primers 87 
2.4.13 Restriction of PCR products 90 
2.4.14 Ligation of PCR products into promoterless pME-lux plasmid 91 
2.4.15 Transformation and screening of recombinant plasmids from pME-lux 92 
2.4.16 DNA sequencing of E. coli recombinant plasmids 93 
2.4.17 Transformation into P. aeruginosa ATCC 9027 94 
2.4.18 RLU comparison between E. coli and P. aeruginosa strains 98 
2.4.19 Plasmid DNA sequencing of P. aeruginosa bioluminescent strains 99 
2.5 Discussion 100 
2.5.1 Characterization of P. aeruginosa cells 100 
2.5.2 Amplification of promoter regions 100 
2.5.3 Purification of amplicons 103 
2.5.4 Plasmid isolation 105 
2.5.5 Restriction 105 
2.5.6 Formation of lux-bearing plasmids 107 
2.5.7 Insertion of promoters into promoterless plasmid vectors 108 
2.5.8 Transformation and screening 111 
2.5.9 Transformation into P. aeruginosa ATCC 9027 112 
2.5.10 Lux expression studies in P. aeruginosa ATCC 9027 114 
2.6 Conclusion 117 
Chapter 3: Validation of P. aeruginosa bioluminescent strains 118 
3.1 Introduction 119 
3.1.1 Method validation 119 
3.1.2 Plasmid copy number 121 
3.2 Aim and objectives 126 
3.3 Materials and methods 127 
3.3.1 Bacterial strains 127 
3.3.2 Promoter strength determination 127 
3.3.3 Linearity and standardisation of inocula 128 
3.3.4 Accuracy testing 128 
3.3.5 Precision testing 129 
Page X 
 
3.3.6 Data analysis 130 
3.3.7 Plasmid copy number 130 
3.3.7.1 DNA extraction 130 
3.3.7.2 Quantitative Polymerase Chain Reaction (qPCR) 131 
3.3.7.3 Melt curve generation 133 
3.3.7.4 Analysis 133 
3.4 Results 134 
3.4.1 Validation 134 
3.4.1.1 Linearity studies for all strains 134 
3.4.1.2 Accuracy 138 
3.4.1.3 Precision 140 
3.4.1.4 Equivalence 142 
3.4.2 Quantitative Polymerase Chain Reaction (qPCR) 144 
3.5 Discussion 149 
3.5.1 Linear range 149 
3.5.2 Limit of quantification, detection and sensitivity 151 
3.5.3 Accuracy studies 152 
3.5.4 Precision and equivalence 153 
3.5.5 Plasmid copy number 154 
3.6. Conclusion 156 
Chapter 4: Bacterial growth and gene expression 157 
4.1 Introduction 158 
4.1.1 Growth and death kinetics 158 
4.1.2 Bacterial growth rate-dependent gene expression 161 
4.2 Aim and objectives 162 
4.3 Materials and methods 163 
4.3.1 Growth and death kinetics of P. aeruginosa wild-type and bioluminescent 
constructs 163 
4.3.2 Growth and death kinetics of P. aeruginosa wild-type and recombinant constructs 
using fluorescence spectroscopy 164 
4.3.3 Data analysis 164 
4.4 Results 165 
4.4.1 Growth and death kinetics of P. aeruginosa wild-type and recombinant constructs
 165 
4.4.2 Promoter strength and sequence analysis 168 
4.4.3 Relationship between RLU, CFU and RFU 170 
4.5 Discussion 175 
4.5.1 Growth and death kinetics of P. aeruginosa wild-type and bioluminescent 
constructs 175 
4.5.2 Promoter strength and sequence analysis 180 
4.6 Conclusion 183 
Page XI 
 
Chapter 5: Efficacies of benzalkonium chloride and benzyl alcohol against 
P. aeruginosa ATCC9027 constructs 184 
5.1 Introduction 185 
5.1.1 Benzalkonium chloride (BKC) and its characteristics 185 
5.1.2 Mode of action of BKC 186 
5.1.3 Benzyl alcohol (BA) 188 
5.1.4 Mode of action of BA 189 
5.1.5 Resistance to BA 189 
5.2 Aim and objectives 190 
5.3 Materials and methods 191 
5.3.1 Bacterial strains 191 
5.3.2 Minimum inhibitory concentration determination for BKC 192 
5.3.3 MIC determination for BA 193 
5.3.4 Preservative efficacy test for BKC 194 
5.3.5 Preservative efficacy test for BA 195 
5.3.6 Data analysis 196 
5.4 Results 197 
5.4.1 Minimum inhibitory concentration of BKC 197 
5.4.2 Minimum inhibitory concentration of BA 198 
5.4.3 Preservative efficacy test for BKC 199 
5.4.4 Preservative efficacy test for BA 209 
5.5 Discussion 220 
5.5.1 Minimum inhibitory concentrations of BKC and BA 220 
5.5.2 Preservative efficacy tests for BKC and BA 222 
6. General discussion and conclusion 229 
References 243 
Appendices 267 
Appendix 1: Promoter sequences 267 
LdcC sequence 267 
LolB sequence 268 
LysS sequence 269 
Spc sequence 270 
Tat sequence 271 
Appendix 2: Promoter characterisation 272 
Appendix 3: Expected sizes of PCR products 275 
Appendix 4: Optimisation of PCR conditions and restriction of DNA 276 
Appendix 5: Expected DNA sequence of promoterless pME-lux 284 
Appendix 6: DNA sequencing of constructs in E. coli. 287 
Page XII 
 
Promoterless pME-lux sequence (EcoRI and SnaBI junction) 287 
Promoterless pME-lux sequence (BamHI junction) 287 
Spc3-pME-lux sequence (EcoRI and SnaBI junction) 287 
Spc5-pME-lux sequence (EcoRI and SnaBI junction) 287 
Spc9-pME-lux sequence (EcoRI and SnaBI junction) 287 
LdcC8-pME-lux sequence (EcoRI and SnaBI junction) 288 
LdcC4b-pME-lux sequence (EcoRI and SnaBI junction) 288 
Lys2-pME-lux sequence (EcoRI and SnaBI junction) 288 
Lys3-pME-lux sequence (EcoRI and SnaBI junction) 288 
Lys6-pME-lux sequence (EcoRI and SnaBI junction) 289 
Lpp4-pME-lux sequence (EcoRI and SnaBI junction) 289 
Lpp8-pME-lux sequence (EcoRI and SnaBI junction) 289 
Tat9-pME-lux sequence (EcoRI and SnaBI junction) 289 
Tat12-pME-lux sequence (EcoRI and SnaBI junction) 289 
Appendix 7: Sequences of all plasmids in P. aeruginosa 291 
pME-lux plasmid 291 
LdcC-pME-lux plasmid 292 
Spc-pME-lux 293 
LysR25-pME-lux 294 
LysG25-pME-lux 295 
LppR3-pME-lux 296 
LppR4-pME-lux 297 
TatH5-pME-lux 298 
TatH9-pME-lux 299 
TatH14-pME-lux 300 
Appendix 8: Validation 301 
Normality and constant variance test 301 
LysR25 301 
LysG25 301 
TatH5 301 
TatH9 302 
TatH14 302 
LppR3 302 
LppR4 303 
LdcC 303 
Spc 303 
Appendix 9: Bacterial growth and gene expression 306 
Appendix 10: Preservative efficacy testing 307 
Appendix 11: List of posters and presentations 316 
 
 
 
Page XIII 
 
List of Figures 
Figure 1.1: Gene expression of a bioreporter gene linked to a promoter 11 
Figure 1.2: Three-dimensional structure of the luciferase heterodimer 18 
Figure 1.3: Reaction mechanism for bacterial lux enzymes 21 
Figure 1.4: Autoinduction/Quorum sensing mechanism in V. fischeri 25 
Figure 1.5: Model structure of RNA polymerase II interaction with promoter regions 34 
Figure 1.6. Subunits of RNA polymerase 35 
Figure 1.7: Modes of transcription initiation 40 
Figure 1.8: Cadaverine pathway 45 
Figure 2.1: Plasmid map of pME4510 49 
Figure 2.2: Plasmid map of pSB417 52 
Figure 2.3: Agarose gel electrophoretic analysis of genomic DNA 72 
Figure 2.4: Confirmative PCR reactions for Ptat, Plpp and PldcC 75 
Figure 2.5: Agarose gel electrophoretic analysis of PCR reaction for Ptat 76 
Figure 2.6: Purification of PlysS, Ptat, Pspc, Plpp and PldcC amplicons 78 
Figure 2.7: Agarose gel electrophoretic analysis for various plasmid isolations 79 
Figure 2.8: Restriction of Plasmids pSB417 and 322-lux 82 
Figure 2.9: Restriction of plasmids pME4510 and pSB417 83 
Figure 2.10: Ligation of excised lux cassette into plasmid vector pME4510 84 
Figure 2.11: Restriction of pMElux recombinant plasmids 85 
Figure 2.12: Restriction of promoterless plasmid pME-lux 86 
Figure 2.13: PCR reactions for PldcC, Plpp, Ptat, PlysS and Pspc 88 
Figure 2.14: Restriction of PCR products 90 
Figure 2.15: Ligation of each of the five restricted amplicons and plasmid pME-lux 91 
Figure 2.16: Restriction of recombinant plasmids 93 
Figure 2.17: Recombinant plasmids from transformed P. aeruginosa ATCC 9027 cells. 96 
Figure 2.18: PCR reactions for PldcC, Plpp, Ptat, PlysS and Pspc from P. aeruginosa clones 97 
Figure 2.19: Relative light output for all E. coli and P. aeruginosa ATCC 9027 strains 98 
Figure 2.20: Promoter-lux-pBR322 plasmid 106 
Figure 2.21: lux-cassette flanked by various restriction sites 106 
Figure 2.22: Promoterless pBR322-lux plasmid map 109 
Figure 3.1: Phases of quantitative PCR quantification 123 
Figure 3.2: Effect of slope on PCR efficiency 124 
Figure 3.3: Melt curve profile for a typical real-time PCR amplification 125 
Figure 3.4: Relationship between RLU and CFU for all P. aeruginosa ATCC 9027 135 
Figure 3.5: Consistent relationship between Log RLU:Log CFU 137 
Figure 3.6: Quantitative PCR reactions for gentamicin and dxS amplification 144 
Figure 3.7: Standard calibration and melt curves for plasmid and genomic DNA 
standards 145 
Figure 3.8: Calibration curves 146 
Figure 3.9: Amplification plots and melt curves for genomic and plasmid DNA 147 
Figure 3.10: Plasmid copy number analysis for all plasmid-bearing strains 148 
Figure 4.1: Bacterial growth phases 158 
Page XIV 
 
Figure 4.2: Growth curve for wild-type and six constructs. 166 
Figure 4.3: Ratio of RLU:CFU for five constructs 167 
Figure 4.4: Relative promoter strength (RLU/CFU) during exponential and stationary 
phases 168 
Figure 4.5: Comparisons of bioluminescence (RLU), colony forming units (CFU), live 
fluorescence (RFU) and total RFU 172 
Figure 4.6: Schematic diagram showing competitive distribution of myristol-ACP 176 
Figure 5.1: Structure of benzalkonium chloride (BKC) 185 
Figure 5.2: Mode of action of BKC 187 
Figure 5.3: BKC efficacy test for all strains challenged with 0.00125% BKC. 202 
Figure 5.4: BKC efficacy test for all strains challenged with 0.000625% BKC. 204 
Figure 5.5: BKC efficacy test for all strains challenged with 0.0003125% BKC. 206 
Figure 5.6: BKC efficacy test for all strains challenged with 0% BKC. 208 
Figure 5.7: BA efficacy test for all strains challenged with 2% BA. 210 
Figure 5.8: BA efficacy test for all strains challenged with 1% BA. 212 
Figure 5.9: BA efficacy test for all strains challenged with 0.5% BA. 214 
Figure 5.10: BA efficacy test for all strains challenged with 0.25% BA. 215 
Figure 5.11: BA efficacy test for all strains challenged with 0.125% BA. 217 
Figure 5.12: BA efficacy test for all strains challenged with 0.06% BA. 218 
Figure 7.1: Agarose gel electrophoretic analysis of PCR reactions for Ptat 276 
Figure 7.2: Agarose gel electrophoretic analysis of PCR reactions for Ptat and Plpp 277 
Figure 7.3: Agarose gel electrophoretic analysis of PCR reactions for PldcC 277 
Figure 7.4: Agarose gel electrophoretic analysis of PCR reactions for PldcC 278 
Figure 7.5: Agarose gel electrophoretic analysis of PCR reactions for Ptat 278 
Figure 7.6: Agarose gel electrophoretic analysis of PCR reactions for Pspc 279 
Figure 7.7: Agarose gel electrophoretic analysis of PCR reactions for PlysS 280 
Figure 7.8: Agarose gel electrophoretic analysis for restriction of plasmids pBR322 and 
pSB417 281 
Figure 7.9: Agarose gel electrophoretic analysis for restriction of plasmids pBR322, 
pSB417 and pBR322-lux 281 
Figure 7.10: Agarose gel electrophoretic analysis for restriction of plasmid pSB417 282 
Figure 7.11: Agarose gel electrophoretic analysis for restriction of the promoterless 
plasmid pBR322-lux 282 
Figure 7.12: Confirmative agarose gel electrophoretic analysis for restriction of the 
promoterless plasmid pBR322-lux 283 
Figure 7.13: Comparisons of bioluminescence (RLU), colony forming units (CFU), live 
fluorescence (RFU) and total RFU 306 
Figure 7.14: BKC efficacy test for all strains 307 
 
 
 
 
Page XV 
 
List of Tables 
Table 1.1: European pharmacopoeial criteria for bacterial and fungal microorganisms. 4 
Table 2.1: Bacterial strains used in this project 54 
Table 2.2: Various antibiotics for antibiotic resistance testing of P. aeruginosa. 56 
Table 2.3: Forward and reverse primers for amplification of five promoter regions 58 
Table 2.4: Various reagents for a PCR reaction. 59 
Table 2.5: Cycling parameters for the PCR reactions. 59 
Table 2.6: Final reaction volumes and annealing temperatures 60 
Table 2.7: Restriction digestion components. 63 
Table 2.8: Ligation reaction components 64 
Table 2.9: Forward and reverse primers for sequencing of insert junctions. 67 
Table 2.10: Susceptibility of P. aeruginosa cells to various antibiotics. 69 
Table 2.11: Promoter sequences for five genes in E. coli and P. aeruginosa 71 
Table 2.12: Specific primers for amplification of the promoter elements. 71 
Table 2.13: Purity and concentration of extracted gDNA samples. 73 
Table 2.14: Optimized PCR reaction conditions for each prototype. 77 
Table 2.15: Purity and concentration of each prototype after PCR purification 78 
Table 2.16: Purity and concentration of isolated plasmids. 80 
Table 2.17: Purity and concentration of isolated pME-lux plasmid. 86 
Table 2.18: New reverse primers tagged with SnaBI restriction site. 87 
Table 2.19: Sizes of PCR amplicons. 87 
Table 2.20: Purity and concentration of purified PCR products. 89 
Table 2.21: Optimized PCR reaction conditions 89 
Table 2.22: E. coli DH5  bacterial colonies post electroporation. 92 
Table 2.23: P. aeruginosa ATCC 9027 bacterial colonies post electroporation. 94 
Table 2.24: Relative Light Units (RLU’s) from P. aeruginosa transformants 95 
Table 3.1: Percentage dilution range for accuracy testing 128 
Table 3.2: Forward and reverse primers for amplification of DxS and gentamicin. 131 
Table 3.3: Various components of a qPCR reaction 132 
Table 3.4: Cycling parameters for quantitative PCR reactions 132 
Table 3.5: Correlation between RLU and CFU for all strains 136 
Table 3.6: Accuracy analysis and Pearson’s correlations. 139 
Table 3.7: Relative standard deviation for precision analysis 140 
Table 3.8: F-test and analysis of variance for precision analysis 141 
Table 3.9: Equivalence analysis 142 
Table 4.1: Promoter sequence comparison 169 
Table 4.2: Pearson’s correlations and significance between CFU, RLU and RFU 173 
Table 4.3: Equivalence between bioluminescence, CFU count and fluorescence 174 
Table 5.1: Concentration range of BKC used for MIC determination 192 
Table 5.2: Concentration range of BA used for MIC determination 193 
Table 5.3: Concentration range of BKC used for PET determination 194 
Table 5.4: Concentration range of BA used for preservative efficacy testing 195 
Table 5.5: Minimum inhibitory concentrations for BKC 198 
Page XVI 
 
Table 5.6: Minimum inhibitory concentration of BA 199 
Table 7.1: Characterization of each of the genes 272 
Table 7.2: Operon prediction 273 
Table 7.3: Plasmid copy number 304 
Table 7.4: Relationship between time and plasmid copy number 305 
Table 7.5: Correlations between RLU, CFU and RFU for all strains 308 
Table 7.6: Correlations between RLU, CFU and RFU for strains 309 
Table 7.7: Log unit reductions of RLU and CFU for all strains at various BKC 
concentrations 310 
Table 7.8: Log unit reductions of RLU and CFU for all strains 313 
Table 7.9: Equivalence between bioluminescence and plate count method. 315 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page XVII 
 
Abbreviations 
3-(N-morpholino) propanesulfonic acid  MOPS  
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid HEPES  
Absorbance  A 
Adenosine triphosphate  ATP 
Aldehyde  RCHO  
Aminoacyl tRNA synthetases  aaRSs  
Aminoglycoside acetyltransferase  AAC  
Aminoglycoside nucleotidyltransferase  ANT 
Aminoglycoside phosphoryltransferase  APH  
Antimicrobial Efficacy Test  AET  
Autoinducer  AI  
Base pair  bp  
Benzalkonium chloride  BKC  
Benzyl alcohol  BA 
-galactosidase  -gal  
Biosynthetic lysine decarboxylase  ldcC 
Blue Fluorescent Protein  BFP  
Bovine serum albumin  BSA 
Colony forming units  CFU  
Correlation coefficient  R2  
Crossing point  Cp  
Cyan Fluorescent Protein  CFP  
Degradative lysine decarboxylases CadA  
Deoxyribonucleic acid  DNA 
Deoxyribonucleoside triphosphate  dNTP  
Downstream core element  DCE                      
Downstream promoter element  DPE 
ECF AlgU  RpoE or s22 
Effective concentration  EC50 
Energy-dependent phase I  EDP-I  
Enhanced GFPs  eGFPs 
Page XVIII 
 
Escherichia coli ATCC 8739  E. coli ATCC 8739 
Ethylenediaminetetraacetic acid  EDTA  
Extracytoplasmic function  ECF’s 
Faraday  F  
Fatty acid  RCOOH 
Fatty acyl group  RCOX                    
Genomic DNA  gDNA  
Green fluorescent protein  GFP 
Growth advantage in stationary phase  GASP  
Initiator  Inr 
Inner membrane  IM  
Light addressable potentiometric sensor  LAPS  
Limit of detection  LOD  
Limit of quantification  LOQ  
Lipopolysaccharides  LPS  
Localization of lipoproteins  Lol  
Luria broth  LB  
Lysyl-tRNA synthetase  LysRS 
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Melting temperature  Tm  
Messenger RNA  mRNA  
Minimum inhibitory concentration  MIC 
Motif ten element  MTE 
Multiple cloning site  MCS 
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Nucleoside triphosphate  NTP  
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P. aeruginosa ATCC 9027 + pME4510  pME4510 
P. aeruginosa ATCC 9027 + pME-lux  pME-lux 
P. aeruginosa ATCC 9027 + spc pME-lux  spc pME-lux 
P. aeruginosa ATCC 9027 + tat H5 pME-lux  tat H5 pME-lux 
P. aeruginosa ATCC 9027 + tat H9 pME-lux  tat H9 pME-lux 
P. aeruginosa ATCC 9027 + tat H14 pME-lux  tat H14 pME-lux 
Percentage relative standard deviation  %RSD  
Photobacterium phosphoreum  P. phosphoreum 
Photorhabdus luminescens  P. luminescens 
Piezoelectric  PZ  
Plasmid copy numbers  PCN  
Polymerase chain reaction  PCR  
Preservative efficacy test  PET  
Promoter for ldcC  PldcC 
Promoter for lpp  Plpp 
Promoter for lysS  PlysS 
Promoter for spc  Pspc 
Promoter for tat  Ptat 
Pseudomonas aeruginosa ATCC 9027  P. aeruginosa ATCC 9027 
Quantitative real-time PCR  qPCR  
Quantitative structure-activity relationship  QSAR 
Quarternary ammonium compounds  QACs  
Quorum-sensing  QS  
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Reduced nicotinamide adenine dinucleotide 
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Ribonucleic acid  RNA 
RNA polymerase II  RNAP 
RpoD  70 
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RpoN  NtrA, 54 or N 
RpoS  S or 38 
Sigma factors   factors  
Sodium chloride  NaCl 
Sodium chloride, Tris, EDTA STE 
Spc ribosomal operon  spc 
Standard deviation  SD  
Stationary phase contact dependent inhibition  SCDI  
Statistical significance  sig 
Sucrose & magnesium chloride electroporation buffer SMEB 
Super optimal broth with catabolic repressor  SOC media 
The International Organisation for Standardisation  ISO  
Threshold cycle  Ct  
Tranfer RNA  tRNA 
Tris EDTA  TE 
Tryptone soya agar  TSA 
Tryptone soya broth  TSB  
Twin-arginine translocase  tat 
Ultra violet  UV 
Viable but non-culturable states  VBNC  
Vibrio fischeri  V. fischeri 
Volts  V 
Wild-type Pseudomonas aeruginosa ATCC 9027  WT 
Yellow Fluorescent Protein  YFP  
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1.1 Antimicrobial preservatives 
1.1.1 Pharmacopoieal requirements 
Substances that inhibit or prevent microbial growth and protect medicinal 
products from antioxidants, degradation and contamination are known as 
antimicrobial preservatives (British Pharmacopoeia, 2008; European 
Pharmacopoeia, 2008; Kramer, Suklje-Debeljak & Kmetec, 2008). These 
are normally used to increase the shelf life of products. Antimicrobial 
preservatives are usually added to medicinal products that do not have 
antimicrobial activity (British Pharmacopoeia, 2008; European 
Pharmacopoeia, 2008). Failure to add these preservatives can lead to 
product contamination and spoilage and can be a hazard to patients. 
Preservatives are chemicals that are usually aggressive to microbial cells. 
Hence they are used to inhibit the proliferation of micro-organisms, which 
under normal conditions would grow and contaminate medicinal products 
(British Pharmacopoeia, 2008; European Pharmacopoeia, 2008).  
Water-based medicinal products, such as solutions, creams, emulsions, 
suspensions, injections and eye-drops are most prone to microbial 
contamination. Hence, microbial preservatives must have the relevant 
properties to combat and prevent this contamination. These properties 
include concentration, pH, chemical composition and physical properties, 
the presence or absence of interfering substances (British 
Pharmacopoeia, 2008; European Pharmacopoeia, 2008; Kramer et al., 
2008). Other factors such as storage temperature, interactions between 
preservative and storage containers and packing play a vital role in 
preservative efficacy and must be tested under the regulations set out in 
several pharmacopoeias (British Pharmacopoeia, 2008; European 
Pharmacopoeia, 2008; United States Pharmacopoeia, 2008).  
The efficacy of the preservative may be altered by the formulation itself. 
Active ingredients and inert ingredients may both affect the efficacy of 
antimicrobial agents; albeit in different ways (Krouse, 2005; Parshionikar 
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et al., 2009; Springthorpe & Sattar, 2005). Likewise, changes in 
temperature, pH and humidity can alter the efficacy of preservatives 
(British Pharmacopoeia, 2008; European Pharmacopoeia, 2008; Kramer 
et al., 2008). Product storage conditions and length of storage affect the 
product efficacy (British Pharmacopoeia, 2008; European Pharmacopoeia, 
2008). Furthermore, diluted products are less efficacious than 
concentrated products. Different microorganisms have different thresholds 
for survival when exposed to antimicrobial products (Parshionikar et al., 
2009; Springthorpe & Sattar, 2005). The effectiveness of the preservative 
in the finished product must be tested over a period of time. Such tests are 
normally referred to as Preservative Efficacy Tests (PET) or Antimicrobial 
Efficacy Tests (AET) (British Pharmacopoeia, 2008; European 
Pharmacopoeia, 2008); in such tests the medicinal product containing the 
preservative in its final container is inoculated with certain microorganisms 
and incubated at a specified temperature. Samples are then tested to 
assess the number of viable organisms present at various intervals of time 
up to 28 days after inoculation (Lundov, Moesby, Zachariae, & Johansen, 
2009). Various pharmacopoeias also specify the type of media and 
diluents to be used for microbial growth and enumeration.  
It is of great importance that the method of application of microorganisms 
is consistent throughout the tests, since different methods of application of 
test microorganisms may result in different amounts of microorganisms 
applied; this may affect efficacy of the antimicrobial product (Parshionikar 
et al., 2009; Springthorpe & Sattar, 2005). Several pharmacopoeial 
standards recommend a minimum inoculum of 105-106 organisms/mL. The 
minimum concentration of microorganisms recommended by the 
European pharmacopoeia is, however, 104 organisms for PET tests. More 
importantly, the characteristics of the microorganisms affects the outcome 
of testing (Parshionikar et al., 2009). For instance, less resistant 
organisms or exponential phase organisms may make the product appear 
more efficacious than it actually is, and vice versa. Stationary phase 
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organisms and more resistant organisms such as organisms with biofilms, 
may make the product appear less effective. 
A significant reduction in the number of viable microorganisms in tests 
signifies that the preservative is effective. The criteria may vary slightly 
between different pharmacopeias. However, the acceptance criteria for 
liquid formulations according to the European criteria (British 
Pharmacopoeia, 2008; European Pharmacopoeia, 2008) are summarized 
in Table 1.1. According to the European Pharmacopeia, successful 
formulations must pass criteria B, although it is recommended that criteria 
A be achieved (British Pharmacopoeia, 2008; European Pharmacopoeia, 
2008). Criteria A requires a 2 log10 unit reduction in number of bacterial 
colony forming units (CFU) by 6 hours post inoculation and a further 1 
log10 unit reduction by 24 hours with no recovery in CFU for 28 days. If 
formulations fail to satisfy criteria A, they must satisfy criteria B, which 
requires a 1 log10 unit reduction in bacterial CFU by 24 hours and further 2 
log10 unit reduction by 7 days with no further increase in CFU for 28 days 
(British Pharmacopoeia, 2008; European Pharmacopoeia, 2008). 
 
Table 1.1: European pharmacopoeial criteria for bacterial and fungal 
microorganisms. (British Pharmacopoeia, 2008; European Pharmacopoeia, 2008) 
Type of 
microbe 
Criteria 
category 
Log unit reductions 
6 hours 24 hours 7 days 14 days 28 days 
Bacteria A 2 3 - - NR 
B - 1 3 - NI 
Fungi A - - 2 - NI 
B - - - 1 NI 
Number of log10 unit reductions required for preservatives to pass the pharmacopoeial 
criteria. NR: No Recovery, NI: No Increase 
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According to the various pharmacopoeias (British Pharmacopoeia, 2008; 
European Pharmacopoeia, 2008), the test microorganisms that need to be 
inoculated and tested are Pseudomonas aeruginosa ATCC 9027, 
Staphylococcus aureus ATCC 6538, Candida albicans ATCC 10231 and 
Aspergillus niger ATCC 16404 (British Pharmacopoeia, 2008; European 
Pharmacopoeia, 2008). The US Pharmacopoeia also requires the 
inoculation of Escherichia coli ATCC 8739 in addition to these five micro-
organisms (United States Pharmacopoeia, 2008). This research project 
focuses on P. aeruginosa ATCC 9027. 
 
1.1.2 Preservative efficacy failures  
Microbial contamination in pharmaceuticals, food and cosmetics has been 
a problem for several decades, partly due to the difficulty in detecting it. It 
is therefore imperative that testing protocols for preservative efficacy be 
improved, such that all microorganisms are detected in due time. P. 
aeruginosa has been one of the most widespread opportunistic microbes 
to have been detected in various cosmetics. In 2013, a study found P. 
aeruginosa contamination in unopened toothpaste (Tan, Tuysuz, & Otuk, 
2013). This pathogen, known to cause microbial keratitis, was also 
detected in a study investigating various contact lens disinfection solutions 
(Amiri, Mohammadinia, Tabatabaee, Askarizadeh, & Behgozin, 2011), 
which therefore failed to comply with the microbiological requirements set 
by The International Organisation for Standardisation (ISO). The 
importance of ‘rubbing and rinsing’ contact lenses in their multipurpose 
contact lens solution was highlighted in an investigation where P. 
aeruginosa was able to thrive in solution when a specific step was omitted 
(Zhu et al., 2011). A fatal episode involving a P. aeruginosa outbreak was 
observed in immunocompromised patients in a haematology unit in Italy, 
when the source of infection was heavily contaminated triclosan soap 
dispensers (Lanini et al., 2011). P. aeruginosa was also detected in cough 
syrups in 2009, when one of the preservative systems employed for a 
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cough syrup failed to be effective (Khanfar, Khalil, & AbuJafal, 2009). 
Many cosmetic products across Europe were recalled between 2005 and 
2008 due to contamination with P. aeruginosa or other bacterial species 
(Lundov & Zachariae, 2008). A study investigating an outbreak of disease 
caused by contaminated mouth swabs across hospitals in Norway found 
that it was linked to P. aeruginosa and identified the source of the 
outbreak as occurring at various points in the manufacturing process 
(Iversen et al., 2007). A study in 2003 reported P. aeruginosa 
contamination in bottle warmers and milk bank pasteurisers in a neonatal 
intensive care unit (Gras-Le Guen et al., 2003). 
These are just a few examples that emphasize how detrimental and lethal 
to human life this pathogen can be. Numerous investigations have been 
done for several decades that highlight the urgent need for novel methods 
for testing the efficacy of preservative systems. 
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1.2. Biosensors 
1.2.1 General introduction to biosensors 
Protection of human and environmental resources against deleterious 
agents such as microbes, toxic chemicals, pollutants and warfare agents 
needs the development of ‘real-time’ devices that can monitor these 
agents. The method of efficacy testing described in the pharmacopeias 
relies upon the growth of microorganisms, which may take at least three 
days for bacteria and up to a week for fungi. Hence, obtaining results is 
time-consuming. Sampling is also laborious and only four or five time 
points can be measured. This obviously has an effect on the time of 
release of products and therefore a cost implication. There is also a 
requirement for skilful personnel able to operate under the time constraints 
that the pharmaceutical, food and cosmetics industries currently face 
(Kramer et al., 2008).  
Traditional methods for detecting microbial contamination have included 
morphological analysis and growth analysis on different media under 
various conditions. Polymerase chain reaction was the next technology 
used (Sperveslage, Stackebrandt, Lembke, & Koch, 1996); it was very 
sensitive but the analysis was time-consuming. PCR is a very sensitive 
method used to amplify minute quantities of DNA and it can therefore 
detect bacterial cells. Various instruments have been used to detect 
minute concentrations of microbes in clinical samples, food and water, 
such as flow cytometry (Perez, Mascini, Tothill & Turner, 1998), 
impedimetry, chromatography, infrared and fluorescence spectroscopy 
and bioluminescence (Ivnitski, Abdel-Hamid, Atanasov & Wilkins, 1999). 
Although traditional monitoring devices and detectors are available, the 
selectivity, specificity and limit of detection of these devices and the time it 
takes to monitor harmful agents are highly compromised. Furthermore, the 
requirement for sample preparation before detection does not allow 
monitoring in ‘real-time’. Hence, biosensor technology has recently been 
developed to detect these agents. Biosensor technology circumvents 
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some of the problems faced using traditional methods and also allows for 
real-time monitoring of these harmful agents (Nivens et al., 2004). 
A biosensor consists of a biological sensing component, a transducer 
(Checa, Zurbriggen, & Soncini, 2012) and a signal processing element. 
The biological sensing component is the sensing device that contains 
biological molecules, such as whole cells, antibodies or enzymes (Nezich, 
2007), that recognize an analyte or a physical/chemical change. The 
sensor is linked to a transducer, which converts the biological response 
from the sensing component into a different type of signal that can be 
processed further. Once an analyte or a change is identified, the 
transducer is activated and the signal is quantitatively detected (Daunert 
et al., 2000; Nivens et al., 2004). Hence, a biological response is 
converted into an electrical signal that can be processed and interpreted 
(Nezich, 2007). The sensing component and the transducer can be 
combined into a single element, for example an enzyme that catalyses a 
light-producing reaction. 
Biosensors can achieve high selectivity so that a specific compound or a 
group of similar compounds can be detected. A wide variety of toxic 
compounds can also be detected. Another property of some biosensors is 
that they are very sensitive and therefore able to detect very low 
concentrations of an analyte. Biosensors are first classified as direct 
detection biosensors or indirect detection biosensors, depending on 
whether they measure the target analyte in real time (direct) or a reaction 
product of a biochemical reaction (indirect) (Ivnitski et al., 1999). 
Biosensors are further classified into four categories, based on the way 
the signals are transduced: optical, electrochemical, mass and thermal 
biosensors (Ivnitski et al., 1999). Direct detection biosensors include 
optical biosensors, bioluminescence biosensors, piezoelectric biosensors 
and impedance biosensors, whereas indirect biosensors include 
fluorescence-labelled biosensors, metabolism-based biosensors and 
electrochemical biosensors. 
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Optical biosensors utilize optical transducers that detect changes in 
thickness or refractive index of cells that bind to immobilized receptors 
(Watts, Lowe, & Pollardknight, 1994). Bioluminescence biosensors take 
advantage of light-emitting products produced as a result of enzymatic 
reactions and are used to monitor whether bacterial cells are present and 
the physiological state of these cells (Prosser, Killham, Glover & Rattray, 
1996). Piezoelectric (PZ) biosensors comprise an antibody-coated PZ 
sensor that is then immersed into a bacterial solution (Le, He, Jiang, Nie & 
Yao, 1995). Binding of bacterial cells to antibodies causes an increase in 
mass. A reduction in resonance frequency of the oscillations is then 
measured. Bacterial Impedance biosensors utilize the fact that impedance 
decreases during bacterial metabolism and this is calculated by measuring 
several different parameters, such as conductance, capacitance or 
resistance (Hadley & Senyk, 1975). Bacteria form charged products from 
uncharged reactants causing an alteration in conductance. 
Fluorescent biosensors utilize labelled molecules that emit light that is 
detected by fluorescence microscopy; for example, fluorescently labelled 
immunoglobulins (Brayton, Tamplin, Huq & Colwell, 1987). Such labelled 
immunoglobulins target carbohydrates and proteins that are embedded in 
bacterial cell membranes and therefore their presence can be used to 
detect the presence of bacterial cells. Metabolism-based biosensors 
monitor the metabolism of bacterial cells by measuring components of the 
electron-transport chain (Takayama, Kurosaki & Ikeda, 1993). Some 
transducers for these biosensors also measure an electrochemical 
metabolite or the use of oxygen during respiration. Electrochemical 
biosensors use a light addressable potentiometric sensor (LAPS) that 
comprises phosphorus coated with silicon and an insulator (Gehring, 
Patterson & Tu, 1998). When the silicon is immersed in an 
immunoreaction solution, there is charge redistribution and the voltage 
potential difference is measured. 
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1.2.2 Whole cell biosensors  
Since micro-organisms are ubiquitous and continuously synthesize 
complex biomolecules in response to environmental changes, they have 
been used as whole-cell microbial biosensors. The advantage of using 
whole-cell biosensors is that they are able to perform complex biological 
processes in a complex matrix. They are able to respond to many 
environmental factors and changes in a very short period of time and 
using multiple pathways and reactions. There is no need for exogenous 
reagents to produce signals since endogenous coenzymes, cofactors and 
co-substrates necessary for enzyme reaction are already present in the 
cells. Hence, multiple biological-recognition and signalling for biosensors 
are possible since reporter micro-organisms support multi-enzyme 
reactions. The signals are detected by receptor proteins, which may be 
present in the microbial whole-cell or genetically introduced into the cell 
(Figure 1.1) (Nivens et al., 2004). Traditional analytical methods give an 
indication about the total concentration of particular analytes while whole 
cell biosensors provide information on bioavailability of pollutants, making 
it potentially a new technology for environmental monitoring (Sinclair, 
Paton, Meharg & Killham, 1999).  The versatility of biosensors comes from 
their ability to measure low concentrations of chemicals, ability to work in 
complex systems and to have quick response times (Sinclair et al., 1999).  
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___________________________________________________________ 
Figure 1.1: Gene expression of a bioreporter gene linked to a promoter. 
(Nivens et al., 2004) A: analyte, R: receptor, D: degradative enzyme as a result of 
degradative gene expression, S: signalling molecule. Under normal circumstances, A 
binds to R and the complex binds to the promoter to initiate expression of the degradative 
gene. In a biosensor, A being the autoinducer binds to its receptor R and the complex 
binds to the promoter that initiates transcription of the bioreporter gene. Expression of the 
reporter gene leads to production of the signal. 
 
Cell-based bioreporters may require nutrition to survive and time to 
produce a detectable signal due to expression of reporter proteins and the 
transfer of analytes across the membrane, which limits the use of 
bioreporters (Nivens et al., 2004). 
 
1.2.3 Applications of biosensors 
Whole cell microbial biosensors can respond either to a specific analyte or 
generally to a group of similar analytes. Biosensors are powerful tools that 
are able to measure analytes at trace concentrations. The actual amount 
of analyte available to the biosensor can be measured rather than the total 
concentration. Depending on the specificity of biosensors, they can 
measure either a specific toxin or general toxicity of pollutants (Sinclair et 
al., 1999). Environmental contamination by heavy metals (Corbisier, Ji, 
Nuyts, Mergeay & Silver, 1993), organic compounds (Heitzer, Webb, 
Thonnard, & Sayler, 1992), industrial toxic waste (Brown et al., 1996), 
BTEX compounds (Sousa, Duffy, Weitz, Glover & Bar, 1998) and 
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chlorinated aromatics (Boyd et al., 1997) have all been detected by 
biosensors. 
Phenolic compounds, such as chlorophenols, are widely used in 
preservatives, herbicides and fungicides and are toxic to microorganisms. 
Chlorophenols disturb the energy transduction pathway by either inhibiting 
electron transport or uncoupling oxidative phosphorylation. Bacterial 
biosensors containing lux-bioreporters depend on ATP, one of the 
products of the electron transport chain. Hence, disruption of the electron 
transport chain leads to inhibition of ATP production, which further 
reduces the light produced by the bioreporter (Sinclair et al., 1999). Such 
a system is an example where bacterial biosensors are used to assess 
chlorophenol toxicity.  
Bacterial cells with a constitutively expressed reporter gene to monitor 
toxic compounds have been used as non-specific whole-cell biosensors 
(Hansen & Sorensen, 2001). The level of expression of the reporter gene 
is high in the absence of toxic agents; however, in the presence of the 
toxic compounds, the toxic effect on the bacteria leads to a reduction in 
light production, which can be measured. This is the basis of the 
commercially available Microtox® assay (Bulich, 1982). The reduction in 
metabolic activity may have been caused by changes in factors such as 
pH, salinity, presence of metals or xenobiotics; hence, the term non-
specific whole-cell biosensors is used. The nature and severity of the 
actual toxic agent may therefore be difficult to assess with such types of 
biosensors (Hansen & Sorensen, 2001). 
Stress-induced whole-cell biosensors have been used to study the effect 
of stress on bacterial cells. Stress may be induced by UV radiation 
(Vollmer, Belkin, Smulski, VanDyk & LaRossa, 1997), gamma irradiation 
(Min, Lee, Moon, LaRossa & Gu, 2000), antimicrobial agents (Bianchi & 
Baneyx, 1999) and oxidative stress (Belkin, Smulski, Vollmer, VanDyk & 
LaRossa, 1996). In these studies, stress-inducible promoters are linked to 
reporter genes to create stress-induced bioreporters. For example, the 
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promoter for katG gene is induced by stress caused by compounds such 
as cigarettes, alcohol and peroxides. The stress response usually involves 
a complex series of pathways and regulatory systems and is therefore 
non-specific and non-selective (Belkin et al., 1996). In another study of 
Mycobacterium tuberculosis, a pathogenic bacterium that causes 
tuberculosis, were exposed to low pH and oxidative stress and the heat-
shock response was studied under these conditions (Wiles, Ferguson, 
Stefanidou, Young & Robertson, 2005). This was achieved by linking the 
hsp60 promoter to the reporter gene. The light signal was obtained when 
the hsp60 promoter was induced under the stressful conditions and the 
reporter gene was transcribed. Hence mycobacteria were able to survive 
under these stressful conditions. 
Specific whole-cell biosensors have been used to study a specific 
response to different compounds (Hansen & Sorensen, 2001). In such 
studies, inducible promoters are linked to reporter genes and transcription 
of the reporter gene occurs when a repressor or activator protein sensitive 
to a specific molecule binds to the promoter (Hansen & Sorensen, 2001). 
For instance, xenobiotics such as phenols (Wise & Kuske, 2000), toluene-
based compounds (Willardson et al., 1998) and middle chain alkanes 
(Sticher et al., 1997) induce specific promoters that regulate the genes for 
degrading these compounds. Hence, when these same promoters are 
linked to reporter genes, transcription of the reporter genes occurs, which 
subsequently gives an indication of toxicity caused by a specific 
compound. These xenobiotics are common soil pollutants and create a 
serious health risk if they are found in drinking water (Hansen & Sorensen, 
2001). 
 
1.2.4 The Microtox system 
The Microtox system is a toxicity bioassay based on the natural 
bioluminescent bacteria Photobacterium phosphoreum and Vibrio fischeri 
(Nunes-Halldorson & Duran, 2003). It is available commercially and works 
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on the basis that a toxic agent alters the metabolism of these bacterial 
cells and eventually reduces cell viability. As the metabolism is reduced, 
the expression of the reporter gene is also reduced, resulting in a 
reduction in bioluminescence. The concentration of the toxic agent 
required to decrease bioluminescence by 50% is called the effective 
concentration (EC50) and this value is used to measure the potency of the 
toxic compound. The Microtox assay is simple and highly sensitive, with a 
rapid response time. It can be used in Quantitative Structure-Activity 
Relationship studies, where the activity/efficacy of potential novel 
antimicrobial agents can be related to their structure. Such assays can 
also be automated, providing a platform for high through-put studies 
(Nunes-Halldorson & Duran, 2003). 
 
1.2.5 Bioreporter genes 
Several bioreporter systems in biosensing devices have been studied and 
utilized in research. These include the -galactosidase system, green 
fluorescent protein system and luciferase system.  
 
1.2.5.1 -galactosidase 
The simplest, most widely used and best studied reporter gene is the lacZ 
gene that codes for the enzyme -galactosidase (Hansen & Sorensen, 
2001). -gal can be used to examine the transfection efficiency of plasmid 
and virus vectors (Yagi, 2007). -gal converts a substrate X-gal (5-bromo-
4-chloro-3-indolyl-β-D-galactopyranoside), a colourless analogue of 
lactose, into a blue insoluble product 5-bromo-4-chloro-3-hydroxyindole 
and galactose. Hence, it can be detected by colorimetric analysis. It can 
also convert a range of other substrates into different coloured products. 
Specific inducible promoters linked to the lacZ reporter gene have been 
made and developed as bacterial biosensors, for example to detect 
xenobiotics and viruses. Biosensors using the lacZ gene have also been 
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utilized for the detection of toxic compounds (Ramanathan, Shi, Rosen & 
Daunert, 1998), chlorocatechols (Guan et al., 2000) and heavy metals 
(Klein, Altenbuchner & Mattes, 1997). Chemicals can be detected in situ 
and in real-time mode by performing electrochemical assays that utilize -
gal (Yagi, 2007). Although the lacZ gene can be expressed under most 
conditions, it requires no oxygen, ATP or cofactors for expression and can 
use a variety of substrates to produce coloured, easily detectable 
products. Its use, however, can be limited, since tedious protein extraction 
processes followed by -galactosidase assays are required for accurate 
quantification of -galactosidase (Hansen & Sorensen, 2001). 
 
1.2.5.2 Green fluorescent protein (GFP) 
The gfp gene, which encodes for green fluorescent protein, has also been 
widely used recently. GFP is an auto-fluorescence reporter protein that 
does not require ATP or any substrates (Roda, 2010; Yagi, 2007). The 
GFP protein requires light at wavelength 395nm or 488nm in order to 
fluoresce (Hansen & Sorensen, 2001). GFP as a bioreporter has been 
used to detect and quantify L-arabinose and also to discriminate between 
D-arabinose and L-arabinose (Shetty, Ramanathan, Badr, Wolford & 
Daunert, 1999). The GFP protein is a very stable protein molecule, 
although variants with a shorter half-life have also been produced (Hansen 
& Sorensen, 2001). Variants of GFP protein with half-lives as short as 40 
minutes have been found to be useful for time-dependent induction 
studies. On the other hand, variants with half-lives greater than 24 hours 
have been used in biosensor studies, where time-dependent accumulation 
in cells or expression from weak promoters or expression under 
unfavourable metabolic conditions is being studied (Hansen & Sorensen, 
2001). Development of mutant GFP proteins, termed enhanced GFPs 
(eGFPs) offered enhanced stability, different spectral properties and better 
signal intensities (Yagi, 2007). Enhanced GFPs have a wide range of 
applications, from measurement of gene expression, identification of 
transplanted cells to analysis of differentiation processes in eukaryotes. 
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Several variants that emit light of different wavelengths upon excitation 
have been engineered; BFP (Blue Fluorescent Protein) (Heim & Tsien, 
1996), CFP (Cyan Fluorescent Protein) (Heim & Tsien, 1996) and YFP 
(Yellow Fluorescent Protein) (Wachter, Elsliger, Kallio, Hanson & 
Remington, 1998), depending on the colour of light they emit. The 
advantage of having such variants is that they can be used in combination 
to detect several analytes. However, the use of GFPs and their variants as 
biosensors is still limited, owing to the fact that there is a time delay 
between protein synthesis and maturation to produce an active 
fluorophore (Yagi, 2007). However, the sensitivity of fluorescence is 
remarkably good and a single bacterial cell expressing the GFP protein 
can be detected (Hansen & Sorensen, 2001). The use of GFP has its 
limitations, such as the requirement for expensive fluorometers and flow 
cytometers for fluorescence analysis.  Since, the lower limit of detection 
for GFP is greater than that of other reporter genes, GFP is less sensitive 
then other reporter genes (Hansen & Sorensen, 2001).  
 
1.2.5.3 Uroporphyrinogen III methyltransferase and DsRed 
The cobA gene from Propionibacterium freudenreichii (Wildt & Deuschle, 
1999) and the dsRed gene from coral Discosoma spp. (Matz, Fardkov, 
Labas, Savitsky & Zaraisky, 1999) are other reporter genes of interest. 
The enzyme encoded by cobA gene is uroporphyrinogen III 
methyltransferase, which causes accumulation of tri-methylated 
compounds. Excitation of these trimethylated compounds with blue or 
ultra-violet light causes these compounds to fluoresce and emit a strong 
red light (Wildt & Deuschle, 1999). The protein encoded by dsRed gene is 
called DsRed protein, which emits red light upon excitation (Matz et al., 
1999). The half-life for DsRed can range from several hours to several 
days and therefore it is not used widely as a biosensor reporter. Both 
cobA and dsRed genes can be used together with GFP protein, since they 
are easily distinguishable (Eckert et al., 2005; Hansen & Sorensen, 2001). 
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1.2.5.4 Luciferases 
The bioluminescent reaction is catalyzed by enzymes known as 
luciferases and the substrates for these enzymes are termed as luciferins. 
Luciferases also require molecular oxygen for their catalysis (Meighen, 
1991). The firefly luciferase is a 62-kDa monomer that is expressed by a 
gene luc. The oxidation of benzothiazoylthiazole luciferin by the luciferase 
in the presence of ATP produces oxyluciferin and light (luminescence) 
(Wiles et al., 2005; Yagi, 2007). The luciferase from the jelly fish Aequorea 
victoria, called Aequorin, oxidizes the luciferin coelenterazine in the 
presence of calcium ions and molecular oxygen to produce 
coelenteramide, carbon dioxide and blue light. The blue light lasts only for 
3 seconds (Lewis, Feltus, Ensor, Ramanathan & Daunert, 1998). Aequorin 
has been used widely as a bioreporter in biosensing studies and 
immunoassays (Lewis et al., 1998). The bacterial luciferases (Lux) from 
various bioluminescent bacteria oxidise reduced flavin mononucleotides 
and fatty aldehydes in the presence of oxygen to produce oxidised flavin 
nucleotide, fatty acids and blue-green light (Yagi, 2007). The bacterial 
luciferase from Photorhabdus luminescens will be utilised in this study. 
 
1.2.5.4.1 lux CDABE cassette 
Bacterial luciferases are encoded by several genes located in the lux 
operon. The lux operon consists of five structural genes luxC, D, A, B and 
E and two regulatory genes luxR and luxI. The sequence of each 
structural gene in the operon is as luxCDABE, which is common for all lux-
operons. An additional luxF gene located between luxB and luxE genes is 
present in most of the Photobacterium species and absent in Vibrio and 
Xenorhabdus lux systems (Meighen, 1991).  
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The luxA and luxB genes encode the  and  catalytic subunits (Figure 
1.2) of the flavin monooxygenase luciferase, respectively (Fisher, 
Raushel, Baldwin & Rayment, 1995; Geiselhart, Osgood & Holmes, 1991; 
Yagi, 2007). This heterodimer is ~80kDa (Wiles et al., 2005). The 
luciferase catalyzes a chemical reaction that produces light (Geiselhart et 
al., 1991; Sung & Lee, 2004). It is comprised of  and  subunits of ~40 
kDa and ~35 kDa, respectively. Bacterial luciferases lack metals, 
prosthetic groups and non-amino acid residues. The  subunit has a 
substrate binding site and is responsible for light emission and rate of 
catalysis, while the  subunit is responsible for the interaction between 
these processes (Nunes-Halldorson & Duran, 2003).  
___________________________________________________________ 
Figure 1.2: Three-dimensional structure of the luciferase heterodimer. The  
and  subunits are shown in red and green respectively (European Bioinformatics 
Institute, 2008). 
 
The luxC, D and E genes encode for the reductase, transferase and 
synthetase subunits of the multienzyme fatty acid reductase complex, 
respectively (Geiselhart et al., 1991; Yagi, 2007). The reductase 
component, also known as the acyl coenzyme A reductase, has a 
molecular mass of 54 kDa. The molecular masses of synthetase and 
transferase are 42 kDa and 33 kDa, respectively. The synthetase subunit 
is only weakly bound to the transferase subunit. Four reductase subunits 
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are found in the centre of the multienzyme complex and each reductase 
subunit is bound to the synthetase subunit. The total molecular mass of 
the multienzyme complex is therefore ~500 kDa (Wall & Meighen, 1986).  
Most of the Photobacteria species have a flavoprotein in the lux system. 
The subunits of the flavoproteins have a molecular mass of approximately 
24 kDa and are encoded by the luxF gene (O'Kane, Vervoort, Muller & 
Lee, 1987). The flavin prosthetic group of the flavoprotein consists of a 
flavin mononucleotide covalently linked to tetradecanoic acid. The function 
of this protein is unknown; however, it is not required for light production 
(Soly, Mancini, Ferri, Boylan & Meighen, 1988). 
Two more genes, luxG and luxH, encoding for 25 kDa proteins, have also 
been discovered (Swartzman, Kapoor, Graham & Meighen, 1990). Lux G 
is known to encode for flavin reductase (Sung & Lee, 2004). Lux H is 
homologous to RibB, which encodes for DHBP synthase (O'Grady & 
Wimpee, 2008). This enzyme catalyses the reaction where ribulose 5’-
phosphate is converted to DHBP (3,4-dihydroxy-2-butanone-4-phosphate) 
(Sung & Lee, 2004). This product undergoes further enzymatic reactions 
to generate riboflavin, which is used to generate FMN. 
 
1.2.5.4.2 Mechanism of action of the lux cassette 
 
The bacterial luciferase oxidizes a long chain aldehyde in the presence of 
reduced flavin mononucleotide to produce long chain fatty acid and blue-
green light at 490nm (Nunes-Halldorson & Duran, 2003; Wiles et al., 
2005). The firefly luciferase requires ATP, whereas the bacterial luciferase 
is highly specific for reduced flavin mononucleotide as the energy source. 
The overall bioluminescence reaction is: 
 
 
O2 + FMNH2 + R-CHO                 H2O + FMN + R-COOH + light (~495nm) 
        (Sung & Lee, 2004) 
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Binding of FMNH2 to the luciferase enzyme E leads to the formation of an 
intermediate (EFH2), constituting the first step of the luminescence 
reaction cascade (Nunes-Halldorson & Duran, 2003). Then EFH2 reacts 
with molecular oxygen, leading to the formation of luciferase-bound flavin 
hydroperoxide intermediate (EFHOOH). Next, EFHOOH binds and reacts 
with the long chain aldehyde to form a flavin-oxygen-aldehyde-
intermediate (E-FOOA). This particular step is the rate limiting step of the 
reaction in which an electron from the dihydroflavin molecule is transferred 
to the peroxide bond of E-FOOA, thereby exciting it and resulting in the 
breakage of the O-O bond (Nunes-Halldorson & Duran, 2003). The 
intermediate E-FOOA is very stable; its slow decay results in the release 
of energy in the form of light at 490nm (Meighen, 1991). Following 
excitation, the aldehyde is oxidized to form a long chain fatty acid, while 
oxidized flavin mononucleotide is released. The enzyme is then able to 
catalyze another reaction (Nunes-Halldorson & Duran, 2003). The enzyme 
flavin reductase, encoded by lux F, reduces the oxidized flavin 
mononucleotide (FMN) to form FMNH2 (Sung & Lee, 2004). This reaction 
mechanism is depicted in Figure 1.3. The rate of turnover of luciferase in 
the bioluminescence reaction is less than the rate of chemical oxidation of 
FMNH2; hence luciferases undergo only a single catalytic cycle (Hastings, 
Potrikus, Gupta, Kurfurst & Makemson, 1985). The fatty acid and reduced 
flavin mononucleotide are then available for another catalytic cycle. 
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_______________________________________________________________________ 
Figure 1.3: Reaction mechanism for bacterial lux enzymes (Adapted from Meighen, 
1991). Catalysis of oxidation of aldehyde molecules into fatty acid molecules using 
energy and oxygen produces blue-green light measured at 490nm. 
 
The multienzyme fatty acid reductase catalyzes the synthesis of aldehyde 
for bioluminescence reactions. The first step in the synthesis pathway is 
the transfer of fatty acyl groups to water or other oxygen and thiol 
acceptors. This step is catalysed by the transferase, which is also acylated 
during the reaction (Wall, Rodriguez & Meighen, 1986). 
 
H2O + RCOX                        RCOOH + XH 
 
Following the transfer of the fatty acyl groups to water, the fatty acid is 
activated with the aid of ATP by the synthetase component to form a fatty-
acyl-intermediate. Once activated, the intermediate is reduced to 
aldehydes with the aid of NADPH. This reaction is catalyzed by the fatty 
acid reductase component of the multienzyme complex (Wall et al., 1986). 
 
RCOOH + NADPH + ATP                       RCHO + NADP + PPi 
 
The light appears very dim in dilute cultures; however, the light intensity 
increases several thousand times during later stages of cellular growth. 
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The growth of bacterial cells therefore precedes the production and 
emission of light (Meighen, 1991). 
 
1.2.6 Bioluminescence 
Different types of signal output for bio-reporters exist; one of them is 
bioluminescence. The bioluminescence system is a highly sensitive and 
contained system for measuring cell viability and gene expression in real 
time (Wiles et al., 2005). Naturally occurring bioluminescent organisms are 
ubiquitous and well distributed throughout different species of fungi, 
fishes, insects and bacteria. Some species (for example, bacteria, algae, 
fireflies) have their own bioluminescent systems, whilst others (for 
example, fishes) have bioluminescent bacteria. The bioluminescence 
systems of luminous beetles (fireflies) and the luminous bacteria (Vibrio 
sp., Photobacterium sp. and Photorhabdus sp.) have been studied (Wiles 
et al., 2005). The luminous bacteria are the most widely distributed 
bioluminescent organisms and can be found in terrestrial environments 
and in water habitats. All the luminescent bacteria are classified into one 
of three genera, namely Vibrio, Photobacterium or Xenorhabdus; of them, 
Xenorhabdus infects only terrestrial organisms (Meighen, 1991; Robinson, 
Tonks, Thorn & Reynolds, 2011).  
Free-living bioluminescent bacteria are found at dilute concentrations, 
whereas the bioluminescent bacteria living in the light organs of fishes and 
squid are found at very high concentrations of ~109 to 1010 cells per mL. 
The autoinducer concentrations increase to high levels in these organs to 
trigger light production (Zarubin, Belkin, Ionescu & Genin, 2012). The 
blue-green light produced is used to disguise the host animal from 
predators by counter-illumination (Dunn & Stabb, 2007). Luminous 
bacteria are attracted and ingested by predators such as fishes. These 
luminous bacteria, once ingested, reside and grow in the nutrient-rich gut 
environment (Zarubin et al., 2012). Hence, bioluminescence is used as a 
signal for food availability. Symbiotic relationships between bioluminescent 
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bacteria and squid have been described; the bioluminescence is used at 
night to mimic daylight so that light-dependent enzymes remain active for 
longer (Heath-Heckman et al., 2013). 
The copepod Guissia princeps is a marine bioluminescent organism that 
produces a luminescent bolus in response to mechanical, electrical or light 
stimuli (Wiles et al., 2005). An example where a bioluminescent system 
acts as a line of defence is where the bolus blinds dark-adapted 
organisms while the copepod swims away from the predator.  
Bioluminescent reporters have the potential to provide continuous real-
time measurements of bacterial growth for application in the 
pharmaceutical, food and cosmetics industries. Therefore, failing 
formulations can be identified early, potentially saving much time and 
money. They can also be used as a rapid screening tools for the selection 
and development of formulations, antimicrobial products and preservatives 
(Naseby, 2007, 2008, 2009). Microorganisms are engineered to express 
the genes required for bioluminescence. The amount of bioluminescence 
is subsequently measured by a luminometer, which takes only minutes to 
measure the light intensity. A high bioluminescence reading indicates the 
presence of a large number of viable microbial cells and a low 
bioluminescence reading indicates the presence of a small number of 
viable microbial cells. In the presence of preservatives, the reduction in 
bioluminescence indicates a reduction in number of viable cells. Hence, 
such biosensors provide a remarkably useful tool for estimating microbial 
numbers at various stages of pharmaceutical manufacturing; in raw 
materials, semi-processed, processed and stored products. 
 
1.2.6.1 Regulation of bioluminescence 
The bioluminescence process, like any other process needs to be 
regulated. It is regulated by a phenomenon called autoinduction or 
quorum-sensing (QS) (Bassler & Losick, 2006). Initially observed in the 
bacteria Vibrio fischeri, autoinduction is a phenomenon in which bacterial 
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cells communicate with each other to assess the size of the bacterial cell 
population; this then results in the expression of certain proteins. Bacterial 
cells produce an extra-cellular signaling molecule known as an 
autoinducer (AI) (Nunes-Halldorson & Duran, 2003). N-acyl homoserine 
lactones (AHLs) are an example of autoinducers in gram negative bacteria 
(Miller & Bassler, 2001). 
The regulatory mechanism is depicted in Figure 1.4. LuxR and luxI, two 
genes that are part of the lux operon, encode for an AHL receptor and an 
autoinducer AHL synthase, respectively, and are involved in the regulation 
of bioluminescence (Dunn & Stabb, 2007; Meighen, 1991). The luxI gene 
is transcribed in the opposite direction to that of luxR gene on the left 
operon. The AHL molecules may diffuse through the outer membrane into 
the culture medium or may be pumped out of the cell, depending on the 
length of the acyl side-chains (Kumari, Pasini & Daunert, 2008). Once in 
the culture medium, the AHL molecules bind to the AHL receptors; for 
example an AHL N-(3-oxo)-hexanoyl-DL-homoserine lactone (3-oxo-C6-
HSL) in V. fischeri binds to its receptor LuxR, leading to the formation of a 
complex called AHL-LuxR (Kumari et al., 2008). This AHL-receptor 
complex subsequently binds to the promoter of the lux operon, PluxI 
(Kumari et al., 2008), and stimulates transcription of the right operon 
(luxCDABE) (Dunn & Stabb, 2007; Meighen, 1991). Activation of the AHL-
LuxR complex results in bioluminescence production. The gene luxI is 
also under the control of the same promoter and is therefore transcribed, 
leading to a positive-feedback loop mechanism (Kumari et al., 2008). 
Binding affinity of the receptor for AHL defines the concentration of 
autoinducer required to stimulate luminescence (Dunn & Stabb, 2007). 
Once a certain threshold level of AHL is reached, luminescence is 
produced by the cells (Nunes-Halldorson & Duran, 2003). The 
concentration of autoinducers is directly proportional to the bacterial load 
present in the environment (Bassler & Losick, 2006); hence, bacterial 
density can be determined by measuring luminescence intensity.  
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Figure 1.4: Autoinduction/Quorum sensing mechanism in V. fischeri (Dunn & 
Stabb, 2007). AHL synthase is constitutively expressed when cell density is low as 
depicted in (a). Synthesis of AHL by AHL synthase leads to the accumulation of AHL in 
the media. When bacterial cell concentration has reached a threshold (b), AHL binds to 
its receptor LuxR and the complex initiates transcription of the luxICDABEG cassette 
(right operon) resulting in bioluminescence. Transcription of luxI also leads to more 
production of AHL synthase.  
 
Bioluminescence by marine bacteria (Nealson, Platt & Hastings, 1970), 
biofilm formation in the lungs of cystic fibrosis patients by Pseudomonas 
aeruginosa (Middleton et al., 2002) and formation of virulence factors by 
Staphylococcus aureus (Miller & Bassler, 2001) are some of the 
characteristic responses produced as a result of QS. Various 
gastrointestinal (GI) tract illnesses due to pathogenesis are thought to be 
a result of QS (Kendall & Sperandio, 2007). In the case of 
bioluminescence, a minimum concentration of 107 cells/mL is required for 
the cells to produce luciferases and catalyze the bioluminescent reaction. 
Bacterial cells therefore assess their cell population in the environment 
and are able to cause an impact in the environment. Quorum-sensing is 
also used by bacterial cells to assess the population of other species in 
the environment (Nunes-Halldorson & Duran, 2003). Even though QS is 
beneficial with respect to bioluminescence, it is harmful with respect to 
pathogenesis and therefore there is a need to detect these autoinducers 
at an early stage. Whole cell biosensors in Escherichia coli and 
Pseudomonas aeruginosa have been developed for the detection of AHLs 
(Kumari et al., 2008).  
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1.3. Pseudomonas aeruginosa 
 
P. aeruginosa is a ubiquitous, opportunistic and extremely pathogenic 
gram negative bacterium found in the environment and it infects 
eukaryotic organisms such as mice, nematodes, insects, humans and also 
plants (Jander, Rahme & Ausubel, 2000). P. aeruginosa is known to infect 
patients who have undergone major surgery (Giamarellou, 2000), patients 
who suffer from cystic fibrosis, cancer, AIDS and patients who have 
severe burns (Lambert, 2002) or neutropenia (Bodey, Bolivar, Fainstein & 
Jadeja, 1983). P. aeruginosa isolates are known to produce biofilms 
around their cell membranes that provide a further protective barrier 
against any invasions. The bacterium produces a large number of 
virulence factors that provide nourishment for the bacterial cell and aid in 
the invasion of the host cell, causing damage to the host. These virulence 
factors interfere with eukaryotic signal transduction and metabolic 
pathways, resulting in the disruption of the cell, and hence they are toxic 
to eukaryotic cells (Nicas & Iglewski, 1985; Whitchurch et al., 2005). In 
cystic fibrosis, P. aeruginosa strains produce an alginate polysaccharide 
that surrounds the cells and aggregates them together (Lambert, 2002). 
P. aeruginosa is still one of the main pathogens that is able to persist in 
harsh environmental conditions and in the presence of various 
antimicrobial agents (Abreu, Tavares, Borges, Mergulhao & Simoes, 
2013). Attachement of P. aeruginosa to surfaces and production of 
biofilms thereafter has made this microorganism a critical problem in 
healthcare environments. Alcohols were employed traditionally as possible 
disinfectants. However, quaternary ammonium compounds have also 
been used recently to combat this pathogen (Abreu et al., 2013). 
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1.3.1 Pseudomonas aeruginosa susceptibility to 
aminoglycosides 
Restricted uptake of drugs, drug inactivation and target alteration are the 
three basic mechanisms that enable bacterial cells to resist the action of 
antimicrobial targets (Lambert, 2002). Antibiotics used to treat infection 
caused by P. aeruginosa have to traverse the cell wall to reach their 
targets; however certain drugs have been shown to be effective. Protein 
synthesis in P. aeruginosa is inhibited by aminoglycosides, such as 
gentamicin, tobramycin and amikacin, that bind to the 30S subunit of 
ribosomes and cause misreading or suppression of protein synthesis 
(Brzezins, Benvenis, Weinstei, Daniels & Davies, 1972). The chromosome 
structure in cells is maintained by an enzyme called DNA gyrase, which is 
inhibited by quinolones such as ciprofloxacin. Transpeptidases that 
assemble peptidoglycan on the outer surface of the cytoplasmic 
membrane are inhibited by -lactams, such as piperacillin, ceftazidime, 
imipenem. The membrane phospholipids that serve as a barrier to 
exogenous compounds are targeted by a class of antibiotics called 
polymixins, such as colomycin and colistin (Lambert, 2002).  
A combined effect of restricted permeability of the outer membrane and 
efficient efflux of antibiotic molecules that manage to penetrate it are the 
two major factors that make P. aeruginosa resistant to a wide range of 
drug classes (Lambert, 2002). Hence drugs such as aminoglycosides and 
polymixins are used to overcome the restricted permeability barrier. When 
P. aeruginosa cells are exposed to aminoglycosides, a series of events 
occur that lead to the disruption of their cytoplasmic membranes. The 
potency of aminoglycosides towards micro-organisms depends on the 
number of amino-sugars linked to a cyclitol moiety (Mingeot-Leclercq, 
Glupczynski & Tulkens, 1999). Gentamicin binds to the 
lipopolysaccharides of the outer membrane, thereby making the cells 
more permeable (Lambert, 2002; Martin & Beveridge, 1986). After 
aminoglycoside binding, the outer membrane becomes more permeable 
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and therefore this facilitates further uptake of aminoglycoside molecules. 
This mechanism of uptake is called self-promoted uptake (Hancock, Raffle 
& Nicas, 1981).  
After crossing the outer membrane, aminoglycosides traverse from the 
periplasmic space through the inner membrane in an energy-dependent 
manner termed energy-dependent phase I (EDP-I) (Bryan & Vandenelzen, 
1975). This step of transporting aminoglycosides through the inner 
membrane is a rate limiting step and is inhibited by divalent cations, high 
acidity or low O2 concentration (Xiong, Caillon, Drugeon, Potel & Baron, 
1996). Observation under an electron microscope suggests that initial 
formation of small vesicles containing materials of the outer membrane, 
followed by the appearance of holes first in the outer membrane, 
peptidoglycan layer and then in the inner membrane, results in the release 
of membranous materials (Lambert, 2002). Aminoglycosides bind to the 
30S ribosomal subunit in another energy-dependent manner termed EDP-
II, once in the cytoplasm (Bryan & Kwan, 1983). This leads to disturbance 
in the elongation of polypeptide chains, leading to premature termination 
(Melancon, Tapprich & Brakiergingras, 1992). These abnormal proteins 
are inserted into the cell membrane, resulting in hyper-permeability and 
increased uptake of aminoglycoside molecules (Busse, Wostmann & 
Bakker, 1992). Even though gentamicin inhibits protein synthesis by 
binding to the 30S ribosomal subunit, it is also responsible for causing cell 
death by disrupting the cell membranes (Martin & Beveridge, 1986; 
Mingeot-Leclercq et al., 1999).  
The susceptibility of P. aeruginosa cells to antibiotics is greatly diminished 
by calcium and magnesium ions at small concentrations (Martin & 
Beveridge, 1986; Zimelis & Jackson, 1973). This is because 
aminoglycosides compete for cationic binding sites of lipopolysaccharides 
on the cell surface (Abdelsayed, Gonzalez & Eagon, 1982). 
Aminoglycosides disrupt the membrane upon binding whereas small 
divalent cations stabilise the membrane (Mao, Warren, Lee, Mistry & 
Lomovskaya, 2001). EDTA and polymyxin are also known to cause 
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excessive membrane leakage by removing calcium and magnesium ions 
as well as lipopolysaccharides and proteins (Martin & Beveridge, 1986; 
Zimelis & Jackson, 1973).  Polymixin B destabilises the outer membrane 
of P. aeruginosa cells in a similar fashion to gentamicin, by binding to 
cation binding sites of LPS molecules (Delcour, 2009). This destabilisation 
results in a self-promoted uptake of polymixin B into the periplasmic 
space. Further transport into the cytoplasm occurs through diffusion of 
polymixin B through the inner membrane (Delcour, 2009). This diffusion is 
mediated by the hydrophobic fatty acid tail of polymixin B.  
 
1.3.2 Antibiotic resistance in Pseudomonas aeruginosa 
It is difficult to control P. aeruginosa with antibiotics because of its ability to 
adapt easily in response to environmental changes, to grow on a wide 
range of substrates and its ability to acquire resistance against a wide 
range of antimicrobial agents. This is possible because P. aeruginosa has 
a large genome of 6.36Mbp that comprises 5567 genes (Lambert, 2002). 
Some of these genes encode for several multi-drug efflux pumps and 
cephalosporinases (Moir, Di, Opperman, Schweizer & Bowlin, 2007). Its 
ability to acquire other genes for resistance from other organisms via 
plasmids, transposons or bacteriophages also adds to the antibiotic 
resistance of P. aeruginosa (Brzezins et al., 1972). 
A number of resistance mechanisms have been identified in P. aeruginosa 
populations with multidrug resistance. The most common mechanism is 
the presence of efflux pumps that pump out antimicrobial drugs from the 
cell. This prevents the antimicrobial drugs from accumulating and acting 
on target areas within the cell (Tenover, 2006). Several mechanisms of 
resistance can co-operate together to produce multiple aminoglycoside 
resistance in P. aeruginosa (MacLeod et al., 2000; Miller et al., 1997;  
Miller, Sabatelli, Naples, Hare & Shaw, 1995). 
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1.3.2.1 Aminoglycoside resistance by enzymatic inactivation 
Drug resistance may also result from drug inactivation by enzymes. These 
enzymes can be either chromosome-encoded or plasmid-encoded (Poole, 
2005; Poole, 2011).  
Various enzymes are involved in the modification/inactivation of 
aminoglycosides in P. aeruginosa; for example, aminoglycoside 
phosphoryltransferase (APH), aminoglycoside acetyltransferase (AAC) 
and aminoglycoside nucleotidyltransferase (ANT) (Azucena & Mobashery, 
2001; Smith & Baker, 2002; Wright, 1999). These enzymes are involved, 
respectively, in the phosphorylation, acetylation and adenylation of 
aminoglycosides. Moreover, resistant P. aeruginosa strains have several 
genes for encoding these enzymes, thereby conferring broad-spectrum 
resistance (Miller et al., 1995). The aminoglycoside gentamicin undergoes 
N-acetylation by the AAC group of enzymes. 
 
1.3.2.2 Impermeability resistance 
Compared to other Enterobacteriaceae, there is limited permeability 
through the outer membrane of P. aeruginosa (Price & Godfrey, 1974); 
this gives it resistance to a variety of drugs (Delcour, 2009; Moir et al., 
2007; Poole, 2005). This mechanism of resistance includes resistance 
acquired as a result of reduced uptake and therefore reduced 
accumulation of aminoglycosides in the cell of P. aeruginosa (Bryan, 
Haraphongse & Vandenelzen, 1976).  
P. aeruginosa also lacks general diffusion porins, making the outer 
membrane less permeable. However, nutrients are transported through 
the outer membrane via specific porins (Nikaido, 2003). Many organisms 
including E. coli, P. aeruginosa, Neisseria gonorrhoeae, Enterobacter 
aerogenes and Klebsiella pneumonia (Achouak, Heulin & Pages, 2001; 
Hancock & Bell, 1988; Nikaido, 2003; Poole, 2004), have been shown to 
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acquire antimicrobial drug resistance via loss or mutations of porins 
(Goossens, 2003). 
 
1.3.2.3 Acquired resistance 
Although the outer membrane of P. aeruginosa provides a barrier against 
various compounds, high level multiple drug resistance is observed due to 
the presence of additional resistance mechanisms involving drug efflux 
systems (Ma, Cook, Hearst & Nikaido, 1994; Poole, Krebes, McNally & 
Neshat, 1993). The multidrug efflux pump also functions in synergy with 
the outer membrane impermeability mechanism (Germ, Yoshihara, 
Yoneyama & Nakae, 1999; Li, Zhang & Poole, 2000). Acquired multidrug 
resistance is usually caused by mutations leading to hyper-expression of 
efflux pump proteins (Kohler et al., 1996; Rella & Haas, 1982). These 
pumps normally transport dyes, detergents, inhibitors, disinfectants, 
organic solvents and homoserine lactones as well as antimicrobial agents 
(Poole, 2001).  
The P. aeruginosa acquired resistance mechanism is characterised by a 
family of efflux pumps belonging to the resistance-nodulation-division 
(RND) family (Nikaido, 1998; Poole, 2004; Saier, Tam, Reizer & Reizer, 
1994). The RND family is one of five families of efflux pumps involved in 
multiple drug resistance. The efflux pump proteins are highly homologous 
to those found in Stenotrophomonas maltophilia, Burkholderia cepacia, 
Burkholderia pseudomallei and the non-pathogen Pseudomonas putida 
(Poole, 2000).  
An example of such an efflux pump in P. aeruginosa is the MexAB-OprM 
pump (Gotoh, Tsujimoto, Poole, Yamagishi & Nishino, 1995; Poole et al., 
1993). This pump is expressed constitutively in wild type cells, providing 
intrinsic resistance. The oprM gene has been found to be conserved in all 
P. aeruginosa strains (Bianco, Neshat & Poole, 1997) and therefore may 
provide intrinsic resistance to all P. aeruginosa strains. This particular 
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pump may also be hyper-expressed in mutated strains (Kohler et al., 
1996; Rella & Haas, 1982) and clinical isolates (Piddock, Hall, Bellido, 
Bains, & Hancock, 1992; Ziha-Zarifi, Llanes, Kohler, Pechere & Plesiat, 
1999). The other efflux pumps are not detectable in wild type cells but are 
hyper-expressed in mutant in-vitro isolates and clinical isolates. 
 
1.3.2.4 Adaptive resistance 
Adaptive resistance (Houang & Greenwood, 1977) refers to the ability of 
P. aeruginosa to adapt itself and grow in the presence of aminoglycosides. 
This type of resistance is characterised by the presence of an inducible 
aminoglycoside drug efflux pump, which is induced in the presence of 
aminoglycosides, resulting in active efflux of the drug (Hocquet et al., 
2003).  
An example of adaptive resistance is illustrated by an outer membrane 
efflux protein OprF, which exists in abundance; albeit predominantly in a 
closed conformation and rarely in an open conformation (Bratu, Landman, 
Gupta & Quale, 2007). Hence, antimicrobial agents are unable to 
penetrate through the outer membrane, which acts as a barrier. 
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1.4. Gene expression 
Gene expression comprises transcription and then translation (Pace, 
1973).  The formation of messenger RNA (mRNA) from template DNA by 
RNA polymerases is called transcription and it is regulated by various 
factors (Pace, 1973). All prokaryotic genes and operons are preceded by 
promoter regions. These regions are specific DNA sequences that are 
recognised by RNA polymerases for transcription initiation. The initiation 
of transcription entails various steps: firstly, location of promoter by RNA 
polymerase and reversible binding of RNA polymerase followed by RNA 
polymerase and DNA conformational changes; then nucleoside 
triphosphate (NTP) binding to the functional RNA polymerase-promoter 
complex (initiation complex) and initial phosphodiester bond synthesis; 
finally the movement of RNA polymerase from the promoter for elongation 
of mRNA to occur (DeHaseth, Zupancic & Record, 1998). 
 
1.4.1 Promoter regions 
The DNA region which regulates the correct initiation of transcription is 
called the core promoter (Juven-Gershon, Hsu, & Kadonaga, 2006; Juven-
Gershon & Kadonaga, 2010). In E. coli, four promoter elements on the 
template DNA have been identified. They include two hexamer promoter 
regions located at positions -10 and -35 upstream to the transcription 
initiation site, the DNA spacer separating the -10 and -35 promoter regions 
and the UP element located between positions -40 and -60 upstream to 
the transcription initiation site (Figure 5) (DeHaseth et al., 1998). The -10 
region is known as the melting module because this is where the DNA 
double helix is melted (Mishra & Chatterji, 1993). The -35 region is called 
the recognition module (Mishra & Chatterji, 1993) and there is a 17 + 2 bp 
region in between the -10 and -35 regions called the spacer region 
(Mishra & Chatterji, 1993). This spacer region is vital in transcription 
because it separates the melting and recognition modules enough for 
RNA polymerase to interact with the promoters effectively (Figure 1.5). 
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_______________________________________________________________________ 
Figure 1.5: Model structure of RNA polymerase II interaction with promoter regions 
(DeHaseth et al., 1998). The consensus sequences for -10 and -35 regions are indicated. 
The UP element is A+T rich and upstream of -35 region. The TGN sequence forms part 
of the extended -10 region and is functional even in the absence of the -35 region. The 
‘jaws’ is the catalytic site for RNA polymerase; makes contact with the DNA start site and 
initiates transcription.  
 
Another conserved feature of promoters, apart from their sequence, is the 
flexibility of the DNA in that region (Vologodskii & Frank-Kamenetskii, 
2013; Werel, Schickor, & Heumann, 1991). DNA bending occurs due to 
thermal fluctuations or protein binding (Huo et al., 2006). A poly-A tract 
found upstream of the recognition module creates a ‘bend’ in the local 
topology of DNA, thereby facilitating promoter recognition and binding 
(Travers, 1987). RNA polymerase recognises promoters by promoter 
sequence recognition and conformational changes in the promoter region 
by transcription factors (Tang, Deshpande & Patel, 2011). The promoter 
bending allows RNA polymerase to bind at promoter regions, while 
preventing it from binding non-promoter regions. They also allow RNA 
polymerase to scan for specific sites within the promoter regions to 
facilitate binding at the required promoter sequences (Tang et al., 2011). 
Promoter activity with respect to DNA topology has been studied 
previously (Huo et al., 2006; Mishra, Gopal, & Chatterji, 1990; Palecek, 
1991) and can be classified into three types, depending on whether 
promoter activity increases, decreases or has no effect with respect to 
negative supercoiling of DNA. Up-regulation or down-regulation of gene 
expression has been shown to correlate with positioning of DNA bending 
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proteins (Huo et al., 2006). Hence, that variation in promoter activity is due 
not only to changes in promoter sequences but also to conformational 
changes in DNA topology and variations in supercoiling. 
Promoter strength is defined as “the rate at which transcriptional 
elongation complexes leave a promoter thereby clearing the site for a 
subsequent encounter with RNAP” (Brunner & Bujard, 1987). It has been 
shown that RNA chain elongation occurs at a rate of 50 
nucleotides/second (Brunner & Bujard, 1987) and therefore promoter 
clearance should take 1 second for effective promoter activity. Promoter 
strength increases as promoter sequences match the consensus 
sequences and therefore any alterations in promoter sequences lead to 
variations in promoter strength (Mishra & Chatterji, 1993). 
 
1.4.2 RNA polymerase 
 
RNA polymerase consists of four subunits , ’ and  that form a 
heteroenzyme. The heteroenzyme forms an active holoenzyme upon 
binding of a  factor (Figure 1.6) (DeHaseth et al., 1998). RNA 
polymerase holoenzyme bound to DNA occupies a region between -50 to 
+20 (Mishra & Chatterji, 1993). This region consists of the promoter 
regions that provide information about transcription efficiency.  
_______________________________________________________________________ 
Figure 1.6. Subunits of RNA polymerase (Mishra & Chatterji, 1993). 2 ’ forms the 
RNA polymerase holoenzyme. Reversible binding of  subunit forms the heteroenzyme. 
 
Page 36 
 
The subunit recognizes the promoter even though it is weakly bound to 
the rest of the enzyme (the core polymerase, E). This subunit is eventually 
released after an initiation complex is formed. Then a phosphodiester 
bond is formed by the core polymerase, depending on the sequence on 
the template strand (DeHaseth et al., 1998). This process of NTP addition 
and phosphodiester bond formation to the elongating mRNA continues 
until the termination signal is reached. The ternary complex of core RNA 
polymerase, RNA and DNA dissociates and is released after chain 
termination. The core polymerase then binds to another  subunit for the 
next transcription cycle (Travers & Burgess, 1969). 
 
1.4.3 Sigma factors 
The function of  factors is to recognise promoter sequences. Various  
factors recognise specific promoter sequences and have different 
regulation properties (Barrios, Valderrama & Morett, 1999). E. coli has 
seven  factors, whereas P. aeruginosa has 24  factors, of which 19 
have extracytoplasmic functions (ECF’s). The P. aeruginosa  factors 
include RpoD ( 70), RpoH ( 32), RpoF (FliA or 28), RpoS ( S or 38), 
RpoN (NtrA, 54 or N); ECF AlgU (RpoE or 22), PvdS and SigX; and a 
collection of uncharacterized  ECF. E. coli has 70, 28, 32, 38, 54, E 
and FecI; of which 70 controls constitutive transcription during the 
exponential growth phase whilst the other factors regulate transcription 
during physiological and environmental changes (Blattner et al., 1997).  
P. aeruginosa 70 controls transcription of all housekeeping genes during 
the exponential phase of growth (Fujita, Tanaka, Takahashi & Amemura, 
1994) and is highly homologous to E. coli 70 (Tanaka & Takahashi, 1991). 
The -10/-35 promoter sequences are recognised by 70 factors (Gruber & 
Gross, 2003; Thony & Hennecke, 1989).  
The consensus sequences of the -10 and -35 promoter regions are 
TATAAT and TTGACC, respectively, in E. coli. The -10 region in P. 
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aeruginosa is also rich in A and T residues; however, the -35 regions may 
not conserved (Ramos & Marques, 1993). The P. aeruginosa -10 
consensus sequence (TAtAAT) shows high similarity to the E. coli -10 
consensus sequence (TATAAT). Similarly, the P. aeruginosa -35 
consensus sequence (TTGACC) shows high similarity to the E. coli -35 
consensus sequence (TTGaCc) (Potvin, Sanschagrin & Levesque, 2007). 
The greater the similarity of the -10 and -35 regions to their consensus 
sequence, the better the promoter function (DeHaseth et al., 1998). 
Spacer regions of 17bp ± 1 nt are required for functional 70 dependent 
promoters; however, spacing regions between 15 and 20 nt have also 
resulted in effective transcription initiation (Ayers, Auble & Dehaseth, 
1989; Hawley & McClure, 1983). 70-dependent promoters initiate 
transcription at a purine (Hawley & McClure, 1983). Although both -10 and 
-35 regions are vital for promoter activity, matching the -10 region to the 
consensus sequence is more important than matching the -35 region 
(Hawley & McClure, 1983; Lane & Darst, 2006; Rhodius & Mutalik, 2010). 
Transcription may be further enhanced by transcription activator proteins 
binding to the  or 70 subunits of RNA polymerase (Martin & Rosner, 
2001; Vakulskas, Brutinel & Yahr, 2010). Promoters can be divided into 
two groups, depending on the location of the DNA sequence relative to the 
-35 region that is bound by the activator proteins in P. aeruginosa (Ebright, 
1993). Hence, class one promoters have activator binding DNA regions 
20bp upstream of the -35 region. Class two promoters have activator 
binding DNA sequences within or in close proximity to the -35 region.  
P. aeruginosa 54 is involved in flagellin biosynthesis (Dasgupta et al., 
2003), pilin biosynthesis (Mattick, Whitchurch & Alm, 1996) and alginate 
production (Ma et al., 1998). P. aeruginosa 54 has also been implicated in 
P. aeruginosa virulence (Hendrickson, Plotnikova, Mahajan-Miklos, 
Rahme & Ausubel, 2001). Promoters recognised by the E 54 family are 
found in the -24 and -12 regions and contain conserved GG and GC 
dinucleotide motifs (Thony & Hennecke, 1989). The GG and GC motifs 
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found in the -24/-12 region specifically interact with the E 54 family 
(Cannon, Austin, Moore & Buck, 1995). A study showed that there are 
eight conserved nucleotides in the -24 region with the sequence 
mrNrYTGGCACG from -31 to -20 (Barrios et al., 1999) and similarly, there 
are 5 conserved nucleotides in the -12 region with the sequence 
TTGCWNNw from position -15 to -8. R represents a purine, Y represents 
a pyrimidine, W represents either A or T, m represents either A or C and N 
represents any nucleotide. They also show that a pyrimidine is always 
found at position -14, with T being the most common (Barrios et al., 1999). 
Similarly, a purine is most common at -20 whereas a pyrimidine is most 
common at -21. G is at least 96% conserved at positions -13, -24 and -25 
whereas C is at least 96% conserved at position -12. Like 70- dependent 
promoters, 54-dependent promoters also initiate transcription at a purine 
(Hawley & McClure, 1983); however 54-dependent promoters become 
non-functional when deletion mutations occur in the -24/-12 regions 
(Keseler & Kaiser, 1995). 
Other sigma factors include S, 38, 22 or SigX. RpoS or 38 is involved in 
secretion of virulence factors like alginate (Hogardt, Roeder, Schreff, Eberl 
& Heesemann, 2004; Sonnleitner et al., 2003), regulation of quorum 
sensing (Latifi, Foglino, Tanaka, Williams & Lazdunski, 1996) and 
formation of biofilms (Davies et al., 1998) during the stationary phase of 
the growth cycle. P. aeruginosa S is classified as a sub-group of 70 and 
is involved in regulating transcription in response to environmental 
changes. These are involved in alginate biosynthesis and metal ion efflux 
(Raivio & Silhavy, 2001). It recognises the -35 promoter region with an 
AAC motif. P. aeruginosa 22 is vital in converting non-mucoid cells to 
mucoid cells by interacting with promoter sequences responsible for 
transcribing alginates (Martin et al., 1993; Schurr, Yu, MartinezSalazar, 
Boucher & Deretic, 1996). P. aeruginosa SigX is also a sub group of 70 
and recognises the promoter sequence for transcription of OprF gene 
(Brinkman, Schoofs, Hancock & De Mot, 1999). The OprF protein is a 
membrane protein that forms part of the drug-efflux system. 
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1.4.4 Upstream elements 
Regions downstream of -10 and upstream of -35 have been shown to be 
bound by RNA polymerase (Ozoline & Tsyganov, 1995). UP elements are 
not highly conserved; however, they consist of alternating A-tracts and T-
tracts (Estrem, Gaal, Ross & Gourse, 1998) and are recognised by RNA 
polymerase bound with alternative -factors (Ross, Aiyar, Salomon & 
Gourse, 1998). UP elements are specifically bound to the  subunits of 
RNA polymerase (Landini & Volkert, 1995; Rhodius & Mutalik, 2010). UP 
elements are found between -40 and -60 in E. coli (Ramos & Marques, 
1993). However, nucleotide sequences shorter than 20bp have also 
shown to function as UP elements. In some promoter regions, nucleotide 
sequences upstream of the -60 region have also contributed transcription 
initiation (Estrem et al., 1998). In P. aeruginosa, these regions lie between 
positions -40 and -80 (Ramos & Marques, 1993). 
UP elements have been found to contain an 11bp distal region and a 4bp 
proximal region. The consensus sequence for the distal region is 
AAA(a/t)(a/t)T(a/t)TTTT, which appears between positions -57 to -47, 
whereas the consensus sequence for the proximal region is AAAA, which 
appears between positions -44 to -41 (Estrem et al., 1998). Although each 
region can function on its own, the regions from -51 to -53 and from -41 to 
-43 are vital (Estrem et al., 1998). Furthermore, the proximal region exerts 
a stronger effect on promoter strength than the distal region (Estrem et al., 
1998). Strong promoters containing a proximal sequence further consist of 
A residues at positions -45 and -46 (Estrem et al., 1998). 
 
1.4.5 Constitutive and induced gene expression 
Initiation of transcription can occur in two different ways. Regulated genes 
usually consist of focused promoters that lead to focused initiation of 
transcription whereas constitutively expressed genes usually comprise of 
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constitutive promoters that lead to constitutive initiation of transcription 
(Figure 1.7) (Juven-Gershon, Hsu, & Kadonaga, 2006).  
_____________________________________________________________ 
Figure 1.7: Modes of transcription initiation (Juven-Gershon et al., 2006). Focused 
mode of transcription initiation is found in regulated genes and consists of only a single 
major transcription start site. Dispersed mode of transcription initiation is found in 
constitutively expressed genes and consists of several weak transcription initiation sites.  
 
Due to the existence of both constitutive and induced promoters, whole-
cell microbial biosensors may be divided into two categories, based on the 
mode of transcription and therefore the type of signals they produce 
(Nezich, 2007). Micro-organisms that produce a signal constantly during a 
healthy state are classified as constitutive bio-reporters (Nezich, 2007). In 
constitutive bio-reporters, the signal production diminishes as cell 
metabolism is inhibited due to an increase in general toxicity level. Hence, 
these biosensors are used to measure general toxicity level in samples. 
Constitutive reporters have the benefit of producing a global response as 
a result of all the enzymes, cofactors and metabolic cascades present in 
the cell. They also have the benefit of assessing the general toxicity of the 
surrounding environment, thereby screening unexpected compounds as 
well. Micro-organisms that produce a signal when induced are classified 
as inducible bio-reporters (Nezich, 2007). These bio-reporters produce a 
signal only when their specific promoter is induced by its specific 
substrate, such as a heavy metal, pesticide, mutagen or organic solvent, 
and transcription is initiated.  
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Both types of bio-reporters can be used in biosensor technology, where 
the promoter is placed upstream to a reporter gene such as lac Z, lux or 
luc genes (Nezich, 2007). These genes produce either a colorimetric 
change or bioluminescence upon activation and the response can be 
monitored and quantified. Whole cell microbial biosensors produced for 
preservative efficacy testing in E. coli ATCC 8739 contain a constitutive 
promoter placed upstream of the lux cassette (Naseby, 2007, 2008, 2009). 
Five different constitutive promoters, namely PlysS, Plpp, Pspc, Ptat and PldcC, 
have been utilized to produce five biosensor strains of E. coli ATCC 8739 
(Naseby, 2007, 2008, 2009). In the current study, the same constitutive 
promoters have been utilized. The genes associated with these 
constitutive promotors are now described in more detail. 
 
1.4.5.1 Lysyl-tRNA synthetase (LysS) gene 
Essential proteins like aminoacyl tRNA synthetases (aaRSs) are highly 
conserved proteins (Lee & Razin, 2005). Translation of mRNA into 
proteins is only possible if these enzymes can catalyze aminoacylation of 
tRNAs to form the 20 different aminoacyl-tRNAs required as building 
blocks for protein synthesis (Lee & Razin, 2005). One such enzyme, the 
Lysyl-tRNA synthetase (LysRS), catalyzes the aminoacylation of lysine to 
tRNA to form Lys-tRNALys (Jakubowski, 1999). There are two genes for 
lysyl-tRNA synthetase (LysRS); the constitutively expressed lysS gene 
and the inducible lysU gene (Emmerich & Hirshfield, 1987). The inducible 
gene lysU is induced by L-leucine, L-alanine, L-leucine dipeptides 
(Hirshfield, Yeh, & Sawyer, 1975), heat shock and growth at low pH 
(Hassani, Pincus, Bennett, & Hirshfield, 1992). 
 
1.4.5.2 Spc ribosomal operon (spc) 
Ribosomal proteins are encoded by genes that are arranged in operons 
(Cerretti, Dean, Davis, Bedwell & Nomura, 1983). Operons are found at 
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different loci in the chromosomes. One such locus, the str locus, 
comprises the S10-spc-alpha operons (Coenye & Vandamme, 2005) that 
encode for ribosomal proteins and are expressed constitutively. The E. 
coli spc operon consists of ribosomal genes rpIN, rpIX, rpIE, rpsN, rpsH, 
rpIF, rpIR, rpsE, rpmD and rpl10 that encode for L14, L24, L5, S14, S8, 
L6, L18, S5, L36 and L15, respectively (Cerretti et al., 1983). The spc 
promoter region is found between the gene encoding the S17 protein (last 
gene of the S10 operon) and the gene encoding the L14 protein (first gene 
of the spc operon) (Post, Arfsten, Reusser & Nomura, 1978). A substantial 
amount of transcription may start from the spc operon and continue into 
the -operon downstream, thereby producing spc- transcripts under 
normal growth conditions. This indicates that the expression of -operon 
may be dictated by the spc promoter to a certain extent (Cerretti et al., 
1983). Furthermore, the spc- transcripts consist of several translation 
control points (Cerretti et al., 1983). Genes found in the S10-spc-  operon 
in E. coli are found outside these clusters in many genomes including that 
of P. aeruginosa (Coenye & Vandamme, 2005). 
 
1.4.5.3 Outer membrane lipoprotein (lpp) 
The inner membrane (IM) and outer membrane (OM) of gram-negative 
bacteria contain lipoproteins that not only maintain the structural integrity 
of cells but also mediate efflux of drugs and act as virulence factors 
(Nikaido, 1996; Remans, Vercammen, Bodilis & Cornelis, 2010b). 
Lipoproteins are synthesized as precursor proteins with an N-terminal 
signal sequence called the lipobox, which is responsible for the 
translocation of these proteins to the IM (Remans, Vercammen et al., 
2010b). There are 90 and 185 different types of lipoproteins in E. coli and 
P. aeruginosa, respectively, and they are the most abundant membrane 
proteins (Remans, Vercammen et al., 2010b). Maturation of lipoproteins 
occurs at the IM, after which they are transported to the OM (Masuda, 
Matsuyama & Tokuda, 2002; Narita & Tokuda, 2007). 
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A mature lipoprotein consists of three acyl chains at the N-terminal that act 
as anchors in the membrane (Remans, Vercammen et al., 2010b). 
Transport of lipoproteins in bacteria is achieved by the Lol (localization of 
lipoproteins) proteins. There are five different Lol proteins that are 
expressed constitutively, LolABCDE (Narita & Tokuda, 2006; Tanaka, 
Narita & Tokuda, 2007; Tokuda & Matsuyama, 2004). The lipoproteins 
destined for the outer membrane are released from the inner membrane 
by the LolDCE complex (Remans, Pauwels et al., 2010a). A water soluble 
complex is formed between the lipoprotein and LolA, a molecular 
chaperone (Remans, Pauwels et al., 2010a), then crosses the periplasm 
to the OM and is received by the lipoprotein-specific outer membrane 
receptor LolB, a lipoprotein (Remans, Pauwels et al., 2010a).  
Since the Lol components are crucial for bacterial cell growth, their 
reduction could therefore be fatal to bacterial cells (Narita, Tanaka, 
Matsuyama & Tokuda, 2002). Hence, the Lol components are targets for 
designing novel drugs aimed against pathogenic gram-negative bacteria. 
Recently, several compounds that inhibit the release of lipoproteins from 
LolA in P. aeruginosa have been developed (Pathania et al., 2009). 
 
1.4.5.4 Twin-arginine translocase (tat) 
Protein transport across the cytoplasmic membrane in bacteria is done by 
the sec-dependent and the twin-arginine-dependent pathways (Muller & 
Klosgen, 2005). The tat transporter has the ability to accept and transport 
folded proteins (de Keyzer, van der Does & Driessen, 2003; Muller & 
Klosgen, 2005). The tat pathway is vital in membrane development and 
cell division (Stanley, Findlay, Berks & Palmer, 2001), electron-transport 
chain and motility (Sargent, 2007), quorum sensing and pathogenesis 
(Ochsner, Snyder, Vasil & Vasil, 2002). Proteins transported by the tat 
pathway exhibit a consensus signal sequence S-R-R-x-F-L-K with x as a 
polar amino acid (Alami et al., 2003) in the N-region consisting of a twin-
arginine motif (Berks, 1996). The tat transporter contains three proteins; 
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TatA, TatB and TatC (Muller & Klosgen, 2005) encoded by tatA, tatB and 
tatC, respectively (Sargent et al., 1998; Sargent, Stanley, Berks & Palmer, 
1999). TatA promoter is responsible for constitutive expression of the tat 
genes (Jack, Sargent, Berks, Sawers & Palmer, 2001). 
A homotetramer of TatB (Lee et al., 2006) and a homodimer of TatC 
(Punginelli et al., 2007) form a complex called TatBC signal recognition 
module and act as receptors for Tat substrates (Alami et al., 2003; Cline & 
Mori, 2001). Multiple protomers of TatA form the transport channel module 
(Dabney-Smith, Mori & Cline, 2006; Gohlke et al., 2005). Both modules 
exist as two separate entities under resting conditions (Dabney-Smith et 
al., 2006). During protein translocation, the TatC component of the signal-
recognition complex recognizes the twin-arginine signal peptides (Alami et 
al., 2003; Cline & Mori, 2001), which bind to the TatBC complex resulting 
in a conformational change in the TatBC complex, leading to the exposure 
of the TatA-binding site (Cline & Mori, 2001). Binding of the signal peptide 
to the TatBC complex depends on the proton motive force (Gerard & 
Cline, 2007; Sargent, 2007). Then TatA binds to the substrate-bound 
TatBC complex (Alami et al., 2003) and the protein is translocated through 
the transport channel (Braun, Davis & Theg, 2007). 
 
1.4.5.5 Lysine decarboxylase (ldcC) 
Lysine decarboxylase is one of the many decarboxylases that attack basic 
amino acids (Lemonnier & Lane, 1998). Decarboxylases are classified into 
two categories. Degradative lysine decarboxylases (CadA) are induced by 
factors such as low oxygen tension, low pH and high concentration of their 
substrates (Lemonnier & Lane, 1998). Biosynthetic lysine decarboxylases 
(LdcC) are produced constitutively at low levels (Yamamoto, Miwa, 
Miyoshi, Furuyama & Ohmori, 1997) and catalyze the synthesis of 
polyamines (Krithika, Arunachalam, Priyanka & Indulekha, 2010; Tabor & 
Tabor, 1985). Expression of LdcC is very weak, suggesting that it is 
regulated by a weak promoter. Low concentrations of the enzyme suggest 
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that either transcription occurs at a low level or the mRNA transcripts are 
unstable (Lemonnier & Lane, 1998).  
High concentrations of polyamines are found in gram-negative bacteria. 
Decarboxylation of L-lysine produces cadaverine, a precursor of 
polyamines. Expression of cadA (for lysine decarboxylase) (Meng & 
Bennett, 1992) is strongly induced under high acidity. To neutralize the 
pH, the reaction product cadaverine is released into the medium 
(Lemonnier & Lane, 1998). L-lysine decarboxylase requires the cofactor 
pyridoxal 5’-phosphate (Fothergill & Guest, 1977) and converts L-lysine to 
cadaverine (Qian, Xia & Lee, 2011) via the cadaverine or decarboxylase 
pathways (Figure 1.8). The ultimate product of this pathway is glutarate. 
 
___________________________________________________________ 
Figure 1.8: Cadaverine pathway (Fothergill & Guest, 1977). This pathway provides an 
alternative pathway for L-lysine metabolism. The first step of this pathway (Reaction 12) 
is the catabolism of L-lysine by lysine decarboxylase. Reactions 13 and 14 are catalyzed 
by cadaverine aminotransferase and I-piperidene dehydrogenase, respectively.  
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1.5. Rationale, aim and objectives of this 
project 
 
Traditionaly preservative efficacy tests (PET) require inoculation of 
preservative formulations with specified micro-organisms, followed by 
plate counting techniques to monitor populations over the next 28 days. A 
further seven days are required for sample processing. Therefore the 
results are not usually available before 42 days after initial set-up. If 
formulations fail, repeated tests are required and new formulations may 
have to be designed. The traditional test is very laborious and hence not 
amenable to high throughput, rapid analysis. The development of 
biosensors for preservative efficacy testing will allow real time monitoring, 
rapid analysis and high throughput screening of preservative formulations, 
therefore saving time and labour inputs and allowing multiple formulations 
testing for rapid optimisation.  
The overall aim of this project is therefore to develop novel whole cell P. 
aeruginosa ATCC 9027 biosensors. The main objectives of this study are: 
 To construct whole cell P. aeruginosa ATCC 9027 bioluminescent 
constructs. 
 To validate the bioluminescent constructs in accordance with 
several documents (ISO, 1994a, 1994b, 1994c, 2000; PDA, 2000), 
using the bioluminescent method and to assess plasmid copy 
number for all plasmid-bearing constructs. 
 To determine the growth and death patterns of the bioluminescent 
constructs using the bioluminescent and plate count methods, to 
evaluate relative promoter strength for five pre-selected promoters 
and relate promoter strength to promoter sequence. 
 To assess the applicability of P. aeruginosa ATCC 9027 and 
bioluminescent constructs for preservative efficacy tests, using 
benzalkonium chloride and benzyl alcohol. 
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2.1 Introduction 
Many applications of recombinant DNA technology have arisen since the 
advent of DNA cloning; for example, regulation of gene expression, 
creation of new proteins to study protein function, hormone synthesis for 
clinical and medical use, evolutionary studies of proteins, generation of 
pest resistant crops, to name just a few (Berg, Tymoczko & Stryer, 2002). 
DNA cloning is a widely used process in which DNA sequences from 
various different sources are joined together and replicated to produce 
larger amounts (Karp, 1999). This is done by introducing a foreign DNA 
segment into vector DNA and transferring the resulting recombinant DNA 
into competent host cells such as those of bacteria, fungi or eukaryotic cell 
lines. In this project, the lux cassette and promoters sequences will be 
joined into vector plasmids to create recombinant DNA, which will be 
transformed into P. aeruginosa ATCC 9027 to develop novel biosensors. 
 
2.1.1 Plasmid vectors 
Bacterial plasmids, used as vectors for DNA cloning, are small, circular, 
extra-chromosomal, double-stranded DNA molecules (Karp, 1999). These 
little entities have contributed significantly to the basic understanding of 
mechanisms in prokaryotic biology; these include gene expression, DNA 
replication and recombination (Khan, 1997). Plasmid vectors range in size 
from one kilobasepair (kb) to a few hundred kb (Antoine & Locht, 1992), 
consist of an origin of replication, some structural genes for antibiotic or 
heavy metal resistance (Lewin, 2008) and several restriction 
endonuclease sites, most of which are confined in the multiple cloning site 
(MCS). The vector plasmid pME4510 (Figure 2.1) from Escherichia coli 
DH5  cells (Rist & Kertesz, 1998) will be used in this study. The 
gentamicin resistance gene will allow for expression of proteins that confer 
resistance to gentamicin thereby providing a selective growth advantage 
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for host cells containing the plasmid, while inhibiting growth of cells that 
lack the resistance gene. 
 
___________________________________________________________ 
Figure 2.1: Plasmid map of pME4510 (Rist & Kertesz, 1998). The 4017bp plasmid 
contains a gentamicin resistance gene (aaC1), together with a number of restriction sites, 
some of which have been highlighted in the diagram. 
 
 
Another feature of plasmids is their ability to be maintained through 
generations in a stable manner inside the host cells. Plasmids should be 
stable and free of burden on their host cell and should overcome 
segregational instability and competitive losses. Under certain conditions, 
plasmid encoded genes may offer a selective advantage to the host during 
growth and proliferation (Haines, Jones, Cheung & Thomas, 2005). For 
instance, the genus Pseudomonas carries many plasmids that offer 
environmental and clinical advantage to the bacterial hosts.  
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2.1.2 Recombinant DNA technology 
One of the applications of recombinant DNA technology is the isolation of 
specific polypeptide-encoding genes (Karp, 1999). However, it may not 
always be feasible to isolate pure, good quality DNA in large enough 
quantities to be of any practical use in further downstream applications. 
Minute amounts of DNA are therefore amplified for such applications by 
polymerase chain reaction (PCR) (Mullis et al., 1986). The PCR procedure 
involves numerous cycles of DNA denaturation, primer hybridisation and 
polymerase extension, thereby ‘amplifying’ the DNA template. What 
makes this method so useful, is the fact that primers hybridise 
complementarily to their sequence on the DNA template, thereby making 
PCR highly specific, and the process doubles the concentration of DNA 
with each cycle making the fragment concentration increase exponentially 
(Mullis et al., 1986). Modification to primer design has allowed molecular 
biologists to directly clone DNA fragments generated by PCR by tagging 
restriction sites at one end of each primer (Kovalic, Kwak & Weisblum, 
1991). As a result, a restriction site allows insertion of PCR products into 
DNA vectors upon digestion. Furthermore, directional cloning is possible 
by merely tagging each primer with a different restriction site. 
Amplified DNA may be used further downstream for processes such as 
restriction digestion using restriction endonucleases (Pingoud & Jeltsch, 
2001). The natural function of restriction endonucleases is to protect the 
host cells from invading foreign DNA, which could be detrimental to the 
host cell. The host cells are able to distinguish foreign DNA since the 
restriction sequences of host DNA are protected by methylation whereas 
foreign DNA is methylation-free (Pingoud & Jeltsch, 1997). 
Foreign and host DNA produce complementary ends that can be linked 
together during the ligation process when they are digested with the same 
restriction endonucleases. The foreign DNA ‘insert’ ligates with the 
digested vector with the aid of an enzyme T4-DNA ligase, to form 
recombinant DNA (Karp, 1999). DNA ligase is an enzyme that catalyses 
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the formation of a phosphodiester bond between two adjacent nucleotides 
in the presence of magnesium ions and ATP (Montecucco, Lestingi, 
Pedralinoy, Spadari & Ciarrocchi, 1990a). Several DNA binding drugs, 
such as ethidium bromide, have been shown to interfere with the ligation 
reaction by intercalating into the minor grooves of DNA and thereby 
inhibiting the formation of active DNA-enzyme complexes (Montecucco, 
Pedralinoy, Spadari, Lestingi & Ciarrocchi, 1990b; Parolin et al., 1990). 
 
2.1.3 Transformation 
Recombinant DNA is introduced into host cells by a process known as 
transformation, after which the host’s replication machinery replicates the 
DNA and passes it on to progeny cells called clones. Methods of 
delivering DNA into cells include bacterial conjugation, chemical 
transformation and electroporation. Transformation is an invaluable 
method in molecular biology, even though the procedures are very labour-
intensive and time-consuming. Bacterial conjugation is the transfer of DNA 
from a donor to a recipient via direct contact between the cells and the 
recipient bacteria, often termed transconjugants (Woodall, 2003). For 
chemical transformation, the host cells are made competent by treating 
them with calcium ions (Karp, 1999). These cells then take up DNA when 
undergoing a heat-shock treatment. Electroporation is a technique that 
uses high voltage electrical pulses to create temporary pores in the cell 
membrane, thereby permeabilising the cell and subsequently introducing 
exogenous material such as proteins, DNA and RNA into the cell 
(Prasanna & Panda, 1997; Smith & Iglewski, 1989).   
Some of the advantages of electroporation include greater transformation 
efficiencies and prevention of the use of toxic chemicals. The technique is 
fast, simple and reproducible with minimum expertise required (Prasanna 
& Panda, 1997). Although E. coli is fairly easy to transform, Pseudomonas 
cells have proven to be difficult to transfer. Part of the reason is because 
Pseudomonas cells produce high molecular weight polysaccharides called 
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alginates that form a layer around the cell membrane, which makes the 
cells viscous and hydrated and clumped together (Shen, Han, Lin & Yu, 
2006). Numerous studies have utilised electroporation as the method of 
choice for transforming Pseudomonas only because other methods have 
very low transformation efficiencies and therefore a higher failure rate 
(Artiguenave, Vilagines & Danglot, 1997; Bassett & Janisiewicz, 2003; 
Diver, Bryan & Sokol, 1990; Farinha & Kropinski, 1990; Shen et al., 2006). 
 
2.2 Aim and objectives 
The aim of this work was to produce bioluminescent constructs of 
Pseudomonas aeruginosa ATCC 9027 using molecular cloning 
approaches. The objectives were: 
 To isolate plasmid pSB417 (Figure 2.2) that contains the lux 
cassette from E. coli cells  (Winson et al., 1998) and restriction to 
excise the lux cassette using restriction endonucleases. 
________________________________________________________________________  
Figure 2.2: Plasmid map of pSB417 (Winson et al., 1998). The 8.5kbp plasmid 
comprises of the ampicillin resistance gene (Amp
r
) and the lux cassette linked to the Plac 
promoter. The lux cassette can be excised by a number of different restriction enzymes. 
 
 To ligate the lux gene cassette into plasmid vector plasmid 
pME4510 to produce a promoterless plasmid pME-lux.  
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 To isolate genomic DNA from P. aeruginosa  
 To amplify the promoter regions by polymerase chain reaction. The 
pre-selected promoters are as follows: 
 PlysS Lysyl-tRNA synthetase promoter 
 Pspc Spc ribosomal protein operon promoter 
 Ptat  Twin arginine translocase protein export system 
promoter 
 Plpp Outer membrane lipoprotein promoter 
 PldcC Lysine decarboxylase promoter 
 To digest the amplified promoter regions with restriction enzymes.  
 To ligate the amplified promoter regions upstream of the lux gene 
cassette to produce recombinant plasmids.  
 To transform recombinant plasmids into electro-competent E. coli 
cells. 
 To screen transformants for recombinant plasmids containing 
promoter-lux inserts by ability to grow on selective media, PCR, 
bioluminescence measurements and DNA sequencing. 
 To transform recombinant plasmids into electro-competent P. 
aeruginosa ATCC 9027 cells. 
 To screen transformants for recombinant plasmids containing 
promoter-lux inserts by DNA sequencing, PCR and 
bioluminescence measurements. 
At each stage, analysis will be done by agarose gel electrophoresis 
and/or absorbance spectrometry and/or luminometer.  
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2.3 Materials and methods 
2.3.1 Bacterial strains 
All bacterial strains used in this project are defined in Table 2.1. 
 
Table 2.1: Bacterial strains used in this project 
Bacterial strain Source 
Wild-type E. coli DH5  Bethesda Research Laboratories., 1986  
E. coli DH5 + pBR322 Balbas et al., 1986 
E. coli DH5 + pSB417 Winson et al., 1998 
E. coli DH5 + pME4510 Rist & Kertesz, 1998 
E. coli DH5 + pBR322-lux Provided by University of Hertfordshire 
Wild-type P. aeruginosa ATCC 9027 (WT) ATCC ® 
P. aeruginosa ATCC 9027 + pME4510 Produced in this study 
P. aeruginosa ATCC 9027 + pME-lux Produced in this study 
P. aeruginosa ATCC 9027 + ldcC pME-lux Produced in this study 
P. aeruginosa ATCC 9027 + spc pME-lux Produced in this study 
P. aeruginosa ATCC 9027 + lys R25 pME-lux Produced in this study 
P. aeruginosa ATCC 9027 + lys G25 pME-lux Produced in this study 
P. aeruginosa ATCC 9027 + lpp R3 pME-lux Produced in this study 
P. aeruginosa ATCC 9027 + lpp R4 pME-lux Produced in this study 
P. aeruginosa ATCC 9027 + tat H5 pME-lux Produced in this study 
P. aeruginosa ATCC 9027 + tat H9 pME-lux Produced in this study 
P. aeruginosa ATCC 9027 + tat H14 pME-lux Produced in this study 
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2.3.2 Bioinformatics 
Promoter sequences for the genes from E. coli were searched against the 
P. aeruginosa genome using BLAST to examine the similarity of these 
sequences in the two species. The five structural genes, namely ldcC, spc 
operon, tatABCD, lolB and lysS, in P. aeruginosa were then found in 
Genbank due to the fact that the promoter sequences from E. coli were 
very dissimilar in the two species. The sequences for the five structural 
genes, together with their upstream sequences, were used to search for 
the promoter sequences, using the software BPROM (Softberry, 2007) to 
identify the -10 and -35 positions. BPROM is a bacterial promotor 
prediction program with a reported accuracy of 80% in E.coli. Once the 
correct promoter sequences were identified, forward and reverse primers 
specific to each promoter were designed using PRIMER 3 software 
(Rozen & Skaletsky, 1998). The primers were designed in such a way that 
the resulting amplicons incorporated the -60 positions of the UP elements 
as well. Artificial restriction sites were also created at the 5’ end of the 
forward primer and the 3’ end of the reverse primer. The melting 
temperatures of the primers containing the restriction sites were calculated 
using ‘BioMath - Tm Calculations for Oligos’ software (Promega 
Corporation, Corporation). Webcutter 2.0 (Heiman, 1997) was used to 
ensure that the promoter sequences had no similarity with the artificially 
added restriction sites. 
 
2.3.3 Gram staining and microscopy 
P. aeruginosa was grown for 24 hours on a nutrient agar plate (Oxoid Ltd) 
incubated at 30oC. The bacterial cells were prepared for gram staining 
according to the gram stain method (Gram, 1884).  
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2.3.4 Antibiotic testing 
P. aeruginosa ATCC 9027 cells were inoculated from a single isolated 
colony into a culture flask containing LB broth (Oxoid Ltd) and incubated 
at 30oC for 24 hours. Aliquots of the cell culture (100 l) were then spread 
onto LB-agar (Oxoid Ltd) plates and incubated at 30oC for 24 hours to 
create working plates. P. aeruginosa ATCC9027 cells were spread onto 
new LB plates from the working plate using an inoculation loop. Several 
antibiotic discs (Oxoid Ltd) were placed, in triplicate, with the aid of a disc 
dispenser onto the plates containing the P. aeruginosa cells. The 
antibiotics tested are shown in Table 2.2. The plates were incubated at 
30oC for 24 hours and examined for inhibition zones. Where present, the 
diameters of the zones of inhibition were measured using a ruler. The 
susceptibility of the cells to the antibiotic was then determined according 
to the BSAC standardised disc susceptibility testing method (Andrews, 
2009). 
 
Table 2.2: Various antibiotics for antibiotic resistance testing of P. aeruginosa. 
Antibiotic Concentration ( g/disc) 
Polymixin B 300 
Tetracycline 30 
Trimethoprim 5 
Erythromycin 15 
Nalidixic acid 30 
Gentamicin 10 
Chloramphenicol 30 
Streptomycin 10 
Kanamycin 5 
Vancomycin 30 
Methicillin 5 
Clindamycin 2 
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2.3.5 Genomic DNA extraction 
P. aeruginosa was grown for 24 hours in a culture flask containing nutrient 
broth and incubated at 30oC in a shaking incubator at 150rpm. Genomic 
DNA (gDNA) extraction from P. aeruginosa was done according to Cheng 
and Jiang (2006), after which the samples were purified and concentrated 
with alcohol. Following final incubation with chloroform, the upper aqueous 
phase (150 L) was transferred to a sterile eppendorf tube and 15 L of 
3M sodium acetate was added. Cold absolute alcohol (375 L) was added 
to the mixture, mixed gently and left for 24 hours to precipitate the DNA. 
The mixture was then centrifuged for 2 minutes. The supernatant was 
discarded and the pellet was washed with 1 mL of 70% ethanol before 
centrifuging for 2 minutes. The pellet was dried for 5 minutes using speed 
vacuum to remove any residual ethanol. The resultant DNA pellet was 
subsequently resuspended in TE buffer (pH 8) and stored at -20oC. The 
concentration and purity of DNA was determined by measuring the 
absorbance at 230, 260, 280 and 320nm on the Eppendorf spectrometer 
(Eppendorf®). 
 
2.3.6 Polymerase Chain Reaction (PCR) 
The promoter regions for each of the five genes, lysyl-tRNA synthetase 
(PlysS), ribosomal operon (Pspc), tatABCD (Ptat), lysine decarboxylase 
(PldcC) and lipoprotein lolB (Plpp) were amplified by designing specific 
forward and reverse oligonucleotide primers (Table 2.3).  Oligonucleotide 
primers were constructed by Invitrogen Ltd. The primers selected to 
amplify the promoter regions were: 
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Table 2.3: Forward and reverse primers for amplification of five promoter regions 
PldcC, Plpp, PlysS, Pspc and Ptat.  
Primer 
Namea Primer 
Primer 
length 
(bases) b 
% GC 
contentc 
Tm 
(oC) d 
ldcC F 5’-CTTCAAGAATTCGGGTTACGCGCGTGCCGG-3' 30 60.0 67 
ldcC R 5'-CTGATTACGTAGTCAAGAGAATGCTGAAGCCGTCCTG-3' 36 55.6 69 
lpp F 5’-CTTCAAGAATTCGTATTGACCCCATAGACAGCTTCG-3' 36 44.4 64 
lpp R 5'-GTGATTACGTAGTCAGCGCAAGGGATTTGTTCATA-3' 39 46.2 67 
lysS F 5’-CTTCAAGAATTCGCTGTCTCTGGGAGCTACTCG-3' 33 51.5 66 
lysS R 5'-GTGATTACGTAGTCAGATAGCGGCCGATTGATTC-3' 35 51.4 67 
spc F 5’-CTTCAAGAATTCGTAACGCGCGGAACTTCCATC-3' 33 48.5 64 
spc R 5'-CTCATTACGTAGTCAAGGTAGATCACCATGGCACGA-3' 36 52.8 68 
tat F 5’-CTTCAAGAATTCGGGGTATTCCTGATCCTGCGCCG-3' 35 54.3 68 
tat R 5'-GTGCATACGTAGTCAGGCGTTCCAGTGAATCTCATCCAG-3' 38 50.0 68 
a
 F denotes forward primer and R denotes reverse primer. Underlined sequences show 
attached restriction sites. The primer length
b
 is between 30-40bp, % GC content
c
 is 
around 50% and the melting temperature
d
 for each primer is between 60-70
o
C. 
 
Stock primer suspensions for tat, lpp, ldcC, lysS and spc were prepared 
by adding 100 L of TE buffer pH 8. Working solutions of primers were 
prepared by adding appropriate volumes of TE buffer (pH 8) resulting in a 
concentration of 25 M. The stocks and the working solutions were stored 
at -20oC until required. 
The initial PCR reaction mixtures were prepared in sterile PCR tubes 
(Table 2.4). Reaction buffer, magnesium chloride, deoxynucleotides, and 
Taq polymerase were purchased from Promega Ltd. The reagents were 
added, making up a total volume of 50 L. Individual PCR reactions for 
each of the promoter regions were prepared. 
 
 
 
 
 
Page 59 
 
Table 2.4: Various reagents for a PCR reaction.  
Reagent Volume ( L)a 
10x Reaction buffer 5 
25mM MgCl2 3 
10mM dNTP 1 
25 M Forward primer 1 
25 M Reverse primer 1 
5U/ L Taq polymerase 0.2 
DNA template 1 
Sterile water 38.8 
a
 Volumes of each reagent at stated concentrations required for 50 L reaction. 
 
The reaction tubes were placed in a Gradient PCR thermocycler 
(Eppendorf Mastercycler Gradient). The conditions used for the PCR 
reaction are summarised in Table 2.5.  
 
Table 2.5: Cycling parameters for the PCR reactions.  
 
 
After optimizing the various reagent concentrations in the PCR reaction 
mixture and the cycling parameters, the final volumes of each reagent and 
the final annealing temperature for each of the five reactions were used 
(Table 2.6). 
 
 
Steps Temperature (oC) Time (minutes) 
1 Initial Heat Denaturation 94 5 
2 Heat Denaturation 
Primer annealing 
Primer extension 
94 
Gradient temperature 
72 
1 
1 
1 
3 Extension 72 10 
4 Quenching 4 infinite 
30 cycles 
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Table 2.6: Final reaction volumes and annealing temperatures for all five PCR 
reactions. 
Reagent Volumes ( L) for each prototype a 
Ptat Plpp PldcC PlysS Pspc 
10x Reaction buffer 10 10 10 10 10 
25mM MgCl2 4 4 3 6 6 
10mM dNTP 2 2 2 2 2 
25 M Forward primer 1 1 1 1 1 
25 M Reverse primer 1 1 1 1 1 
5U/ L Taq polymerase 0.5 0.5 0.5 0.5 0.5 
DNA template 2 2 2 2 2 
Sterile water 79.5 79.5 80.5 77.5 77.5 
Total volume 100 100 100 100 100 
Annealing temp (oC) 54 54 54 68 54 
a
 Volumes of each reagent at stated concentrations required for 100 L reaction. 
Optimised annealing temperatures are also mentioned. 
 
A PCR reaction lacking the DNA template was also prepared as a 
negative control. Following PCR, 5 l of the products from each reaction 
tube were resolved on a standard 1.5% agarose gel. A 100bp standard 
DNA marker (Promega Ltd) was also loaded on the gel for verification of 
PCR product sizes. 
 
2.3.7 Purification of DNA 
Two different methods for purification of PCR products were investigated. 
They included the use of SIGMA ALDRICH® GenElute PCR clean up kit 
(Sigma Aldrich Co.) according to the manufacturer’s instructions and the 
use of a gel extraction kit (QIAGEN). 
For the purposes of purifying DNA by the gel extraction method, the DNA 
samples (25 l) were first analysed on a 0.8% agarose gel. The gel was 
run at a constant voltage of 60V for 120 minutes. The gel was 
subsequently placed for 10 minutes in staining solution that contained 
ethidium bromide in gel running buffer, after which it was placed in 
destaining solution (sterile distilled water). The gel fragment to be purified 
was excised from the agarose gel under UV light using a sterile, sharp 
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scalpel and placed in an eppendorf tube. The weight of the tube before 
and after addition of the gel slice was noted. The DNA fragment was then 
purified using the QIAquick® Gel Extraction kit (Qiagen Ltd) according to 
the manufacturer’s instructions.  
The purified products were subjected to ethanol precipitation to 
concentrate the DNA. The purified products were then analysed by 
agarose gel electrophoresis on a standard 1.5% agarose gel to examine 
recovery of pure products. 
 
2.3.8 Agarose gel electrophoresis 
Agarose gel electrophoresis was used for DNA analysis. For gDNA, a 
standard 0.8% (w/v) agarose gel containing 0.24g agarose (Fischer 
Scientific Ltd) in 30 mL gel running buffer was prepared. For PCR 
products, a standard 2% (w/v) agarose gel containing 0.6g agarose in 30 
mL gel running buffer was prepared. For plasmids, a standard 0.8% (w/v) 
agarose gel containing 0.24g agarose in 30 mL gel running buffer was 
prepared. The gel was placed in a gel tank containing 300 mL of gel 
running buffer. DNA samples were prepared by adding gel loading dye at 
a ratio of 5:1 respectively and loaded onto the gels as carefully as 
possible. Standard DNA markers (1kb and 100bp represented by M1 and 
M2 respectively) (Promega Ltd), depending on the molecular weight of the 
expected fragment, were also loaded onto the gel. The gels were run at 
100V for approximately 60 minutes. The gels were subsequently stained 
with ethidium bromide (250 mL of 1 x Gel running buffer contained 50 L 
of 5 mg/mL ethidium bromide) for 15 minutes and then de-stained with 
sterile distilled water for 5 minutes before visualizing under UV radiation 
on a UV-transilluminator (Ingenius Syngene Bioimaging).  
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2.3.9 Plasmid isolation 
E. coli DH5  cells containing the promoterless pBR322-lux plasmids and 
E. coli DH5  cells containing the pSB417 plasmids (all provided by Dr. 
David Naseby, University of Hertfordshire) were grown by inoculating a 
single isolated colony of each of the strains into culture flasks containing 5 
mL of LB (Luria-Bertani) broth and 100 g/mL ampicillin under sterile 
conditions and incubated in a shaking incubator (200rpm) at 37oC for 24 
hours. E. coli DH5  cells containing pME4510 plasmids were grown by 
inoculating a single isolated colony of each of the strains into culture flasks 
containing 5 mL of LB (Luria-Bertani) broth and 10 g/mL gentamicin 
under sterile conditions and incubated in a shaking incubator (200rpm) at 
37oC for 24 hours. Plasmid DNA was extracted from each of the three 
strains using the QIAprep® Spin Miniprep kit (Qiagen Ltd) according to the 
manufacturer’s instructions. The concentration and purity of plasmid DNA 
were determined by measuring the absorbance at 230, 260, 280 and 
320nm on the Eppendorf spectrometer. The plasmids were also analyzed 
by agarose gel electrophoresis on a standard 0.8% agarose gel to 
examine the purity and conformation of the plasmids. 
 
2.3.10 Restriction 
All restriction digest reactions were set up according to the manufacturer’s 
protocols. Restriction endonucleases, restriction buffers and bovine serum 
albumin (BSA) were purchased from New England Biolabs. The PCR-
amplified products were digested with the restriction endonucleases EcoRI 
and SnaBI simultaneously in a double digestion mix. The plasmid 322-lux 
and pSB417 were digested with EcoRI and BamHI simultaneously in 
double digests. The reaction mix in each case was prepared according to 
Table 2.7. 
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Table 2.7: Restriction digestion components. 
 Volumes of each component ( L)a 
 PCR 
products 
322-lux pSB417 
Sterile distilled water 16.3 32.6 32.6 
RE buffer x10 2 4 4 
BSA (10 g/ L) 0.2 0.4 0.4 
Respective DNA (1 g/ L) 1 2 2 
EcoRI endonuclease (10U/ L) 1 1 1 
BamHI endonuclease (10U/ L) - 1 1 
SnaBI endonuclease (5U/ L) 2 - - 
Total Volume 20 40 40 
a
 Required volumes of each reagent at stated concentrations shown. 
 
Each reaction was incubated at 37oC for 1 hour, after which the reactions 
were inactivated by incubation at 80oC for 10 minutes. Subsequently, 4 l 
of each reaction mix was analyzed on an agarose gel. A standard 1.5% 
agarose gel was prepared for PCR products, whereas a standard 0.8% 
agarose gel was prepared for plasmids. The agarose gels were run as 
described in the gel electrophoresis protocol (section 2.3.8). After 
successful restriction, the digested fragments were subjected to the 
ligation protocol. 
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2.3.11 Ligation 
All ligation reactions were done according to the manufacturer’s protocols 
(Promega Ltd). The ligation reactions were prepared by mixing together 
the various reagents for ligation (Table 2.8). The digested PCR products 
and digested plasmids were mixed in a ratio of 10:1. 
 
Table 2.8: Ligation reaction components 
Ligation reagent Volume of reagent ( L) a 
Sterile distilled water - 
Ligase reaction buffer x5 4 
Plasmid 2.5 
PCR product 12.5 
Total Volume 19 
a
 Required volumes of each reagent at stated concentrations mentioned. 
 
Each reaction was incubated at 65oC for 10 minutes and then cooled to 
4oC. T4 DNA ligase (1 L of 1U/ L) was added to each 20 L ligation 
reaction. The reactions were then incubated at 18oC for 24 hours, after 
which the reactions were inactivated by incubation at 65oC for 10 minutes. 
Subsequently 10 l of each reaction mix was analyzed on a standard 0.8% 
agarose gel (section 2.3.8). After successful ligation, the ligated products 
were stored at -20oC or prepared for transformation. 
 
2.3.12 Preparation of electro-competent cells 
Electro-competent E. coli DH5  bacterial cells were prepared as 
described by Choi, Kumar & Schweizer (2006). Electro-competent P. 
aeruginosa ATCC 9027 bacterial cells were prepared as described by 
Farinha & Kropinski (1990) and Diver, Bryan & Sokol (1990). However, 
slight modifications were made. An isolated colony of P. aeruginosa cells 
was inoculated from a working agar plate into 10 mL of LB broth in a 
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universal bottle and incubated for 24 hours in a shaking incubator at 30oC 
and 250rpm. The culture (1 mL) was further inoculated into a culture flask 
containing 100 mL LB broth and incubated for 8 hours in a shaking 
incubator at 30oC and 250rpm until the O.D. of 0.8 was obtained. The 
bacterial culture was then treated with alginate lyase (1.28 U/mL) as 
described by Shen, Han, Lin, & Yu (2006) and incubated at 40oC for 20 
minutes. The bacterial culture was then cooled at 4oC for 10 minutes. All 
further centrifugation and cell-washing steps were done at 4oC. The 
resultant culture was centrifuged at 3500g for 10 minutes. The resulting 
supernatant was discarded. The bacterial pellet was re-suspended in 100 
mL sterile MilliQ water and then re-centrifuged at 3500g for 10 minutes. 
The resultant pellet was resuspended in 50 mL of sterile MilliQ water and 
then re-centrifuged at 3500g for 10 minutes. The pellet was then washed 
twice in 50 mL of sterile electroporation buffer before re-centrifuging at 
3500g for 10 minutes. After the final centrifugation, the pellet was 
resuspended in 2 mL of sterile electroporation buffer. The suspension was 
aliquoted into 100 L aliquots and stored at -70oC until required or used 
directly for electroporation. 
Various electroporation buffers were used for the preparation of electro-
competent cells: 300 mM sucrose, 10% glycerol, 1 mM HEPES buffer, 
Ringers solution, 15% glycerol containing 1 mM MOPS, and 1 mM HEPES 
pH 7.0 containing 300 mM sucrose and 1 mM magnesium chloride 
(SMEB). 
 
2.3.13 Electroporation 
Electrocompetent cells (40 l) were thawed on ice before adding 3 l of 
plasmid DNA. The cells were mixed gently before transferring them into an 
ice-cold electroporation cuvette which had a gap of 2 mm. The Bio-Rad 
Gene Pulser electroporation unit was set at 2.5 kV, 200  resistance and 
25 µF capacitance. The cuvette was placed in the unit and an electric 
pulse was delivered. Immediately after the pulse, 1 mL of SOC media was 
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added to the cuvette. The cell culture was transferred into a sterile 
universal tube and incubated at 37oC and 150rpm for 1 hour. An aliquot of 
the culture (100 L) of the cells was plated on an LB agar plate containing 
10 g/mL gentamicin. The inoculated agar plate was then incubated in an 
inverted position at 37oC for 24 hours until colonies appeared. An aliquot 
of electro-competent cells lacking the addition of plasmid DNA was also 
pulsed as a negative control. Electroporated P. aeruginosa cell cultures 
were incubated at 30oC instead of 37oC. 
 
2.3.14 Screening of transformants 
Each transformed colony was inoculated onto a secondary LB agar plate 
containing 10 g/mL gentamicin and also into a culture flask containing 5 
mL of LB broth and 10 g/mL gentamicin and incubated for 16 hours at 
37oC. Upon growth, a single isolated colony from the secondary plate was 
then inoculated into a culture flask containing 5 mL of LB broth and 10 
g/mL gentamicin and incubated for 24 hours at 37oC in a shaking 
incubator shaking at 250rpm for the purposes of plasmid isolation. All 
incubations were done at 30oC for P. aeruginosa cells. Plasmids were 
isolated from each of the cultures (section 2.3.9). A small aliquot (2 L) 
was analyzed on a standard 0.8% agarose gel. Another aliquot (10 L) of 
the plasmid sample was subjected to restriction analysis as described in 
section 2.3.10. A small sample (5 L) of the restriction reaction was also 
analyzed on a standard 0.8% agarose gel to examine the presence of the 
inserted region. Another plasmid aliquot was subjected to PCR 
amplification as described in section 2.3.6 to amplify the promoter region if 
it had been inserted into the plasmid. 
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2.3.15 Bioluminescence measurement 
Each transformed colony was inoculated into 9 mL LB broth containing 10 
g/mL gentamicin and incubated for 24 hours (37oC for E. coli and 30oC 
for P. aeruginosa). The cultures (1 mL) were placed into sterile culture 
tubes and placed into the Celsis Advance Luminometer. The luminometer 
was programmed to measure relative light units (RLU) of the samples at 
30oC. Sterile LB broth (1 mL) was used as a negative control for the 
measurement of bioluminescence. The lowest limit of detection was pre-
set to be 200 RLU. 
 
2.3.16 DNA sequencing 
Transformed E. coli colonies that were found to contain the plasmids of 
interest together with lux insert and promoter inserts were sent for DNA 
sequencing to GATC Biotech, to assess the nucleotide sequence of the 
inserts. Since the lux cassette was too long to be sequenced, only the 5’-
end of luxC and the 3’-end of luxE were sequenced. The primers designed 
to sequence the promoter regions, the luxC link at the EcoRI restriction 
site and the luxE link at the BamHI restriction site are listed in Table 2.9: 
Table 2.9: Forward and reverse primers for sequencing of insert junctions.  
Primer Name a Primer 
pME-EcoRI F 5’-CTTCATTTTTCCATCTTTGC-3' 
LuxC R 5'-TCGGGATAATTAGCAGAGAA-3' 
pME-BamHI F 5’-TGTCCATTTTAGCCTCCTTA-3' 
LuxE R 5'-TATCTGTTGTTTGTCGGTGA-3' 
a F denotes forward primer and R denotes reverse primer.  
Stock primer suspensions were prepared by adding 100 L of Tris buffer 
pH 8. Working solutions of primers were prepared by adding appropriate 
volumes of tris buffer pH 8, resulting in a DNA concentration of 25 M. 
The stocks and the working solutions were stored at -20oC until required. 
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Working solutions were further diluted to a concentration of 10 pM as 
required by GATC Biotech. 
 
2.3.17 Long-term storage of all strains 
Stock cultures of P. aeruginosa ATCC 9027 bioluminescent strains and 
negative controls were inoculated into vials of bacterial preservation 
systems containing treated beads in cryo fluid (Fisher Scientific UK Ltd) 
according to manufacturer’s protocols and stored at -70oC for long-term 
storage. LB agar slopes and plates, with/without 10 g/mL gentamicin 
were streaked from the treated beads and incubated at 30oC for 24 hours 
to create master slopes and plates, respectively. Each strain from the 
master plate was inoculated onto a working LB agar plate with/without 10 
g/mL gentamicin and incubated for 16 hours at 30oC and used for further 
applications. 
 
2.3.18 Data analysis 
Relative light units and CFU counts were tabulated using Microsoft Excel. 
Mean values and sample standard deviations were calculated using the 
built-in functions of Excel. Both RLU readings and CFU counts were 
converted to Log units. A scatter diagram was plotted for determining the 
relationship between RLU reading and CFU count. The ratio of Log RLU: 
Log CFU was also calculated and a column chart was plotted against all 
serial dilutions. Pearsons’ correlations (R-values) were determined, if any, 
for RLU against CFU using general correlation formulas found in MS 
Excel. 
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2.4 Results 
2.4.1 Gram staining 
P. aeruginosa cells were grown on media to create stocks and working 
cultures. A characteristic blue-green colour was observed in all cultures 
containing these species. Upon gram staining, pink rod shaped bacterial 
cells of size 0.5 m in width and 2 m in length were observed. 
 
2.4.2 Antibiotic susceptibility 
P. aeruginosa ATCC9027 cells were found to show resistance against 
most of the antibiotics tested, as no clear inhibition zones were observed 
(Table 2.10). However, clear, and well-defined zones were observed in the 
presence of gentamicin and polymixin B, indicating susceptibility to these 
antibiotics. Zones of inhibition observed in the presence of streptomycin 
and nalidixic acid were too small to classify the cells as susceptible. 
Table 2.10: Susceptibility of P. aeruginosa cells to various antibiotics. 
Antibiotic Concentration 
( g/disc) 
Zone of 
inhibition (mm) a 
Susceptibility 
Polymixin B 300 14 15 15 Susceptible 
Tetracycline 30 0 0 0 Resistant 
Trimethoprim 5 0 0 0 Resistant 
Erythromycin 15 0 0 0 Resistant 
Nalidixic acid 30 9 9 8 Intermediate 
Gentamicin 10 15 16 17 Susceptible 
Chloramphenicol 30 0 0 0 Resistant 
Streptomycin 10 11 8 9 Intermediate 
Kanamycin 5 0 0 0 Resistant 
Vancomycin 30 0 0 0 Resistant 
Methicillin 5 0 0 0 Resistant 
Clindamycin 2 0 0 0 Resistant 
a
 Diameters of zones of inhibition indicate whether P. aeruginosa was resistant, 
intermediate or susceptible to stated concentrations of different antibiotics. 
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2.4.3 Bioinformatics 
The gene sequences for each of the genes tat, lysS, lpp, ldcC and spc 
were retrieved from the genomic DNA sequence of P. aeruginosa 
(Genbank accession number AE004091 version 2) and are presented in 
Appendix 1. Identification and characterization of the genes within the 
retrieved sequences was performed using the database MicrobesOnline 
(Price, Huang, Alm & Arkin, 2005). The start and stop position of each 
gene, together with the strand on which transcription occurs is detailed in 
Table 7.1 in Appendix 2. This table also shows the gene transcribed and 
the translated product. Table 7.2 in Appendix 2 predicts whether the 
genes lie in the same operon and gives the confidence of the prediction. 
From these tables, it was shown that the genes for outer membrane 
lipoprotein (lolB or lpp), lysine decarboxylase (ldcC) and the spc operon 
were transcribed on the negative strand while the genes for lysyl-tRNA 
synthetase (lysS) and twin arginine translocase (tat) were transcribed on 
the positive strand. Table 7.2 in Appendix 2 also indicates the various 
genes in the spc operon and the tat operon. The statistical prediction 
value (bOp) indicates whether the gene lies in the same operon as the 
next gene or in a different operon. In the spc operon, the first gene was 
rplQ and the last gene was rpsL. Similarly, the gene hisI was predicted to 
be the first gene in the tat operon and tatC the last. The gene lolB (lpp) 
was predicted to be located in the same operon as the ipk gene. The 
genes lysS and ldcC were found not to be part of any operons. 
 
The promoter regions, predicted with BPROM from Softberry Inc., were 
highlighted in the gene sequences. These regions were compared with the 
promoter regions for the same genes in E. coli (Table 2.11). The 
nucleotide sequences for the five promoters in the two species E. coli and 
P. aeruginosa were found to be dissimilar.  
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Table 2.11: Promoter sequences for five genes in E. coli and P. aeruginosa.  
 
 
 
 
 
 
 
 
 
 
Specific forward and reverse primers were designed (Table 2.12) to 
amplify the promoter regions for each of the five genes. All the forward 
primers were tagged with an EcoRI restriction site at the 5’-end, while all 
the reverse primers were tagged with a SalI restriction site at the 5’-end. 
Table 2.12: Specific primers for amplification of the promoter elements. 
 
a
 F denotes forward primer and R denotes reverse primer. Underlined sequences show 
attached restriction sites. The primer length
b
 is between 30-40bp, % GC content
c
 is 
around 50% and the melting temperature
d
 for each primer is between 60-70
o
C. 
Promoter Position E. coli P. aeruginosa 
ldcC 
-10 GGCTATGAT ATGTATAAA 
-35 TTTTTA CTGCTG 
lpp 
-10 ATAAAAAAT TGTCATGAT 
-35 TTTAAT TGGGCT 
lysS 
-10 AAGAAAAAT GGGCATTGT 
-35 TTTATG TTTCCT 
spc 
-10 TGTTATAAT CGATAAATT 
-35 TTTCTA TTTCAG 
tat 
-10 ACGTATAAT TGGCACACT 
-35 TTCATC TAGCCA 
Primer 
Name
 a
 Primer 
Primer length 
(bases)
b
 % GC
c
  
Tm 
(
o
C)
d
 
ldcC F 5’-CTTCAAGAATTCGGGTTACGCGCGTGCCGG-3' 30 60 67 
ldcC R 5’-CTGATGTCGACGTCAGTGGGTGGAAGCGACGATGCG-3' 36 55.6 69 
lpp F 5’-CTTCAAGAATTCGTATTGACCCCATAGACAGCTTCG-3' 36 44.4 64 
lpp R 5’-CTGATGTCGACGTCAGTCTTGTGGATAAGTGACTGGCAG-3' 39 46.2 67 
lysS F 5’-CTTCAAGAATTCGGTGTCGGTGATGAGATCGTCG-3' 34 50 66 
lysS R 5’-CTGATGTCGACGTCAGCCTATTCCGAGCTGAACGAC-3' 36 50 67 
spc F 5’-CTTCAAGAATTCGTAACGCGCGGAACTTCCATC-3' 33 48.5 64 
spc R 5’-CTGATGTCGACGTCAAGGTAGATCACCATGGCACGA-3' 36 52.8 68 
tat F 5’-CTTCAAGAATTCGGGGTATTCCTGATCCTGCGCCG-3' 35 54.3 68 
tat R 5’-CTGATGTCGACGTCACGGCGTTCCAGTGAATCTC-3' 38 50 68 
Page 72 
 
2.4.4 Genomic DNA extraction 
Genomic DNA was extracted from P. aeruginosa cells. A sharp band of 
high molecular weight indicated the presence of genomic DNA (gDNA) 
(Figure 2.3). However, a smear of DNA of low molecular weight indicated 
the presence of nucleic acid contaminants in the samples (Figure 2.3A). 
The gDNA samples were then subjected to ethanol precipitation treatment 
in an attempt to purify the gDNA from the contaminating nucleic acid, and 
re-analyzed by agarose gel electrophoresis. A sharp DNA band of high 
molecular weight was observed after the precipitation process (Figure 
2.3B), however, the low molecular weight DNA smear of contaminating 
nucleic acid had disappeared, indicating that the contaminants had been 
precipitated out.  
 
 
 
 
 
 
 
 
 
___________________________________________________________ 
Figure 2.3: Agarose gel electrophoretic analysis of genomic DNA extracted 
from P aeruginosa. A: Lane 1 and 2: genomic DNA samples extracted in duplicate. B: 
Lane 1: genomic DNA sample after ethanol precipitation. 
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The purity and concentration of the genomic DNA extracts were estimated 
by measuring the absorbance at various wavelengths; 230, 260, 280 and 
320nm (Table 2.13). Values of at least 1.8 were expected for A (260/280) 
and A (260/230). The specified absorbance ratios for samples 1 and 2 were 
found to be less than 1.8; indicating that the purity of both samples was 
low. Analysing these ratios further, it was observed that the contaminating 
factor was proteins since the absorbance at 280nm was high. Hence, the 
samples were precipitated with the aid of ethanol. Following ethanol 
precipitation, absorbance ratios of 1.85 for A (260/280) and 5 for A (
260/230) 
were achieved; indicating that the DNA was pure. However, a lot of DNA 
was lost during the precipitation process, indicated by the reduction in 
band intensity and concentration before and after ethanol precipitation. 
 
Table 2.13: Purity and concentration of extracted gDNA samples. 
Absorbance was measured at 230nm, 260nm, 280nm and 320nm. Absorbance ratios 
A(
260
/280) and A(
260
/230) and the concentrations were calculated by the spectrophotometer. 
 
Following gDNA extraction, the purified gDNA was used as a template for 
downstream polymerase chain reactions. 
 
 
 
Sample Name Before ethanol 
precipitation 
After ethanol 
precipitation 
A (260/280) 1.49 1.21 1.85 
A (260/230) 1.77 1.26 5 
A230 0.338 0.941 0.011 
A260 0.597 1.19 0.057 
A280 0.401 0.985 0.031 
A320 0 0.561 0.001 
Concentration ( g/mL) 1195 2379 114 
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2.4.5 Polymerase Chain Reaction (PCR) 
Expected sequences and sizes for amplicons are shown in Appendix 3.  
Several PCR reactions were done for the amplification of the promoter 
regions and the results of the optimisation of PCR conditions are shown in 
Appendix 4. Amplification of Ptat was done at various annealing 
temperatures and MgCl2 concentrations (Appendix 4, Figure 7.1). No Ptat 
amplicons were observed in lanes 17-20 (0.25mM MgCl2 and annealing 
temperatures of 53oC, 56oC, 58oC and 60oC). Two bands for Ptat 
amplicons of approximately 100bp and 200bp were observed in lanes 21 
and 23 (0.75mM MgCl2 and annealing temperature of 53
oC and 58oC). 
However, only one band for Ptat amplicon of approximately 100bp was 
observed in lanes 22 and 24 (0.75mM MgCl2 and annealing temperatures 
of 56oC and 60oC). 
Further amplification of tat (Appendix 4, Figure 7.2) revealed bright bands 
of approximately 175bp for the Ptat amplicon in lanes 1-8 (1mM and 
1.5mM MgCl2 and annealing temperatures of 53
oC, 56oC, 58oC and 60oC).  
No Plpp amplicons (Appendix 4, Figure 7.2) were observed in lanes 9-15 
(0.25mM and 0.75mM MgCl2). A band for Plpp amplicon of less than 100bp 
was observed in lanes 16 (0.75mM MgCl2, annealing temperature of 
54oC), 17 and 19 (1mM MgCl2, annealing temperatures of 48
oC and 52oC, 
respectively) and lane 23 (1.5mM MgCl2, annealing temperature of 52
oC). 
A bright band for Plpp amplicon of approximately 200bp was observed in 
lanes 18 and 20 (1mM MgCl2, annealing temperatures of 50
oC and 54oC, 
respectively).  
Amplification of PldcC using the primer pair ldcC F and ldcC R (Appendix 4, 
Figure 7.3) revealed a bright band of approximately 275bp in lanes 1-6 
(0.75mM and 1mM MgCl2 and annealing temperatures of 50
oC, 52oC, 
54oC and 56oC). A diffuse band of approximately the same size was 
observed in lanes 7 and 8 (1mM MgCl2 and annealing temperatures of 
54oC and 56oC, respectively). Several bands were observed in lanes 9-12 
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(1.5mM and annealing temperatures of 50oC, 52oC, 54oC and 56oC). This 
indicated that there was non-specific amplification. The samples in lanes 
7, 8 and 9 did not resolve as expected; hence these samples were re-
analyzed on a gel (Appendix 4, Figure 7.4). A bright band of approximately 
275bp was observed in lanes 1-6 (0.75mM and 1mM MgCl2 and annealing 
temperatures of 50oC, 52oC and 54oC). Several bands due to non-specific 
amplification were observed in lane 7 (1.5mM and annealing temperature 
of 50oC).  
Following optimization of the PCR conditions, a confirmatory PCR using 
the optimized conditions was done for Ptat, Plpp and PldcC. Sharp bands of 
approximately 175bp, 200bp and 275bp were obtained for Ptat, Plpp and 
PldcC, respectively (Figure 2.4). The molecular sizes of the bands obtained 
for Plpp and PldcC were as expected; however the band for Ptat was smaller 
than the expected size. 
 
 
 
 
 
 
 
 
 
___________________________________________________________ 
Figure 2.4: Confirmative PCR reactions for Ptat, Plpp and PldcC. The PCR 
reactions for Ptat, Plpp and PldcC contained 1.5mM MgCl2, 1mM MgCl2 and 1mM MgCl2, 
respectively, and were done at 54
o
C. 
 
 
Several PCR reactions were then done for Ptat (Appendix 4, Figure 7.5) at 
various annealing temperatures and MgCl2 concentrations to optimize the 
conditions to obtain a band of the correct molecular size. A bright band of 
under 200bp was observed in all the lanes. Lanes 8-20 also produced 
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bands of approximately 100bp. This was due to non-specific binding of the 
primers. A faint band of approximately 450bp was observed in lane 1 and 
faint bands of less than 300bp were also observed for lanes 11, 12, 16, 
17, 19 and 20. No amplicon of the expected size was observed in any of 
the PCR reactions. The PCR reaction was repeated on an alternative non-
gradient PCR machine using the same PCR conditions as before. A band 
of approximately 200bp was obtained as expected (Figure 2.5). 
 
 
 
 
 
 
 
 
___________________________________________________________ 
Figure 2.5: Agarose gel electrophoretic analysis of PCR reaction for Ptat. The 
PCR reaction contained 1.5mM MgCl2, and was performed at 54
o
C. 
 
Amplification of promoter region Pspc using the primers pairs spc F and 
spc R at various annealing temperatures and MgCl2 concentrations 
(Appendix 4, Figure 7.6) showed Pspc amplicons of approximately 125bp in 
all reactions containing MgCl2 concentrations of 0.75mM, 1mM and 
1.5mM and done at annealing temperatures of 50oC, 52oC, 54oC, 56oC 
and 58oC.  
Amplification of promoter region PlysS using the primers pairs lysS F and 
lysS R at various annealing temperatures and MgCl2 concentrations 
(Appendix 4, Figure 7.7) resulted in the expected amplicon size of 260bp 
observed in lanes 2-15 of gel A, all lanes of gel B and C, lanes 1 and 2 of 
gel D and lanes 5-8 of gel E. However, various other bands indicating non-
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specific binding of the primers, were observed in lanes 11-15 of gel A and 
B, lanes 1-4 of gel C and lanes 1-3 of gel D. The lowest molecular size 
bands indicated the presence of primer dimers in the reactions. 
The PCR conditions for the amplification of each promoter region were 
summarised (Table 2.14) after optimization of the conditions.  
 
Table 2.14: Optimized PCR reaction conditions for each prototype.  
Reagent Volume of reagent ( L) 
Ptat Plpp PldcC PlysS Pspc 
10x PCR reaction buffer 10 10 10 10 10 
25mM MgCl2
 c 6 4 4 4 6 
25 M Forward primer a 1 1 1 1 1 
25 M Reverse primer a 1 1 1 1 1 
10mM dNTP's 2 2 2 2 2 
gDNA template 2 2 2 2 2 
5U/ L Taq polymerase 0.4 0.4 0.4 0.4 0.4 
Sterile distilled water 77.6 79.6 79.6 79.6 77.6 
Total 100 100 100 100 100 
Annealing temperature b 54oC 54oC 54oC 62oC 58oC 
a
 Forward and reverse primers specific to each prototype were used. 
b
 Optimised 
annealing temperature
 
and 
c
optimised magnesium chloride volume. 
 
2.4.6 Purification of PCR products 
PCR reaction products for all five promoter amplicons were then purified 
using the QIAGEN PCR purification kit and analyzed on a gel (Figure 2.6), 
once it was ensured that the DNA band was eluted in the correct step 
during the purification process. Bands of approximately 275bp, 175bp 
(Figure 2.6A) and 125bp (Figure 2.6B) for purified products PlysS, Ptat and 
Pspc, respectively, were observed.  Bands of 225bp and 275bp in lanes 1-2 
(Figure 2.6C) for purified Plpp and PldcC, respectively, were observed.  
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Figure 2.6: Purification of PlysS, Ptat, Pspc, Plpp and PldcC amplicons. A: purified 
PlysS and Ptat PCR products. B: purified Pspc PCR products. C: purified Plpp and PldcC in 
lanes 1-2 respectively. 
 
 
The purity and concentration of all five purified amplicons were estimated 
by measuring the absorbance at various wavelengths (Table 2.15). 
Absorbance ratios greater than 1.7 were obtained. 
 
Table 2.15: Purity and concentration of each prototype after PCR purification.  
Sample Name PlysS Ptat Plpp PldcC Pspc 
A (260/280) 1.75 1.75 1.70 1.75 1.68 
A (260/230) 1.95 1.88 1.74 1.89 1.77 
A230 0.706 0.374 0.615 0.765 0.389 
A260 1.374 0.704 1.073 1.444 0.687 
A280 0.786 0.403 0.632 0.823 0.408 
A320 0.071 0.043 0.105 0.081 0.067 
Concentration 
( g/mL) 69 35 54 72 34 
Absorbance was measured at 230nm, 260nm, 280nm and 320nm. The absorbance 
ratios A(
260
/280) and A(
260
/230) and the concentrations were calculated by the 
spectrophotometer. 
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2.4.7 Plasmid isolation 
Each plasmid, pBR322, pSB417, pME4510 and promoterless pBR322-lux, 
was isolated from its respective E. coli strain and analyzed by agarose gel 
electrophoresis. Bands of different molecular weights were obtained. 
However, it was difficult to determine the exact size of the plasmid without 
restriction. The different bands of the plasmid corresponded to the various 
conformations of the plasmid. Plasmid bands of approximately 3.5kbp 
were observed for plasmid pBR322 (Figure 2.7A) isolated using the 
QIAGEN (lanes 1 and 2) and the Sigma kits (lanes 3 and 4). Three 
plasmid bands of approximately 8kbp, 10kbp and a higher molecular size 
were observed for plasmid pSB417 isolated using the Sigma kit (Figure 
2.7A, lanes 5 & 6). Three plasmid bands of approximately 10kbp and 
higher molecular sizes were observed for plasmid pBR322-lux isolated 
using the Sigma kit (Figure 2.7B). A band of approximately 3.5kbp was 
observed for plasmid pME4510 (Figure 2.7C). 
 
 
 
 
 
 
 
 
___________________________________________________________ 
Figure 2.7: Agarose gel electrophoretic analysis for various plasmid 
isolations. A: Plasmids pBR322 isolated using the Qiagen and Sigma kits were 
represented in lanes 1-2 and 3-4 respectively. Plasmids pSB417 isolated using the 
Sigma kit was represented in lanes 5 and 6. B: The promoterless plasmid pBR322-lux 
isolated using the Sigma kit was represented in lane 1. C: The plasmid pME4510 isolated 
was represented in lane 1. 
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The purity and concentration of all the isolated plasmids were estimated 
by measuring the absorbance at various wavelengths (Table 2.16). 
Absorbance ratios greater than 1.7 for A(260/280) were obtained. Very low 
absorbances at 320nm indicated low amounts of salt impurities and 
therefore high purity of samples. Suitable concentrations of plasmids were 
obtained for use in further restriction digestions.    
 
Table 2.16: Purity and concentration of isolated plasmids.  
Sample Name pBR322 pSB417 pBR322-lux 
A (260/280) 1.8 1.76 1.70 1.78 1.79 1.80 1.76 1.75 
A (260/230) 2.16 2.28 2.30 2.54 1.74 1.77 1.84 1.69 
A230 0.502 1.060 1.079 0.726 1.047 0.819 1.294 1.371 
A260 1.083 2.418 2.487 1.846 1.817 1.451 2.382 2.317 
A280 0.602 1.374 1.462 1.035 1.016 0.805 1.353 1.325 
A320 0.085 0.043 0.040 0.033 0.005 0.002 0.006 0.013 
Concentration 
( g/mL) 
54 121 124 92 91 73 119 116 
Absorbance was measured at 230nm, 260nm, 280nm and 320nm. The absorbance 
ratios A (
260
/280) and A(
260
/230) and the concentrations were calculated by the 
spectrophotometer. 
 
2.4.8 Restriction of plasmids pBR322, pSB417, 322-lux and 
pME4510 
Double digestion of plasmid pBR322 with EcoRI and PstI (Appendix 4, 
Figure 7.8) for one hour produced two bands of approximately 3.5kbp and 
750bp (lane 2). Double digestion of plasmid pSB417 with SalI and PstI for 
one hour produced only one band of approximately 8.5kbp (lane 4) 
instead of two bands.  
Absence of the appearance of two bands from plasmid pSB417 restriction 
with SalI and PstI led to further investigations (Appendix 4, Figure 7.9). 
Single restriction analysis of plasmid pSB417 with SalI (lane 1) and PstI 
(lane 2) produced single bands of 5.8kbp instead of the expected two 
bands. However double restriction analysis of pBR322-lux with the same 
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enzymes SalI and PstI (lane 3) revealed two bands of approximately 
6.5kbp and 2.9kbp. Double restriction analysis of pSB417 with EcoRI and 
BamHI together (lane 5) also produced two bands of approximately 5.8kbp 
and 2.7kbp. Double restriction analysis of pBR322 with EcoRI and BamHI 
together (lane 6) produced two bands of approximately 5.8kbp and 
3.9kbp. 
The absence of the appearance of two bands from plasmid pSB417 
restriction with SalI and PstI was confirmed when single digests (Appendix 
4, Figure 7.10A) of the plasmid with SalI (lane 2) and PstI (lane 3) 
revealed single bands of 8.5kbp in each reaction. Further analysis of the 
restriction of the SalI-restricted fragment with PstI also revealed a single 
band of 8.5kbp. Restriction analysis of plasmid pSB417 with SalI and XbaI 
(Appendix 4, Figure 7.10B) revealed that the digestion was incomplete as 
shown by the presence of undigested plasmid band (8.5kbp). However 
more importantly, two bands of approximately 3.8kbp and 4.6kbp were 
also produced.  
Double restriction digest of the promoterless plasmid pBR322-lux with 
EcoRI and BamHI (Appendix 4, Figure 7.11A) produced two bands of 
approximately 3.9kbp and 5.8kbp (lanes 2 and 3). A single restriction 
digest of the plasmid with SnaBI (Appendix 4, Figure 7.11B) also 
produced a fragment of approximately 10kbp.  
This indicated that the reverse primers for the promoter regions had to be 
re-designed to incorporate the SnaBI restriction site at the 5’-end instead 
of the SalI restriction site to allow ligation of the promoter amplicons into 
the promoterless pBR322-lux plasmid. Hence the reverse primers were re-
designed while the original forward primers containing the EcoRI 
restriction site were used. The PCR reactions for all the 5 promoters were 
re-optimized. 
Restriction of the promoterless pBR322-lux plasmid with both EcoRI and 
SnaBI was done successfully (Appendix 4, Figure 7.12). Single restriction 
digests of the plasmid with SnaBI (lane 2) and EcoRI (lane 4) produced 
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single fragments of ~10kbp in each reaction (Appendix 4, Figure 7.12A). 
Single consecutive restriction digests of plasmid with SnaBI first (lane 2 of 
gel B) and then EcoRI (lane 3 of gel B) also produced a single fragment of 
~10kbp. Finally, a double restriction digest of the plasmid with SnaBI and 
EcoRI also produced a single fragment of ~10kbp (gel C), as expected. 
Subsequently, plasmids pSB417 and 322-lux were digested with EcoRI 
and BamHI in double digests (Figure 2.8). Two bands of 5.8kb and 2.5kb 
were observed in lane 2 following digestion of plasmid pSB417. Similarly, 
two bands of approximately 5.8kb and 3.8kb were observed in lane 4. The 
5.8kbp fragment corresponded to the excised lux cassette.  
 
 
 
 
 
 
 
 
___________________________________________________________ 
Figure 2.8: Restriction of Plasmids pSB417 and 322-lux. Plasmids pSB417 and 
322-lux digested in double digests with EcoRI and BamHI are represented in lanes 2 and 
4 respectively with the isolated plasmids pSB417 and 322-lux represented in lanes 1 and 
3 respectively. 
 
The plasmid pME4510 was digested with EcoRI and BamHI in a double 
digest for 1 hour. A band of approximately 4kb for digested plasmid was 
observed in lane 2 (Figure 2.9). Plasmid pSB417 harbouring the lux 
cassette was also digested by the same procedure as plasmid pME4510. 
Two bands of approximately 5.8kb and 2.5kb, corresponding to the 
excised lux cassette and remaining plasmid sequence, respectively, were 
observed in lane 4 following digestion of plasmid pSB417. 
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Figure 2.9: Restriction of plasmids pME4510 and pSB417. Undigested and 
digested plasmid pME4510 are represented in lanes 1 and 2 respectively. Undigested 
and digested plasmid pSB417 are represented in lanes 3 and 4 respectively. The plasmid 
was digested by EcoRI and BamHI in a double digest. 
 
2.4.9 Ligation of lux cassette into pME4510. 
Ligation of the excised lux cassette from plasmid pSB417 into the plasmid 
vector pME4510 (Figure 2.10) was done. Digested pME4510 and pSB417 
produced fragments of 3.8kbp (lane 1) and 5.8kbp and 2.7kbp (lane 2) 
respectively. Ligation of the lux cassette from plasmid pSB417 into the 
plasmid vector was observed by the presence of several bands in lane 3 
indicating re-circularization of the recombinant plasmids (Figure 2.10). The 
presence of a 3.8kbp fragment in lane 3 indicated that excess plasmid 
vector was also present in the ligation reaction. 
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Figure 2.10: Ligation of excised lux cassette into plasmid vector pME4510. 
Restricted plasmids pME4510 and pSB417 are represented in lanes 1 and 2 
respectively. Ligation of lux cassette from plasmid pSB417 into the plasmid vector is 
represented in lane 3.  
 
2.4.10 Transformation and screening of pME-lux 
Transformation of recombinant plasmid pME-lux into electro-competent E. 
coli DH5  cells with successful ligation reactions produced over 200 
colonies of transformants; of which, 24 colonies were selected at random 
for screening. Following plasmid isolation from all 24 colonies and 
digestion to assess the presence of the lux cassette, only seven out of 24 
recombinant plasmids harboured the lux cassette (Lanes 2, 4, 5, 15, 16, 
19 and 21) (Figure 2.11). The expected DNA sequence of pME-lux is 
shown in Appendix 5. 
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Figure 2.11: Restriction of pMElux recombinant plasmids isolated from 
transformed E. coli DH5  cells. The plasmids were digested by EcoRI and BamHI in a 
double digest. 
 
2.4.11 Restriction of pME-lux plasmids 
Following successful transformation of the promoterless pME-lux 
plasmids, the next stage was to insert promoters upstream of the lux 
cassette. Restriction analysis was done to assess the ability of restriction 
endonucleases EcoRI and SnaBI to digest the plasmids (Figure 2.12) 
because the promoter amplicons were flanked by EcoRI and SnaBI 
restriction sites. Plasmids from seven isolates that harboured the lux 
cassette in plasmid pME-lux were also digested in a double digest with 
EcoRI and SnaBI to assess the presence of intact restriction sites (Figure 
2.12). Plasmids in lanes 1, 2, 3 and 7 produced single fragments of 10kbp 
and therefore harboured intact EcoRI and SnaBI restriction sites. Lane 5 
was replicated in lane 6 in error; hence these two samples are based on 
the same restriction reaction. Plasmids in lanes 4 and 8 remained 
undigested, indicating that their restriction sites were non-functional. 
Plasmids in lanes 5, 6 and 8 produced fragments of incorrect molecular 
weights. 
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Figure 2.12: Restriction of promoterless plasmid pME-lux. Double restriction 
digests of pME-lux with EcoRI and SnaBI. 
 
 
Plasmid pME-lux in lane 1 of Figure 2.12 was subsequently used for all 
further manipulations. The purity and concentration of the isolated plasmid 
pME-lux was estimated by measuring the absorbance at various 
wavelengths (Table 2.17). Absorbance ratios greater than 1.7 were 
obtained.  
 
Table 2.17: Purity and concentration of isolated pME-lux plasmid.  
Sample Name pME-lux 
A (260/280) 1.79 
A (260/230) 2.43 
A230 1.016 
A260 2.470 
A280 1.377 
A320 0.019 
Concentration ( g/mL) 123 
Absorbance (A) was measured at 230nm, 260nm, 280nm and 320nm. The absorbance 
ratios A (
260
/280) and A(
260
/230) and the concentrations were calculated by the 
spectrophotometer. 
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2.4.12 PCR with new primers 
New reverse primers were designed in order to replace the SalI restriction 
site with the SnaBI restriction site (Table 2.18). 
Table 2.18: New reverse primers tagged with SnaBI restriction site.  
Primer 
Name
 a
 
Primer
 b
 Primer length 
(bases)
 c
 
% 
GC
d
 
Tm 
(
o
C)
 e
 
ldcC F 5’-CTTCAAGAATTCGGGTTACGCGCGTGCCGG-3' 30 60 67 
ldcC R 5'-CTGATTACGTAGTCAAGAGAATGCTGAAGCCGTCCTG-3' 37 48.7 67 
lpp F 5’-CTTCAAGAATTCGTATTGACCCCATAGACAGCTTCG-3’ 36 44.4 64 
lpp R 5'-GTGATTACGTAGTCAGCGCAAGGGATTTGTTCATA-3' 35 42.9 63 
lysS F 5’-CTTCAAGAATTCGCTGTCTCTGGGAGCTACTCG-3' 33 51.5 66 
lysS R 5'-GTGATTACGTAGTCAGATAGCGGCCGATTGATTC-3' 34 47.1 64 
spc F 5’-CTTCAAGAATTCGTAACGCGCGGAACTTCCATC-3' 33 48.5 64 
spc R 5'-CTCATTACGTAGTCAAGGTAGATCACCATGGCACGA-3' 36 47.2 66 
tat F 5’-CTTCAAGAATTCGGGGTATTCCTGATCCTGCGCCG-3' 35 54.3 68 
tat R 5'-GTGATTACGTAGTCAGCAACAGTCCATGGAAAAGC-3' 35 45.7 64 
a
 F denotes forward primer and R denotes reverse primer. 
b
 Underlined sequences show 
attached restriction sites. The 
c 
primer length is between 30-40bp, % GC content
d
 is 
between 40-60% and the 
e 
melting temperature for each primer is between 60-70
o
C. 
 
Based on the promoter region being amplified by the new set of primer 
pairs, the sizes of the amplicons and the sizes of each amplicon after 
restriction with EcoRI and SnaBI were calculated (Table 2.19). The 
nucleotide sequences for the amplicons for each promoter region are 
represented in Appendix 1. 
Table 2.19: Sizes of PCR amplicons. 
  PCR products using new primersa 
  Size Size after restriction 
lysS 125 110 
tat 206 191 
lpp 161 146 
ldcC 225 210 
spc 134 119 
a
Sizes of PCR amplicons before and after digestion with EcoRI and SnaBI. 
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Several PCR reactions were then done for the amplification of each 
promoter region Ptat, Plpp, PldcC, Pspc and PlysS, using the primers pairs tat F 
and tat R, lpp F and lpp R, ldcC F and ldcC R, spc F and spc R, lysS F 
and lysS R respectively. The reactions were done at various annealing 
temperatures ranging from 52oC to 68oC and MgCl2 concentrations 
ranging from 0.75mM to 1.5mM. 
A confirmatory PCR using the optimized conditions was performed for the 
amplification of all five promoter regions (Figure 2.13). Bands of 
approximately 225bp (lane 1), 160bp (lane 2), 200bp (lane 3), 125bp (lane 
4) and 135bp (lane 5) were obtained for PldcC, Plpp, Ptat, PlysS and Pspc, 
respectively.   
___________________________________________________________ 
Figure 2.13: PCR reactions for PldcC, Plpp, Ptat, PlysS and Pspc as represented in 
lanes 1, 2, 3, 4 and 5 respectively. 
 
The purity and concentration of all five purified PCR products were 
estimated by measuring the absorbance at various wavelengths (Table 
2.20). Absorbance ratios greater than 1.7 for A(260/280) and A (
260/280) were 
obtained, as expected. Furthermore, the absorbance ratios for A(260/230) 
were greater than 2. Very low absorbances at 320nm indicated low 
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amounts of particles in the solution and therefore high purity of samples. 
High concentrations of PCR products were obtained and this indicated 
that the purified PCR products could be used for further restriction 
digestions. 
Table 2.20: Purity and concentration of purified PCR products.  
Sample Name PldcC Plpp Ptat PlysS Pspc 
A (260/280) 1.8 1.79 1.78 1.77 1.77 
A (260/230) 2.11 2.18 2.08 2.14 2.21 
A230 0.712 0.476 0.766 0.443 0.599 
A260 1.500 1.037 1.596 0.949 1.322 
A280 0.834 0.581 0.897 0.537 0.749 
A320 0.028 0.026 0.047 0.025 0.026 
Concentration ( g/mL) 75 52 80 47 66 
Absorbance (A) was measured at 230nm, 260nm, 280nm and 320nm. The absorbance 
ratios A (
260
/280) and A(
260
/230) and the concentrations were calculated by the 
spectrophotometer. 
 
The optimised PCR conditions for each prototype are summarised in 
Table 2.21.  
Table 2.21: Optimized PCR reaction conditions for amplification of all promoter 
regions.  
Reagent Volume of reagent ( L) 
Ptat Plpp PldcC PlysS Pspc 
10x PCR reaction buffer 10 10 10 10 10 
25mM MgCl2 6 4 3 6 6 
25 M Forward primera 1 1 1 1 1 
25 M Reverse primera 1 1 1 1 1 
10mM dNTP's 2 2 2 2 2 
gDNA template 2 2 2 2 2 
5U/ L Taq polymerase 0.4 0.4 0.4 0.4 0.4 
Sterile distilled water 77.6 79.6 80.6 77.6 77.6 
Total 100 100 100 100 100 
Annealing temperature 66oC 54oC 64oC 68oC 58oC 
a
Forward and reverse primers specific to each promoter were used. 
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2.4.13 Restriction of PCR products 
The purified PCR products for all five promoter regions were subjected to 
restriction in a double digest by the restriction endonucleases EcoRI and 
SnaBI. The digested fragments were then analyzed by agarose gel 
electrophoresis (Figure 2.14). Restriction of amplicons PlysS (lane 2), PldcC 
(lane 4) and Ptat (lane 6) with EcoRI and SnaBI produced fragments of 
approximately 110bp, 210bp and 200bp, respectively (Figure 2.14A). 
Restriction of amplicons Plpp (lane 2) and Pspc (lane 4) (Figure 2.14B) 
produced fragments of approximately 200bp. There were no observable 
differences in the mobilities of the undigested and digested fragments on 
the gel, suggesting that such small differences in low-molecular weight 
fragments were not resolved well on the gel. 
 
 
 
 
 
 
 
 
___________________________________________________________ 
Figure 2.14: Restriction of PCR products. PCR products were digested in a 
double digest by EcoRI and SnaBI. Figure A: Undigested and digested PlysS is 
represented in lanes 1 and 2 respectively. Undigested and digested PldcC is represented 
in lanes 3 and 4 respectively. Undigested and digested Ptat is represented in lanes 5 and 
6 respectively. Figure B: Undigested and digested Plpp is represented in lanes 1 and 2 
respectively. Undigested and digested Pspc is represented in lanes 3 and 4 respectively. 
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2.4.14 Ligation of PCR products into promoterless pME-lux 
plasmid 
Aliquots of ligation reaction products of each digested promoter fragment 
Pspc, PldcC, Plpp, PlysS and Ptat with the restricted promoterless plasmid 
pME-lux (lane 1) were analyzed by agarose gel electrophoresis (Figure 
2.15). Bands of ~10kbp corresponding to spc-pME-lux, ldcC-pME-lux, lpp-
pME-lux, lysS-pME-lux and tat-pME-lux in various gels were obtained in 
all cases. However, several other bands of low molecular sizes were also 
obtained during the ligation reactions.  
 
 
 
 
 
 
 
 
 
___________________________________________________________ 
Figure 2.15: Ligation of each of the five restricted amplicons and plasmid 
pME-lux. Promoterless plasmid pME-lux digested with EcoRI and SnaBI is shown in 
lane 1 of all gels. (A) Ligation reaction of Pspc with digested promoterless plasmid is 
represented in lane 2. (B) Ligation reaction of PldcC with digested plasmid is shown in lane 
2. (C) Ligation reaction of Plpp and PlysS with digested plasmid is shown in lanes 2 and 3 
respectively. (D) Ligation reaction of Ptat with digested plasmid is shown in lane 2. 
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2.4.15 Transformation and screening of recombinant plasmids 
from pME-lux 
Transformation of recombinant plasmids containing the promoter 
amplicons into electro-competent E. coli DH5  cells was successful and 
the numbers of colonies produced in each case are detailed in Table 2.22. 
Table 2.22: E. coli DH5  bacterial colonies post electroporation.  
Prototype Number of colonies 
No plasmid 0 
pME4510 200 
pMElux 24 
ldcC-pME-lux 13 
lysS-pME-lux 11 
tat-pME-lux 163 
spc-pME-lux 9 
lpp-pME-lux 39 
Each electroporation mixture contained 3 L ligation mix and 40 L electrocompetent cells. 
 
Successful transformants were selected, based on their ability to grow in 
the presence of gentamicin. All colonies were sub-cultured onto secondary 
agar plates as well as into LB broth. Plasmids were isolated from all 
colonies and digested with EcoRI and SnaBI to assess the presence of 
the amplicons. Following plasmid isolations and restriction analysis to 
assess the presence of promoter amplicons, a confirmatory gel was run to 
confirm the presence of the promoter regions (Figure 2.16). Three out of 
12 colonies were shown to harbour Pspc, as represented in lane 2-4. Two 
out of 10 colonies were found to harbour PldcC, as represented in lane 5-6. 
Three out of 8 colonies were found to harbour PlysS, as represented in 
lanes 7-9. Two out of 10 colonies were found to harbour Plpp, as 
represented in lanes 10-11. Two out of 6 colonies were found to harbour 
Ptat, as represented in lanes 12-13. Lane 1 of the gel represents restriction 
of the promoterless pME-lux as a negative control. 
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___________________________________________________________ 
Figure 2.16: Restriction of recombinant plasmids isolated from transformed E. 
coli DH5  cells. Lane 1 represents promoterless pME-lux. Lanes 2-4 represent restriction 
of spc-pMElux recombinant plasmids. Lanes 5-6 represent restriction of ldcC-pME-lux. 
Lanes 7-9 represent restriction of lysS-pME-lux recombinant plasmids. Lanes 10-11 
represent restriction of lpp-pME-lux recombinant plasmids. Lanes 12-13 represent 
restriction of tat-pME-lux recombinant plasmids. All plasmids were digested in a double 
digest with EcoRI and SnaBI. 
 
2.4.16 DNA sequencing of E. coli recombinant plasmids 
All thirteen recombinant plasmids isolated from E. coli transformant strains 
were sent for DNA sequencing to analyse the nucleotide sequence for 
inserted promoter and lux cassette regions. All plasmids were found to 
harbour the defined promoter inserts between EcoRI and SnaBI restriction 
sites. Similarly, all plasmids were found to harbour the lux cassette 
between EcoRI and BamHI restriction sites. DNA sequences for each of 
the thirteen plasmid isolates are represented in Appendix 6.  
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2.4.17 Transformation into P. aeruginosa ATCC 9027 
Transformation of recombinant plasmids containing the promoter 
amplicons and the lux cassette into electro-competent P. aeruginosa 
ATCC 9027 cells was attempted using a variety of electroporation buffers. 
No transformant colonies were obtained on selective media when 300mM 
sucrose, 10% glycerol or 25mM HEPES buffer containing 300mM glucose 
and 5mM calcium chloride was used as the electroporation buffer, even 
after several attempts. Transformation was also unsuccessful when the 
amount of plasmid was varied, recovery time post-electroporation was 
varied and when capacitance and resistance parameters on the 
electroporation equipment were varied.  
Following numerous unsuccessful attempts to transform P. aeruginosa, a 
further range of alternative electroporation buffers were used. These 
included 15% glycerol containing 1mM MOPS, Ringers solution, and 1mM 
HEPES pH 7.0, containing 300mM sucrose and 1mM magnesium 
chloride. Ringers solution was most effective as an electroporation buffer, 
followed by 1mM HEPES pH 7.0, containing 300mM sucrose and 1mM 
magnesium chloride and lastly 15% glycerol containing 1mM MOPS. The 
numbers of transformant colonies obtained after screening on selective 
media are detailed in Table 2.23. 
Table 2.23: P. aeruginosa ATCC 9027 bacterial colonies post electroporation.  
Prototype 
Number of colonies with various electroporation buffers 
Ringers 
solution 
Glycerol-MOPS HEPES-sucrose-MgCl2 
No plasmid 0 0 0 
pME4510 1 3 18 
pMElux 7 0 0 
ldcC-pME-lux 8 1 2 
lysS-pME-lux 8 12 1 
tat-pME-lux 3 0 11 
spc-pME-lux 1 2  
lpp-pME-lux 7 0 0 
Total 35 18 32 
Each electroporation mixture contained 3 L ligation mix and 40 L electrocompetent cells. 
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All colonies were sub-cultured onto secondary agar plates as well as into 
LB broth. Each of the transformant colonies was also assessed for 
bioluminescence ability by measuring relative light units (Table 2.24) and 
comparing to the negative controls pME4510 and pMElux.  
 
Table 2.24: Relative Light Units (RLU’s) from P. aeruginosa transformants.  
Plasmid 
isolate from 
E. coli 
P. aeruginosa 
transformant  
Mean 
RLU 
 Plasmid 
isolate from 
E.coli 
P. aeruginosa 
transformant 
Mean 
RLU 
pME4510 H14 90  pMElux R3 79 
 H15 90   R9 90 
 H21 85   R13 88 
 H23 91   R15 77 
 H31 111   R23 100 
 H41 102   R28 87 
 H42 110   R29 82 
 G2 91  spc3 R1 81 
 G3 89  spc5 G1a 280579 
 G4 88   G1b 96 
 R2 92  ldcC8 H1a 645355 
lpp4 R1 90   H1b 110 
lpp4 R1 86  ldcC4b G1 86 
 R3 553431   R1 84 
 R4 3036426   R9 85 
 R6 191   R15 91 
 R11 85   R17 88 
lys6 R8 101   R20 87 
 R10 2252009   R21 84 
 R14 2519292   R22 92 
 R25 5307196   R23 92 
 R26 271  lpp8 R3 96 
 R27 816220  tat9 H1 80 
 R28 114   H2 87 
 R29 2090   R11 89 
 G1 743591   R12 1042124 
 G4 1651257   H5 3798007 
 G8 2487095   H8 916 
 G10 2142399   H9 1108108 
 G14 64984   H11 292688 
 G16 90   H12 703611 
 G17 624   H13 318533 
 G22 100   H14 2103569 
 G25 2790726  tat12 R1 149 
 G27 674549   H8 6277 
 G28 4120437   H10 1218121 
 G29 178553  lys3 H1 97 
 
The letters G, R and H next to the P. aeruginosa transformant number represents 
glycerol containing MOPS, ringers solution and sucrose containing HEPES respectively; 
the type of electroporation media used during preparation of electro-competent cells. 
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Plasmids were isolated from transformants that produced 
bioluminescence greater than a threshold value of 200 RLU’s from Table 
2.24 (Figure 2.17). Transformants harbouring plasmids pME4510 and 
pME-lux as negative controls were not expected to produce 
bioluminescence and therefore transformants that failed to produce 
bioluminescence were also subjected to plasmid isolation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
___________________________________________________________ 
Figure 2.17: Recombinant plasmids from transformed P. aeruginosa ATCC 
9027 cells. (A) Lanes 1-6 represent plasmid pME4510. Lanes 6-19 represent 
recombinant plasmids isolated from lysS-pMElux. (B) Lanes 1-6 represent recombinant 
plasmids pMElux. (C) Lane 1 represents ldcC-pMElux, lanes 2-7 represent tat-pMElux, 
lane 8 represents lys-pMElux, and lanes 9, 10 and 11 represent tat-pMElux, spc-pMElux 
and lys-pMElux respectively.  
 
A  M1 1    2   3    4   5    6    7    8    9  10  11 12  13 14  15  16  17  18  19 
Marker 
size (bp) 
12216 
8144 
6108 
5090 
4072 
3054 
2036 
1636 
B 
 M1    1      2     3     4     5     6   M1 C  1      2     3     4     5     6     7      8      9   10    11    M1 
Page 97 
 
Following plasmid isolation, the recombinant plasmids were digested with 
EcoRI and SnaBI to assess the presence of the amplicons. Due to the 
wide range of resolution required to visualise the promoter regions (100-
250bp) as well as the plasmid bands (10kb), the promoter regions were 
not observed upon restriction analysis. Therefore the recombinant 
plasmids isolated from P. aeruginosa were subjected to PCR 
amplification, results of which would show the presence of promoter 
inserts, if any. Figure 2.18 represents the presence of promoter regions in 
the recombinant plasmids isolated from P. aeruginosa and therefore 
successful introduction of lux-based recombinant plasmids and the 
creation of constitutively expressed lux-based bioluminescent constructs. 
According to Figure 2.18A, a band approximately 200bp in lanes 1-2 
indicates the amplification of Plpp. Bands of 220bp and 150bp in lanes 3 
and 4 indicate the amplification of PldcC and Pspc, respectively. A band of 
200bp in lanes 5-17 represents amplification of PlysS. Similarly, a band of 
200bp in lanes 1-7 of Figure 2.18B represents the amplification of Ptat. 
Bands of 100bp were also observed in lanes 1, 3, 5 and 7 of Figure 2.18B, 
indicating mis-priming of the primers. 
 
 
 
 
 
 
 
 
___________________________________________________________ 
Figure 2.18: PCR reactions for PldcC, Plpp, Ptat, PlysS and Pspc from P. 
aeruginosa clones. (A) Lpp-pMElux is represented in lanes 1-2. LdcC-pMElux and 
spc-pMElux are represented in lanes 3 and 4 respectively. Lys-pMElux is represented in 
lanes 5-17. (B) tat-pMElux is represented in gel B. 
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2.4.18 RLU comparison between E. coli and P. aeruginosa 
strains 
Relative production of bioluminescence for various bioluminescent 
prototypes in E. coli and P. aeruginosa bioluminescent strains were 
compared (Figure 2.19). It was observed that the strain harbouring the 
promoterless plasmid in E. coli produced greater bioluminescence 
compared to its counterpart in P. aeruginosa. However, all P. aeruginosa 
bioluminescent strains containing promoters produced bioluminescence at 
various magnitudes higher than their counterparts in E. coli. For instance, 
the lys-pME-lux was found to be 500 times more bioluminescent in P. 
aeruginosa than in E. coli. LdcC-pME-lux and spc-pME-lux produced less 
bioluminescence compared to Lys-pME-lux, Lpp-pME-lux and Tat-pME-
lux. Different variants of the same strain also produced bioluminescence 
of different magnitudes; for example, three variants of Tat-pME-lux 
produced different levels of bioluminescence even though these three 
strains contained the Ptat. 
___________________________________________________________ 
Figure 2.19: Relative light output for all E. coli and P. aeruginosa ATCC 
9027 strains.      Promoterless pMElux,     lysS,      ldcC,      spc,      lpp,       tat strains. 
Error bars show standard deviation for n=3 samples. Bioluminescence was measured at 
490nm from 1 mL of each strain grown for 24 hours.  
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2.4.19 Plasmid DNA sequencing of P. aeruginosa 
bioluminescent strains 
All plasmid-bearing strains produced from P. aeruginosa were sent for 
DNA sequencing to analyse the nucleotide sequence for inserted 
promoter and lux cassette. All plasmids from bioluminescent strains were 
found to harbour the defined promoter inserts between EcoRI and SnaBI 
restriction sites and the lux cassette between EcoRI and BamHI restriction 
sites. DNA sequences for each of the plasmid isolates are represented in 
Appendix 7.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 100 
 
2.5 Discussion 
2.5.1 Characterization of P. aeruginosa cells 
Gram staining analysis of the bacterial cells revealed pink rod-shaped 
cells of approximately 2 m in length, indicating that the bacterial cells 
were gram negative. Moreover when these cells were grown on agar 
plates, a characteristic blue-green colour was observed, indicating that 
procyanin, a water-soluble product (Reyes, Bale, Cannon & Matsen, 1981) 
was produced. This pigment is produced only by P. aeruginosa cells 
(Reyes et al., 1981); hence the species of the bacterial cells was 
confirmed. The P. aeruginosa species was tested for susceptibility against 
several antibiotics. Out of 12 antibiotics tested, the Pseudomonas cells 
were found to be susceptible to gentamicin and polymixinB (Table 2.10). 
This result correlates to other studies that also found Pseudomonas to be 
susceptible to gentamicin and polymixinB (Andrews, 2009; Kronvall, 
1982). This information was later used to search for a plasmid containing 
gentamicin-resistant or polymixinB-resistant gene and compatible with P. 
aeruginosa cells. 
 
2.5.2 Amplification of promoter regions 
The lux cassette in plasmid pSB417 is flanked by a number of restriction 
sites that include SalI and PstI (Winson et al., 1998). Similarly, plasmid 
pBR322 has various restriction sites in the MCS, including EcoRI and PstI. 
Therefore, to ligate the promoter region at the 5’-end of the lux cassette, 
an artificial SalI restriction site was tagged in the reverse primers such that 
the 3’-end of the promoter region would match the 5’ end of the lux 
cassette by sharing a SalI restriction site. Similarly, an artificial EcoRI 
restriction site was tagged at the 5’-end of the forward primers such that 
the 5’-end of the promoter matches the 5’-end of the MCS of plasmid 
pBR322. Finally the 3’-end of the lux cassette matched the 3’-end of 
plasmid pBR322 by sharing a PstI restriction site.  
Page 101 
 
Amplification of all promoter regions was successful after optimising 
various parameters for PCR. Successful amplification of all five promoter 
regions confirmed that the DNA template was of high purity, concentration 
and of working quality. It also confirmed that the dNTP mixture, 
magnesium chloride, Taq polymerase and reaction buffer were working. 
Optimizing magnesium chloride concentration in PCR reactions is vital. 
Magnesium chloride concentrations in the range of 1.5-4mM are required 
for specific amplification and prevent non-specific amplification (Oste, 
1989). Multiple bands produced during the optimization process were due 
to non-specific annealing of primers to the template DNA. Non-specific 
binding of primers is also enhanced by high magnesium chloride 
concentrations. In most cases, this was observed when a magnesium 
chloride concentration of 1.5mM was used and therefore magnesium 
chloride concentrations were reduced.  
The effect of mis-matched nucleotide bases was observed in the 
sequencing data, where one or two nucleotides did not match the original 
template sequence. For example, there was an addition of an adenine 
nucleotide 3bp downstream of the SnaBI restriction site in the strain 
labelled ‘spc9-pME-lux’ in E. coli (appendix 6). Each set of sequencing 
data also showed that the first 80 nucleotides had a high level of 
degeneracy. This degeneracy was due to inherent difficulties faced during 
sequencing reactions. However, the region where the nucleotide did not 
match the sequence was not vital for promoter activity; that is it was not 
present in the -10 and -35 regions. The nucleotide mismatch was probably 
due to the Taq DNA polymerase lacking proof-reading ability as it does not 
contain 3’-5’ exonuclease activity (Eckert & Kunkel, 1991). Hence PCR 
reactions catalysed by this enzyme are prone to errors in incorporation of 
mis-matched nucleotide bases. The fidelity of Taq polymerase is 10 fold 
less compared to that of T4 or T7 polymerases that also lack the 3’-5’ 
exonuclease activity. However, the conditions of the PCR reactions can 
greatly affect the fidelity of the Taq polymerase. Some conditions, such as 
decreasing magnesium chloride concentration and pH of reaction (Eckert 
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& Kunkel, 1990), increase fidelity. On the other hand, increasing 
incubation temperature from 70 to 80oC (Eckert & Kunkel, 1991) and 
dNTP concentration from 1 M to 1mM (Eckert & Kunkel, 1991) reduces 
the fidelity of the enzyme. Hence, it was desirable to use low dNTP and 
magnesium chloride concentrations for more accurate PCR amplification.  
Amplification of Plpp PldcC and Pspc resulted in amplicons which were 
approximately of the correct molecular size. However, amplification of Ptat 
resulted in an amplicon that was smaller than the expected size and 
therefore the reaction was performed using exactly the same conditions 
but on an alternative non-gradient PCR machine. Using this machine, 
amplicons of the correct molecular size were obtained. This suggests that 
even a slight difference in annealing temperature can affect the 
amplification to obtain the correct products. Gradient PCR machines have 
varied temperatures across the blocks and therefore may contribute to 
sub-optimal temperatures. Since optimal temperatures are vital for PCR 
reactions, the requirement for thermal cyclers that allow stringent and 
accurate maintenance and control of temperature is vital. A study 
(Hoelzel, 1990) emphasized that a thermal cycler consisting of a metal 
block heater was crucial to provide uniform heating and cooling in all the 
wells/tubes. 
With regards to the importance of temperature in PCR reactions, the 
denaturation temperature and the reannealing temperature are the most 
crucial (Bej, Mahbubani & Atlas, 1991b). In this study, the denaturation 
temperature was set at 94oC as a standard denaturation temperature. If 
the denaturation temperature is too low, the double stranded DNA 
template will not denature to form single stranded DNA. On the other 
hand, the DNA is prone to damage at high temperatures especially during 
the denaturation step. At high temperatures cytosine is converted to uracil, 
which is an analogue of thymine (Eckert & Kunkel, 1991). Hence, such 
base substitution can lead to errors in the amplified sequences and this 
could be another reason for mismatches between the template DNA and 
amplified DNA. The reannealing temperature is equally important since it 
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dictates the specificity of the reaction. The reannealing temperature is 
partially dictated by the primer pairs and therefore needs to be optimized. 
Extensive work was carried out to optimize the reannealing temperature 
for PCR reactions for each of the promoter sequences. Low annealing 
temperatures results in the primers binding to non-target DNA, thereby 
producing multiple PCR products. If the temperature is too high, the 
primers cannot anneal to the target template and therefore no 
amplification is observed. A 2-step PCR can be performed if the expected 
amplification products range between 100-300bp. The only difference 
between a normal PCR and a two-step PCR reaction is that the extension 
temperature is the same as the annealing temperature in the latter (Bej, 
DiCesare, Haff & Atlas, 1991a). 
The prerequisite of high concentrations of amplicons for subsequent 
restriction and ligation reactions required that the PCR reactions be scaled 
up to 200 L-250 L. These PCR products were then purified using the 
PCR purification kit and the pure products were eluted in 50 L. This step 
of eluting larger volumes of PCR reactions into smaller volumes brought 
about an intrinsic ‘concentrating effect’ of the PCR products during the 
purification step. This procedure was desirable to avoid ethanol 
precipitation to concentrate the amount of DNA available for subsequent 
reactions. Ethanol precipitation has the disadvantage of lower yield of the 
PCR products during the procedure and it is also time consuming. 
The various promoter sequences of P. aeruginosa were documented and 
utilised successfully in this study for the first time. 
 
2.5.3 Purification of amplicons 
The PCR products were then purified by two different methods; using the 
gel extraction and PCR purification kits. In both cases, there seemed to be 
a substantial loss of the products. Hence, PCR reaction volumes were 
scaled up. There was no remarkable difference between the two methods 
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for the recovery of products as observed by absorbance readings. Hence 
the PCR purification method using the SIGMA ALDRICH® GenElute PCR 
clean up kit was subsequently used for purifying PCR products as it was a 
very rapid method and did not require gel extraction, exposure to UV 
radiation or staining with ethidium bromide. Ethidium bromide is an 
intercalating agent that inserts itself between bases of the DNA double 
helix and can cause an insertion of an extra base during DNA replication. 
The consequence of this is that a frameshift mutation is caused (Dale & 
Park, 2004). Moreover, the restriction endonuclease EcoRI digests both 
DNA strands at the consensus sequence 5’-GAATTC-3’, producing sticky 
ends. However, in the presence of ethidium bromide EcoRI digests only 
one of the two DNA strands producing a nick in the DNA rather than a 
sticky end (Balagurumoorthy, Adelstein & Kassis, 2008). Exposure to UV 
light causes two adjacent pyrimidine bases to form covalent bonds 
between them. Once these covalent bonds are formed, the DNA is unable 
to replicate. This damage is usually repaired; however, a mutation is 
created as a result of such repair (Dale & Park, 2004). For these reasons, 
the PCR purification method was preferred; however, small aliquots of the 
purified products were analysed on agarose gels to confirm that the 
correct PCR products were obtained and purified. 
The PCR products were required to be sequenced after purification to 
ascertain that the products were the actual promoter regions being 
amplified. Several attempts were made at sequencing the purified 
amplicons; however no sequence data were available. This was because 
the PCR products were unstable during the transit of the samples to the 
sequencing facility. The next approach therefore was to clone the 
amplified products into a vector before attempting to sequence them, as 
adviced by the sequencing facility (GATC®). 
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2.5.4 Plasmid isolation 
The aim was to insert the lux cassette followed by the amplified promoter 
regions into the plasmid pME4510. Plasmid pME4510 contains a 
gentamicin resistance gene and is compatible in Pseudomonas (Rist & 
Kertesz, 1998).  
Plasmid isolation was successful and, in most cases, several 
conformations of the plasmids were obtained, as observed by the 
presence of several bands and the difference in their mobilities when 
resolved on an agarose gel. The difference in mobilities showed that linear 
DNA migrates more slowly than any other conformation of DNA. 
Supercoiled DNA molecules migrate much faster and hence much further 
compared to linear DNA molecules (Berg et al., 2002; Karp, 1999). 
Various bands represent different conformations of the plasmid DNA 
molecules, such as super-coiled structures, open circular structures, linear 
plasmid and concatemers (Lahijani, Hulley, Soriano, Horn & Marquet, 
1996). Concatemers may be obtained if the plasmid DNA was isolated 
whilst the bacterial cells were undergoing replication. 
 
2.5.5 Restriction 
Digestion of plasmid pSB417 with the two enzymes SalI and PstI 
produced only one fragment of linearised 8.5kbp plasmid, instead of the 
expected two fragments of molecular size 5.8kbp and 2.7kbp and 
therefore further investigations were performed. Single restriction digests 
were performed to determine whether both restriction enzymes were 
functional. The production of linearised fragments of 8.5kbp confirmed that 
both enzymes were functional. Further investigation to determine whether 
both these enzymes were compatible together in a double digest was 
performed by digesting pBR322-lux with these two enzymes in a double 
digest (Figure 2.20). 
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_______________________________________________________________________ 
Figure 2.20: Promoter-lux-pBR322 plasmid (adapted from Bolivar et al., (1977). Tet
r
 
and ori represent the tetracycline resistance gene and origin of replication, respectively. 
Relevant restriction endonucleases sites are also shown. 
 
Again, the production of two fragments as expected confirmed that these 
two enzymes were compatible when used together in a double digest. 
Hence the inability to produce two fragments of plasmid pSB417 by 
digestion with SalI and PstI suggested that one of the restriction sites was 
absent. It was confirmed that the SalI and PstI restriction sites in the 
plasmid pSB417 were lost/mutated at either the 5’-end of the lux cassette 
or at the 3’-end of the lux cassette. A double restriction digest with SalI 
and XbaI produced two fragments of 3.8kbp and 4.7kbp (Figure 2.21), 
which confirmed that the restriction sites were lost/mutated at the 5’-end of 
the lux cassette.  
_______________________________________________________________________ 
Figure 2.21: lux-cassette flanked by various restriction sites (Winson et al., 1998). 
Digestion with XbaI and SalI would be expected to produce two fragments of 
approximately 2kbp and 3.8kbp as shown, and also a third fragment of 2.7kbp for the 
remainder of the plasmid. 
~2kb
p 
3.8kb
p 
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Failure of pSB417 digestion with SalI and PstI led to the investigation to 
determine whether the lux cassette could be excised with EcoRI and 
BamHI. The functionality of the enzymes in a double digest was also 
assessed by digesting the plasmid pBR322. Digestion of plasmid pSB417 
with BamHI and EcoRI was successful, since two fragments of ~5.8kbp 
and 2.7kbp were produced as expected. However, absence of SalI and 
PstI restriction sites on plasmid pSB417 suggested that the reverse 
primers needed to be redesigned in order to incorporate a SnaBI 
restriction site rather than a SalI restriction site.  
 
2.5.6 Formation of lux-bearing plasmids 
The aim was to excise the lux cassette out of the plasmids pSB417 or 
322-lux and insert it into the vector plasmid pME4510 (Rist & Kertesz, 
1998). Double digestion of plasmid pSB417 with EcoRI and BamHI 
produced two fragments of the correct molecular sizes of 5.8kbp and 
2.7kbp. Similarly, double digestion of plasmid 322-lux with EcoRI and 
BamHI produced two fragments of correct molecular sizes of 5.8kbp and 
4kbp. The 5.8kbp band corresponded to the lux cassette.  
Isolated plasmid pME4510 was digested with EcoRI to confirm the 
molecular weight of the plasmid. A linear fragment of approximately 4kb 
confirmed the identity of the plasmid. Transformation of plasmid pME4510 
into electro-competent E. coli DH5  cells was successful since cells which 
harboured the plasmid after transformation were found to grow on LB 
plates containing 10 g/mL gentamicin. This further confirmed that the 
4kbp plasmid pME4510 harboured the gentamicin resistance gene. 
Restriction digestion of this plasmid with EcoRI and BamHI and 
subsequent ligation with the lux cassette from plasmid pSB417 was 
successfully achieved since re-circularisation of the recombinant plasmid 
was observed. The resultant plasmid produced various bands of higher 
molecular weight, which indicated that the plasmid had re-circularised into 
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different conformations and that the lux cassette was successfully inserted 
into the plasmid vector. Hence, ligation was successfully achieved. 
Circularisation of recombinant plasmid post ligation indicated that the 
ligation products were actual clones and not self-ligated plasmids. Circular 
DNA transforms with much greater efficiency compared to linear DNA 
(Frerix, Geilenkirchen, Mueller, Kula & Hubbuch, 2007). The ligation 
mixtures were then subjected to electroporation into E. coli DH5  cells 
and screening of transformants confirmed the presence of the lux cassette 
in vector pME4510, producing pME-lux.  
 
2.5.7 Insertion of promoters into promoterless plasmid vectors 
Initial design of reverse primers containing the SnaBI site failed 
amplification on multiple occasions, even when various PCR parameters 
were optimised. In-silico studies using the OligoCalc calculator for the 
analysis of the newly designed primers confirmed that these primers 
formed hairpin loops (Kibbe, 2007) and hence could not anneal to the 
template DNA. Redesign of new reverse primers containing the SnaBI site 
lacking possibility of hairpin loop formation produced successful 
amplification products. The PCR products were purified and digested in 
double restriction digests using EcoRI and SnaBI. EcoRI digestion 
produces sticky ends while SnaBI digestion produces blunt ends. Hence, 
the digested PCR product contained a sticky EcoRI site at the 5’-end and 
a blunt SnaBI site at the 3’-end. This sort of digestion would allow for 
directional cloning where the promoter insert would ligate only in one 
orientation into the promoterless plasmid (Figure 2.22). 
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___________________________________________________________ 
Figure 2.22: Promoterless pBR322-lux plasmid map (Vincze, Posfai & Roberts, 2003). 
The lux cassette, that is, lux c, d, a, b, e are represented by ORFs a, e, c, d and b 
respectively. The ampicillin resistant gene is represented by ORF g. The partial 
tetracycline resistant gene is represented by ORF f.  indicates that cleavage is affected 
by CpG methylation and # indicates that cleavage is affected by other methylation. 
 
The promoterless plasmid pME-lux were digested with EcoRI and SnaBI 
in two separate single digests to ensure that a single fragment of 
linearised plasmid was obtained in both cases. This digestion was 
successful as linearized plasmid of ~10kbp was obtained. Subsequently 
the plasmid was digested with SnaBI and EcoRI in a double digest and 
linearized plasmid was obtained, as expected. Although a double digest 
under normal circumstances would produce two fragments, in this case 
only one visible fragment was produced because the restriction sites for 
both enzymes in the plasmid appear to be very close together. There is 
less than 20bp difference between the two restriction sites on this plasmid. 
Such small fragments would run off the gel when resolving larger 
fragments.  
Following successful restriction of the PCR products and the promoterless 
plasmid, the two were ligated together in 24 hour ligation reactions. 
Ligation of promoter regions into the promoterless plasmid vectors was 
performed at the ratios of 3:1, 5:1, 7:1 and 10:1 of promoter inserts: 
plasmid vector respectively. A ratio of 10:1 for vector:insert during ligation 
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proved more successful because the size of the insert was relatively small 
(100-250bp) compared to the size of the vector (10kbp). Hence a very 
high concentration of the inserts was required, such that there were a 
significant number of inserts at the target ends compared to the number of 
inserts being intertwined inside the long linear DNA vector. 
Bands of higher molecular sizes were obtained, indicating that new 
products had been formed. These products probably could be a result of 
cross-ligation of restricted PCR products and promoterless plasmid rather 
than a product of self-ligation of the plasmid only. This was because the 
linearised plasmid contained one sticky end and a blunt end, which would 
make it difficult for self-ligation. Furthermore, the ratio of 10:1 for promoter 
insert to plasmid vector used during ligation was considered high enough 
to prevent self-ligation dominance. Therefore, there was greater 
confidence that the ligation products were actual clones and not self-
ligated plasmids. Moreover, plasmid re-circularisation post ligation gave 
more confidence that the ligation products were actual clones and not self-
ligated plasmids. Circular DNA transforms with much greater efficiency 
than linear DNA (Frerix et al., 2007). Multiple bands of various molecular 
weights were also obtained in ligation products. These may correspond to 
the PCR products forming multimeric structures. However these 
multimeric structures would not be expected to be of very high molecular 
sizes; hence, these higher molecular weight bands may indicate presence 
of fragments of plasmid. DNA bands of the correct molecular weight were 
also obtained, indicating that intact plasmid was still present in the ligation 
reaction. 
Post-ligation, the ligation mixture was heat-inactivated to denature the 
ligase enzyme. This was crucial for successful electroporation since active 
ligase inhibits electroporation. Furthermore, a high salt concentration in 
the ligation mixture also causes arcing during electroporation. Hence, all 
glassware was rinsed with deionised sterile water rather than with sterile 
distilled water before use. Electro-competent cells were also prepared 
using sterile deionised water rather than sterile distilled water. The ligase 
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buffer has large amounts of salt; hence, a maximum volume of 3 L of the 
ligation reaction was used during electroporation to prevent arcing.  In the 
future, if higher ligation volumes are required, other ways of reducing salt 
content in the ligation mixture include ethanol precipitation and drop 
dialysis (Schlaak, Hoffmann, May & Weimann, 2005).  
 
2.5.8 Transformation and screening 
Transformation of ligation mixtures into P. aeruginosa was unsuccessful 
on several attempts. However, transformation of the same mixtures into E. 
coli was successful, as evidenced by the appearance of bacterial colonies 
on agar plates containing gentamicin. The plasmid pME-lux contains the 
gentamicin-resistant gene. Hence, in the presence of gentamicin, only 
bacterial colonies that contain the plasmids are able to survive and grow. 
Transformants underwent a process of screening for clones containing 
either pBR322-lux or pME-lux with the promoter inserted in it. Circular 
plasmid DNA was obtained when plasmids were isolated from 
transformants during screening. Most transformants were found to contain 
circular plasmids of the correct molecular size. However, restriction 
analysis was required to confirm the correct molecular size of the plasmid 
and whether the plasmid harboured the promoter insert or not.  
Transformation and plasmid isolation also showed that the bacterial cells 
were able to convert linear plasmid DNA into circular plasmid DNA. 
Interestingly, on screening some promoterless-lux transformants, it was 
also found that a small proportion of the transformants harboured a 
plasmid of molecular size much smaller than the expected ~10kbp size. 
Most isolated plasmids of 10kb resulted in a linear fragment of 
approximately 10kb, as expected during restriction analysis; however, it 
was found that the smaller plasmids resulted in linear DNA bands of 
smaller molecular weights ranging from approximately 1.6kb-4kb. Hence, 
it seems that the plasmid was too large to be handled by the E. coli strain 
and therefore part of it may have been excised out. The fact that the 
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transformants harbouring these small plasmids grew on agar plates 
containing ampicillin suggests that the ampicillin-resistant gene was 
retained. The origin of replication was also retained since these 
transformants were able to grow and replicate the plasmid as well; albeit a 
smaller plasmid. Clearly, the lux cassette was lost since the lux cassette 
itself is 5.8kbp in size. This sort of behaviour with plasmids losing part of 
their DNA sequence, has been observed previously (Clancy, Mann, Davis, 
& Calos, 1984), when plasmids have lost between 1-5kb of their DNA 
sequence during transformation. In another study performed by Maier et 
al. (2007), plasmids also lost part of their DNA sequences. 
Screening the transformed colonies derived from pME-lux, it was revealed 
that some colonies harboured the specified promoter region. These strains 
that showed positive results for incorporation of promoter regions into the 
promoterless plasmid pME-lux were named ldcC-pME-lux, lysS-pME-lux, 
tat-pME-lux, spc-pME-lux and lpp-pME-lux. Sequence analysis of all 
thirteen E. coli strains to ascertain that the plasmids harboured the 
promoter regions of interest showed that DNA sequences of all promoter 
regions were correct. Sequencing data revealed that the amplicon inserted 
into the plasmids matched the specified promoter regions as expected 
(Appendix 6). Sequencing data also revealed that the manipulations at the 
three restriction sites EcoRI, BamHI and SnaBI were performed as stated 
in the protocols and that all three restriction sites remained functional after 
the manipulations, in case further manipulations were required in the 
future. Furthermore and more importantly, it was also revealed that the 
orientation of the promoter regions matched the orientation of the lux 
cassette and therefore any transcription of the lux cassette would be a 
result of the initiation by the promoters in the same orientation. 
 
2.5.9 Transformation into P. aeruginosa ATCC 9027 
Initial attempts to transform electro-competent P. aeruginosa cells failed 
on numerous occasions. This may have been because P. aeruginosa, 
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unlike E. coli, develops an alginate barrier around its membrane. Alginates 
are polysaccharides comprised of monomeric units of either uronic acid -
D-mannuronate (M) or uronic acid- -L-guluronate (G) or both (Shen et al., 
2006). Alginate is involved in the formation of biofilms that protect P. 
aeruginosa cells from pathogen attack and antibiotics and other invading 
bodies (Boyd & Chakrabarty, 1994). Introduction of DNA into P. 
aeruginosa cells containing alginates has therefore proved to be more 
difficult. P. aeruginosa cells were therefore treated with the enzyme 
alginate lyase prior to preparing electro-competent cells, to destroy the 
alginate barrier and prepare the cells to receive plasmids. Alginate lyase 
degrades alginate polysaccharides into their individual monomeric units by 
breaking the 1-4 O-glycosidic bonds (Wong, Preston & Schiller, 2000). 
Unfortunately, transforming electro-competent P. aeruginosa after alginate 
lyase treatment alone did not produce any transformant colonies in 
several attempts. Therefore, further optimisation of preparation of 
competent cells and the electroporation procedure was required. 
Several electroporation buffers were utilised to optimize the 
electroporation buffer suitable for P. aeruginosa transformation. Various 
electroporation buffers found from previous studies and used for the 
preparation of electro-competent cells were 300mM sucrose (Smith & 
Iglewski, 1989), 10% glycerol (Artiguenave et al., 1997; Bloemberg, 
Otoole, Lugtenberg & Kolter, 1997), 25mM HEPES buffer containing 
300mM glucose and 5mM calcium chloride, Ringers solution, 15% glycerol 
containing 1mM MOPS (Farinha & Kropinski, 1990) and finally 1mM 
HEPES pH 7.0, containing 300mM sucrose and 1mM magnesium chloride 
(Diver et al., 1990). No transformant colonies were obtained when 
sucrose, glycerol or HEPES buffer were used individually. However, 
numerous transformant colonies were obtained on selective media when 
the electro-competent cells were prepared in either Ringers solution or a 
combination of buffers containing additives such as glycerol with MOPS or 
sucrose with HEPES and magnesium chloride. This indicated that P. 
aeruginosa required low ionic strength buffers in the electroporation 
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solutions, by contrast with E. coli. The P. aeruginosa cells are larger than 
E. coli cells and therefore may undergo cell lysis at a greater rate than E. 
coli when non-ionic electroporation buffers are used. This is because the 
inclusion of non-ionic electroporation buffers creates an osmotic gradient 
when cells are electroporated and therefore P. aeruginosa cells are 
unable to recover post-electroporation. Hence, the inclusion of minimal 
amounts of salts such as magnesium chloride was beneficial to the 
recovery of P. aeruginosa cells after electroporation. Magnesium chloride 
is important in the maintenance of the structural integrity of the 
lipopolysaccharides (LPS) of bacterial membranes (Dennis & Sokol, 
1995). Hence, the omission of magnesium chloride destabilises the LPS 
and this destabilisation is further enhanced during electroporation, such 
that P. aeruginosa cells are unable to recover after electroporation. 
The importance of requiring salt for recovery of P. aeruginosa cells after 
electroporation was illustrated with the use of Ringers solution as an 
electroporation buffer. Ringers solution is a salt solution that contains 
sodium chloride, potassium chloride and calcium chloride. When high salt 
solution was used as an electroporation buffer it caused arcing during 
electroporation of P. aeruginosa cells such that the time constants of 
electroporation achieved were in the range 0.1-1.0 msec. However, 
transformation was successful when Ringers solution was used because 
transformant colonies were obtained upon plating the electroporated cells 
on selective media. In fact, all the P. aeruginosa cells harbouring the 
plasmid pME-lux and lpp-pME-lux were obtained when Ringers solution 
was used.  
 
2.5.10 Lux expression studies in P. aeruginosa ATCC 9027 
Investigating the ability of Pseudomonad promoters to initiate transcription 
of the lux cassette and produce bioluminescence showed that the 
bioluminescence from E. coli strains containing P. aeruginosa promoters 
was significantly less than that of the negative control (the promoterless E. 
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coli strain). This indicated that the Pseudomonas promoters were not well-
recognised by the E. coli transcription machinery. However, the 
Pseudomonas aeruginosa bioluminescent strains containing P. 
aeruginosa promoters produced bioluminescence of several magnitudes 
greater than that of their E. coli counterparts. This was because P. 
aeruginosa’s transcription machinery was able to recognise the promoter 
sequences that originated from Pseudomonas itself. A study by Rist & 
Kertesz (1998) also mentioned the fact that promoters originating from P. 
aeruginosa were not recognised by E. coli.  
Transformants were also tested for bioluminescence ability and successful 
results were obtained where all five bioluminescent strains produced 
significant bioluminescence compared to the promoterless strain. LdcC 
and Spc exhibited the least expression of bioluminescence, while both 
variants of Lys exhibited similar expression of bioluminescence. Strain Lpp 
R4 bioluminesced three times greater than Lpp R3. Strains Tat S14 and 
S5 bioluminesced two-times and three-times greater than Tat S9 
respectively. Variations in bioluminescence between different variants 
containing the same promoter suggested that plasmid copy number may 
vary between the variants or the variants have incorporated mutations 
within the promoter regions. Upon DNA sequencing, it was found that the 
same point mutations were present in all the plasmids; however, there 
were no significant mutations in the promoter regions or the whole 
plasmids that would lead to differences in lux expression. Plasmid copy 
number analysis also showed that plasmid copy numbers were not 
significantly different between different variants (as analysed in Chapter 
3.4.2. Therefore, the possible reason for variation in bioluminescence 
between variants may be due to possible cell injury sustained during 
transformation that is also inherited by progeny cells. 
There is very limited information about promoter structure and 
characterisation in Pseudomonas aeruginosa and therefore the data from 
this study will also aid in the understanding of promoters from 
Pseudomonas aeruginosa. Following successful development of working 
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bioluminescent constructs, the data from this study will allow quantification 
of bioluminescence per colony forming unit at various stages of the 
bacterial growth cycle. 
This study reports, for the first time, the development of recombinant E. 
coli bioluminescent constructs containing constitutive P. aeruginosa 
promoters. This allows monitoring of the recognition and functionality of 
Pseudomonas-based promoters in E. coli (that is, whether the E. coli 
transcription machinery was able to recognize the Pseudomonad 
promoters and initiate transcription). In future, such recombinant systems 
may lead to promoter functional studies targeted at understanding closely 
the sequence requirements of promoter sequences in relation to 
recognition by RNA polymerase and rates of transcription initiations. 
This study reports for the first time the development of functional whole 
cell microbial bioluminescent constructs in Pseudomonas aeruginosa 
using constitutive promoters for monitoring the global health states of 
Pseudomonas cells. These bioluminescent constructs provide the basis 
for use in testing efficacy of various antimicrobial agents and other 
compounds including novel antibiotics against P. aeruginosa. They may 
also be used for studying the strength of promotors in causing gene 
expression and how it can be influenced by environmental conditions.  
Furthermore, the promoterless strain lacks any promoters upstream of the 
lux cassette and therefore may be used as a screening tool for further 
evaluation of other DNA sequences that may not currently be recognised 
as promoters. 
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2.6 Conclusion 
 
Insertion of the promoter-lux insert into the host plasmid pME4510 and 
subsequent transformation into E. coli DH5  cells was successfully 
achieved. The transfer of plasmids from E. coli to P. aeruginosa was more 
challenging, since transformation into P. aeruginosa failed on numerous 
occasions. However, optimising the electroporation buffer to suit 
Pseudomonas was vital in achieving successful results with transforming 
plasmids. Electroporation of plasmids into Pseudomonas was more 
successful when electroporation buffers included salts that aid in post-
electroporation recovery of the cell membranes. Transformants of 
Pseudomonas aeruginosa ATCC 9027 were successfully generated and 
confirmed by plasmid extractions from transformants and subjecting them 
to restriction digestion analysis, PCR amplification of promoter regions 
and DNA sequence analysis. Transformants were also tested for 
bioluminescence ability and successful results were obtained where all 
five bioluminescent strains produced significant bioluminescence 
compared to the promoterless strain. LdcC and Spc exhibited the least 
expression of bioluminescence, while both variants of Lys exhibited similar 
expression of bioluminescence. Strain Lpp R4 bioluminesced three times 
greater than Lpp R3. Strains Tat S14 and S5 bioluminesced two-times and 
three-times greater than Tat S9 respectively.  
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3.1 Introduction 
3.1.1 Method validation 
Method validation is defined as a process of determining whether a 
particular method is appropriate for its proposed use (Green, 1996; 
Gonzalez & Herrador, 2007). Validating a method therefore follows 
method development and optimisation. Immediately following method 
development, the operational limits and performance features for new 
methods need to be ascertained. This process forms part of the primary 
validation. Following successful primary validation, the new method is 
utilised to gather data and collect evidence that the new method meets the 
criteria that are set up during primary validation (ISO, 2000). Primary 
validation is usually conducted in the same laboratory as method 
development and aims to define certain criteria based on the method’s 
performance in the laboratory. Validation of microbiological methods may 
be qualitative as well as quantitative. Parameters that need to be 
determined for new microbiological method validation are accuracy, 
precision, sensitivity, limit of detection and limit of quantification, linearity, 
range and equivalence. 
Accuracy is defined as closeness of the true results obtained by the test 
method to those of the current method (ISO, 1994a, 1994b; Kramer et al., 
2008; Krouse, 2005; PDA, 2000). Accuracy, which is expressed as 
percentage recovery of microorganisms following serial dilution, is limited 
to between 30 and 300 colonies for any particular dilution using the plate 
count method. Any new method is expected to perform better or in a 
similar manner to the traditional plate count method. The acceptance 
criterion is therefore set at 70% recovery. 
Precision is defined as the level of agreement between individual test 
results when the method is applied to samples in replicate (Kramer et al., 
2008; PDA, 2000). Precision is usually expressed as standard deviation or 
percentage relative standard deviation (% RSD) and may be divided into 
reproducibility and repeatability. The difference between repeatability and 
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reproducibility is that the former refers to validation conducted in the same 
laboratory by the same analyst using the same equipment, while the latter 
refers to the validation performed in the same laboratory but under varying 
conditions (ISO, 1994b, 1994c; PDA, 2000). The acceptance criterion is 
set between 15-30% RSD. 
Sensitivity is defined as the minimum quantitative measurement of 
bioluminescence units that can be detected by a certain number of micro-
organisms (Parshionikar et al., 2009) and is usually determined by testing 
serial dilutions of known microbial number in replicate.  
Limit of detection (LOD) is defined as the detection of smallest and 
greatest number of microorganisms in a sample (Kramer et al., 2008; 
Krouse, 2005; PDA, 2000). Hence, the LOD only establishes qualitatively 
the presence or absence of microorganisms. It is therefore vital that this 
determination be performed in replicate. Limit of quantification (LOQ) is 
defined as the accurate and precise quantification of the least number of 
microorganisms in a sample (Krouse, 2005; PDA, 2000). LOQ 
determination should be performed in replicate at five different points, at 
least, across the range. 
Linearity is defined as the relationship in which the results from the new 
method are directly proportional to the number of microorganisms present 
in a sample within the range (Kramer et al., 2008; Krouse, 2005; PDA, 
2000). Determination of linearity should be performed in replicate at five 
different points, at least, across the range. Correlation coefficient (r) gives 
a measure of the proportionality and should lie in between 0.8 and 1.0 for 
a good linear relationship. In the case of microbial growth and gene 
expression, log-linear calibration curves are usually established. 
Range is defined as the interval between the smallest and greatest 
number of microorganisms that can be quantified with precision, accuracy 
and linearity (Krouse, 2005; PDA, 2000). Validation of this range should 
include samples at both of the extremes of the range as well as within the 
range. Equivalence is defined as a measure of the similarity between the 
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results obtained from the new method and the traditional method (PDA, 
2000). Due to the variation in sampling microorganisms, both methods 
should be done in parallel. Equivalence is measured by performing two-
way analysis of variance (ANOVA) and a student t-test; and determining 
the significant difference between the two methods (Kramer et al., 2008). 
Finally, it is imperative to remember that absolute quantification of the true 
number of microorganisms may be impossible. The basic reason for this is 
that microbiological methods are based on an assumption that 
microorganisms are dispersed equally through normal distribution in 
cultures. However, this is not the case. In fact, the skewed distribution 
leads to erroneous interpretation of statistical data and therefore microbial 
counts are transformed to a log10 –scale to convert the data into a normal 
distribution (Krouse, 2005; Parshionikar et al., 2009). 
 
3.1.2 Plasmid copy number 
Protein productivity from recombinant plasmids in bacteria is dependent 
on number, structure and stability of plasmids. Plasmids must be able to 
exist stably inside their host cell with minimum effects on metabolic and 
genetic load (del Solar & Espinosa, 2000). The first stage of the plasmid 
life cycle as it enters a host is called establishment. During this stage, the 
plasmid must be able to divide rapidly prior to host cell division.  The next 
stage is when the plasmid is maintained during steady state growth of the 
bacterial host. On average, plasmids replicate once per cell replication. 
Hence the plasmid numbers remain virtually the same and under tight 
control of negative control systems (del Solar & Espinosa, 2000; 
Nordstrom & Dasgupta, 2006).  
Plasmid stability and maintenance has been a dilemma for many years, 
although in laboratory settings, this is easily achieved by antibiotic 
resistance genes on the plasmid and the addition of antibiotics to culture 
media. Therefore, to understand recombinant protein productivity better, it 
is essential to understand plasmid stability and determine plasmid copy 
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number. These features also allow better understanding of cell replication 
in the presence of plasmid DNA. Plasmid copy number is defined as the 
number of plasmid copies present per bacterial cell or per bacterial 
chromosome (Coronado, Vazquez, Cebolla & Palomares, 1994; Lee, Kim, 
Shin & Hwang, 2006a; Lee, Ow & Oh, 2006b) and can vary between a few 
to hundreds per cell (Nordstrom & Dasgupta, 2006). It has also been 
shown that bacterial cells in biofilms have increased numbers of plasmid 
copies compared to bacterial cells in planktonic states (Cook & Dunny, 
2013). 
Generally, plasmid copy number can be determined using either indirect 
or direct methods. Indirect methods include measurement of recombinant 
reporter protein activity normalised to number of bacterial cells. However, 
more direct methods include chromosomal and plasmid DNA extraction 
and quantification by DNA hybridisation, gel electrophoresis and high 
performance liquid chromatography (Lee et al., 2006a; Lee et al., 2006b; 
Skulj et al., 2008). It must be appreciated that these methods are 
laborious, time-consuming, inaccurate and inefficient. Gel electrophoresis 
further proves to have low sensitivity. Furthermore, plasmid profiles 
obtained using gel electrophoresis indicate several isoforms; supercoiled, 
open-circular, linear, multimers. With the advent of conventional PCR, 
sensitivity of plasmid copy number determination has increased and large 
numbers of samples can be processed. However the disadvantage with 
conventional PCR is the subsequent quantification of DNA by gel 
electrophoresis. 
Quantitative PCR (qPCR) is now widely used for DNA quantification and 
identification because it provides high sensitivity and improved speed, it is 
less laborious and gives reliable results in ‘real-time’ mode that does not 
require separation of plasmid DNA from chromosomal DNA (Lee et al., 
2006a; Lee et al., 2006b; Skulj et al., 2008). Quantitative PCR is similar to 
conventional PCR; however, amplification of DNA is measured by 
fluorescence detection during amplification instead of end-point detection. 
Conventional PCR determines the amount of DNA accumulated at the end 
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point whereas quantitative PCR establishes the point when amplification is 
first detected (Huggett & Bustin, 2011). Fluorescent detection is based on 
the ability of non-specific fluorescent dyes such as Sybr® Green to bind to 
double stranded DNA in its minor groove (Huggett & Bustin, 2011; Li, Xi, 
Yang, Hawkins & Schubart, 2003). The dye fluoresces upon double-
stranded DNA binding; hence as the amount of amplified product 
increases after each PCR cycle, the fluorescence intensity increases. It is 
this increase in fluorescence that is recorded with each cycle. The cycle 
number at which the fluorescence intensity is detected above a 
background threshold is referred to as threshold cycle (Ct) or crossing 
point (Cp) (Wong & Medrano, 2005) as exemplified in Figure 3.1.  
___________________________________________________________ 
Figure 3.1: Phases of quantitative PCR quantification. Adapted from Wong & 
Medrano (2005). Linear ground, early exponential, log-linear and plateau 
phases are shown. Ct values are measured at the first observable signal 
above baseline. 
 
The signal output from quantitative PCR can be divided into four phases 
(Figure 3.2) (Wong & Medrano, 2005). The linear ground phase is the first 
phase of PCR and indicates that there is no increase in fluorescence. 
Threshold background fluorescence is determined at this stage. The early 
exponential phase is the second phase where amplification has just 
begun. It is used to calculate the Ct value since the fluorescence level is 
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greater than the threshold value. The third phase is the log-linear phase 
when amplification is increasing at an exponential rate. This means that 
PCR products double with each cycle increment. The final phase is the 
plateau phase when the reagent concentrations become limiting and 
therefore there is no significant amplification or fluorescence increase. 
The Ct value is vital in quantifying the number of plasmids because it is 
inversely proportional to the copy number (Huggett & Bustin, 2011; Wong 
& Medrano, 2005), meaning that the copy number is large at low Ct values 
and small at high Ct values. Ct values can be affected by PCR efficiency. 
Theoretically, amplification efficiency is regarded as 1 when fluorescence 
doubles with every cycle. However, in reality this may not be the case. 
Hence, efficiencies between 90 and 110%, calculated from the slope of a 
calibration curve being between -3.3 and -3.6, are acceptable (Applied 
Biosystems; Fraga, Meulia & Fenster, 2008; Wong & Medrano, 2005). 
___________________________________________________________ 
Figure 3.2: Effect of slope on PCR efficiency. Ct refers to the threshold number of 
cycles at which product amplification is first detected. Quantity refers to the concentration 
of intial DNA template present in the reaction mix in a log scale (Applied Biosystems). 
 
The correlation coefficient (r) of a standard curve also provides a good 
indicator of PCR efficiency (Applied Biosystems). Generally, r-values 
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greater than 0.99 indicate a strong correlation between the Ct value and 
DNA concentration. 
The high specificity of quantitative PCR is emphasized in dissociation 
curve analysis (Huggett & Bustin, 2011; Lee et al., 2006a; Lee et al., 
2006b; Li et al., 2003; Wong & Medrano, 2005), which follows at the end 
of the amplification process. Also known as melt curve analysis, the 
double stranded DNA product post-amplification undergoes a melting 
process by constant increment in temperature. At a particular temperature 
called the melting temperature (Tm), double stranded DNA melts and 
converts to single stranded DNA and the fluorophore unbinds as the DNA 
melts. As a result, the fluorescence intensity decreases drastically. 
Different PCR products have different Tm; therefore, any non-specific 
products formed during the amplification process can be detected from the 
melt curve analysis (Figure 3.3). 
___________________________________________________________ 
Figure 3.3: Melt curve profile for a typical real-time PCR amplification. 
Adapted from Lee et al. (2006b). The temperature at which single-stranded PCR 
products are observed is the Tm temperature that results into peaks. Peaks at 
temperatures different from the Tm are non-specific PCR prodcuts (dotted line) that result 
from mis-priming. 
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3.2 Aim and objectives 
The aim of this work was to validate all the bioluminescent strains using 
the bioluminescence method to determine whether the newly created 
bioluminescent constructs were functional and stable. 
The objectives of these studies were:  
 To assess the parameters such as linear range, accuracy, 
precision, equivalence, limit of detection and limit of quantification 
as set out in various documentations (ISO, 1994a, 1994b, 1994c, 
2000; PDA, 2000) using the bioluminescent method.  
 To assess plasmid copy numbers by quantitative PCR. 
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3.3 Materials and methods 
3.3.1 Bacterial strains 
The Pseudomonas bacterial strains used for validation assays are listed in 
section 2.3.1. All bioluminescent strains and negative controls from the 
master plates were inoculated onto working LB agar plates containing 
10 g/mL gentamicin (except for WT that was inoculated into LB without 
antibiotic) and incubated for 24 hours at 32oC. Upon growth, single 
isolated colonies of all strains from the secondary plate were then 
inoculated into culture flasks containing 5 mL of LB broth and 10 g/mL 
gentamicin (except for WT that was inoculated into LB without antibiotic) 
and incubated for 24 hours at 32oC in an incubator shaking at 250rpm. 
 
3.3.2 Promoter strength determination 
For determination of promoter strength, isolated colonies of all variants of 
the P. aeruginosa ATCC 9027 bioluminescent strains and negative 
controls were grown as described in section 3.3.1. Cultures were then 
grown by inoculating 20 L of the starter cultures into culture flasks 
containing 9 mL of LB broth and 10 g/mL gentamicin (except for WT that 
was inoculated into LB without antibiotic) and incubating at 32oC in a 
shaking incubator shaking at 250rpm for 24 hrs.  
An aliquot (0.5 mL) was withdrawn from each culture flask and serially 
diluted into 4.5 mL of buffered peptone water (Oxoid Ltd). An aliquot (1 
mL) of each dilution was transferred into a culture tube aseptically for RLU 
determination as described in section 2.3.15.  
For CFU determination, aliquots (0.1 mL) of each dilution were also 
spread aseptically on LB agar plates containing 10 g/mL gentamicin 
(except for WT that was spread on LB agar plates lacking antibiotic) and 
incubated at 32oC for 48 hrs. 
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3.3.3 Linearity and standardisation of inocula 
The objectives of this experiment were to determine the linear range of the 
assay, standardise the inocula for preservative efficacy tests and to 
determine the dilution factor to be used for accurate RLU measurements. 
Strains were grown as described in section 3.3.1. Following incubation, all 
samples were serially diluted 10 fold seven times in buffered peptone 
water. Aliquots (1 mL) of undiluted and diluted cultures were transferred 
into culture tubes aseptically for bioluminescence measurements. Relative 
light units (RLU) were measured using the Celsis Advance Luminometer 
as described in section 2.3.15. Aliquots (100 L) of undiluted and diluted 
cultures were plated as described in section 3.3.2. 
 
3.3.4 Accuracy testing 
The objective of this experiment was to determine the accuracy of the 
bioluminescent method. Strains were grown as described in section 3.3.1. 
Following incubation, all samples were serially diluted 10-fold in buffered 
peptone water. For undiluted, 10-fold and 100-fold diluted samples, further 
dilutions were performed, in triplicate, with buffered peptone water as 
indicated in Table 3.1. 
Table 3.1: Percentage dilution range for accuracy testing 
Cells (%) Volume of cell culture ( L) Volume of diluent ( L) 
0 0 1000 
10 100 900 
25 250 750 
50 500 500 
75 750 250 
90 900 100 
100 1000 0 
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Aliquots (1 mL) of each dilution were transferred into culture tubes 
aseptically for bio-luminescence measurements as described in section 
2.3.15. Aliquots (100 L) of each undiluted and each diluted culture were 
transferred onto TSB Agar plates as described in section 3.3.2.  
Mean RLU values were calculated by summing the RLU values in a group 
and then dividing the sum by the number of RLU values. Standard 
deviation was calculated by using the STDEV function in MS EXCEL for a 
group of RLU values. Recovery (%) was calculated for each dilution for all 
strains. 
Percentage Recovery was calculated as follows:  
 
Mean RLU at given number of cells  
    Mean RLU at 100% cells 
______________________________       x   100 
Expected dilution factor 
___________________________________________________________ 
Equation 1: Percentage recovery calculation 
 
3.3.5 Precision testing 
The objective of this experiment was to determine the precision of the 
bioluminescent method. Strains were grown as described in section 3.3.1. 
Following incubation, all samples were serially diluted 10-fold in buffered 
peptone water. This procedure was repeated 10 times. Aliquots (1 mL) of 
each dilution were transferred into culture tubes aseptically for bio-
luminescence measurements as described in section 2.3.15. Aliquots 
(100 L) of undiluted and diluted cultures were transferred onto TSB agar 
plates as described in section 3.3.2. 
Mean and standard deviation values were calculated for each dilution as 
described in section 3.3.5. Percent relative standard deviations (%RSD) 
for each dilution were calculated as follows: 
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 Standard deviation of RLU      x 100 
     Mean RLU 
___________________________________________________________ 
Equation 2: Relative standard deviation calculation 
 
3.3.6 Data analysis 
Statistical analysis was done using SPSS for Windows. The data were 
checked for normality (Shapiro-Wilk test) and constant variance. 
Pearson’s correlations between bioluminescence reading and plate count 
were performed at a significance level of 95% for data obtained from 
linearity and accuracy studies. One-way ANOVA and an F-test at a 
significance level of 95% were performed on precision data to determine 
the variability between the bioluminescence and plate counting methods. 
Two-way analysis of variance (ANOVA) at a significance level of 95% was 
performed between bioluminescence and plate count data to determine 
the equivalence between both methods. 
 
3.3.7 Plasmid copy number 
All strains were grown as described in section 3.3.1. An isolated colony of 
each strain was inoculated into 100 mL LB containing 10 g/mL 
gentamicin (except for WT that was inoculated into LB without antibiotic) 
and incubated at 32oC and 150 rpm shaking conditions for 28 days. 
Samples were taken from each of the flasks at 6 hours and 24 hours after 
inoculation, followed by sampling at 7 days, 14 days, 21 days and 28 days 
after inoculation. 
 
3.3.7.1 DNA extraction 
For calibration of standard curves, genomic DNA was isolated according 
to the manufacturer’s protocol using the GenElute Bacterial Genomic DNA 
Kit purchased from Sigma-Aldrich®. Plasmid DNA was extracted as 
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described in section 2.3.9. For samples of unknown DNA concentration, 
total DNA was extracted by using the QIAamp® DNA Mini and Blood Mini 
Kit purchased from QIAGEN according to the manufacturer’s protocol. All 
eluates containing DNA were either stored at -20oC or used for further 
analysis. 
 
3.3.7.2 Quantitative Polymerase Chain Reaction (qPCR) 
For the determination of plasmid copy number, specific forward and 
reverse oligonucleotide primers were designed for the DxS gene, a 
housekeeping gene on the chromosome, and the gentamicin gene on the 
plasmid (Table 3.2) using PRIMER 3 software. The melting temperatures 
of the primers were calculated using ‘BioMath - Tm Calculations for 
Oligos’ software (Promega Corporation). Oligonucleotide primers were 
then constructed by Invitrogen Ltd.  
Table 3.2: Forward and reverse primers for amplification of DxS and gentamicin. 
Primer 
Name
 a
 Primer 
Primer length 
(bases)
 b
 
% GC 
content
c
 Tm (
o
C)
 d
 
DxS F 5’-CATCAGGTAAACTGCTGGCCTCTC-3' 24 54 54 
DxS R 5'-CCGACGGTATACAGCAGGTACTGG-3' 24 58 56 
Gent F 5’-GCACTGCATAATTCTCTTACTGTCA-3' 25 40 49 
Gent R 5'-GCTCTCTATACAAAGTTGGGCATAC-3' 25 44 51 
a
 F denotes forward primer and R denotes reverse primer. The primer length
b
 is between 
30-40bp, % GC content
c
 is around 50% and the melting temperature
d
 for each primer is 
between 60-70
o
C. 
 
Stock and working primer suspensions were prepared as described in 
section 2.3.6. The initial qPCR reaction mixtures were prepared in sterile 
PCR tubes (Table 3.3). The Platinum SYBR® Green qPCR SuperMix-UDG 
Kit was purchased from Invitrogen Ltd. The following reagents were added 
making up a total volume of 50 L. 
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Table 3.3: Various components of a qPCR reaction.  
Reagent Volume ( L) 
 DxS gene Gentamicin gene 
Sybr Green Mix 25 25 
Bovine Serum Albumin 1 1 
10 M DxS Forward primer 1  
10 M DxS Reverse primer 1  
10 M Gent Forward primer  1 
10 M Gent Reverse primer  1 
Genomic DNA template 1  
Plasmid DNA template  1 
Sterile water 21 21 
Total volume 50 50 
Volumes for each reagent at stated concentrations for qPCR of dxS and gent genes. 
 
The reaction tubes were placed in the quantitative PCR thermocycler 
(DNA Engine Peltier Thermal cycler with Chromo4 Real-time PCR 
detector from Biorad). The cycling conditions for the qPCR reactions were 
optimised from another study (Lee et al., 2006) (Table 3.4). 
  
Table 3.4: Cycling parameters for quantitative PCR reactions 
 
Several qPCR reactions were performed at a range of annealing 
temperatures between 45oC – 60oC and 46oC – 56oC for gentamicin and 
DxS gene amplification, respectively. Upon optimisation, the PCR 
reactions were performed at 60oC and 46oC, respectively. A PCR reaction 
Steps Temperature (oC) Time (minutes) 
1 Start 50 2 
2 Initial Heat Denaturation 96 10 
3 Heat Denaturation 
Primer annealing 
Primer extension 
95 
Gradient temperature 
72 
1 
1 
1 
4 Extension 72 10 
5 Plate read   
6 Melt curve 40-95 (read at every 
0.2oC) 
2 sec at each 
temperature 
30 cycles 
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lacking the DNA template was also prepared as a negative control. 
Following PCR, 10 l of the products from each reaction tube were 
resolved on a standard 1.5% agarose gel prepared as specified in section 
2.3.8. A 100bp standard DNA marker was also loaded on the gel for 
verification of PCR product sizes. 
 
3.3.7.3 Melt curve generation 
Melting point analysis was performed to differentiate target PCR products 
from misprimed products. After completion of PCR, temperatures were 
decreased to 40oC and then increased at a rate of 0.2oC every two 
seconds until they reached 95oC. The fluorescent signal at each 
temperature increment was measured and a melt curve was constructed. 
 
3.3.7.4 Analysis 
Standard calibration curves were generated for genomic and plasmid 
DNA. Various concentrations of genomic and plasmid DNA were used to 
determine the Ct values and construct calibration curves. Concentrations 
were then extrapolated from respective Ct values for unknown samples 
and the corresponding concentrations of genomic DNA and plasmid DNA 
were determined. Plasmid copy numbers were calculated using the 
formula: 
 
PCN per genome =  genomic DNA size (bp)  x  Amount of plasmid DNA ( g) 
        plasmid DNA size (bp)     Amount of genomic DNA ( g) 
___________________________________________________________ 
Equation 3: Plasmid copy number calculation (Lee et al., 2006). 
 
Pearson’s correlations were calculated between plasmid copy number and 
time at a significance level of 95% using SPSS. 
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3.4 Results 
3.4.1 Validation 
The bioluminescent method was validated against the traditional method 
of plate counting using several validation parameters. 
 
3.4.1.1 Linearity studies for all strains 
Relative production of bioluminescence was compared to CFU count for 
all P. aeruginosa bioluminescent strains to determine the linear range of 
the bioluminescent assay (Figure 3.4). Relative light unit (RLU) 
measurements were determined for each serial dilution for all strains. 
Wild-type, pME4510 and pMElux provided negative controls with respect 
to RLU measurements and produced bioluminescence readings of 102 
RLU. Sigmoidal relationaships between RLU and CFU were obtained for 
all bioluminescent strains. Statistical analysis of the data using normality 
test (Shapiro-Wilk) and constant variance test showed that the P-values 
and W-values for all bioluminescent strains were greater than 0.05. 
Therefore all bioluminescent strains passed the normality and the constant 
variance tests (Appendix 8).  
A horizontal relationship between RLU and CFU count in the range from 
1-104 CFU counts was observed. When CFU count decreased below 103 
CFU/mL, bioluminescence remained constant at baseline and was 
undistinguishable from the negative controls. This indicated that the lower 
limit of detection for RLU measurements was limiting measurement of 
bioluminescence for those samples. RLU reading increased 
proportionately with increase in CFU count from 104 to 108 CFU/mL. 
Furthermore, good correlations were observed for RLU per CFU count 
from 104 to 107 CFU/mL. However, detection of bioluminescence for all 
bioluminescent constructs was less than expected for 108 CFU/mL as 
compared to 107 CFU/mL as shown by a non-linear relationship when 
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CFU count was greater than 107 CFU/mL. Consistent results were 
observed for all bioluminescent strains compared to the negative controls 
that harboured either the plasmid only or the promoterless plasmid. In all 
cases, ldcC and spc gave the lowest light output and lys gave the highest 
light output per CFU.  
___________________________________________________________ 
Figure 3.4: Relationship between RLU and CFU for all P. aeruginosa ATCC 
9027 bioluminescent strains. Bioluminescence and CFU counts were measured from 1 
mL, in triplicate, for all strains grown for 24 hours. Error bars indicate standard deviation 
from n=3. 
 
Following from Figure 3.4, the relationships between RLU and CFU for all 
strains were quantified and the correlations indicated in Table 3.5. Strong 
correlations were obtained for the range 103 – 107 CFU/mL. This was the 
linear range of the graph (Figure 3.4). Correlations were slightly less for 
the wider range 103 – 108 CFU/mL. Correlations were significant at P<0.01 
for all bioluminescent constructs within the range 103 – 107 CFU/mL. 
Correlations were significant for most strains at P<0.01 for the range 103 – 
108 CFU/mL; however, the significance was P<0.05 for lppR4 and spc. 
Correlations were significant (P<0.01) but not as good for the full range of 
serial dilutions tested for all bioluminescent strains except lysG25. This 
indicated that it was not advisable to examine undiluted cultures for RLU 
measurements.  
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Table 3.5: Correlation between RLU and CFU for all strains 
Strain 102 to 108 Range 103 to 108 Range 103 to 107 Range 
Correlation Sig. Correlation Sig. Correlation Sig. 
lysS6 R25 0.965** 0.000 0.965** 0.002 0.999** 0.000 
lysS6 G25 0.787* 0.020 0.773 0.071 0.997** 0.000 
tat H5 0.970** 0.000 0.970** 0.001 0.998** 0.000 
tat H9 0.951** 0.000 0.951** 0.003 0.977** 0.004 
tat H14 0.928** 0.001 0.927** 0.008 0.970** 0.006 
Lpp R3 0.966** 0.000 0.965** 0.002 0.999** 0.000 
Lpp R4 0.902** 0.002 0.900* 0.015 0.974** 0.005 
LdcC8 H1a 0.932** 0.001 0.930** 0.007 0.999** 0.000 
spc5 G1a 0.856** 0.007 0.850* 0.032 0.990** 0.001 
pME4510 G4 -0.790* 0.020 -0.780 0.067 -0.833 0.080 
pME4510 R2 -0.628 0.096 -0.600 0.208 -0.852 0.067 
pMElux R28 -0.814* 0.014 -0.811 0.050 -0.747 0.147 
pMElux R29 -0.628 0.095 -0.659 0.155 -0.799 0.105 
** Correlation significant at 0.01 level. * Correlation significant at 0.05 level. 
 
Relative production of bioluminescence per CFU count was determined at 
a range of serial dilutions for all P. aeruginosa bioluminescent strains 
(Figure 3.5) after 24 hours of growth. Consistent results were observed for 
10-fold and 100-fold dilutions and hence these two dilutions were chosen 
to depict the light output per unit CFU for all the bioluminescent strains 
with an objective of determining relative strength of five different 
promoters. It was observed that both variants of lpp (lpp R3 and lpp R4) 
produced similar RLU readings per CFU. Similarly, both strains of lys 
produced similar RLU readings per CFU. Strain tat H5 produced three-fold 
and two-fold higher bioluminescence than its variants tat H9 and tat H14, 
respectively.  Strains harbouring ldcC and spc gave the lowest light output 
of the five promoters. Beyond 10-5 dilutions the log RLU: log CFU 
increased with increase in dilution factor and therefore correlations were 
poor. All negative controls were observed to produce bioluminescence 
less than the lower limit of detection. 
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___________________________________________________________ 
Figure 3.5: Consistent relationship between Log RLU:Log CFU at various 
serial dilutions for all P. aeruginosa ATCC 9027 bioluminescent strains. pME4510 and 
pMElux are control strains that do not bioluminesce. Bioluminescence was measured at 
490nm from 1 mL of each strain that was serially diluted 1:10. 
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3.4.1.2 Accuracy 
The next step of the validation process was to determine the accuracy of 
the bioluminescent method compared to the traditional plate count 
method. It was elucidated whether the acceptance criteria of 100% + 30% 
was achieved. The percentage recovery of bioluminescence from 
undiluted cultures and serially diluted cultures were tested. As shown in 
Table 3.6, the percentage recoveries of undiluted cultures (108 CFU/mL) 
for all bioluminescent constructs were outside the acceptance criteria of 
70%. However, 10-fold and 100-fold serially diluted cultures produced 
recoveries of between 70% and 130%. These dilutions for all strains 
therefore passed the acceptance criteria. 
Furthermore, it was determined whether bioluminescence reduced with 
each diluted suspension within the ten-fold serial dilutions. Pearson’s 
correlations indicated that there was a very strong relationship between 
bioluminescence and CFU count within the diluted suspensions for all 
serial dilutions (r > 0.8) except the undiluted cultures of ldcC (r = 0.45). 
Strong correlations were also found to be statistically significant at P<0.01 
in most cases except undiluted cultures of spc, which was significant at 
P<0.05. 
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Table 3.6: Accuracy analysis and Pearson’s correlations. 
 Strain 
 Number 
of cells 
(CFU/mL) 
Recovery (%) at indicated dilution of number of 
cells Pearson’s 
correlation 
Significance 
0 10 25 50 75 90 100 
ldcC 10 8  0 1148 696 314 218 178 100 0.449 0.312 
  10 7  0 115 120 111 108 105 100 0.998
**
 0.000 
  10 6  0 120 99 103 96 102 100 0.999
**
 0.000 
Spc 10 8  0 611 365 168 132 126 100 0.801
*
 0.030 
  10 7  0 121 128 112 109 107 100 0.997
**
 0.000 
  10 6  0 87 93 93 101 99 100 0.999
**
 0.000 
lys R25 10 8  0 218 163 107 84 85 100 0.969
**
 0.000 
  10 7  0 76 84 89 89 96 100 0.997
**
 0.000 
  10 6  0 92 95 80 102 102 100 0.995
**
 0.000 
lys G25 10 8  0 379 236 119 131 106 100 0.937
**
 0.002 
  10 7  0 89 95 103 104 104 100 0.999
**
 0.000 
  10 6  0 100 82 78 77 85 100 0.985
**
 0.000 
lpp R3 10 8  0 325 215 129 118 120 100 0.963
**
 0.001 
  10 7  0 73 89 97 103 96 100 0.999
**
 0.000 
  10 6  0 78 80 86 90 94 100 0.997
**
 0.000 
lpp R4 10 8  0 101 234 100 93 103 100 0.944
**
 0.001 
  10 7  0 89 104 108 108 106 100 0.998
**
 0.000 
  10 6  0 77 83 86 92 96 100 0.998
**
 0.000 
tat H5 10 8  0 250 190 98 94 98 100 0.970
**
 0.000 
  10 7  0 80 95 97 102 104 100 0.999
**
 0.000 
  10 6  0 83 89 87 96 95 100 0.998
**
 0.000 
tat H9 10 8  0 245 220 134 119 114 100 0.966
**
 0.000 
  10 7  0 94 109 107 106 105 100 0.999
**
 0.000 
  10 6  0 103 100 94 92 93 100 0.998
**
 0.000 
tat H14 10 8  0 489 192 126 132 106 100 0.931
**
 0.002 
  10 7  0 118 125 106 106 103 100 0.998
**
 0.000 
  10 6  0 84 88 92 93 97 100 0.999
**
 0.000 
** Correlation is significant at the 0.01 level (2-tailed). * Correlation is significant at the 0.05 level (2-
tailed). 
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3.4.1.3 Precision 
The next step of the validation process was to determine the precision of 
the bioluminescent method. Mean RLU measurements of ten replicates 
are depicted in Table 3.7. The percentage Relative Standard Deviation 
(%RSD) of undiluted cultures (108 CFU/mL) and serially diluted cultures 
for all the strains remained less than 30%. These dilutions for all strains 
therefore passed the acceptance criteria. 
 
Table 3.7: Relative standard deviation for precision analysis 
  
108  107  106  105  104  103  102  
lys R25 
Mean 6322442 1861133 123430 6517 733 255 255 
SD 70662.5 109515.4 8405.4 162.4 60.3 20.5 10.1 
RSD (%) 1.1 5.9 6.8 2.5 8.2 8.0 4.0 
lys G25 
Mean 2267296 1895567 126476 8821 888 261 192 
SD 102029.5 71422.8 9584.5 246.2 22.7 29.7 30.3 
RSD (%) 4.5 3.8 7.6 2.8 2.6 11.4 15.8 
ldcC 
Mean 45032 59773 6929 716 227 161 151 
SD 581.1 1054.0 135.6 66.5 29.7 38.9 27.2 
RSD (%) 1.3 1.8 2.0 9.3 13.1 24.2 18.1 
lpp R3 
Mean 337625 170840 31230 2615 430 212 150 
SD 30466.0 16758.1 3113.8 49.3 31.5 29.0 18.4 
RSD (%) 9.0 9.8 10.0 1.9 7.3 13.7 12.3 
lpp R4 
Mean 2935995 1928565 255642 22804 2400 351 144 
SD 12330.6 15099.7 21503.8 358.6 103.6 39.7 18.6 
RSD (%) 0.4 0.8 8.4 1.6 4.3 11.3 12.9 
spc 
Mean 199261 150778 30598 2640 455 265 140 
SD 1269.8 4332.2 880.6 76.1 15.9 26.0 27.1 
RSD (%) 0.6 2.9 2.9 2.9 3.5 9.8 19.4 
tat H5 
Mean 2179922 1245812 139368 16680 1796 377 192 
SD 57150.3 25666.8 4830.7 579.9 55.8 31.2 47.2 
RSD (%) 2.6 2.1 3.5 3.5 3.1 8.3 24.6 
tat H9 
Mean 276691 125557 11092 1888 438 161 150 
SD 14690.3 3032.4 184.1 57.1 24.0 28.4 15.5 
RSD (%) 5.3 2.4 1.7 3.0 5.5 17.6 10.3 
tat H14 
Mean 702540 266494 77984 6805 812 231 143 
SD 10189.0 9845.9 1116.6 61.8 27.8 15.0 37.3 
RSD (%) 1.5 3.7 1.4 0.9 3.4 6.5 26.0 
Mean RLU measurements, standard deviation (SD) and relative standard deviation (RSD) 
are indicated at each serial dilution performed in ten replicates. 
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One-way analysis of variance and F-tests were conducted to determine 
the significance of variability in the precision data. Using the F-tables, the 
critical value from an F-distribution with 2, 15 degrees of freedom was 
3.68. The F-values (Table 3.8) obtained for all bioluminescent strains were 
less than the critical value and therefore there was no significant 
difference between the bioluminescent method and the plate counting 
method. This was further confirmed by analysis of variance where the 
significance values were greater than 0.05, implying that there was no 
significant difference between the two methods. 
 
Table 3.8: F-test and analysis of variance for precision analysis. 
Strain 
F-test (P<0.05) 
F-value* Significance 
ldcC 1.278 0.307 
spc 1.276 0.308 
lysR25 1.224 0.322 
lysG25 1.250 0.315 
lppR3 1.275 0.308 
lppR4 1.242 0.317 
tatH5 1.255 0.313 
tatH9 1.276 0.308 
tatH14 1.271 0.309 
*Critical value with 2, 15 degrees of freedom at a 0.05 significance level was 3.68. 
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3.4.1.4 Equivalence 
Equivalence of the bioluminescent and plate counting method was 
determined by performing two-way ANOVA on results obtained from the 
precision analysis. Table 3.9 shows the statistical significance values for 
each of the bioluminescent constructs and shows that there was no 
significant difference (P<0.05) between the bioluminescent value and CFU 
count for each theoretical CFU value.  Hence the bioluminescent method 
and plate count method are equivalent.  
 
Table 3.9: Equivalence analysis.  
Strain Theoretical 
value 
CFU RLU ANOVA (P< 
0.05) 
lys R25 1.00E+08 1.70E+08 6.32E+06 0.505 
  1.00E+07 1.70E+07 1.86E+06  
  1.00E+06 1.70E+06 1.23E+05  
  1.00E+05 1.70E+05 6.52E+03  
  1.00E+04 1.70E+04 7.33E+02  
  1.00E+03 1.70E+03 2.55E+02  
lys G25 1.00E+08 1.70E+08 2.27E+06 0.49 
  1.00E+07 1.70E+07 1.90E+06  
  1.00E+06 1.70E+06 1.26E+05  
  1.00E+05 1.70E+05 8.82E+03  
  1.00E+04 1.70E+04 8.88E+02  
  1.00E+03 1.70E+03 2.61E+02  
ldcC 1.00E+08 1.60E+08 4.50E+04 0.486 
  1.00E+07 1.60E+07 5.98E+04  
  1.00E+06 1.60E+06 6.93E+03  
  1.00E+05 1.60E+05 7.16E+02  
  1.00E+04 1.60E+04 2.27E+02  
  1.00E+03 1.60E+03 1.61E+02  
lpp R3 1.00E+08 1.51E+08 3.38E+05 0.499 
  1.00E+07 1.51E+07 1.71E+05  
  1.00E+06 1.51E+06 3.12E+04  
  1.00E+05 1.51E+05 2.62E+03  
  1.00E+04 1.51E+04 4.30E+02  
  1.00E+03 1.51E+03 2.12E+02  
lpp R4 1.00E+08 1.56E+08 2.94E+06 0.51 
  1.00E+07 1.56E+07 1.93E+06  
  1.00E+06 1.56E+06 2.56E+05  
  1.00E+05 1.56E+05 2.28E+04  
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  1.00E+04 1.56E+04 2.40E+03  
  1.00E+03 1.56E+03 3.51E+02  
spc 1.00E+08 1.54E+08 1.99E+05 0.494 
  1.00E+07 1.54E+07 1.51E+05  
  1.00E+06 1.54E+06 3.06E+04  
  1.00E+05 1.54E+05 2.64E+03  
  1.00E+04 1.54E+04 4.55E+02  
  1.00E+03 1.54E+03 2.65E+02  
tat H5 1.00E+08 1.69E+08 2.18E+06 0.489 
  1.00E+07 1.69E+07 1.25E+06  
  1.00E+06 1.69E+06 1.39E+05  
  1.00E+05 1.69E+05 1.67E+04  
  1.00E+04 1.69E+04 1.80E+03  
  1.00E+03 1.69E+03 3.77E+02  
tat H9 1.00E+08 1.58E+08 2.77E+05 0.49 
  1.00E+07 1.58E+07 1.26E+05  
  1.00E+06 1.58E+06 1.11E+04  
  1.00E+05 1.58E+05 1.89E+03  
  1.00E+04 1.58E+04 4.38E+02  
  1.00E+03 1.58E+03 1.61E+02  
tat H14 1.00E+08 1.59E+08 7.03E+05 0.491 
  1.00E+07 1.59E+07 2.66E+05  
  1.00E+06 1.59E+06 7.80E+04   
  1.00E+05 1.59E+05 6.81E+03   
  1.00E+04 1.59E+04 8.12E+02   
  1.00E+03 1.59E+03 2.31E+02   
RLU measurements and CFU count for all bioluminescent constructs at each serial 
dilution. Statistical significance is shown at P<0.05.
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3.4.2 Quantitative Polymerase Chain Reaction (qPCR) 
To determine plasmid copy numbers and to ascertain if the plasmid 
remained stable during the course of the study, qPCR experiments were 
performed. Several PCR reactions were performed to optimise the 
annealing temperatures for successful amplification of both dxS and 
gentamicin genes. Finally, the annealing temperatures were set at 46oC 
and 60oC for dxS and gentamicin amplification, respectively. Quantitative 
PCR amplification products of gentamicin (Figure 3.6 A) and DxS (Figure 
3.6 B) for five bioluminescent strains spc, ldcC, lppR4, lysR25 and tatH5 
were further resolved by gel electrophoresis for visual satisfaction. 
___________________________________________________________ 
Figure 3.6: Quantitative PCR reactions for gentamicin and dxS 
amplification. Reactions were performed using final optimised conditions for 
amplification of gentamicin gene (A) and dxS gene (B) for the strains of spc, ldcC, lppR4, 
lysR25 and tatH5 in lanes 1, 2, 3, 4 and 5, respectively, in both cases. 
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Standard calibration curves were constructed for genomic and plasmid 
DNA (Figure 3.7). A range of concentrations of genomic and plasmid DNA 
were used to perform quantitative PCR to determine their Ct values. As 
the concentration of plasmid (Figure 3.7A) and genomic DNA (Figure 
3.7C) increased, the Ct value decreased. Melt curve analysis for both 
plasmid amplification (Figure 3.7B) and genomic amplification (Figure 
3.7D) also indicated single maxima at approximately 85oC, suggesting that 
pure PCR products were obtained. 
___________________________________________________________ 
Figure 3.7: Standard calibration and melt curves for plasmid and genomic 
DNA standards. Figure A and B correspond to calibration curves and melt curves, 
respectively, for plasmid DNA, while figure C and D refer to calibration curves and melt 
curves, respectively, for genomic DNA. Serial dilutions of plasmid and genomic DNA 
extracted from Pseudomonas bioluminescent constructs were used for quantification of 
genomic and plasmid DNA by real-time PCR for the construction of calibration curves. 
 
 
 
 
Page 146 
 
Calibration curves for genomic and plasmid DNA, were generated (Figure 
3.8). Ct values were found to decrease proportionately as the 
concentration of DNA template increased in each case. The slope for both 
curves was computed to be -3.40 for genomic DNA and -3.57 for plasmid 
DNA. The R2 values were found to be greater than 0.98 indicating high 
efficiency of PCR. The efficiencies of the standard curves were derived to 
be 96.8% for genomic and 90.7% for plasmid DNA. 
 
________________________________________________________________________ 
Figure 3.8: Calibration curves for genomic (A) and plasmid (B) DNA amplification.  
Quantitative PCR was performed using various concentrations of template DNA. Ct 
values are plotted against DNA concentration on a log10 scale. Linear inverse relationship 
between Ct values and log10 DNA concentration is observed and the corresponding 
correlation coefficients are shown. 
 
 
Samples of total DNA extracted from bacterial cultures of all strains at 
defined time points along the growth curve were analysed by qPCR. 
Examples of Ct values and melt curve analysis for genomic and plasmid 
amplification are shown in Figure 3.9. As expected, the wild-type strain 
lacked plasmid DNA and therefore Figure 3.9C indicated an amplification 
plot with a Ct value of 31, which was significantly different to Ct values 
obtained for all other strains with plasmids. 
 
B A 
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________________________________________________________________________ 
Figure 3.9: Amplification plots and melt curves for genomic and plasmid 
DNA samples. A and B corresponds to amplification plots and melt curves, respectively, 
for genomic DNA extracted from 24 hour cultures. C and D refer to amplification plot and 
melt curves, respectively, for plasmid DNA extracted from 24 hour cultures. Total DNA 
extracted from Pseudomonas bioluminescent constructs at various time points along their 
growth kinetics were used for quantification of genomic and plasmid DNA by real-time 
PCR. 
 
Ct values were obtained and plasmid copy numbers for each strain 
calculated at pre-defined time points (Appendix 8, Table 7.3). By plotting 
the plasmid copy number profiles for all plasmid-bearing strains (Figure 
3.10), it was shown that plasmid copy number for all plasmids was 
greatest at 6 hours, with 100 and 120 copies for constructed variants and 
pME4510 plasmids, respectively. Plasmid copy number then decreased 
greatly by 24 hours with recombinant variants showing approximately 50 
copies and pME4510 showing approximately 80 copies. The PCN after 24 
hours remained consistent throughout the 28 days. Correlations between 
time and plasmid copy number were weak and insignificant (P<0.05) 
(Appendix 8, Table 7.4). Weak relationships between plasmid copy 
number and time suggested that plasmids remained stable throughout the 
duration of the study. 
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________________________________________________________________________ 
Figure 3.10: Plasmid copy number analysis for all plasmid-bearing strains. 
Plasmids copy numbers are represented at exponential phase (6 hours) and stationary 
phase (from 24 hours up to 28 days). Error bars represent standard deviations from n=3. 
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3.5 Discussion 
Novel rapid methods of microbial detection need to be validated and 
compared with existing traditional methods that are approved by various 
bodies. The validation parameters for the bioluminescent method were 
therefore addressed according to various documents (Kramer et al., 2008; 
PDA, 2000). The parameters validated were linearity, accuracy, precision, 
equivalence and limit of detection and quantification.  
 
3.5.1 Linear range 
The bioluminescence and CFU counts for all cultures of Pseudomonas 
bioluminescent constructs were measured at a series of dilutions after 24 
hours of growth. Bioluminescence readings were found to reduce at a 
linear rate with increase in dilution factor (Figure 3.4), meaning that as the 
number of cells decreased the production of bioluminescence reduced at 
an equal rate. The range where the rate of increase was linear was 
between 104 and 108 CFU/mL for strong promoters and 105 to 108 
CFU/mL for weak promoters. Correlations between RLU and CFU were 
found to be strong (r >0.97) and significant (P<0.01) within the range 103 
to 107 cells.  Correlations coefficients decreased slightly when undiluted 
cultures were incorporated into the range. However, these correlations 
were also found to be significant. Good correlations were also found by 
another study (Neilson, Pierce & Maier, 1999) which showed that there 
was a linear relationship between bioluminescence and cell number. 
Furthermore, Neilson and his colleagues also showed that the amount and 
timing of bioluminescence is highly dependent on changes in cell 
numbers. 
It was observed that the ratio of bioluminescence to CFU count for 
undiluted cultures were less than those of 10-fold diluted cultures, implying 
that undiluted cultures hindered the accurate detection of 
bioluminescence. This was because the high number of bacterial cells in 
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undiluted cultures caused cultures to be turbid, thereby diffracting light. 
This is called the inner filter effect (Kao, Asanov & Oldham, 1998). The 
other possiblity of detector saturation, whereby bioluminescence is 
measured above the upper limit of detection, was omitted since the 
bioluminescence produced was less than the saturation threshold, which 
is 1x108 RLU as specified by the manufacturer. Additionally the 
bioluminescence produced by weak promoters resulted in a similar 
turbidity effect compared to that of strong promoters even though the RLU 
from the undiluted cultures of weak promoters were less than that of 10-
100 fold of diluted cultures with strong promoters. Furthermore, the 
linearity validation indicated that the requirement of 106 cells inocula for 
preservative efficacy testing was within the linear range and therefore the 
inner-filter effect would not affect the preservative testing regimes. 
Consistent ratios of log RLU per log CFU were observed for 10-fold and 
100-fold diluted samples, indicating that RLU reading reduced 
proportionally as CFU count also reduced. The relationship between RLU 
and CFU weakened beyond 104 fold dilution for weak promoters and 
beyond 105 fold dilutions for strong promoters since bioluminescence of 
such dilute cultures was similar to the background value.  
It was observed that both strains of lys and lpp produced similar RLU 
readings per CFU. Strains harbouring ldcC and spc gave the lowest light 
output. Strain tat S5 produced three-fold and two-fold greater 
bioluminescence than its variants tat S9 and tat S14, respectively. The 
variation in bioluminescence per CFU for different variants of the same 
bioluminescent strain may be explained by the fact that there is a variation 
in plasmid copy number per cell or the gene expression is dependent on 
plasmid topology and conformation. The fact that DNA conformation and 
topology is a factor for strength of gene expression has been was noted 
previously in numerous studies (Mishra et al., 1990; Palecek, 1991; 
Travers, 1987; Werel et al., 1991). Furthermore, plasmid topology is a 
factor of plasmid DNA sequence. However, after full plasmid sequencing 
analysis, no significant differences in plasmid sequences between the 
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three variants of tat were found. Hence, the plasmid copy numbers for the 
strains were investigated.  
 
3.5.2 Limit of quantification, detection and sensitivity 
The lower limit of detection was estimated to be 102 RLU as observed by 
the negative control strains with respect to bioluminescence. This showed 
that further serial dilutions produced bioluminescence close to the lower 
limit of detection of the luminometer and therefore the RLU:CFU ratios did 
not provide a true reflection of the health state of the bacterial cells. 
Sensitivity of the bioluminescent method was determined to be 103 
CFU/mL and therefore the bioluminescent method has proved to be highly 
sensitive. The lower limit of quantification was 103 CFU/mL, which is also 
reported in the validation document (PDA, 2000) and with studies using 
ATP bioluminescence (Kramer et al., 2008). According to a review of 
methods for rapid microbiological assay (Shintani, Sakudo & McDonnel, 
2011), the sensitivity of the ATP bioluminescent method was quoted as 
greater than 102-103 CFU/mL. However, a disadvantage of the ATP 
bioluminescent method was that there is a high rate of false positive 
results due to the fact that non-microbial ATP cannot be distinguished 
from microbial ATP and in particular microbial ATP from luciferase 
pathway (Kramer et al., 2008). Furthermore, the ATP bioluminescent 
method requires cell lysis and extraction of ATP for each sample. This can 
be very labourious and time-consuming, requiring destructive sampling, 
and therefore does not provide data in a ‘real-time’ mode. 
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3.5.3 Accuracy studies 
Accuracy of the bioluminescent method was assessed by determining the 
percentage recovery of undiluted cultures and serially diluted cultures. 
Accuracy assessment of the bioluminescent method does not determine 
the absolute number of bacterial cells in a sample and therefore 
‘percentage recovery’ of cells was utilised to determine how accurate the 
bioluminescent method was compared to the traditional plate counting 
method. For samples to pass the accuracy validation, the percentage 
recovery was required to be between 70% and 130% (PDA, 2000).  
Percentage recoveries for undiluted cultures were outside the acceptance 
criteria. Undiluted samples indicated wider fluctuations in bioluminescence 
measurements, thereby affecting the recovery process. These fluctuations 
were probably not due to fluctuations in gene expression but rather due to 
inner filter effects caused by highly turbid cultures (Kao et al., 1998). This 
trend has been reported previously (Lei, Mulchandani, Chen, Wang & 
Mulchandani, 2003; Mulchandani, Chen & Mulchandani, 2006; 
Mulchandani, Lei, Chen, Wang & Mulchandani, 2002). However, 
percentage recoveries of 10-fold and 100-fold diluted cultures were found 
to be within the acceptance criteria and therefore passed the accuracy 
validation analysis. Furthermore, correlations between RLU and CFU were 
found to be significant (P<0.01) within the diluted suspensions of each 
serial dilution tested. Hence the bioluminescent method was very accurate 
within the linear working range and thus the bioluminescent method as a 
microbial testing method passed the criteria set out in accordance with 
various documents (ISO, 1994a, 1994b, 1994c; PDA, 2000). 
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3.5.4 Precision and equivalence 
Precision measures the repeatability of any method by measuring the 
relative standard deviation within replicate samples. The acceptance 
criteria require that the relative standard deviation is less than 30% of the 
variation within replicates of the samples to pass the precision 
assessment (PDA, 2000). Furthermore, one-way analysis of variance and 
an F-test determined the significance of variability in the precision data. 
The F-test showed that there was no significant difference between the 
bioluminescent method and the plate counting method for all 
bioluminescent strains, since the F-values were less than the critical value 
(3.68). This was further confirmed by analysis of variance, where the 
significance values were greater than 0.05, implying that there was no 
significant difference between the two methods. Therefore, the 
bioluminescent method as a microbial testing method passed the criteria 
set out in accordance with various documents (ISO, 1994a, 1994b, 1994c; 
PDA, 2000). The % RSDs for all dilutions for all the strains tested were 
found to be less than 30%. The maximum of % RSDs for 102 CFU/mL was 
26%, which was still less than 30%. This was because bioluminescence at 
102 CFU/mL is undetectable due to the lower limit of detection. According 
to Kramer et al. (2008), the precision of the ATP bioluminescence method 
was found to be 24.9% and 26% for 108 CFU/mL and 104 CFU/mL, 
respectively. The precision of the bioluminescent method using the 
bioluminescent constructs designed in this study was less than 10% and 
less than 15% for 108 CFU/mL and 104 CFU/mL, respectively. This 
indicated that the whole cell microbial bioluminescent method may be 
more precise than the ATP bioluminescent method, even though the ATP 
bioluminescent method is accepted as an alternative method for testing 
preservatives according to the pharmacopoeias. 
Equivalence measures the variability between the traditional plate 
counting method and the bioluminescent method. Two-way ANOVA 
showed no significant difference between the two methods for all 
bioluminescent strains. No significant difference between the 
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bioluminescent and the plate counting methods was also shown by other 
studies (Quilliam, Williams & Jones, 2012; Sun, Connor, Pennington & 
Lawrenz, 2012; Thorn, Nelson & Greenman, 2007). A study comparison 
between CFU count and ATP bioluminescence also showed that both 
methods were equivalent (Kramer et al., 2008).  
 
3.5.5 Plasmid copy number 
Plasmid copy numbers for all strains were evaluated with the objective of 
determining plasmid stability throughout 28 days as well as the underlying 
reasons for differences in gene expression by different variants of 
bioluminescent constructs containing tat promotors. Plasmid copy 
numbers were determined by adapting the qPCR methods used 
previously (Lee et al., 2006b). Establishing the rate of amplification of the 
dxS and gentamicin genes on the genome and plasmid, respectively, 
provided the basis for comparing the numbers of plasmid copies per 
genomic DNA. This was achieved by determining the relationship between 
DNA concentration and Ct value. It was found that Ct values decreased as 
DNA concentration increased as expected; therefore, there was an 
inverse relationship between Ct value and DNA concentration. Correlation 
coefficients of 0.993 and 0.988 and negative slopes for genomic and 
plasmid DNA, respectively, also indicated a strong inverse relationship 
between DNA concentration and Ct values for both plasmid and genomic 
DNA. 
Ct values can be affected by the efficiency of PCR reactions. 
Theoretically, amplification efficiency is regarded as 1 when fluorescence 
doubles with every cycle. Practically, this may not be the case. Hence 
efficiencies between 90-110%, calculated from the slope of a calibration 
curve being between -3.3 and -3.6 are acceptable (Applied Biosystems; 
Fraga et al., 2008; Wong & Medrano, 2005). Calibration curves for 
genomic and plasmid DNA were generated with high efficiencies of -3.40 
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and -3.57 for genomic and plasmid DNA, respectively, as exemplified from 
the slopes. This equated to efficiencies of 96.8% and 90.7% for genomic 
and plasmid DNA, respectively.  
Melt curve analysis was performed after amplification of plasmid and 
genomic DNA segments. Single peaks were obtained for amplification 
products of both DxS and gentamicin genes, indicating that there was no 
non-specific amplification and that the products of amplification were pure. 
Plasmid copy numbers of all plasmid-bearing strains were determined at 
various time points along the growth and death curves, up to 28 days. This 
was achieved by determining the concentrations of plasmid DNA and 
genomic DNA at various time points and computing them to determine 
plasmid copy number per genome. As shown in Figure 3.10, plasmid copy 
number for all strains was greatest during the exponential phase with 
pME4510 strain showing 120 copies and the recombinant constructs 
showing 100 copies. This is the phase when the cells are dividing 
exponentially and therefore the plasmids are replicating before the cells 
replicate. During stationary phase, plasmid copy numbers were 
approximately 80 and 50 for strain pME4510 and recombinant constructs, 
respectively. This means that increase in plasmid size from 4kb for 
pME4510 to 10kb for the recombinant constructs was associated with 
reduced plasmid copy number. Previous studies have also shown that 
plasmid copy number decreases as plamid size increases (Smith & 
Bidochka, 1998). This is because greater amounts of resources are 
required to maintain and replicate larger plasmids compared to those 
required for smaller ones. All plasmid copy numbers remained consistent 
throughout the 28 days, indicating that the plasmids were stably 
maintained by the cells. This was further confirmed by a lack of correlation 
between time and plasmid copy number that were also insignificant 
(P<0.05) for each of the strains tested. Stability of plasmids was regarded 
as vital for this study since preservative efficacy tests required stable 
plasmids to be maintained throughout the duration of the test. 
Furthermore, instability of certain plasmids as observed in chapter 2 led to 
Page 156 
 
the investigation of plasmid stability in these working bioluminescent 
strains. Also, the variation in bioluminescence between variants containing 
the same promoter sequence was not due to differences in plasmid copy 
number. 
 
3.6. Conclusion 
Validation of the bioluminescent constructs was successful. The linear 
range was between 104 to 108 CFU/mL for strong promoters and between 
105 to 108 CFU/mL for weak promoters and bioluminescence increased 
proportionately with increase in number of cells. The lower limit of 
detection was estimated to be 102 RLU as observed by the negative 
control strains with respect to bioluminescence. The lower limit of 
quantification was 103 CFU/mL. Accuracy of the bioluminescent method 
was assessed by determining the percentage recovery of cultures; 10-fold 
and 100-fold diluted cultures were found to lie within the acceptance 
criteria and therefore passed the accuracy validation analysis. Precision 
measures the repeatability of any method by measuring the relative 
standard deviation within replicate samples. The % RSDs for all dilutions 
for all the strains tested were found to be less than 30% and hence the 
samples passed the precision assessment. Plasmids were stably 
maintained by the cells throughout 28 days.  
This study has therefore shown that the bioluminescent method passed all 
the criteria required for validation. All the constructs have therefore been 
successfully validated and the bioluminescent method shown to be at 
least equivalent if not better than the traditional plate counting method and 
the ATP determination method. The newly created recombinant constructs 
are functional and stable and therefore may be utilised for further studies. 
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Chapter 4: Bacterial growth and gene 
expression 
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4.1 Introduction 
4.1.1 Growth and death kinetics 
Many natural environments present unfavourable conditions for bacterial 
growth and division, such as low nutrient availability, less favourable 
temperature, pH and osmolarity. However, bacteria have evolved 
strategies to survive under such unfavourable conditions and 
subsequently grow under favourable conditions. This phenomenon of 
growth and survival is termed a ‘feast or famine’ phenomenon. 
Nevertheless, most studies and experiments involving bacteria are 
performed in closed systems. In systems such as the laboratory bacterial 
batch cultures where conditions are optimum, bacterial cells go through 
five phases of growth in sequence (Figure 4.1). 
___________________________________________________________ 
Figure 4.1: Bacterial growth phases. Cells growing in a closed system under 
optimum conditions. Numbers 1-5 represent lag, exponential, stationary, death and long-
term stationary phases, respectively. Dotted coloured lines represent the GASP 
phenotype (Finkel, 2006; Navarro Llorens, Tormo & Martinez-Garcia, 2010).  
 
The lag phase is characterised by growth in cell volume but not in 
numbers, increased metabolism and synthesis of proteins, RNA and DNA 
(Al-Qadiri et al., 2008). Considering that the source of cells at inoculation 
arrives from the stationary phase of previous batches, cells become 
rapidly adapted in their new environment during early lag phase; this 
represents the transition from stationary phase (Rolfe et al., 2012). During 
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this phase there is a high concentration of RNA polymerase (Klumpp & 
Hwa, 2008; Proshkin, Rahmouni, Mironov & Nudler, 2010). Transcription 
for proteins required for lag and log phases of growth is initiated because 
certain promoters possess a strong binding affinity for RNA polymerase 
(Rolfe et al., 2012). It is thought that collection of these proteins beyond a 
certain threshold may be an indicator for cells to enter the exponential 
phase of growth (Rolfe et al., 2012). 
The exponential or log phase of growth occurs where the environment is 
conducive to the growth of cells and therefore the cells are actively 
dividing at a constant rate (Al-Qadiri et al., 2008; Navarro Llorens et al., 
2010). The rate of growth at this stage is considered in terms of the 
doubling time or generation time (Al-Qadiri et al., 2008). Although the 
growth rate is constant, it does depend on various factors such as media 
type, temperature, space and oxygen availability. 
The stationary phase features a balance between cell division and cell 
death. During this phase, populations consist of a mixture of healthy cells 
and damaged, dying cells. Nutrients become limiting, metabolites increase 
in concentration and there is spatial congestion due to the increased 
number of cells. Certain bacteria also produce secondary metabolites 
during this phase, while other bacteria prepare for sporulation (Al-Qadiri et 
al., 2008). However, when bacteria from the stationary phase are 
inoculated into a fresh medium, the degenerative process stops and 
instead the bacteria prepare for growth and division, meaning the cells 
enter the lag phase. This process is termed reversible conditional 
senescence (Nystroem, 2007). Hence, bacterial cells in their lag phase 
rejuvenate, repair oxidative damage and prepare for growth and division. 
The death phase is symbolized by an exponential decrease in number 
viable cells due to reduction in cellular energy, changes in pH and further 
accumulation of metabolites (Al-Qadiri et al., 2008). Nutrients are then 
released back to the medium, since 99% of the cells die and degrade. 
However, the surviving cells exploit this new environment to their 
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advantage and utilise the nutrients released for their growth. This leads to 
the long-term stationary phase (Finkel, 2006), where there are repeated 
rounds of cell death and re-growth of survivors; each time, the surviving 
population shows a difference in phenotype. For example, the surviving 
cells are better adapted to utilize nutrients and grow in a metabolite-rich 
medium. This phase is characterised by several phenotypes: the growth 
advantage in stationary phase phenotype, viable but non-culturable states 
as well as a stationary phase contact dependent inhibition state (Navarro 
Llorens et al., 2010).  
The GASP phenotype is defined as the ability of mature bacterial cells 
from long-term cultures to outcompete young cells from fresh cultures 
(Zambrano & Kolter, 1996; Zinser & Kolter, 2004). Mature cells have an 
advantage over fresh young cells due to their ability to scavenge glucose, 
ammonia and amino acids (Navarro Llorens et al., 2010). 
Certain bacterial cells enter a dormant state upon prolonged starvation. 
Such cells are viable and metabolically active, albeit with decreased levels 
of metabolic activity; however, they cannot grow and divide in culture 
media. Hence, these cells are termed as viable but non-culturable cells 
(VBNC) (Navarro Llorens et al., 2010; Oliver, 2005). Factors contributing 
to the VBNC state include starvation, low oxygen concentration and low 
incubation temperature, amongst others (Rowan, 2010). Cells in the 
VBNC state have been shown to be resuscitated by changes in certain 
conditions (Zhong, Chen, Zhang & Jiang, 2009). For instance, a simple 
temperature shift can resuscitate certain cells. Resuscitated cells are able 
to express pathogenicity; this is a major problem in the hospital, food and 
pharmaceutical industries and preservative systems, since it presents a 
significant risk to human health (Oliver, 2005). These VBNC cells may 
also initiate new infectious diseases but the risk to human health is even 
more pronounced because traditional methods of detection will not detect 
these cells. 
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Stationary phase contact dependent inhibition (SCDI) (Lemonnier et al., 
2008) is a phenomenon where cells undergo mutations as a result of 
serial culturing and the emerging mutant cells inhibit the growth of parent 
un-mutated cells. Mutated strains have been shown to produce glycogen 
in increased amounts. 
 
4.1.2 Bacterial growth rate-dependent gene expression 
Bacterial cells replicate rapidly under favourable conditions and such rapid 
growth and division is tightly integrated and controlled by various 
metabolic, genetic and biochemical pathways. These global networks 
synchronize gene expression with various stages of replication in the 
growth cycle (Scott & Hwa, 2011) in response to changing environment. 
Quantitative study of gene expression is therefore dependent on the 
physiological status of the cell. Any change in the state of the cell due to 
change in the environment is thereby brought about by changes in gene 
expression. Therefore, growth rate is a factor of constitutive gene 
expression. Alterations in growth environment dictate changes in cell 
physiology as characterised by variations in nucleoid structure, density of 
DNA superhelices and RNA polymerase specificities (Bordes et al., 2003; 
Sobetzko, Travers & Muskhelishvili, 2012). The amounts of protein and 
chromatin also change in response to changes in growth rate.  
Growth rate-dependent constitutive gene expression can be studied by 
measuring growth rate-dependent parameters in the cell, such as gene or 
plasmid copy number or RNA polymerase concentration (Gerosa, 
Kochanowski, Heinemann & Sauer, 2013; Klumpp & Hwa, 2008). For the 
purpose of this study, the global gene expression as a factor of growth 
rate is quantified by measuring constitutive expression of the lux cassette 
placed under constitutive promoters. 
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4.2 Aim and objectives 
The aim of this work was to determine the growth and death pattern of the 
recombinant constructs as compared to wild-type P. aeruginosa 
ATCC9027.  
The objectives of this work were: 
 To determine the growth and death patterns of all strains at various 
time points up to 28 days by constitutive gene expression using the 
bioluminescence method and traditional plate counting method. 
 To compare the data obtained by both methods.  
 To evaluate the promoter strengths of bioluminescent constructs by 
constitutive gene expression at various stages of growth and relate 
the strengths to promoter sequences. 
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4.3 Materials and methods 
4.3.1 Growth and death kinetics of P. aeruginosa wild-type and 
bioluminescent constructs 
The bacterial strains used for growth and death kinetic studies were: 
Wild-type P. aeruginosa ATCC 9027 (WT) 
P. aeruginosa ATCC 9027 + Promoterless pME-lux 
P. aeruginosa ATCC 9027 + ldcC pME-lux 
P. aeruginosa ATCC 9027 + spc pME-lux 
P. aeruginosa ATCC 9027 + lys R25 pME-lux 
P. aeruginosa ATCC 9027 + lpp R4 pME-lux 
P. aeruginosa ATCC 9027 + tat H5 pME-lux 
 
All these strains were grown as specified in section 3.3.1. Isolated 
colonies were then inoculated into 100 mL LB containing 10 g/mL 
gentamicin (except for WT that was inoculated into LB without antibiotic) 
and incubated at 32oC and 150 rpm shaking conditions for 28 days. 
Samples were retrieved at each hour upon inoculation from each of the 
flasks for the first 48 hours followed by sample retrieval at 7 days, 14 
days, 21 days and 28 days. All samples were serially diluted 10 fold seven 
times in buffered peptone water (Oxoid Ltd). Aliquots (1 mL) of each 
undiluted culture and diluted culture were transferred into culture tubes 
aseptically for bio-luminescence measurements. Relative light units (RLU) 
were measured as described in section 2.3.15. Aliquots (100 L) of each 
undiluted and diluted culture were transferred onto LB agar plates as 
described in section 3.3.2. 
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4.3.2 Growth and death kinetics of P. aeruginosa wild-type and 
recombinant constructs using fluorescence spectroscopy 
Strains were grown as described in section 3.3.1. Upon inoculation, 
samples were retrieved, in triplicate, from each of the flasks after periods 
of 0 hours, 2 hours, 4 hours, 6 hours, 12 hours, 24 hours, 48 hours, 
followed by sample retrieval at 7 days, 14 days, 21 days and 28 days. 
Cultures were centrifuged at 13000rpm for five minutes and the 
supernatants were discarded. Samples were prepared according to 
manufacturer’s instructions (LIVE/DEAD® BacLight Bacterial Viability Kit 
from Molecular Probes®).  
Following staining, 200 L of each sample was transferred to a black 96-
well microtitre plate for measuring fluorescence. The plate was placed in a 
fluorescent plate reader (Promega Glomax Multidetection system using 
fluorescent module and fluorescent optical kit) and fluorescence was 
measured using excitation wavelengths of 490nm and 525nm and 
emission wavelengths of 510-570nm and 580-640nm for live and dead 
cells, respectively. 
 
4.3.3 Data analysis 
Relative bioluminescences per unit CFU were calculated by determining 
the ratios of RLU:CFU. 
Pearson’s correlations between relative bioluminescence, plate count and 
relative fluorescence reading were performed at a significance level of 
P<0.05. 
Two-way analysis of variance (ANOVA) at a significance level of P<0.05 
was performed between relative bioluminescence, plate count and relative 
fluorescence data to determine the equivalence between these methods. 
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4.4 Results 
4.4.1 Growth and death kinetics of P. aeruginosa wild-type and 
recombinant constructs 
The growth and death kinetics of Pseudomonas aeruginosa wild-type and 
recombinant constructs were evaluated for 28 days. The bioluminescence 
intensity was measured and compared against colony forming units at 
each hour up to 48 hours then by every 7 days up to 28 days (Figure 4.2). 
Bioluminescence intensity was shown to increase proportionally up to 12 
hours, followed by stabilisation up to 24 hours. There was a slight decline 
from 24 hours to 48 hours. Colony forming units (CFU) for all strains were 
104 for the first 3 hours, indicating a constant lag phase. CFU counts for all 
bioluminescent strains increased up to 12 hours, reaching 108 CFU/mL 
whilst the CFU counts for the wild-type increased to108 CFU/mL by 8 
hours. Further growth was observed for the wild-type strain, reaching 109 
CFU/mL up to 24 hours. However, the growth was at a much reduced 
rate. A similar pattern to that of the wild-type was observed for the 
promoterless strain. Stationary phase onset was at 12 hours for all the 
strains and remained constant up to 48 hours.  
Over 28 days, bioluminescence of all five bioluminescent constructs 
decreased. However, there was an increase in bioluminescence for all five 
bioluminescent constructs at 14 days. After 14 days, the bioluminescence 
continued to decrease. After 48 hours, CFU count declined constantly 
throughout the duration of the experiments, reaching 103 CFU/mL. 
However, wild-type and promoterless CFU count remained stable from 14 
and 21 days onwards, decreasing to less than 107 and less than 105 
CFU/mL, respectively. 
Overall, the promoter with the greatest bioluminescence during the 
exponential phase was lpp-pMElux, followed by lys-pMElux, tat-pMElux, 
ldcC-pMElux and spc-pMElux. However, during stationary phase, tat-
pMElux had the greatest bioluminescence, followed by lys-pMElux and 
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lpp-pMElux producing similar bioluminescence, and finally ldcC-pMElux 
and spc-pMElux. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
___________________________________________________________ 
Figure 4.2: Growth curve for wild-type and six constructs. Bioluminescence 
measurements up to 48 hours and 28 days are shown in figure A and B respectively. 
CFU determinations up to 48 hours and 28 days are shown in figure C and D 
respectively.         ldcC,       spc,       lys,       tat,       lpp,        pMElux,        PA9027 (WT). 
 
 
B 
D C 
A 
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To determine the strength of each of the promoters during the growth and 
death cycle, the ratios of RLU to CFU were assessed (Figure 4.3). During 
the exponential growth phase, lpp-pMElux produced the highest 
bioluminescence per CFU, peaking at 5 hours with a ratio of 0.45 (Figure 
4.3A). This was followed by tat-pMElux, ldcC-pMElux and lys-pMElux, 
each reaching a maximum at 4 hours, with ratios of 0.18, 0.15 and 0.10, 
respectively. Finally, spc-pMElux reached a maximum at 7 hours with a 
ratio of 0.001. Constant bioluminescence per CFU was observed for all 
bioluminescent strains from 12 to 48 hours.  
________________________________________________________________________ 
Figure 4.3: Ratio of RLU:CFU for five constructs. A: Up to 48 hours, B: Up to 28 
days. Ratios of RLU:CFU are indicative of promoter strength.       ldcC,       spc,       lys, 
tat,       lpp. 
 
 
After 14 days (336 hours), the ratios did not increase proportionately with 
increase in time throughout the duration of the assays (Figure 4.3B). 
 
 
 
A B 
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4.4.2 Promoter strength and sequence analysis 
The strength of five promoters was evaluated by determining the relative 
bioluminescence per CFU count, in an attempt to relate each of the 
strengths to their respective promoter sequences. As illustrated in Figure 
4.4, the promoter strength for the five bioluminescent constructs was 
found to be lpp>tat>lys>ldcC>spc in order of decreasing strength during 
exponential phase.  
___________________________________________________________ 
Figure 4.4: Relative promoter strength (RLU/CFU) during exponential and 
stationary phases. Bioluminescence and CFU count were measured at various time 
points along the growth curve and relative bioluminescence produced by a colony 
forming unit was calculated and is represented as a ratio of RLU to CFU. Relative 
promoter strength at various time points is shown.       ldcC,     spc,     lys,     tat,     lpp. 
 
Each promoter sequence was analysed for the -10 and -35 promoter 
sequences and the distance of the spacer regions (Table 4.1). This was 
related to the promoter strength for each bioluminescent (Figure 4.4).  
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Table 4.1: Promoter sequence comparison 
  -10 -35 Spacer region 
Consensus ***TATAAT TTGACA 17 
      
 
Ptat TGG  CACACT TAGCCA 14 
PlolB TGT  CATGAT TGGGCT 14 
PlysS GGG  CATTGT TTTCCT 16 
PldcC ATG  TATAAA CTGCTG 13 
Pspc CGA  TAAATT TTTCAG 19 
Red letters indicate differences from the consensus sequence. 
It was shown that the -35 region of Pspc contained the most differences (4 
out of 6bp) compared to consensus sequence (TTGACA) in P. aeruginosa 
and also the spacer region was 19 bp as opposed to 17bp. These 
differences may therefore relate to Pspc being the weakest promoter of the 
five. Similarly, PldcC also contained 4 out of 6bp differences in the -35 
region compared to the consensus sequence. However, the spacer region 
was found to be 13bp. The -10 regions of Pspc and PldcC indicated 2bp and 
1bp differences, respectively, from the consensus sequence. This may 
explain why PldcC was the stronger promoter of the two.  
Plys was found to contain 3bp differences from the consensus sequence in 
both -10 and -35 regions. The spacer region was found to be 16bp, 
closest to the consensus spacing. Plpp and Ptat both contain spacer 
regions of 14bp. However, Plpp has 3bp differences from the consensus 
sequence in the -35 region and 2bp differences in the -10 region. Ptat 
contains 2bp differences from the consensus sequence in the -35 region 
and 3bp differences in the -10 region. Comparing the promoter strength to 
sequences for these three promoters, both Ptat and Plys have 3bp 
differences from the consensus sequence in the -10 region and their 
strengths are similar during the exponential phase. Plpp has the highest 
expression during exponential phase as it contains only 2bp differences 
from the consensus sequence in the -10 region as opposed to 3bp 
differences in the same region for Ptat and Plys. 
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Plpp and Plys have 3bp differences from the consensus sequence in the -35 
region. On the other hand Ptat has 2bp differences from the consensus 
sequence in the -35 region. Comparing the promoter strength to 
sequences for these three promoters, both Plpp and Plys contain 3bp 
differences from the consensus sequence in the -35 region and their 
strengths are similar during stationary phase. Ptat has shown the most 
constitutive expression during stationary phase since it has only 2bp 
differences in the -35 region as opposed to 3bp differences in the same 
region for Plpp and Plys. 
 
4.4.3 Relationship between RLU, CFU and RFU 
Pearson’s correlations were performed for bioluminescence readings and 
CFU counts (Table 4.2). Strong correlations coefficients (r > 0.91) were 
observed for all recombinant constructs up to 24 hours and the 
correlations were statistically significant (P<0.01). The correlations were 
significantly weaker for ldcC and spc strains up to 48 hours; however 
significant strong correlations were maintained for lys, tat and lpp strains, 
with tat showing the strongest correlation (r > 0.98). Throughout the 28 
days thereafter, correlations remained weak for ldcC and spc, while 
stronger correlations (r > 0.6) were observed for lys and lpp (P<0.01). 
Strong correlation coefficients (r > 0.95) were obtained for tat (P<0.01). 
The decrease in correlation between bioluminescence and CFU after 48 
hours led to further investigations of the state of recombinant cells. 
LIVE/DEAD BacLight stains, comprising Syto-9 and propidium iodide 
fluorescent dyes, were utilised to differentiate cells between live and dead 
bacterial cells along the growth and death curve. Fluorescence output was 
measured as relative fluorescence unit (RFU) produced by bacteria 
stained with these two dyes. As exemplified in Figure 4.5 and Figure 7.13 
in Appendix 9, for all strains tested, it was shown that RFU readings 
increased proportionally as CFU count and RLU increased until 48 hours. 
After 48 hours, RFU readings remained relatively stable. However, CFU 
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count and RLU decreased greatly. Moreover, the difference between live 
cells RFU and total cells RFU remained insignificant, indicating that the 
cells were in a live state.  
Correlations were strong between RFU and CFU (r > 0.91) up to 7 days 
for recombinant constructs and up to 28 days for wild-type and 
promoterless strains. These correlations were found to be statistically 
significant (P<0.01). However, the correlations between RFU and CFU 
decreased for up to 28 days for ldcC, spc and lpp strains. These 
correlations were not significant and therefore there was a clear difference 
between the CFU and RFU profiles for these strains. Strains lys and tat 
showed significant correlations (r > 0.6) between CFU and RFU at 28 
days. 
Correlations were strong between RLU and RFU (r > 0.96) and statistically 
significant (P<0.01) up to 24 hours for all constructs tested. Correlations 
decreased for ldcC and spc at 14 and 21 days, respectively. These 
correlations were found to be insignificant, thereby indicating a clear 
difference between the RLU and RFU profiles for these two strains. 
However, the correlations significantly improved (P<0.05) after 14 and 21 
days respectively for ldcC (r > 0.77) and spc (r > 0.64). Correlations 
decresed significantly to r > 0.6 at 7 days for lys and tat, after which the 
correlations significantly increased to r > 0.75 up to 28 days. Correlations 
of lpp remained strong (r > 0.83) and significant throughout the 28 days. 
Figure 4.5 and Figure 7.13 in Appendix 9 shows that the rate of decline in 
CFU count and RLU compared to RFU was much less for wild-type than 
for recombinant strains. The promoterless strain also showed a decline in 
CFU count and RLU compared to the RFU. However, the reduction was 
not as rapid as with the recombinant strains. Strong correlations (r > 0.91) 
were observed between CFU and RFU for wild-type and promoterless 
strains throughout 28 days. 
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___________________________________________________________ 
Figure 4.5: Comparisons of bioluminescence (RLU), colony forming units 
(CFU), live fluorescence (RFU) and total RFU at various time points. Time in 
hours is represented on X-axis of all graphs.     CFU,     RLU,     Live RFU and      Total 
RFU. A: lysS, B: pME-lux, C: WT. 
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Table 4.2: Pearson’s correlations and significance between CFU, RLU and RFU 
at various time points for strains used for growth curve studies. 
    ldcC Spc lysR25 lppR4 tatH5 pMElux WT 
CFU:RLU 
24hrs 0.918
**
 0.940
**
 0.996
**
 0.951
**
 0.997
**
     
 (0.000) (0.000) (0.000) (0.000) (0.000)     
48hrs 0.375
**
 0.358
*
 0.848
**
 0.773
**
 0.987
**
     
 (0.008) (0.016) (0.000) (0.000) (0.000)     
7 days 0.376
**
 0.360
*
 0.843
**
 0.744
**
 0.986
**
     
 (0.007) (0.014) (0.000) (0.000) (0.000)     
14 days 0.225 0.289
*
 0.624
**
 0.622
**
 0.959
**
     
 (0.113) (0.049) (0.000) (0.000) (0.000)     
21 days 0.214 0.289
*
 0.600
**
 0.608
**
 0.961
**
     
 (0.128) (0.046) (0.000) (0.000) (0.000)     
28 days 0.235 0.313
*
 0.615
**
 0.623
**
 0.962
**
     
 (0.090) (0.029) (0.000) (0.000) (0.000)     
  
 
  
 
  
 
      
CFU:RFU 
24hrs 0.996
**
 0.995
**
 0.998
**
 1.000
**
 1.000
**
 1.000
**
 1.000
**
 
 (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) 
48hrs 0.972
**
 0.992
**
 0.980
**
 0.998
**
 0.992
**
 0.997
**
 0.996
**
 
 (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) 
7 days 0.965
**
 0.990
**
 0.972
**
 0.949
**
 0.976
**
 0.939
**
 0.989
**
 
 (0.000) (0.000) (0.000) (0.000) (0.000) (0.001) (0.000) 
14 days 0.461 0.548 0.652 0.580 0.606 0.910
**
 0.983
**
 
 (0.212) (0.127) (0.057) (0.102) (0.084) (0.001) (0.000) 
21 days 0.451 0.541 0.652
*
 0.582 0.610 0.913
**
 0.984
**
 
 (0.191) (0.106) (0.041) (0.078) (0.061) (0.000) (0.000) 
28 days 0.459 0.541 0.657
*
 0.587 0.617
*
 0.915
**
 0.984
**
 
 (0.156) (0.085) (0.028) (0.057) (0.043) (0.000) (0.000) 
  
 
  
 
  
 
      
RLU:RFU 
24hrs 0.995
**
 0.991
**
 0.997
**
 0.976
**
 0.966
**
     
 (0.000) (0.000) (0.000) (0.001) (0.002)     
48hrs 0.237 0.200 0.688 0.836
*
 0.626     
 (0.608) (0.667) (0.088) (0.019) (0.133)     
7 days 0.284 0.224 0.650 0.834
*
 0.630     
 (0.496) (0.595) (0.081) (0.010) (0.094)     
14 days 0.783
*
 0.662 0.765
*
 0.908
**
 0.803
**
     
 (0.013) (0.052) (0.016) (0.001) (0.009)     
21 days 0.775
**
 0.648
*
 0.759
*
 0.908
**
 0.802
**
     
 (0.009) (0.043) (0.011) (0.000) (0.005)     
28 days 0.776
**
 0.640
*
 0.758
**
 0.899
**
 0.804
**
     
 (0.005) (0.034) (0.007) (0.000) (0.003)     
**. Correlation is significant at the 0.01 level (2-tailed), *. Correlation is significant at the 0.05 level (2-
tailed). Significance values are shown in brackets. 
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Equivalence between the three methods was determined for each 
bioluminescent strain by performing analysis of variance at a significance 
level of P<0.05 (Table 4.3). No significant differences were found between 
the bioluminescent and plate count methods or between fluorescence and 
plate count methods since values were greater than 0.05. Significant 
differences were found between bioluminescence and fluorescence for 
bioluminescent strains except spc since values were less than 0.05. 
 
Table 4.3: Equivalence between bioluminescence, CFU count and fluorescence. 
 
ANOVA (P<0.05) 
Strain RLU:CFU RLU:RFU CFU:RFU 
ldcC 0.572 0.017* 0.148 
spc 0.392 0.052 0.508 
lys R25 0.265 0.033* 0.547 
lpp R4 0.464 0.034* 0.332 
tat H5 0.525 0.023* 0.219 
* P-values less than 0.05 indicate significant difference between bioluminescence and 
fluorescence. 
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4.5 Discussion 
Bacterial growth and survival has been studied numerous times and has 
been shown to follow the standard pattern of five stages under favourable 
conditions. The aim of this study was to determine the growth and death 
patterns of all the bioluminescent strains produced and to compare them 
with those of wild-type P. aeruginosa ATCC 9027. Moreover, the 
bioluminescence method was compared to the traditional plate counting 
method to determine whether the bioluminescence method may be used 
as a determinant of bacterial growth and death kinetics.  
 
4.5.1 Growth and death kinetics of P. aeruginosa wild-type and 
bioluminescent constructs 
Wild-type and promoterless strains of P. aeruginosa were shown to grow 
up to 109 CFU/mL, whereas all constructs with promoters grew up to 108 
CFU/mL. This may indicate a metabolic load of the gene expression of the 
lux cassette onto bacterial cells. It is unlikely that there could be a genetic 
load because the difference in size between the promoterless pMElux 
plasmid and promoter-lux plasmids was approximately 200bp. However, 
the luciferase pathway is highly energy-dependent and requires the 
essential cofactors NADPH, FMNH2 and ATP. Moreover, the luciferase 
pathway has been shown to utilise myristol-ACP as the lipid substrate 
(Figure 4.6) (Close et al., 2012). Myristol-ACP is also essential for 
membrane lipid formation. Hence, there may be competition for the 
requirement of myristol-ACP between membrane lipid formation and 
luciferase pathway. Furthermore, myristol-ACP may also be utilised in the 
luciferase pathway at the expense of membrane formation, thereby 
reducing the formation of cell membranes of bioluminescent strains 
compared to the wild-type. This phenomenon of bioluminescence taking 
precedence has also been shown previously (Zarubin et al., 2012). This 
hypothesis is supported by the growth of the promotorless strain. The 
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promoterless strain contains the lux cassette. However, its transcription 
was minimal; therefore, the growth rate of the promoterless strain was 
similar to that of the wild-type because myristol-ACP was utilised for 
membrane formation rather than in the luciferase pathway. 
___________________________________________________________ 
Figure 4.6: Schematic diagram showing competitive distribution of 
myristol-ACP (Close et al., 2012). 
 
The lag phase lasted for approximately 3 hours. This was observed as 
bacterial cell counts remained constant for the first four hours upon 
inoculation into growth medium. However, there was an increase in 
bioluminescence during the lag phase, suggesting that increased 
constitutive gene expression was occurring during the lag phase with cells 
showing increased transcription rates for protein synthesis (Al-Qadiri et al., 
2008) and replication of genomic and plasmid DNA to prepare the cells for 
cell division. Also, increase in bioluminescence per cell showed that there 
was increase in number of plasmids per cell as the cell increased 
resources before cell division into daughter cells. Hence bioluminescent 
constructs showed increase in gene expression at constant bacterial 
counts. Peaking on the RLU:CFU plot (Figure 4.3) were observed for all 
promoter containing constructs during the lag phase, indicating increased 
gene expression per bacterial cell. This aspect of bioluminescence 
detection prior to cell replication may provide a useful tool in detection of 
early microbial growth. 
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Following the lag phase, all recombinant constructs and the negative 
control strains entered the exponential growth phase. This phase lasted 
from approximately 3 hours to 12 hours. Increase in constitutive gene 
expression was proportional to CFU as cells replicated exponentially. This 
showed that there was constant gene expression as the cells replicated 
constantly (Al-Qadiri et al., 2008). Strong correlations between RLU and 
CFU count were also shown by Thorn et al. (2007). Tailing of the peaks on 
the RLU:CFU plot were observed as the gene expression per bacterial cell 
count stabilised to linear relationships. This means that the increased 
gene expression per CFU count, as observed during the lag phase, 
reduced so that consistent gene expression was observed with cell 
replication. 
The onset of the stationary phase was observed at 12 hours. There was 
no net increase or decrease in bioluminescence or bacterial cell count. 
From the RLU:CFU plot, it was observed that constant light was produced 
per bacterial cell. Bioluminescence was observed to decline during the 
stationary phases of ldcC and spc strains. This may have been due to 
lower or no binding affinities of other sigma factors during the stationary 
phase. Hence transcription initiation from these two promoters would 
reduce during stationary phase. Pspc is also a binding site for soxS, as 
revealed by Softberry analysis. SoxS proteins are activator proteins that 
bind to the soxbox sequences (Wood et al., 1999). For the strains with 
weak promoters, that is ldcC and spc, strong correlations between CFU 
and Relative Fluorescence Units (RFU) indicative of cell viability were 
observed between 48 hours and seven days. But there were weaker 
correlations between bioluminescence and CFU or RFU. This indicated 
that cells maintained the ability to culture but were unable to utilise the 
luciferase pathway. This may have been due to their promoters being less 
recognised by the stationary phase sigma factors called sigma-38. Other 
studies have shown that P. aeruginosa sigma-38 is predominant during 
stationary phase (Raivio & Silhavy, 2001). 
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After 14 days, bioluminescence production was not proportional to 
bacterial cell count. Bioluminescence was observed to increase while 
bacterial count decreased, thereby indicating that gene expression was 
increasing but bacterial cells did not replicate. This inconsistency between 
bioluminescence and CFU count may indicate that bacterial cells are able 
to illuminate and are therefore viable; however, these are non-culturable 
on agar media. This was further confirmed when differences were 
obtained between the bioluminescence method and fluorescence method 
for all bioluminescent strains except spc. Fluorescence detection with the 
aid of Molecular Probes® Live/Dead® BacLightTM staining comprising of 
two dyes Syto-9 and propidium iodide (Berney, Hammes, Bosshard, 
Weilenmann & Egli, 2007; Molecular Probes) discriminated between 
viable and non-viable live cells. These two dyes are DNA intercalators 
(Berney et al., 2007); Syto-9 crosses intact membranes of viable cells and 
fluoresces green whereas Propidium iodide is able to cross damaged 
membranes only (non-viable cells) and fluoresces red. Hence, viable cells 
and non-viable cells can be distinguished by their fluorescence output. 
This method of estimating viable and non-viable cells is a rapid method 
that has been used in numerous studies (Ferreira, Pereira, Pereira, Melo 
& Simoes, 2011; Harrison et al., 2008). Investigations showed that cells 
remained fluorescent throughout 28 days. With the loss in culturability, 
bioluminescent constructs seemed to be entering a state of VBNC after 7 
days. Furthermore, reduction in bioluminescence also suggested reduced 
gene expression, which is another characteristic of possible VBNC state 
(Navarro Llorens et al., 2010). VBNC state is a long-term stationary 
phenotype, which is characterised by cell death and survivors scavenging 
dead cell metabolites. Therefore there is a dynamic pattern of cell death 
and cell growth. However, the total number of cells remains the same. In 
such states, bioluminescence is observed to be reduced as cells divert 
their energy usage towards adaptation and growth in metabolite-rich 
environments rather than the expensive luciferase pathway. Such 
observation is a characteristic of the GASP (Growth Advantage in 
Stationary Phase) phenotype described in previous studies (Navarro 
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Llorens et al., 2010). Conversion of phase from stationary to long-term 
stationary phase seems to occur between 7 and 14 days. This has been 
indicated by the fact that correlations are strong between fluorescence 
and bioluminescence but weaker between fluorescence and culturable 
cells.  
Over the next 14 days the bioluminescence decreased with further 
reduction in bacterial count. Wild-type CFU count decreased up to 14 
days. However, the CFU count of the promoterless strain decreased up to 
21 days, after which the CFU counts were stable. It has been shown that 
the inability of the bioluminescent strains to survive as well as wild-type 
and promoterless strains may be due to the metabolic load they carry. The 
metabolic load on the bioluminescent constructs may also play a crucial 
role in driving cells towards VBNC states when conditions were stressful 
so that bioluminescent cells did not have the capability to replicate. 
Bacterial cells are robust cells able to survive ever-changing 
environments. Survival strategies include control of transcription and 
translation to minimise energy wastage as a result of excess synthesis of 
mRNA and proteins (Neilson et al., 1999).  
For the strains with strong promoters, that is lys, lpp and tat, strong 
correlations up to 14 days indicate that a highly significant number of cells 
were viable, expressing the lux cassette and were culturable. Strong 
correlations between bioluminescence and plate counting have also been 
observed previously (Thorn et al., 2007). For all recombinant strains with 
promoters, after 14 days strong correlations between RLU and RFU 
indicate that only viable cells are expressing the lux cassette. Statistical 
evaluation using ANOVA at P<0.05 found no significant difference 
between relative bioluminescence and CFU count and between CFU 
count and relative fluorescence reading.  
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4.5.2 Promoter strength and sequence analysis 
Promoter strength of the five selected promoters was investigated by 
determining the bioluminescence rates per CFU. Promoter strength for all 
bioluminescent constructs was further related to their respective promoter 
sequences. During exponential phase, the promoter strength decreased in 
the order lpp>tat>lys>ldcC>spc while during stationary phase the 
promoter strength decreased in the order tat>lpp>lys>ldcC>spc, as 
indicated from the RLU:CFU plot. Weak expression of LdcC was also 
investigated by Lemonnier & Lane (1998). They suggested that it is 
regulated by a weak promoter and that low levels of the enzyme 
suggested that either transcription occured at a low level or the mRNA 
transcripts were unstable (Lemonnier & Lane, 1998). 
The -35 region of Pspc contained the most differences from the consensus 
sequence and also the spacer region was longer than the 17bp observed 
in the consensus sequence. These differences may relate to Pspc being 
the weakest of the five promoters. PldcC also contained the most 
differences in the -35 region. However, the spacer region was found to be 
the smallest. Also the -10 regions of Pspc and PldcC have a 2bp and 1bp 
difference from the consensus. This may explain why PldcC was the 
stronger out of the two promoters. The importance of the spacer region 
was highlighted because PldcC and Pspc consist of spacer regions whose 
distances are at extremes of the consensus requirement. Hence, these 
two promoters were found to be the weakest of all five promoters 
investigated. Similar results have been reported previously where 
promoters containing spacer regions of 17bp have shown higher 
expression in vitro and in vivo, compared to those with longer or shorter 
spacer regions (Ayers et al., 1989; Mulligan, Brosius & McClure, 1985; 
Stefano & Gralla, 1982). 
Plys was found to contain 3bp differences from the consensus in both -10 
and -35 regions. The spacer region was the closest to the consensus 
spacer. Plpp and Ptat both contain spacer regions 3bp shorter than the 
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consensus spacer region. However, Plpp has 3bp differences in the -35 
region and 2bp differences in the -10 region. On the other hand Ptat has 
2bp differences in the -35 region and 3bp differences in the -10 region. 
Comparing the promoter strength to sequences for these three promoters, 
both Ptat and Plys have 3bp differences in the -10 region and their strengths 
are similar during exponential phase. Plpp had the greatest level of 
expression during exponential phase as it contains only 2bp differences in 
the -10 region as opposed to 3bp differences in the same region for Ptat 
and Plys. Outer membrane lipoprotein is one of the most abundant proteins 
(Inouye & Inouye, 1985) and therefore its expression controlled by Plpp has 
been indicated by Plpp showing the highest expression during exponential 
phase. Softberry analysis of promoter sequences revealed that Plpp is also 
a binding site for rpoS18, a transcription binding factor (Yan, Lovley, & 
Krushkal, 2007). Sigma 38 (rpoS) is produced in response to stress and is 
active during stationary phase. 
Plpp and Plys have 3bp differences in the -35 region. On the other hand, Ptat 
has 2bp differences in the -35 region. Comparing the promoter strength to 
sequences for these three promoters, both Plpp and Plys contain 3bp 
differences in -35 region and their strengths are similar during stationary 
phase. Ptat had relatively stable expression during stationary phase 
compared to that of other promoters and it has only 2bp differences in the 
-35 region as opposed to 3bp differences in the same region for Plpp and 
Plys. The transport of proteins to cytoplasmic membranes through the Tat 
pathway is vital (Jack et al., 2001) and therefore it is very important to 
maintain the expression of the tat proteins. Hence, it seems that the -10 
region is more crucial for gene expression in the exponential phase while 
the -35 region is more crucial for gene expression during the stationary 
phase.  
The most important elements of a promoter region are -10 region, -35 
region and the spacer region in between them (DeHaseth et al., 1998). 
Various studies have shown that gene expression increases with 
increased similarity to the consensus sequences (Harley & Reynolds, 
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1987; Kammerer, Deuschle, Gentz & Bujard, 1986). Furthermore, the -10 
and -35 promoter sequences are recognised by the σ subunit of RNA 
polymerase and therefore any differences in these regions would affect 
their gene expression (Harley & Reynolds, 1987). Ptat showed the smallest 
number of differences in the -35 region whereas Pspc and PldcC showed the 
most differences and therefore Ptat showed higher expression than Pspc 
and PldcC. Therefore, it would be expected that PldcC showed high gene 
expression. However, this was not the case as its spacer region was too 
small. Various studies have shown that the upstream half of the -10 region 
is more important to σ factors (Dombroski, 1997; Dombroski, Johnson, 
Lonetto & Gross, 1996; Dombroski, Walter, Record, Siegele & Gross, 
1992); therefore the spacer region would cause a greater impact than 
regions downstream of the -10 region.  
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4.6 Conclusion 
Increased gene expression per bacterial CFU for 3 hours showed the lag 
phase of bacterial growth. Exponential phase of bacterial cells was 
defined where the gene expression per bacterial cell count stabilised to 
linear relationships. The onset of the stationary phase was observed at 12 
hours, where there was no net change in bioluminescence and bacterial 
cell counts, therefore consistent RLU:CFU was observed.  
Relative promoter strength of the five promoters in Pseudomonas 
aeruginosa decreased in the order lpp>tat>lys>ldcC>spc during the 
exponential phase and in the order tat>lpp>lys>ldcC>spc during the 
stationary phase. Plpp showed the greatest level of expression during the 
exponential phase while both Plpp and Plys showed similar strengths during 
the stationary phase. Ptat showed relatively stable expression during the 
stationary phase compared to all other promoters tested.  
The bioluminescent method was equivalent to the traditional plate 
counting method since no statistically significant differences were 
observed. Correlations between bioluminescence, fluorescence and CFU 
count provide an indication of growth and death kinetics of the bacterial 
cells. Strong correlations between bioluminescence and CFU count 
indicated healthy metabolising and reproducing cells, while weak 
correlations between CFU and bioluminescence indicated that the cells 
were metabolising but unable to reproduce on media. A metabolic load of 
lux expression was observed on bacterial cells as bioluminescence was 
less at increased CFU count. Coupling of bioluminescence to bacterial 
metabolism with respect to constitutive gene expression provides a 
powerful, non-destructive tool for studies of bacterial growth during various 
growth phases in real time mode. Bioluminescence has been shown to 
give an earlier indicator of the health state of bacterial cells compared to 
traditional plate counting. 
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Chapter 5: Efficacies of benzalkonium 
chloride and benzyl alcohol against P. 
aeruginosa ATCC9027 constructs 
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5.1 Introduction 
5.1.1 Benzalkonium chloride (BKC) and its characteristics 
Benzalkonium chloride (BKC), classified as a quarternary ammonium 
compound (QAC), is a synthetic nitrogenous cationic antimicrobial agent 
with amphoteric surface-acting properties (Baudouin, Labbe, Liang, Pauly 
& Brignole-Baudouin, 2010; Fazlara & Ekhtelat, 2012). BKC consists of 
two hydrophobic hydrocarbon regions and a hydrophilic polar region 
(Figure 5.1) (Ferreira et al., 2011).  
___________________________________________________________ 
Figure 5.1: Structure of benzalkonium chloride (BKC) showing polar hydrophilic 
(blue) and non-polar hydrophobic region (purple). Adapted from Gilbert & Moore (2005). 
 
These molecules are highly water-soluble (Fazlara & Ekhtelat, 2012). BKC 
is widely used in the food industry, hospitals and households as a 
disinfectant and antiseptic sanitizer (Fazlara & Ekhtelat, 2012). In 
pharmaceutical preparations, BKC is primarily used as a biocide or 
antimicrobial preservative in eyewashes, nasal sprays (Graf, 2001; 
Hodges, Denyer, Hanlon & Reynolds, 1996; Lenoir, Adriaens & Remon, 
2011; Marple, Roland & Benninger, 2004), ophthalmic solutions (Mohanty, 
Acharya & Mishra, 2012; Rase, Bodkhe, Kshirsagar & Bedi, 2011; Ryan, 
Fain, Lovelace & Gelotte, 2011), amongst others. Interestingly, 
benzalkonium chloride is also used as an antimicrobial agent in acrylic 
carpets (Khajavi, Sattari & Ashjaran, 2007). 
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BKC is a broad-spectrum antimicrobial agent that possesses activity 
against both gram-positive and gram-negative bacteria as well as fungi 
and viruses. BKC cannot be classified as an antibiotic due to its lack of 
selectivity (McDonnell & Russell, 1999). BKC possesses both 
bacteriostatic and bactericidal properties.  
There is increasing concern over BKC resistance, especially in 
Pseudomonas aeruginosa. Resistance of Pseudomonas to BKC was 
reported as early as 1969 (Adair, Geftic & Gelzer, 1969). One reason for 
this is because P. aeruginosa forms biofilms that provide a protective 
barrier, facilitate the formation of bacterial clusters and therefore provide 
bacteria with intrinsic resistance towards some antimicrobial agents. 
Pseudomonas is able to adapt to BKC, a feature known as antimicrobial 
tolerance, whereby BKC binds to the biofilm polymer and becomes 
ineffective. Increased synthesis of proteins involved in oxidative stress 
response, alginate synthesis and synthesis of cell membrane components 
have also been reported (Sheldon, 2005; Szomolay, Klapper, Dockery & 
Stewart, 2005). Although BKC is able to penetrate through the biofilm 
layers, Pseudomonas cells take advantage of the delay in penetration, 
thereby showing intrinsic resistance (Bridier, Dubois-Brissonnet, Greub, 
Thomas & Briandet, 2011). Another reason for intrinsic resistance is the 
expression of efflux pumps that are able to actively remove BKC back into 
the extracellular environment. Such resistance mechanisms provide one 
of the major reasons for persistent and repeated infections caused by 
Pseudomonas. 
 
5.1.2 Mode of action of BKC 
BKC is thought to change the hydrophobicity of bacterial cell membranes, 
thereby altering the cell membrane functions. Bacterial cell membranes 
carry a net negative charge on their surface, with cations stabilising the 
negative charge (Fazlara & Ekhtelat, 2012).  
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BKC, being cationic, mimics the effect of the stabilising membrane cations 
by binding tightly to bacterial cell membranes (Figure 5.2) (Fazlara & 
Ekhtelat, 2012; Gilbert & Moore, 2005). Furthermore, it has been shown 
that the hydrophobic region of BKC interacts with the hydrophobic region 
of the cell surface membrane while the hydrophilic region of BKC forms 
channels through the membrane leading to its permeabilisation (Ferreira 
et al., 2011; Gilbert & Moore, 2005). The cell membranes are damaged 
and the intracellular materials are liberated from the cells, thereby 
disrupting the cell homeostasis significantly. Formation of BKC pores also 
facilitates the entry of BKC molecules into the cells at high concentrations, 
coagulating the cytoplasm by its surfactant properties (Fazlara & Ekhtelat, 
2012).  
 
 
 
 
 
 
 
 
___________________________________________________________ 
Figure 5.2: Mode of action of BKC. Steps a-f indicate the effect of increasing 
concentration of BKC on cell membranes leading to decreased fluidity and phospholipid 
micelle formation (Gilbert & Moore, 2005). 
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5.1.3 Benzyl alcohol (BA) 
Benzyl alcohol is a volatile, cheap, non-flammable aromatic alcohol that is 
soluble in water up to a concentration of 4% (v/v) (GE healthcare, 2012). 
Benzyl alcohol is converted by oxidation to benzoic acid via the 
intermediate benzaldehyde. However, the reaction is very slow in aqueous 
solutions with no significant decrease in benzyl alcohol concentration for 
up to 3 years (GE healthcare, 2012). Interestingly, the activity of benzyl 
alcohol as a preserving agent is greatly reduced in the presence of 
polysorbate 80, rubber, polyethylene or polystyrene (Akers, 2002). 
Benzyl alcohol is widely used as a preservative in pharmaceutical and 
cosmetic products. Benzyl alcohol is widely used in cosmetics, shampoos, 
toilet soaps and household cleaners, detergents (Scognamiglio, Jones, 
Vitale, Letizia & Api, 2012) and it remains one of the most commonly used 
preservative in multi-dose peptide and protein products (Meyer, Ni, Hu & 
Shi, 2007; Roy, Jung, Kerwin, Randolph & Carpenter, 2005). Benzyl 
alcohol is used as a volatile preservative for fruits and vegetables (Utama, 
Wills, Ben-Yehoshua & Kuek, 2002) and was found to have germicidal 
properties against P. aeruginosa. Heparin lock solutions used in hospitals 
for catheters also use benzyl alcohol as a preservative because of its 
convenience and low price (Shenep et al., 2011). However, following 
neonatal deaths its use has been abandoned in many hospitals 
(Gershanik, Boecler, Ensley, McCloskey & George, 1982). High 
concentrations of benzyl alcohol in cosmetic products are not permitted 
because they pose a high risk of allergic reactions. In fact, it is one of the 
most frequently reported allergens (Saiyasombati & Kasting, 2003). 
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5.1.4 Mode of action of BA 
Benzyl alcohol is less effective against gram negative bacteria compared 
to gram positive bacteria and fungi (Meyer et al., 2007). Its mode of action 
against bacterial cells is not very well understood. However, it is thought 
that benzyl alcohol causes membrane damage and protein denaturation 
followed by metabolic interference and cell lysis (McDonnell & Russell, 
1999). Benzyl alcohol is thought to interact with phosphatidylcholine 
vesicles, thereby altering membrane properties and organisation 
(Fishman, Rottem & Citri, 1980). At high concentrations of benzyl alcohol, 
proteins are denatured and form protein aggregates (Gupta & Kaisheva, 
2003). It is thought that benzyl alcohol disrupts tertiary structures of 
proteins, thereby denaturing them (Lam, Patapoff & Nguyen, 1997). 
 
5.1.5 Resistance to BA 
Resistance to benzyl alcohol has been reported in P. aeruginosa (Singh, 
Kaur, Chakraborti, Jain & Banerjee, 2006). Pseudomonas aeruginosa 
cells have been shown to produce lipase in high amounts that 
transesterify benzyl alcohol to benzyl acetate. The lipase was shown to 
convert 90% of benzyl alcohol to benzyl acetate in 3 hours (Singh, Singh, 
Singh, Chisti & Banerjee, 2008). 
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5.2 Aim and objectives 
The aim of this work was to assess the applicability of Pseudomonas 
aeruginosa ATCC 9027 and bioluminescent constructs for preservative 
efficacy tests with benzalkonium chloride and benzyl alcohol. 
The objectives of this work were: 
 To evaluate minimum inhibitory concentrations of BKC and BA. 
 To compare preservative efficacy testing using the 
bioluminescence method, traditional plate counting method and 
fluorescence method. 
 To evaluate five promoter-lux variants in a biosensor system for 
preservative efficacy testing.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 191 
 
5.3 Materials and methods 
5.3.1 Bacterial strains 
The Pseudomonas bacterial strains used for determining MIC and efficacy 
of BKC were described in section 3.3.1. The bacterial strains used for BA 
testing were: 
Wild-type P. aeruginosa ATCC 9027 (WT) 
P. aeruginosa ATCC 9027 + pME4510 
P. aeruginosa ATCC 9027 + Promoterless pME-lux 
P. aeruginosa ATCC 9027 + ldcC pME-lux 
P. aeruginosa ATCC 9027 + spc pME-lux 
P. aeruginosa ATCC 9027 + lys R25 pME-lux 
P. aeruginosa ATCC 9027 + lpp R4 pME-lux 
P. aeruginosa ATCC 9027 + tat H5 pME-lux 
All strains were grown as described in section 3.3.1.  
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5.3.2 Minimum inhibitory concentration determination for BKC 
Stock BKC (Sigma-Aldrich®) was prepared in sterile distilled water at a 
concentration of 5.12% (w/v) and pH of 7.0. The stock was filter-sterilised 
and stored at 20oC in the dark. Working stocks of BKC were prepared at a 
concentration of 0.16% (w/v) in sterile distilled water. Various 
concentrations of BKC were then prepared in tryptic soya broth according 
to Table 5.1 for MIC determination. The volume of inoculum was set at 1% 
of total reaction volume in accordance with pharmacopoeial guidelines. 
Therefore, the inoculum volume used was 50 L of cell culture for 5 mL 
total reaction volume. 
Table 5.1: Concentration range of BKC used for MIC determination 
 
Each of the suspensions of BKC were prepared, in triplicate, in sterile cell 
culture plates and incubated for 24 hours at 32oC and 100 rpm. The 
absorbance for each cell culture was measured at 600nm and recorded 
after incubation. 
 
Final BKC 
concentration 
(%) 
Volume 
of BKC 
( L) 
Volume of 
TSB (mL) 
Volume of 
inoculum 
( L) 
Total 
volume 
(mL) 
0.04 1250 3.7 50 5 
0.02 625 4.325 50 5 
0.01 312.5 4.637 50 5 
0.005 156.25 4.793 50 5 
0.0025 78.125 4.871 50 5 
0.00125 39.06 4.910 50 5 
0.0006 19.53 4.930 50 5 
0.0003 9.766 4.940 50 5 
0 0 4.950 50 5 
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5.3.3 MIC determination for BA 
Determination of BA (Sigma-Aldrich®) MIC was performed by preparing 
various concentrations of BA in tryptic soya broth according to Table 5.2. 
Undiluted BA was used for each preparation due to the limitation of 
solubility in water to prepare stock BA solutions. 
Table 5.2: Concentration range of BA used for MIC determination 
Final BA 
concentration 
(%) 
Volume of 
BA ( L) 
Volume of 
TSB (mL) 
Volume of 
inoculum ( L) 
Total 
Volume 
(mL) 
2 100 4.850 50 5 
1 50 4.900 50 5 
0.5 25 4.925 50 5 
0.25 12.5 4.938 50 5 
0.125 6.25 4.944 50 5 
0.0625 3.125 4.947 50 5 
 
Each of the suspensions of BA were prepared, in triplicate, in sterile cell 
culture plates and incubated for 24 hours at 32oC and 100 rpm. The 
absorbance for each cell culture was measured at 600nm and recorded 
after incubation. 
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5.3.4 Preservative efficacy test for BKC 
BKC stock solution of 5.12% was prepared in sterile distilled water and 
filter-sterilised under aseptic conditions. BKC working solutions were 
prepared at various concentrations, ranging from 0.0003125% to 0.02%, 
in a total reaction volume of 100 mL using sterile distilled water as diluent 
as shown in Table 5.3. 
Table 5.3: Concentration range of BKC used for PET determination 
Working BKC 
concentration 
(%) 
Volume 
of stock  
( L) 
Volume 
of water  
(mL) 
Volume of 
inoculum 
(mL) 
Total 
volume 
(mL) 
0.02 4000 95 1 100 
0.01 2000 97 1 100 
0.005 1000 98 1 100 
0.0025 500 98.5 1 100 
0.00125 250 98.75 1 100 
0.000625 125 98.875 1 100 
0.0003125 62.5 98.9375 1 100 
0 0 99 1 100 
 
All strains were grown as described in section 3.3.1 Following incubation, 
aliquots (1 mL) of all cultures were centrifuged at 13000 rpm for 1 minute. 
The supernatant was discarded and the pellets were each re-suspended 
in 1 mL of sterile distilled water. This wash procedure was repeated once 
more before final re-suspension in sterile distilled water. Ten-fold dilutions 
were performed for WT, pME4510 and pME-lux strains in sterile distilled 
water.  
For preservative efficacy testing, 1 mL of each of the washed (and in 
some cases diluted) cultures were inoculated aseptically into various 
concentrations of the preservative (Table 5.3) and incubated at 22oC and 
150 rpm for 28 days. 
Page 195 
 
Samples were retrieved aseptically from each flask at various time points 
as per the preservative efficacy testing requirements: 0 hours, 6 hours, 24 
hours, 7 days, 14 days, 21 days and 28 days. All samples were serially 
diluted 10-fold seven times in buffered peptone water (containing a 
mixture of peptides from partially hydrolysed proteins). Aliquots (1 mL) of 
each undiluted culture and diluted culture were transferred into culture 
tubes aseptically for bio-luminescence measurements as described in 
section 2.3.15. Aliquots (100 L) of each undiluted and diluted culture 
were transferred onto TSB Agar plates as described in section 3.3.2. 
Samples were prepared for fluorescence quantification (section 4.3.2).  
 
5.3.5 Preservative efficacy test for BA 
BA working solutions were prepared at various concentrations, ranging 
from 0.0625% to 2%, in a total reaction volume of 100 mL using sterile 
distilled water as diluent (Table 5.4). 
Table 5.4: Concentration range of BA used for preservative efficacy testing 
Final BA 
concentration 
(%) 
Volume 
of stock 
( L) 
Volume of 
inoculum 
(mL) 
Volume 
of water 
(mL) 
Total 
volume (mL) 
2 2000 1 97 100 
1 1000 1 98 100 
0.5 500 1 98.5 100 
0.25 250 1 98.75 100 
0.125 125 1 98.875 100 
0.0625 62.5 1 98.938 100 
 
Preservative efficacy testing of benzyl alcohol was performed according to 
section 5.3.4. 
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5.3.6 Data analysis 
Pearson’s correlations between bioluminescence reading and plate count 
were performed at a significance level of P<0.05 for data obtained from 
each concentration of preservative.  
Log unit reductions in plate count and relative bioluminescence were 
calculated as: 
(Log10 CFU at time t and concentration c) – (Log10 CFU at time t0 and concentration c0) 
___________________________________________________________ 
Equation 5.1: Log unit reduction 
 
Two-way analysis of variance (ANOVA) at a significance level of P<0.05 
was performed between bioluminescence and plate count data in order to 
determine the equivalence between these two methods. 
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5.4 Results 
5.4.1 Minimum inhibitory concentration of BKC 
The minimum inhibitory concentration of benzalkonium chloride was 
evaluated for all the strains by measuring absorbance at 600nm after 
challenge with a range of concentrations of BKC (0.0003% and 0.04%). 
Growth of wild-type, pME4510 and pMElux bacterial strains was observed 
in the negative controls (0% BKC), as well as dilute concentrations 
between 0.0003% and 0.005% (Table 5.5). The MIC of BKC for these 
three strains was therefore found to be 0.01%. The absorbance values 
obtained for wild-type, pME4510 and pMElux strains with 0% BKC were 
greater (>2.25) than those of the bioluminescent constructs (1.75). This 
was because these three strains grow up to 109 CFU/mL compared to the 
bioluminescent constructs that grow up to 108 CFU/mL, as discussed in 
section 4.5.1. However, for all bioluminescent constructs strains the MIC 
shifted to 0.00125%, whilst bacterial growth was observed at a BKC 
concentration of 0.0006%. Negative absorbance values were obtained for 
all strains tested at a BKC concentration of 0.04%. This concentration was 
too high and hence too toxic for bacterial cells. Physical observation of 
0.04% BKC solutions indicated a cloudy appearance compared to all other 
solutions. This may also have had an effect on absorbance readings. 
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Table 5.5: Minimum inhibitory concentrations for BKC against all strains. 
 
Absorbance
 a
 at 600nm at various BKC concentrations (%) 
BKC conc (%) 0 0.0003 0.0006 0.0013 0.0025 0.005 0.01 0.02 0.04 
WT 2.40 2.42 2.39 2.30 2.36 0.80 0.10 0.13 -0.01 
pME4510 2.31 2.43 2.42 2.32 2.30 0.34 0.07 0.08 -0.08 
pMElux 2.35 2.28 2.20 2.15 2.17 0.10 0.06 0.09 -0.05 
ldcc 1.86 1.76 1.74 0.01 0.08 0.12 0.08 0.04 -0.01 
spc 1.85 1.77 1.72 0.01 0.09 0.11 0.06 0.03 -0.01 
lys R25 1.84 1.87 1.68 0.04 0.02 0.03 0.03 0.03 -0.10 
lys G25 1.87 1.84 1.86 0.04 0.04 0.05 0.08 0.04 -0.02 
lpp R3 1.88 1.86 1.86 0.03 0.03 0.03 0.03 0.04 -0.10 
lpp R4 1.86 1.77 1.85 0.01 0.02 0.03 0.04 0.04 -0.03 
tat H5 1.86 1.78 1.77 0.01 0.01 0.10 0.11 0.01 -0.05 
tat H9 1.85 1.78 1.75 0.01 0 0.08 0.08 0.02 -0.07 
tat H14 1.86 1.80 1.78 0.01 0.02 0.11 0.07 0.06 -0.07 
a 
Absorbance was measured at 600nm. 
Green indicates growth of P. aeruginosa. Red indicates no growth of P. aeruginosa. 
 
5.4.2 Minimum inhibitory concentration of BA 
The minimum inhibitory concentration of benzyl alcohol against all 
bacterial strains was evaluated by measuring absorbance at 600nm and 
bioluminescence of bacterial cells challenged with a range of 
concentrations of BA for 24 hours. The concentration range of the 
preservative tested was between 0.0625% and 2%. Growth for all 
bacterial strains was observed in dilute concentrations between 0.0625% 
and 0.125% (Table 5.6). However, the growth of all bacterial strains was 
reduced at BA concentrations of 0.25% and 0.5%. Absorbance and 
bioluminescence reduced greatly when bacterial strains were exposed to 
1% or 2% benzyl alcohol. The MIC of BA for all strains was therefore 
found to be 1%. The absorbance values obtained for wild-type, pME4510 
and pMElux strains with 0% BKC were higher compared to the 
bioluminescent constructs. This is because these three strains grow up to 
109 CFU/mL compared to the bioluminescent constructs that grow up to 
108 CFU/mL, as discussed in section 4.5.1.  
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Table 5.6: Minimum inhibitory concentration of BA against all strains. 
  
Relative bioluminescence (RLU)
a
 at 
various BA concentrations (%) 
  
Absorbance
 b
 at 600nm at various BA 
concentrations (%) 
Strain 0.0625 0.125 0.25 0.5 1 2 0.0625 0.125 0.25 0.5 1 2 
WT 197 214 218 212 244 275 2.452 2.437 1.931 0.103 0.030 0.055 
pME4510 227 221 174 148 154 193 2.422 2.413 1.831 0.094 0.030 0.044 
pMElux 149 149 137 137 144 156 2.330 2.367 1.730 0.050 0.031 0.048 
ldcC 18225 20367 7495 4615 286 326 1.743 1.711 1.396 0.256 0.028 0.027 
spc 17458 17329 5795 4692 180 209 1.785 1.728 1.408 0.266 0.022 0.029 
lys R25 250841 236308 224372 75247 167 178 1.679 1.681 1.387 0.225 0.026 0.027 
lys G25 408692 419256 235003 155118 218 246 1.674 1.654 1.319 0.179 0.026 0.027 
lpp R3 113056 112845 69318 37068 194 184 1.678 1.665 1.368 0.214 0.025 0.030 
lppR4 841075 624454 242494 199408 161 178 1.728 1.744 1.351 0.182 0.024 0.024 
tat H5 357933 294127 162740 114918 132 139 1.729 1.747 1.325 0.231 0.026 0.027 
tat H9 179145 213899 100449 48486 114 128 1.624 1.633 1.273 0.216 0.025 0.024 
tat H14 83472 97596 63554 21869 155 152 1.571 1.608 1.290 0.188 0.022 0.020 
a Relative bioluminescence was measured at 490nm. 
b 
Absorbance was measured at 600nm. 
Green indicates growth of P. aeruginosa. Red indicates no growth of P. aeruginosa. 
 
5.4.3 Preservative efficacy test for BKC 
The effect of various concentrations of BKC was evaluated with all the 
strains exposed to preservative challenge. Bioluminescence, CFU count 
and fluorescence measurement were recorded at time intervals as defined 
by several pharmacopoeias. Wild-type P. aeruginosa and P. aeruginosa 
with either plasmid pME4510 or pMElux were used as negative controls 
for bioluminescence detection. Correlation coefficients and their 
significance are shown in Table 7.5 in Appendix 10. Log unit reductions in 
CFU and RLU are shown in Table 7.7 of Appendix 10. Equivalence 
between the bioluminescence method and traditional plate count method 
for BKC is shown in Table 7.9, Appendix 10.  
At high BKC concentrations of 0.02% and 0.01% (Appendix 10, Figure 
7.14), negative control strains were 105 CFU/mL, bioluminescence was 
undetectable upon inoculation for bioluminescent constructs; however, 
CFU count in the range of 103 CFU/mL were observed for all 
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bioluminescent constructs. Hence, there was a 3 log reduction in CFU 
immediately upon inoculation. A further 3 log reduction in CFU was 
observed by 6 hours. It was therefore shown that bioluminescence was 
undetectable at such high concentrations of BKC upon inoculation of the 
strains with considerable reduction in CFU count. No CFU count was 
detected beyond time 0.  
Bioluminescence was detected at 0 hour only for the strong promoters 
(lysR25 and lysG25) challenged with 0.005% and 0.0025% BKC 
(Appendix 10, Figure 7.14). No bioluminescence was detected at 
subsequent time points or for all other strains. For all strains, CFU count 
was 105 and 106 CFU/mL upon challenge with the same concentrations of 
BKC, respectively. No CFU count was detected beyond time 0. 
Correlations between bioluminescence and plate counts for lysR25 and 
lysG25 strains challenged with 0.005% BKC were found to be statistically 
significant (P<0.05) with correlation coefficients of 0.8 and 0.78 
respectively. This was because lys was the strongest promoter out of the 
five promoters tested and therefore it produced higher levels of 
bioluminescence. At BKC concentrations of 0.0025%, correlations 
between bioluminescence and plate count were significant (P<0.01), with 
correlation coefficients greater than 0.9. Relative fluorescence (RFU) 
measurements were taken to determine viability of cells with respect to 
CFU counts. RFU readings were measured for strains challenged with 
0.0025% BKC. RFU measurements for control strains and bioluminescent 
constructs were 105 and 106 RFU/mL, respectively, at only 0 hour time 
point. No further RFU readings were detectable for the subsequent time 
points.  
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Bioluminescence was detected at 0 hour for all constructs of lysS, lpp and 
tat (except ldcC and spc) challenged with 0.0125% BKC (Figure 5.3A). No 
bioluminescence was detected at subsequent time points or for all other 
strains. CFU counts were 105 and 106 CFU/mL for all control strains and 
bioluminescent strains, respectively (Figure 5.3B). No CFU count was 
detected after 0 hour. RFU measurements (Figure 5.3C) for control strains 
and bioluminescent strains were 105 and 106 RFU/mL, respectively, at 
time 0. No further RFU readings were detectable for the subsequent time 
points. Correlations between bioluminescence and CFU count, for all the 
strong promoter strains were significant (P<0.01) with correlation 
coefficients greater than 0.96. Viability testing of all the strains also 
resulted in significant correlations (P<0.01) between culturable cells and 
fluorescence, with correlation coefficients greater than 0.98. Correlations 
between bioluminescence and fluorescence were also significant 
(P<0.01), with coefficients greater than 0.96 for the bioluminescent 
constructs.  
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Figure 5.3: BKC efficacy test for all strains challenged with 0.00125% BKC. 
Measured at various time points up to 672 hours by (A) Relative bioluminescence, (B) 
CFU count and (C) Relative fluorescence. 
 WT          pME4510          pMElux         ldcC          spc         lysR25           lysG25           
lppR3        lppR4         tatH5         tatH9         tatH14 
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Bioluminescence was 103 and 104 RLU/mL for bioluminescent constructs 
with weak and strong promoters, respectively, when challenged with 
0.0006% BKC (Figure 5.4A). Bioluminescence then reduced by 1 log unit 
at 6 hours for lysR25, lysG25, lppR3 and lppR4. No bioluminescence was 
detected up to 28 days for all other strains. CFU counts were greater than 
105 and 106 CFU/mL, respectively, for all control strains and 
bioluminescent strains upon challenge with the same concentration of 
BKC (Figure 5.4B). CFU counts for bioluminescent constructs 
subsequently decreased to 104 CFU/mL at 6 hours and decreased further 
at 24 hours. No CFU counts were detected after 24 hours. RFU was 
measured for strains challenged with 0.0006% BKC (Figure 5.4C) and 
these were 105 and 106 RFU/mL for control strains and bioluminescent 
strains, respectively, at 0 hour. RFU for control strains subsequently 
decreased to 104 RFU/mL at 6 hours; however, for bioluminescent 
constructs RFU reduced to 104 RFU/mL at 24 hours. No further RFU 
readings were detectable for later time points. Correlations between 
bioluminescence and CFU count were significant (P<0.01) for all 
bioluminescent constructs with coefficients greater than 0.99. Correlations 
between bioluminescence and fluorescence were significant (P<0.01). 
However, the coefficients were slightly lower and ranged between 0.86 – 
0.97 for all bioluminescent constructs. Furthermore, significant correlations 
(P<0.01) between CFU and RFU were obtained for all bioluminescent 
constructs except lysR25. However, the coefficients ranged between 0.85-
0.97. Correlations for lysR25 were significant at P<0.05 with a coefficient 
of 0.85 indicating that not all cells were culturable. This was further 
confirmed when fluorescence was 104 RFU/mL at 6 and 24 hours but no 
CFU counts were detected for negative control strains at the same time 
points. A 2 log and 3 log reduction in CFU at 6 hours and 24 hours, 
respectively, was therefore observed for all bioluminescent strains. This 
related to a >2 log and 4 log reduction in bioluminescence at 6 hours and 
24 hours, respectively. 
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Figure 5.4: BKC efficacy test for all strains challenged with 0.000625% BKC. 
Measured at various time points up to 672 hours by (A) Relative bioluminescence, (B) 
CFU count and (C) Relative fluorescence. 
 
 
WT          pME4510          pMElux         ldcC          spc         lysR25           lysG25           
lppR3        lppR4         tatH5         tatH9         tatH14 
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Bioluminescence was 103 and 104 RLU/mL for bioluminescent constructs 
with weak and strong promoters, respectively, when challenged with 
0.0003% BKC (Figure 5.5A). Bioluminescence decreased by a log unit for 
all promoters within 6 hours and by a further log unit for all promoters 
except ldcC and spc by 24 hours. No bioluminescence was detected from 
24 hours up to 28 days for all strains. CFU counts were 106 CFU/mL 
(Figure 5.5B) for all strains at time 0. CFU counts for bioluminescent 
constructs decreased by a log unit by 24 hours and by 2 log units by 7 
days. CFU counts for all bioluminescent strains except ldcC and spc were 
detected at 103 CFU/mL at 14 days followed by undetectable levels up to 
28 days. No CFU counts were detected beyond 6 hours for the negative 
control strains. A similar pattern of fluorescence to CFU was found for all 
strains up to 24 hours. Relative fluorescence for negative control strains 
and bioluminescent strains (Figure 5.5C) declined even further to 103 
RFU/mL and 104 RFU/mL, respectively, at 7 days. From 14 days onwards, 
negative control strains and ldcC and spc were undetectable. Strains lys, 
lpp and tat fluoresced consistently throughout the rest of the experiment. 
Correlations between bioluminescence, CFU count and fluorescence were 
significant (P<0.01). However, the correlations between bioluminescence 
and fluorescence were slightly reduced for all bioluminescent strains 
except tatH5 and tatH14. Correlations between culturable cells and 
fluorescence were also reduced slightly for lysR25, lysG25 and tatH14.  
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Figure 5.5: BKC efficacy test for all strains challenged with 0.0003125% 
BKC. Measured at various time points up to 672 hours by (A) Relative bioluminescence, 
(B) CFU count and (C) Relative fluorescence.  
 
WT          pME4510          pMElux         ldcC          spc         lysR25           lysG25           
lppR3        lppR4         tatH5         tatH9         tatH14 
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Correlations between CFU and RFU were significant (P<0.01) for negative 
control strains wild-type and pME4510 throughout 28 days when they 
were challenged with different concentrations of BKC. However, the 
correlations were slightly reduced to 0.89 and 0.93, respectively, when 
these strains were challenged with 0.0006% BKC. A similar pattern was 
found for the promoterless strain, where correlations were significant 
(P<0.05) and there was slight reduction in correlation coefficient to 0.85 
with 0.0006% BKC challenge.  
Bioluminescence was detected throughout 28 days for all promoter-lux 
constructs when challenged with 0% BKC (Figure 5.6A). CFU counts for 
all strains were approximately 106 CFU/mL and remained consistent 
throughout 28 days (Figure 5.6B). RFU measurements for all strains were 
106 RFU/mL throughout 28 days and remained consistent (Figure 5.6C). 
The correlations between bioluminescence and CFU count were found to 
be weak and non-significant. However, correlations between culturable 
cells and fluorescence for all strains except ldcC, lysR25 and tatH14 were 
significant (P<0.05) with correlation coefficients above 0.8 when 
conditions were starved for 28 days. 
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Figure 5.6: BKC efficacy test for all strains challenged with 0% BKC. 
Measured at various time points up to 672 hours by (A) Relative bioluminescence, (B) 
CFU count and (C) Relative fluorescence. 
 WT          pME4510          pMElux         ldcC          spc         lysR25           lysG25           
lppR3        lppR4         tatH5         tatH9         tatH14 
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5.4.4 Preservative efficacy test for BA 
The effect of various concentrations of BA was evaluated when the strains 
were exposed to preservative challenge. Bioluminescence, CFU count 
and fluorescence measurement were recorded at time intervals as 
specified by several pharmacopoeias. Correlations between 
bioluminescence, cell count and fluorescence are shown in Appendix 10, 
Table 7.6. Log unit reductions in CFU count and bioluminescence are 
shown in Table 7.8 of Appendix 10. Equivalence between the 
bioluminescence method and traditional plate count method for BA is 
shown in Table 7.9 of Appendix 10. 
Wild-type P. aeruginosa and P. aeruginosa with either plasmid pME4510 
or pMElux were used as negative controls for bioluminescence detection. 
At 2% BA, bioluminescence of 102 - 103 RLU/mL (Figure 5.7A), CFU count 
of 106 CFU/mL (Figure 5.7B) for bioluminescent constructs and 103 – 104 
CFU/mL for negative controls and fluorescence of 106 RFU/mL (Figure 
5.7C) were observed at 0 hours. A 2 log unit reduction in CFU was 
observed immediately after inoculation for the negative strains. 
Interestingly, fluorescence of 105 RFU/mL was also observed at 6 hours 
for all bioluminescent constructs, pME4510 and pMElux strains. However, 
no RLU and CFU counts were detected beyond 0 hour. Correlations 
between bioluminescence and CFU count and between bioluminescence 
and fluorescence were both significant (P<0.05) for all bioluminescent 
constructs except lysR25; however, they were lower than expected, with 
correlation coefficients ranging from 0.79 to 0.83.  
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________________________________________________________________________ 
Figure 5.7: BA efficacy test for all strains challenged with 2% BA. Measured 
at various time points up to 672 hours by (A) Relative bioluminescence, (B) CFU count 
and (C) Relative fluorescence. 
   WT    pME4510   pMElux          ldcC    spc     lysR25         lppR4          tatH5 
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Bioluminescence of approximately 103 RLU/mL (Figure 5.8A) from all 
bioluminescent constructs was detected at 0 hours when challenged with 
1% BA. Bioluminescence then reduced by a half log unit at 6 hours for all 
bioluminescent constructs and completely for spc. Bioluminescence 
reduced further by a half log unit at 24 hours and completely for ldcC. No 
bioluminescence was detected at subsequent time points or for all other 
strains. CFU counts for all strains were 106 CFU/mL after challenge with 
the same concentration of BA (Figure 5.8B). A slight reduction in CFU 
counts was observed at 6 and 24 hours for all bioluminescent strains. A 6 
log unit reduction in CFU was observed at 6 hours for negative control 
strains and at 7 days for bioluminescent strains. Relative fluorescence for 
all strains was 106 RFU/mL after challenge with the same concentration of 
BA (Figure 5.8C). A slight reduction in RFU was observed at 6 and 24 
hours for all strains. No RFU counts were detected after 24 hours. 
Correlations were significant (P<0.01) between bioluminescence, CFU 
count and fluorescence, with correlation coefficients greater than 0.92.  
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________________________________________________________________________ 
Figure 5.8: BA efficacy test for all strains challenged with 1% BA. Measured 
at various time points up to 672 hours by (A) Relative bioluminescence, (B) CFU count 
and (C) Relative fluorescence. 
 
 
  WT    pME4510   pMElux          ldcC    spc     lysR25         lppR4          tatH5 
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A gradual decrease in RLU from 104 RLU/mL (ldcC, spc) and 105 RLU/mL 
(lys, tat, lpp) respectively, to approximately 102 RLU/mL, within the first 7 
days was observed for strains challenged with 0.5% BA (Figure 5.9A). 
Bioluminescence then remained consistent up to 28 days for 
bioluminescent strains with strong promoters. However, bioluminescence 
for ldcC and spc declined further by 2 log units and 1 log unit, respectively, 
at 21 days after which it was undetectable. CFU counts for all control 
strains and bioluminescent strains were 106 CFU/mL after challenge with 
the same concentration of BA (Figure 5.9B). A log unit reduction was 
observed for all strains up to 24 hours. Subsequently, a 2 log unit 
reduction was observed for all bioluminescent constructs and no CFU 
count was detected for negative control strains at 7 days. CFU count 
remained stable at approximately 103 CFU/mL for all bioluminescent 
strains between 7 and 14 days. Finally a log unit reduction in CFU count to 
approximately 102 CFU/mL was observed at 21 days and it then remained 
stable at 28 days. RFU readings followed the same pattern as CFU count 
for all strains tested (Figure 5.9C). Correlations between CFU count, 
bioluminescence and fluorescence were significant (P<0.01) with 
coefficients greater than 0.97. A 6 log unit reduction in CFU was observed 
at 7 days and > 2 log unit reduction in bioluminescence was observed at 
28 days. 
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Figure 5.9: BA efficacy test for all strains challenged with 0.5% BA. 
Measured at various time points up to 672 hours by (A) Relative bioluminescence, (B) 
CFU count and (C) Relative fluorescence. 
 
 
 
 
 
  WT    pME4510   pMElux          ldcC    spc     lysR25         lppR4          tatH5 
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Bioluminescence gradually decreased for all strains challenged with 
0.25% BA (Figure 5.10A), by a half log unit within 24 hours. Subsequently 
bioluminescence remained stable for the duration of the studies. CFU 
count (Figure 5.10B) and RFU (Figure 5.10C) declined very slightly within 
14 days, after which the CFU and RFU remained consistent at 105 
CFU/mL and 105 RFU/mL, respectively, for all strains except the wild-type, 
which decreased further to 104 CFU/mL and 104 RFU/mL.  
 
________________________________________________________________________ 
Figure 5.10: BA efficacy test for all strains challenged with 0.25% BA. 
Measured at various time points up to 672 hours by (A) Relative bioluminescence, (B) 
CFU count and (C) Relative fluorescence. 
  WT    pME4510   pMElux          ldcC    spc     lysR25         lppR4          tatH5 
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A gradual reduction in bioluminescence was observed up to 24 hours, 
when all strains were challenged with 0.125% BA (Figure 5.11A). After 24 
hours bioluminescence remained fairly consistent throughout the 
remainder of the experiments. CFU count remained consistent for the first 
24 hours after which there was a log unit decrease for all strains (Figure 
5.11B). Although CFU count of all the bioluminescent constructs remained 
consistent until the end of the experiment, the wild-type strain was found 
to increase very slowly at a rate of half a log unit within 3 weeks. 
Fluorescence data also showed a similar pattern (Figure 5.11C). 
Correlations between bioluminescence and CFU count were significant at 
P<0.05 (except for tatH5) with coefficients reduced to between 0.77 – 0.87 
for all bioluminescent constructs. Correlations between bioluminescence 
and fluorescence were also found to reduce to a similar range with 
significance only at P<0.05. However, significant correlations between 
culturable cells and fluorescence were obtained, indicating that 
bioluminescence decreased before cell count decreased. 
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Figure 5.11: BA efficacy test for all strains challenged with 0.125% BA. 
Measured at various time points up to 672 hours by (A) Relative bioluminescence, (B) 
CFU count and (C) Relative fluorescence. 
 
 
  WT    pME4510   pMElux          ldcC    spc     lysR25         lppR4          tatH5 
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Bioluminescence remained consistent throughout the duration of the 
experiment for all strains, when they were challenged with 0.06% BA 
(Figure 5.12A). No fluorescence experiments were performed for the 
strains challenged with 0.06% BA. Interestingly, CFU count increased by a 
half log unit within 28 days (Figure 5.12B). Correlations between 
bioluminescence and CFU count were significant (P<0.01) with r-values 
between 0.89 and 0.95 for all bioluminescent strains except spc where the 
correlation (r = 0.76) was significant at P<0.05.  
 
 
 
________________________________________________________________________ 
Figure 5.12: BA efficacy test for all strains challenged with 0.06% BA. 
Measured at various time points up to 672 hours by (A) Relative bioluminescence, (B) 
CFU count and (C) Relative fluorescence. 
 
  WT    pME4510   pMElux          ldcC    spc     lysR25         lppR4          tatH5 
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Correlations between culturable cell numbers and fluorescence (>0.9) 
were significant (P<0.01) for negative control strains wild-type, pME4510 
and pMElux when challenged with different concentrations of BA over 28 
days. 
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5.5 Discussion 
Benzalkonium chloride (BKC), a synthetic nitrogenous cationic molecule, 
is widely used as an antimicrobial preservative in food industries, hospitals 
and household products as well as pharmaceutical preparations (Fazlara 
& Ekhtelat, 2012). Its bactericidal properties have promoted its use in 
eyewashes, nasal sprays (Graf, 2001; Hodges et al., 1996; Lenoir et al., 
2011; Marple et al., 2004) and ophthalmic solutions (Mohanty et al., 2012; 
Rase et al., 2011; Ryan et al., 2011). 
Benzyl alcohol (BA) is a synthetic volatile aromatic alcohol that is widely 
used as an antimicrobial preservative in pharmaceutical preparations and 
cosmetic products (Scognamiglio et al., 2012). It is used increasingly in 
multi-dose protein and peptide products (Meyer et al., 2007; Roy et al., 
2005). In this study, the efficacies of BKC and BA were assessed using 
the novel bioluminescent method in parallel with the traditional plate count 
method and fluorescence detection in an attempt to compare the three 
methods. 
 
5.5.1 Minimum inhibitory concentrations of BKC and BA 
All strains of P. aeruginosa were challenged with different concentrations 
of BKC, ranging from 0.0003% to 0.04%. The MIC for wild-type, pME4510 
and pMElux was found to be 0.01%. This result has been confirmed by 
another study that found the MIC for wild type P. aeruginosa to be 0.01% 
(Osman, El-Hendawy, Hassan, Abdel-All, & Dina Ezzat, 2012). The MIC 
for bioluminescent constructs was found to be 0.00125%. Several studies 
have also shown that the MIC of BKC against P. aeruginosa is non-
uniform. Studies found the MIC to be 0.006% (Fazlara & Ekhtelat, 2012) 
or 0.0032% (Kamysz & Turecka, 2005). Yet another study indicated the 
MIC to be 0.025% after 120 hours of contact time (Khajavi et al., 2007).  
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The change in MIC from 0.01% for wild-type to 0.00125% for 
bioluminescent constructs suggests that the bioluminescent constructs are 
more vulnerable to BKC challenge than the wild-type. The studies suggest 
that the incorporation of the lux cassette under constitutive promoters may 
be detrimental to the cells by providing a metabolic load on the cells. 
Furthermore, incorporation of just the lux cassette into the plasmid had no 
effect on the MIC. However, further incorporation of promoters changed 
the MIC significantly. The strength of the promoters, however, did not 
have any effect on the MIC shift. Physical observations of growth of 
bioluminescent constructs compared to that of wild-type also showed that 
bioluminescent constructs produced significantly less biofilms at 24 hours. 
This may explain the metabolic load/detrimental effects of active 
expression of the lux cassette that result in cells being more susceptible to 
benzalkonium choride. Gilbert and Moore (2005) have shown a positive 
correlation between biofilm formation and increase in MIC. Changes in 
MIC in gram-negative bacteria may be due to certain factors that alter the 
susceptibility of bacterial cells against preservatives. These factors include 
alterations in phenotype, efflux pumps, expression of enzymes, 
chromosomal and plasmid-based alterations (Gilbert & McBain, 2003). 
They also suggested that plasmids provide low levels of resistance 
against preservatives.  
Strains were challenged with different concentrations of BA, ranging from 
0.06% to 2%. The MIC for all strains tested using the bioluminescence 
and absorbance methods were 1%. Similar results have been shown in 
other studies (GE healthcare, 2012; Meyer et al., 2007). This shows that 
the bioluminescence method may be utilised instead of absorbance to 
determine MIC of antimicrobial agents. Such a method also provides a 
rapid frontline screening platform for testing novel antimicrobial agents for 
antimicrobial potential. Results from the MIC determination were used to 
determine the concentration range to be used for antimicrobial efficacy 
testing of BKC and BA. 
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5.5.2 Preservative efficacy tests for BKC and BA 
Preservative efficacy testing (PET) was performed according to the 
requirements of the pharmacopoeias. This study aimed at utilising the 
novel bioluminescent strains to determine antimicrobial efficacy of BKC 
and BA using the bioluminescence method of detection in parallel to the 
traditional plate counting method. Different concentrations of BKC, ranging 
from 0.02% to 0.0003% (w/v) and BA, ranging from 0.06% to 2% (
v/v), were 
used for the PET against all P. aeruginosa strains used in the study.  
The MIC of BKC against the wild-type was 0.01%. However, under 
starved conditions in preservative efficacy testing, the wild-type strain was 
susceptible at 0.00125% BKC. Similarly, the MIC of BA for wild-type and 
bioluminescent constructs was 1%. However, it was surprising that 
significant bacterial growth and bioluminescence was observed at 24 
hours for bioluminescent constructs challenged with 1% BA during the 
preservative efficacy testing. MIC determination is performed using growth 
medium, thereby providing cells with a chance to survive in the presence 
of antimicrobials by utilising the available energy sources. The change in 
biocide susceptibility relates to the fact that in nutrient-depleted 
environments (PET), the bacterial cells are slow-growing as opposed to 
nutrient-rich environments (MIC determination in presence of media) when 
the bacterial cells grow and form biofilms (Fazlara & Ekhtelat, 2012). In 
the presence of growth media, the cells were strong enough (unstarved) to 
provide intrinsic resistance against antimicrobials as compared to their 
susceptibility when the cells were starved during preservative efficacy 
testing. Biocide activity may be significantly compromised in nutrient-rich 
environments due to the biofilm formation in such environments. Nutrient 
depleted environments trigger a stress response by bacterial cells (Gilbert 
& McBain, 2003). Initiation of stationary phase leads to dormant 
phenotypes where cells adopt a ‘resting’ nature. A study (Foley, Marsh, 
Wellington, Smith & Brown, 1999) also showed increased rpoS expression 
in nutrient-rich environments. In nutrient limiting environments, the 
detrimental effect of metabolic burden has also been highlighted in a study 
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where lack of glucose has shown increased susceptibility of P. aeruginosa 
to benzalkonium chloride (Mc Cay, Ocampo-Sosa & Fleming, 2010). Lack 
of magnesium, which is vital for Pseudomonas cell membrane 
development, has also been shown to increase susceptibility of the cells to 
antimicrobial agents (Manzoor, Lambert, Griffiths, Gill & Fraise, 1999) 
Observation of bacterial growth as evidenced by increase in 
bioluminescence and CFU count when cells were challenged with BA 
indicated that Pseudomonas cells utilise BA as a source of nutrients in the 
absence of growth media. A previous study has shown that Pseudomonas 
aeruginosa cells produce lipase that transesterify 0.2% benzyl alcohol to 
benzyl acetate (Singh et al., 2008). This phenomenon was also observed 
when Pseudomonas cells were challenged with 0.06% BA, where CFU 
count increased by a half log unit within 28 days.  
Negative control strains were observed to be more vulnerable to BKC 
challenge than to bioluminescent constructs. This was indicated by the 
susceptibility of negative control strains at 0.0006% BKC, whereas the 
bioluminescent constructs were resistant to BKC at the same 
concentration. The promoterless strain also behaved in the same manner 
as the wild-type and hence it was more susceptible than the 
bioluminescent constructs. This indicated that the incorporation of the 
plasmid and therefore expression of the genes on the plasmid provided a 
protection against BKC for all bioluminescent cells. Growth of the 
promoterless strain in a manner similar to the wild-type suggested that it 
was not plasmid incorporation but rather the expression of the lux cassette 
that was conferring resistance of bioluminescent constructs to BKC.  
Most interestingly, the correlation between bioluminescence and CFU 
count in the absence of preservative was weak and non-significant. 
However, the correlation between culturable cell count and fluorescence 
was significant (P<0.05), with a correlation coefficient greater than 0.8. 
This indicated that the cells were culturable. However, their 
bioluminescence pathway was affected. This was further confirmed with a 
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significant difference between the bioluminescent method and plate 
counting method when ANOVA was performed. Under starved conditions, 
bacterial cells lack the fundamental resources of energy production and 
therefore cannot perform certain energy-demanding reactions because of 
a lack of an energy source. One such example is the bioluminescence 
pathway, which is energy-demanding in the form of NADPH, FMNH2 and 
ATP (Meighen, 1991). Other metabolic pathways include biofilm 
production and virulence determination.  
High concentrations of BKC (0.02%-0.0025%) and BA (2%) were found to 
be too toxic for the cells, even though the inocula were 106 CFU/mL in 
accordance with the pharmacopoeial requirements. This was observed by 
immediate arrest in bioluminescence and significant reduction in CFU 
count, hence indicating an immediate bactericidal effect of the biocide. 
Typical in-use concentrations of BKC and BA as antimicrobial agents are 
0.01-0.02% (Osman et al., 2012; Rase et al., 2011; Ryan et al., 2011) and 
1-2% (GE healthcare, 2012; Meyer et al., 2007) respectively. The 
immediate bactericidal effect has been observed because cell membranes 
are virtually dissolved at such high concentrations of BKC and therefore 
immediate bactericidal effect is observed (Lambert & Hammond, 1973). At 
high BKC concentrations, micelles are formed leading to solubilisation of 
the hydrophobic membrane (Gilbert & Moore, 2005). BKC also forms 
dimers, which interact strongly with the cell membrane, thereby exerting a 
stronger antimicrobial effect (Gilbert & Altaae, 1985). A high concentration 
of BA is thought to cause protein denaturation and aggregation (Gupta & 
Kaisheva, 2003). Benzyl alcohol at a concentration of 1% causes soluble 
protein aggregates; thus the effect on bacterial cells is not as rapid as that 
of 2% BA (Gupta & Kaisheva, 2003).  
Fluorescence detection with the aid of Molecular Probes® Live/Dead® 
BacLightTM staining comprising of two dyes Syto-9 and propidium iodide 
(Berney et al., 2007; Molecular Probes) discriminated between viable and 
non-viable live cells. These two dyes are DNA intercalators (Berney et al., 
2007); Syto-9 crosses intact membranes of viable cells and fluoresces 
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green whereas propidium iodide is able to cross damaged membranes 
only (non-viable cells) and fluoresces red. Hence, viable cells and non-
viable cells can be distinguished by their fluorescence output. This method 
of estimating viable and non-viable cells is a rapid method that has been 
used in numerous studies (Ferreira et al., 2011; Harrison et al., 2008). At 
BKC concentrations of 0.0006% and 0.0003% and a BA concentration of 
1% correlations, between bioluminescence, CFU count and fluorescence 
were significant (P<0.05) for all bioluminescent constructs. However, a 
decrease in the correlation coefficients between fluorescence and 
bioluminescence and between fluorescence and culturability suggested 
that a few cells had become non-culturable. At low BKC concentrations, 
the membrane perturbations lead to loss of membrane fluidity and stable 
hexagonal arrangements of phospholipids are formed (Gilbert & Moore, 
2005). Therefore cells may not be able to grow and replicate on media.  
Although concentrations of 0.0006% BKC and 2% BA fulfilled the criteria 
of the pharmacopoeias, the latter does not take into account cells that are 
viable but undetected using the plate count method. This may further 
explain why microbial contamination has been a problem in numerous 
pharmaceutical products for several decades; a recent study by Tan et al 
(2013) found P. aeruginosa contamination in unopened toothpaste. 
Another recent study also showed the importance of detection of viable, 
non-culturable cells in the food industry (Elizaquível, Aznar & Sánchez, 
2014). The capability of viable but non-culturable bacterial cells to cause 
product spoilage and potentially pose as a threat for infections has been 
shown in various studies (Colwell et al., 1996; Rahman, Shahamat, 
Chowdhury & Colwell, 1996). It is therefore imperative that testing 
protocols for preservative efficacy be improved such that all 
microorganisms bypassing the protocols are detected in due time. 
P.aeruginosa has been one of the many widespread opportunistic 
microbes to have been detected in various pharmaceutical preparations 
and cosmetics.  
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At mid-range BA concentrations of 0.5% and 0.25%, bioluminescence, 
CFU count and fluorescence were detected throughout 28 days and 
correlations between these three parameters were significant (P<0.01). 
Another study observed insignificant protein aggregation and precipitation 
at 0.5% BA (Gupta & Kaisheva, 2003), suggesting that bacterial cells 
would be viable.  
At a lower BKC concentration of 0.0006%, correlations between 
bioluminescence and CFU count were significant (P<0.05) for all 
bioluminescent constructs Correlations between bioluminescence and 
fluorescence were reduced. Decrease in bioluminescence prior to cell 
count was observed when cells were challenged with 0.0006% BKC; 
bioluminescence decreased by two log units within 6 hours, whereas 
fluorescence reduced by a half log unit. CFU count also reduced by two 
log units, suggesting that bioluminescence decreased before cell viability 
decreased. Initial reduction in bioluminescence followed by reduction in 
CFU count indicates that the binding of the biocide to membrane proteins 
and creating osmotic gradients such that the constituents of the cells leak 
out (Lambert & Hammond, 1973) leading to subsequent disturbances to 
optimum environments for luciferase reactions. This is rapidly followed by 
reduction in CFU count where the cell constituents have leaked out to 
detrimental levels such that cell death is observed. Furthermore, 
denaturation of proteins and formation of protein aggregates (Gupta & 
Kaisheva, 2003) including the luciferase enzymes imposes an immediate 
detrimental effect on the bioluminescence pathway. Hence this 
phenomenon of reduction in gene expression prior to reduction in cell 
number may serve as an early indicator of the effects of preservative on 
microbial death and therefore the bioluminescent method may be used to 
detect widespread death of microbial cells during antimicrobial efficacy 
testing. Bioluminescence has been shown to give an earlier indicator of 
the health state of bacterial cells compared to traditional plate counting. 
Correlations between bioluminescence, cell count and fluorescence 
measured at the minimum inhibitory concentrations of BKC were also 
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significant for all the bioluminescent constructs. Analysis of variance tests 
give an indication whether the bioluminescent and plate count method 
were equivalent. These tests were performed at P<0.05. For various 
concentrations of BKC and BA during preservative efficacy tests, it was 
found that there was no significant difference between the bioluminescent 
method and traditional plate counting method for concentration ranges of 
0.0003% - 0.02% BKC and 0.25% - 2% BA as observed by P-values being 
greater than 0.05. The bioluminescent construct tatH5 had no significant 
difference between the bioluminescent method and traditional plate 
counting method at a concentration of 0.125% BA as well. This therefore 
indicated that the bioluminescent method may be used to detect microbes 
during antimicrobial efficacy testing. Previous studies have also utilised 
the bioluminescent method to examine the efficacy of biocides such as 
phenol, chlorhexidine digluconate and ethanol (Choi & Gu, 1999; Dhir & 
Dodd, 1995; Robinson et al., 2011). Testing model preservative systems 
used in pharmaceutical preparations against P. aeruginosa using the ATP 
bioluminescent method showed incompliance of the preservative systems 
to the pharmacopoeial requirements (Kramer et al., 2008). This was 
because initial ATP levels in P. aeruginosa were low (Kramer et al., 2008). 
ATP among other energy compounds are regarded as markers that inform 
about the global health state of bacterial cells. Therefore reduction in initial 
levels of such markers indicate immediate effect of antimicrobial agents on 
bacterial cells. Such immediate effects would not be detected by the ATP 
bioluminescent method since this method requires ATP extraction from 
cells, thereby presenting a physical disadvantage for detection of 
immediate effects. Coupling of bioluminescence to cell viability with 
respect to constitutive gene expression provides a powerful, non-
destructive tool for studies of bacterial growth under preservative 
challenge in real time.  
Bioluminescent signals as a result of gene expression from PldcC and Pspc 
were weak. As a result the strains with these promoters showed weaker 
and non-significant correlations between bioluminescence and CFU 
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counts when challenged with BKC concentrations between 0.00125% and 
0.01%. There strains therefore are not suitable candidates for preservative 
efficacy testing.  
Strong correlations between bioluminescence, CFU count and 
fluorescence were obtained for BKC concentrations between 0.0003% 
and 0.0025% against strains lys, lpp and tat. Similarly, strong correlations 
between the three parameters were obtained for BA concentrations 
between 0.125% and 2% against strains lysR25, lppR4 and tatH5. The 
bioluminescent method and traditional plate counting method were found 
to be equivalent for concentrations of 0.0003% - 0.02% BKC and 0.25% - 
2% BA during preservative efficacy tests. The bioluminescent method and 
traditional plate counting method were found to be equivalent for construct 
tatH5 at a concentration of 0.125% BA as well. To conclude, these 
bioluminescent constructs are therefore strong candidates for selection for 
incorporation into a biosensor system for preservative efficacy testing.  
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6. General discussion and conclusion 
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In this study, bioluminescent constructs were developed from P. 
aeruginosa ATCC9027 using molecular cloning techniques. Insertion of 
the promoter-lux insert into the host plasmid pME4510 and subsequent 
transformation into E. coli DH5  cells was successfully achieved. 
Pseudomonas promoters were not well-recognised by the E. coli 
transcription machinery because the Pseudomonas aeruginosa 
bioluminescent constructs containing the same P. aeruginosa promoters 
produced bioluminescence of several magnitudes greater than that of their 
E. coli counterparts. A study by Rist & Kertesz (1998) also suggested that 
promoters originating from P. aeruginosa were not recognised by E. coli. 
During the development of these bioluminescent constructs, it was found 
that plasmid pSB417 lacked SalI and PstI restriction sites. Construction of 
plasmid pSB417 by Winson et al (1998) included functional SalI and PstI 
restriction sites, amongst other restriction sites in the multiple cloning site. 
However, this study reports non-functional or lack of these two restriction 
sites in this plasmid as observed by failure to digest the plasmid with these 
functional restriction enzymes.  
Transfer of plasmids from E. coli to P. aeruginosa was more challenging; 
however, optimisation of the electroporation buffer to suit Pseudomonas 
was vital in achieving successful results. Electroporation buffers consisting 
of salts aided in post-electroporation recovery of the cell membranes and 
therefore resulted in successful transformation. Other studies have also 
shown the importance of salts in transformation (Diver et al., 1990; 
Farinha & Kropinski, 1990). Inclusion of small amounts of salts such as 
magnesium chloride was beneficial to the recovery of P. aeruginosa cells 
after electroporation because it is important in the maintenance of 
structural integrity of the lipopolysaccharides (LPS) of bacterial 
membranes (Dennis & Sokol, 1995). All recombinant strains carrying 
promoter-lux inserts produced bioluminescence whereas the promoterless 
strain did not. Therefore novel bioluminescent constructs were 
successfully produced in P. aeruginosa ATCC 9027. These different 
constructs have been named:  
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P. aeruginosa ATCC 9027 + ldcC pME-lux 
P. aeruginosa ATCC 9027 + spc pME-lux 
P. aeruginosa ATCC 9027 + lys R25 pME-lux 
P. aeruginosa ATCC 9027 + lys G25 pME-lux 
P. aeruginosa ATCC 9027 + lpp R3 pME-lux 
P. aeruginosa ATCC 9027 + lpp R4 pME-lux 
P. aeruginosa ATCC 9027 + tat H5 pME-lux 
P. aeruginosa ATCC 9027 + tat H9 pME-lux 
P. aeruginosa ATCC 9027 + tat H14 pME-lux 
Two other variants in P. aeruginosa ATCC 9027 were also produced. The 
promoterless variant bearing the lux-cassette on the plasmid was named 
P. aeruginosa ATCC 9027 + promoterless pME-lux. The other variant P. 
aeruginosa ATCC 9027 + pME4510 was also produced in P. aeruginosa. 
These may be used as a tool for further manipulation.  
There is very limited information in the literature about promoter structure 
and characterisation in Pseudomonas aeruginosa and therefore the data 
from this study contributes to a better understanding of promoters from 
Pseudomonas aeruginosa. Promoter strength of the five selected 
promoters was investigated by determining the bioluminescence per cell 
count and further related to the respective promoter sequences. During 
the exponential phase of growth, the promoter strength decreased in the 
order of lpp>tat>lys>ldcC>spc while during the stationary phase of growth 
the promoter strength decreased in the order of tat>lpp>lys>ldcC>spc. 
Weak expression of LdcC was also shown by Lemonnier and Lane (1998). 
The importance of the tat pathway for the transport of proteins to the 
cytoplasmic membrane has been shown previously (Jack et al., 2001) and 
therefore high expression from Ptat would be expected. This has been 
shown because the promoter strength of Ptat was strong compared to the 
other promoters. 
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The importance of the spacer region was emphasized because PldcC and 
Pspc consist of spacer regions whose distances were 13bp and 19bp 
respectively. The consensus spacer region between -35 and -10 is 17 + 2 
bp (Mishra & Chatterji, 1993). Expression of genes from promoters with 
such spacer regions has been shown to be high compared to that of 
promoters with shorter or longer spacer regions (Stefano & Gralla, 1982). 
These two promoters were found to be the weakest of all five promoters 
investigated. Plpp had the highest level of expression during the 
exponential phase compared to that of the other four promoters. Ptat had 
relatively stable expression during the stationary phase compared to that 
of the other promoters. Plpp is also a binding site for rpoS18 (Yan et al., 
2007), a transcritption binding factor that binds in response to stress 
during the stationary phase. Hence the expression of lux cassette from 
Plpp was found to be altered during the stationary phase, such that its 
expression was less than that from Ptat and PlysS. From the promoter 
strength and sequence data for the five promoters tested, it was indicated 
that the -10 region seemed to be crucial for constitutive gene expression 
in the exponential phase while the -35 region seemed to be crucial for 
constitutive gene expression during the stationary phase. This was 
confirmed by various other studies, which have shown that the upstream 
half of the -10 region is more important for recognition by σ factors 
(Dombroski, 1997; Dombroski, Johnson, Lonetto & Gross, 1996; Dombroski, 
Walter, Record, Siegele & Gross, 1992) and subsequently for successful gene 
expression. 
Bioluminescent constructs were validated successfully in accordance with 
various regulatory documents (ISO, 1994a, 1994b, 1994c; PDA, 2000), 
using the bioluminescent method. Bioluminescence was found to increase 
proportionately to CFU count for the range between 104 and 108 CFU/mL 
for strong promoters and between 105 and 108 CFU/mL for weak 
promoters. The lower limit of detection was estimated to be 102 RLU, as 
observed by the bioluminescence detection from bioluminescent 
constructs as compared to negative control strains. The sensitivity of the 
bioluminescent method was 103 CFU/mL. According to a review of 
Page 233 
 
methods for rapid microbiological assays (Shintani et al., 2011), the 
sensitivity of the ATP bioluminescent method was greater than 102-103 
CFU/mL and therefore the sensitivity achieved in this work was 
comparable to that of the ATP bioluminescent method. It was observed 
that bioluminescence of undiluted cultures (108 CFU/mL) was less than 
that of 10-fold diluted cultures, implying that turbid undiluted cultures 
hindered the accurate detection of bioluminescence by diffracting light 
away from the detector. This is known as the inner-filter effect (Kao et al., 
1998). However, the linearity validation indicated that the requirement of 
106 cells of inoculum for preservative efficacy testing was within the linear 
range and therefore the inner filter effect would not affect preservative 
testing regimes. 
The percentage recovery of cells indicated the level of accuracy of the 
bioluminescent method compared to the traditional plate count method 
and should lie between 70% and 130% (PDA, 2000). Percentage 
recoveries using the bioluminescent method were between 70% and 
130% for all bioluminescent strains; therefore, the bioluminescent method 
was accurate. Precision of the bioluminescent method was measured by 
relative standard deviation (RSD) of 10 replicates and should be less than 
30% (PDA, 2000). Furthermore, statistical analysis by F-test and one-way 
analysis of variance showed no significant difference in precision between 
the bioluminescent method and the plate counting method for all 
bioluminescent strains. Therefore, the bioluminescent method passed the 
criteria set out in various documents for a microbial testing method (ISO, 
1994a, 1994b, 1994c; PDA, 2000). Precision testing using the 
bioluminescent method for all constructs resulted in a RSD less than 15% 
for the range 104 to108 CFU/mL. The ATP bioluminescent method, which 
is accepted as an alternative PET method according to the 
pharmacopoeia, resulted in RSDs of 24.9% and 26% for 108 and 104 
CFU/mL, respectively (Kramer et al., 2008), whereas the precision of 
bioluminescence for the constructs designed herein was less than 10% 
and less than 15% for 108 and 104 CFU/mL, respectively. This indicated 
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that the whole cell microbial bioluminescent method was more precise 
than the ATP bioluminescent method.  
The bioluminescent method was also deemed equivalent, accurate and 
precise in the range 104 to108 CFU/mL under the criteria for determining 
these parameters (ISO, 1994a, 1994b, 1994c, 2000; PDA, 2000). 
Correlations between the bioluminescent method and plate count method 
were strong and significant when the strains were tested for accuracy, 
precision and linearity. No significant difference between the 
bioluminescent and the plate counting method was also found in other 
studies (Quilliam et al., 2012; Sun et al., 2012; Thorn et al., 2007). 
Equivalence measurements by analysis of variance showed no significant 
difference between the bioluminescent and plate count method. Therefore, 
the bioluminescent constructs gave equivalent or better accuracy, 
precision and linearity compared to the plate count method and met the 
validation criteria. All the recombinant constructs were validated 
successfully. This means that the bioluminescent constructs have a great 
potential for use in PET. Although numerous studies have suggested 
replacement of the traditional plate counting methods with whole cell 
microbial bioluminescent methods (Willardson et al., 1998; Wise & Kuske, 
2000), it is believed that this study reports for the first time the use of 
validated bioluminescent constructs developed in a pharmacopoeial-
defined test microorganism P. aeruginosa ATCC9027 in microbiological 
testing methods. 
Stability of plasmids was regarded as vital for this study, since 
preservative efficacy tests require that stable plasmids are maintained 
throughout the duration of the test. All plasmid copy numbers remained 
constant throughout the 28 day period, indicating that the plasmids were 
stably maintained by the cells. Plasmid copy number for all strains was 
greatest during the exponential phase of growth, where pME4510 strain 
had 120 copies and the recombinant constructs had 100 copies. This is 
the phase when the cells are dividing rapidly and therefore the plasmids 
are replicating before the cells replicate. During the stationary phase of 
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growth, plasmid copy number was found to be approximately 80 and 50 
for strain pME4510 and recombinant constructs respectively. Previous 
studies have also shown that plasmid copy number decreases as plasmid 
size increases (Smith & Bidochka, 1998). 
The growth and death kinetics for all strains developed were compared to 
that of the wild-type and the performance of the bioluminescent method 
was assessed for determination of the health states of all constructs at 
various growth phases. Good correlations were observed between 
bioluminescence and fluorescence for the 28 day period for all 
bioluminescent constructs indicating that all viable cells were 
bioluminescent. The lag phase for all bioluminescent constructs lasted for 
approximately 3 hours, as indicated by peaking on the RLU:CFU plot 
indicating increased gene expression per bacterial cell count, which may 
have been due to an increase in plasmid copy number. Increased gene 
expression during lag phase was also defined by Al-Qadiri et al (2008). 
This aspect of bioluminescence detection prior to cell replication may 
provide a useful tool in early microbial growth detection. Following the lag 
phase, all strains entered the exponential growth phase for up to 
approximately 12 hours. Tailing of the peaks on the RLU:CFU plot was 
observed as the gene expression per bacterial cell count stabilised to 
linear relationships. Constant gene expression during the exponential 
phase of growth was also shown by Al-Qadiri et al (2008) and Thorn et al 
(2007). Bioluminescence has therefore been shown to give an indicator of 
the health state of bacterial cells comparable to that of traditional plate 
counting. The onset of the stationary phase was observed at 12 hours, 
after which there was no net increase or decrease in bioluminescence or 
bacterial cell counts. From the RLU:CFU plot, it was observed that 
constant light was produced per bacterial cell after 12 hours up to 48 
hours for strong promoters. After 48 hours of growth, bioluminescence 
production was not proportional to bacterial cell count. A decrease in 
bioluminescence from PldcC and Pspc during the stationary phase may be 
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due to these promoters being less recognised by sigma-38, which is 
predominant during stationary phase (Raivio & Silhavy, 2001). 
A metabolic load of gene expression of the lux cassette was observed on 
bacterial cells. The luciferase pathway is highly energy-dependent and 
utilises myristol-ACP as the lipid substrate (Close et al., 2012), which is 
also essential for membrane lipid formation. Hence, there may be 
competition for myristol-ACP between membrane lipid formation and the 
luciferase pathway. Myristol-ACP may be utilised in the luciferase pathway 
at the expense of membrane formation, thereby reducing the rate of 
formation of cell membrane of bioluminescent constructs compared to that 
of wild-type. This hypothesis of metabolic load was supported by various 
observations. Firstly, growth of the bioluminescent strains was slower than 
that of the promoterless strain, which grew in a similar manner to the wild-
type. Secondly, the change in MIC from 0.01% for wild-type and pMElux to 
0.00125% for bioluminescent constructs suggested that the 
bioluminescent constructs were more vulnerable to BKC challenge 
compared to the wild-type. Incorporation of the lux cassette under 
constitutive promoters was detrimental to the cells by providing a 
metabolic load on the cells. Thirdly, physical observation of 
bioluminescent cell growth compared to wild-type also showed that 
bioluminescent constructs produced considerably less biofilm at 24 hours 
than the wild-type. Hence, this may be the cause of the increased 
susceptibility to BKC against bioluminescent constructs as opposed to the 
wild-type, which explained the metabolic load/detrimental effect of 
expression of the lux cassette on bioluminescent constructs as compared 
to wild-type P. aeruginosa. A study by Gilbert and Moore (2005) has also 
shown a positive correlation between biofilm formation and increase in 
MIC. Therefore, decrease in biofilm formation would increase susceptibility 
of bioluminescent constructs to BKC. 
A decrease in culturability of bioluminescent constructs by comparison 
with wild-type may suggest that the metabolic load on the bioluminescent 
constructs played a crucial role in converting cells towards VBNC states 
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when conditions were stressful, since bioluminescent constructs did not 
have the ability to replicate. Weaker correlations between cell culturability 
and fluorescence were observed during growth and death phases as a 
result of differences between these two variables. Wild-type cells were 
culturable throughout 28 days; however, the culturability of the 
promoterless strain and bioluminescent strains decreased at 7 days and 
14 days, respectively, indicating that not all cells were culturable. 
Therefore, conversion of phase from stationary phase to long-term 
stationary phase seems to occur between 7 and 14 days. However, the 
correlations between bioluminescence and fluorescence using vital 
staining indicate that only viable cells are expressing the lux cassette. A 
decrease in relative bioluminescence also suggested reduced gene 
expression; another characteristic of possible VBNC state (Navarro 
Llorens et al., 2010). Viable but non-culturable states were also observed 
under preservative challenge. This was supported by a decrease in 
bioluminescence by two log units within 6 hours, whereas the 
fluorescence was decreased by a half log unit when all bioluminescent 
constructs were challenged with 0.0006% BKC.  
In this study, the use of bioluminescent constructs as biosensors was 
evaluated during antimicrobial efficacy testing using BKC and BA. The 
study has shown that bioluminescence is suitable for monitoring health 
states of P. aeruginosa constructs. The bioluminescent method was able 
to measure different levels of microbial population (CFU) in media as well 
as under preservative challenge. Strong correlations between 
bioluminescence and plate count were statistically significant during 
growth and death kinetic studies. Furthermore, it was possible with the 
bioluminescent method to study the effects of preservative on the viability 
of bacterial cells. During BKC and BA PET, good correlations between 
bioluminescence, cell count and fluorescence were obtained for all the 
bioluminescent constructs. These correlations were also statistically 
significant, therefore indicating that the bioluminescent method may be 
used to detect microbes during antimicrobial efficacy testing. Coupling of 
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bioluminescence to bacterial metabolism with respect to constitutive gene 
expression provides a powerful, non-destructive tool for studies of 
bacterial growth under preservative challenge in real time. 
At concentrations of 0.0006% BKC and 2% BA, 2 log unit and 3 log unit 
reductions in CFU at 6 hours and 24 hours for all bioluminescent 
constructs indicated that these concentrations of BKC and BA fulfilled the 
pharmacopoeial requirements of a preservative challenge (European 
Pharmacopoeia, 2008). However, the presence of non-viable cells may 
further explain why microbial contamination has been a problem in 
numerous pharmaceutical products for several decades; the recent study 
by Tan et al (2013) found P. aeruginosa contamination in unopened 
toothpaste. Another recent study also showed the importance of detection 
of viable but non-culturable cells in food industry testing (Elizaquível et al., 
2014). It is therefore imperative that testing protocols for preservative 
efficacy are improved, such that all micro-organisms are detected in due 
time. P. aeruginosa has been one of the many opportunistic microbes to 
have been detected in various pharmaceutical preparations and 
cosmetics. Testing model preservative systems used in pharmaceutical 
preparations against P. aeruginosa using the ATP bioluminescent method 
showed incompliance of the preservative systems to the pharmacopoeial 
requirements (Kramer et al., 2008). This was because P. aeruginosa had 
reduced initial ATP level (Kramer et al., 2008). ATP, among other energy 
compounds is regarded as a marker that informs about the overall health 
state of bacterial cells. Therefore, reduction in initial levels of such 
markers indicates an immediate effect of antimicrobial agents on bacterial 
cells. Such immediate effects would not be detected by the ATP 
bioluminescent method, since this method requires ATP extraction from 
cells, thereby presenting a physical disadvantage for detection of 
immediate effects. For the strains with strong promoters, strong 
correlations between bioluminescence, fluorescence and culturability 
indicate that a large number of cells were viable, culturable and 
expressing the lux cassette. Coupling of bioluminescence to bacterial 
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metabolism with respect to constitutive gene expression provides a rapid, 
powerful and non-destructive tool for studies of bacterial growth during 
various growth phases in real time.  
The relationship between antimicrobial concentration and response of 
microbes was good, as indicated for all concentrations and strains during 
MIC determination. The efficacies of BKC and BA were assessed using 
the novel bioluminescent method in parallel with the traditional plate count 
method in an attempt to compare the two methods. The MICs for BA 
against all strains tested were found to be 1% using bioluminescence and 
absorbance methods. This showed that the bioluminescence method may 
be utilised instead of the absorbance method to determine the MIC of 
antimicrobial agents. Such a method also provides a rapid frontline 
screening platform for testing novel antimicrobial agents for antimicrobial 
potential. 
It was concluded that strains with PldcC and Pspc were not suitable 
candidates for preservative efficacy testing because of the decrease in 
bioluminescence during the stationary phases of ldcC and spc strains and 
because both strains produced weaker bioluminescent signals than other 
bioluminescent constructs. Good correlations between bioluminescence, 
CFU count and fluorescence were obtained for BKC concentrations 
between 0.0003% and 0.0025% against strains lys, lpp and tat. Similarly, 
good correlations between the three parameters were obtained for BA 
concentrations between 0.125% and 2% against strains lysR25, lppR4 
and tatH5. There was no significant difference between the 
bioluminescent method and the traditional plate counting method for 
concentrations ranging from 0.0003 - 0.02% BKC and 0.25 - 2% BA. The 
bioluminescent method and traditional plate counting method were 
equivalent for concentrations of BKC (0.0003 - 0.02%) and BA (0.25 - 2%) 
during preservative efficacy tests. These bioluminescent constructs 
therefore are good candidates for selection for preservative efficacy 
testing. At greater concentrations, the bioluminescent method and 
traditional plate counting method were also found to be equivalent for 
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construct tatH5 at a concentration of 0.125% BA. Together with the results 
from growth and death kinetics, where tatH5 showed the greatest 
constitutive expression, it can be concluded that this candidate is 
preferred for testing various antimicrobial agents.  
Preservative efficacy testing using traditional methods takes at least 28 
days plus set up time and incubation time; additionally it is very laborious 
and time-consuming and is usually repeated. Furthermore, a range of 
concentrations of various preservatives need to be tested for antimicrobial 
efficacy, making the challenge test expensive, prolonged and laborious. 
Therefore, industries are reluctant to invest their finance, knowledge and 
equipment to conduct these tests. Use of whole cell microbial 
bioluminescent constructs therefore provides a rapid, accurate, non-
destructive and less laborious method that gives results in real time. 
Results from validation of the bioluminescent method using P. aeruginosa 
bioluminescent constructs were accurate and precise across a linear 
range of microbial population. The whole cell microbial bioluminescent 
method has proved to be equivalent/better than both the traditional plate 
counting method and the ATP bioluminescent method. Therefore, the 
whole cell microbial bioluminescent method provides a platform for rapid 
antimicrobial efficacy testing. Furthermore, the bioluminescent method 
could be applied as a rapid, front-line screening platform for determination 
of minimum inhibitory concentration of novel compounds in 
pharmaceutical, food and cosmetics industries. 
Coupling of bioluminescence to cell viability with respect to constitutive 
gene expression provides a powerful, non-destructive tool for studies of 
bacterial growth under preservative challenge in real time. 
Bioluminescence provides an earlier indicator of the health state of 
bacterial cells than traditional plate counting. By validation, growth and 
death kinetics, and subsequent antimicrobial efficacy testing, it has been 
shown that the bioluminescent method has several advantages over the 
traditional plate count method. Firstly, results are produced in real time. 
Secondly, use of the bioluminescent method allows early detection of 
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microbial cell death during death kinetics or in response to challenge with 
antimicrobial agents since they express the lux cassette constitutively, 
these bioluminescent constructs have the ability to screen a broad 
spectrum of antimicrobial agents. Due to high risk of contamination during 
sampling of cultures over a 28 day period, the bioluminescent method 
reduces the dectection of contaminating microbes that would normally be 
detected as positives with the plate counting method. Hence, the 
bioluminescent method reduces the detection of false positives and 
thereby provides specificity. Cell viability can be monitored in the presence 
of various concentrations of preservatives with this method, as opposed to 
the detection of cell culturability using the plate count method.  
In conclusion, this study reports for the first time the construction and 
development of functional whole cell microbial bioluminescent constructs 
in Pseudomonas aeruginosa ATCC 9027 using constitutive promoters for 
examination of overall health states of Pseudomonas cells when 
challenged with various antimicrobial agents. From the results and 
experience obtained from this study, it can be concluded that the 
bioluminescent method represents a valid alternative method for 
preservative efficacy testing in pharmaceutical development. It is an 
economical method with respect to labour, time and materials required. 
The bioluminescent method of detection provides a rapid, simple, 
sensitive, quantitative and cost-effective way of detecting microbial 
content in real-time without the need for laborious and destructive 
extraction procedures and expensive reagents.  
Future work will include conducting reproducibility studies as part of the 
validation of the bioluminescent constructs. Such a validation should 
include precision testing in different laboratories, different analysts, 
different reagent batches and different instruments but using the same 
analytical protocol.  
Following a full validation, pharmaceutical formulations should be tested 
against the bioluminescent constructs for testing antimicrobial efficacy 
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using the bioluminescent method. Currently, the preservative efficacy 
testings were performed with preservatives in water. According to the 
pharmacopoeias, full pharmaceutical formulations, such as ophthalmic 
solutions, should be tested to assess any interfering components of the 
formulations that may stimulate or hinder the growth of micro organisms.  
The bioluminescent constructs should be tested as part of consumable 
products that would be supplied to consumers. The bioluminescent 
constructs are to be supplied as freeze-dried strains in sterile multi-well 
plates. The multi-well plates may contain different concentration of micro 
organisms with positive and negative controls. The plates may also 
contain different micro organisms that are specified in the pharmacopoeia. 
The plates would be placed in an incubated luminometer connected to a 
signal processor that will automatically process data in real time mode. 
Such a system would therefore form a functional biosensor system. 
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Appendices 
Appendix 1: Promoter sequences 
LdcC sequence 
Locus:       NC_002516               2256 bp    DNA     linear 
Definition:  Orn/Arg/Lys decarboxylase LdcC. 
>gi|110645304:1974821-1977076 
CCTGCCCATGCACCACGGGCGCCGCGTTCAGCGTGTCGCCCGGTCCACCAGCAAGGTGTCGCAGAACTGCTCG
AAACGGCGGATCCTGCCGTCCTCTACCGTCCATACGTGTGCCACACGTGCTTCGAACGACTTGCCGCTGCGAC
GGTGGGTCGCTGCATATCGACCGACGGCGATCACGCTGTCGCCGCCGTCGATCAGGCGCTCGATCTCGACCCT
GAAGCCCTCCCAGTCCCGTTGCAAGGCCTGGAACACACCGGCGCCGATGGCGGCCGCGCCGACATAGGTGCCG
GCCAGCGGGAAACCGGCCATTTCCGTCCATTCGGTGCGTTCGTCCATGTCCGCCAGCATTCCGGCGAGGTCCC
CACGGCTAGAGGCCGCATAGTGATCGCTGACGATCCGATAAGCGCTGCGCATCGTTGTCGCTCCGTAGCAGGG
CAGAGAGGTCCATGCTCCTCGCTGGCGGGAGCGGAGGCAAGCGCGGCGCGCCGACTTGTGTTGCCGCGACCTT
TTCTTACAAGGGCAAGCCGCCGGGGGTTACGCGCGTGCCGGCAAGTCTCTACCCTGAGCCGACCGGCGGGGTT
CGCCCGCCTGCTGCTCGGGATCAACAATGTATAAAGACCTCAAATTTCCCGTCCTCATCGTCCATCGCGACAT
CAAGGCCGACACCGTTGCCGGCGAACGCGTGCGGGGCATCGCCCACGAACTGGAGCAGGACGGCTTCAGCATT
CTCTCCACCGCCAGCTCCGCCGAGGGGCGCATCGTCGCTTCCACCCACCACGGCCTGGCCTGCATTCTGGTCG
CCGCCGAAGGTGCCGGGGAAAACCAGCGCCTGCTGCAGGATGTGGTCGAACTGATCCGCGTGGCCCGCGTGCG
GGCGCCGCAATTGCCGATCTTCGCCCTCGGCGAGCAGGTGACCATCGAGAACGCGCCGGCCGAGTCCATGGCC
GACCTGCACCAGTTGCGCGGCATCCTCTACCTGTTCGAAGACACCGTGCCGTTCCTCGCCCGCCAGGTCGCCC
GGGCGGCGCGCAACTACCTGGCCGGGCTGCTGCCGCCATTCTTCCGTGCGCTGGTCGAGCACACCGCGCAGTC
CAACTATTCCTGGCATACGCCGGGCCACGGCGGCGGTGTCGCCTATCGCAAGAGTCCGGTGGGACAGGCGTTC
CACCAGTTCTTCGGGGAGAACACGCTGCGTTCCGACCTGTCGGTCTCGGTCCCCGAGCTGGGATCGCTGCTCG
ACCATACCGGCCCCCTGGCCGAGGCCGAGGACCGTGCCGCGCGCAATTTCGGCGCCGACCATACCTTCTTCGT
GATCAATGGCACTTCCACCGCGAACAAGATCGTCTGGCACTCCATGGTCGGTCGCGAAGACCTGGTGCTGGTG
GACCGCAACTGCCACAAGTCGATCCTCCACTCGATCATCATGACCGGGGCGATACCGCTCTACCTGACTCCGG
AACGCAACGAACTGGGGATCATCGGGCCGATCCCGCTGAGCGAATTCAGCAAGCAGTCGATCGCCGCGAAGAT
CGCCGCCAGCCCGCTGGCGCGCGGCCGCGAGCCGAAGGTGAAGCTGGCGGTGGTGACTAACTCCACCTACGAC
GGCCTGTGCTACAACGCCGAGCTGATCAAGCAGACCCTCGGCGACAGCGTCGAGGTGTTGCACTTCGACGAGG
CTTGGTACGCCTATGCCGCGTTCCACGAGTTCTACGACGGACGCTATGGCATGGGCACCTCGCGCAGCGAGGA
GGGACCCCTGGTGTTCGCCACCCACTCCACGCACAAGATGCTCGCCGCCTTCAGCCAGGCCTCGATGATCCAC
GTGCAGGATGGCGGGACCCGGAAGCTGGACGTGGCGCGCTTCAACGAAGCCTTCATGATGCACATCTCGACCT
CGCCGCAGTACGGCATCATCGCTTCGCTGGACGTGGCTTCGGCGATGATGGAAGGGCCCGCCGGGCGTTCGCT
GATCCAGGAGACCTTCGACGAGGCCCTCAGCTTCCGCCGGGCCCTGGCCAACGTACGGCAGAACCTGGACCGG
AACGACTGGTGGTTCGGCGTCTGGCAGCCGGAGCAGGTGGAGGGCACCGACCAGGTCGGCACCCATGACTGGG
TGCTGGAGCCGAGCGCCGACTGGCACGGCTTCGGCGATATCGCCGAAGACTACGTGCTGCTCGACCCGATCAA
GGTCACCCTGACCACCCCGGGCCTGAGCGCTGGCGGCAAGCTCAGCGAGCAGGGGATTCCGGCCGCCATCGTC
AGCCGCTTCCTCTGGGAGCGCGGGCTGGTGGTGGAGAAAACCGGTCTCTACTCCTTCCTGGTGCTGTTCTCGA
TGGGCATCACCAAGGGCAAGTGGAGCACCCTGGTCACCGAACTGCTCGAATTCAAGCGCTGTTACGACGCCAA
CCTGCCGCTGCTTGACGTCTTGCCCTCCGTGGCCCAGGCCGGCGGCAAGCGCTACAACGGAGTGGGCCTGCGC
GACCTCAGCGACGCCATGCACGCCAGCTACCGCGACAACGCCACGGCGAAGGCCATGAAGCGCATGTACACGG
TGCTGCCGGAGGTCGCGATGCGGCCGTCCGAGGCCTACGACAAGCTGGTGCGCGGCGAGGTCGAGGCGGTACC
GATCGCTCGGTTGGAAGGGCGCATCGCGGCCGTCATGCTGGTACCCTATCCGCCGGGTATCCCGCTGATCATG
CCGGGTGAGCGCTTCACCGAGGCGACCCGCTCGATCCTCGACTATCTCGAGTTCGCGCGGACCTTCGAGCGCG
CCTTCCCTGGTTTCGACTCCGATGTGCATGGCCTGCAGCATCAGGACGGACCGTCCGGGCGCTGCTATACCGT
TGAATGCATAAAGGAATGA 
 
hypothetical protein ldcC 
 
Forward Primer 5’-CTTCAAGAATTCGGGTTACGCGCGTGCCGG-3’ 
Reverse primer:  5'-CTGATTACGTAGTCAAGAGAATGCTGAAGCCGTCCTG -3' 
 
Softberry analysis 
 Promoter Pos:   1878 LDF-  0.47 
-10 box at pos. 1863 ATGTATAAA Score 44 (part of gene start position also) 
-35 box at pos. 1844 CTGCTG    Score 12 
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LolB sequence 
LOCUS:       NC_002516      618 bp    DNA     linear 
DEFINITION:  Outer membrane lipoprotein lolB.  
>gi|110645304:5236774-5237391 
CACGCCTTGCTCGAACAGGTGGCGCGCGACCAGGGTGATGGTCTCGCCGGCGCCGATCAGCAGCGCCTGGCTG
CGGTGCAGGTCGCTGAAGATCTGCTTGGCCAGGCTCACCGCGGCGAACGCCACGGACACCGGGTTCTCGCCGA
TGGCGGTATCGGTGCGGACGGTCTTCGCCGTACTGAAGGTGGCCTGGAACAGGCGGCCGAGCAGCGGACCGAC
GGTGCCGGCCTCGCGCGCGACGGCGTAGGCCGACTTCATCTGGCCGAGGATCTGCGGCTCGCCGAGGACCATC
GAGTCGAGGCCGGAGGCCACGCGCATCATGTGGCGCACCGCGTCTTCGTCCTGGTGCACATAGGCACAGGCGC
GCAACTCGTCGAGAGTCAGGCGATGGTAGTCCGCCAGCCAGGCGAGCACGTCGTCCGCGGTCGGATGGTCGAT
CTCCAGGTAGAGTTCGCTCCGGTTGCAGGTCGACAGGATGGCCGCCTCGCGGCTGGTGGTCAGGCGGCAGAGC
TGCTGCAGCGCCTCGACCATCTGTTCCGGAGTGAAAGCCACGCGCTCGCGGACAGCCACCGAGGCGGTCTTGT
GATTGATGCCGAGGGCAATGAAGGCCATGCAGGATCGCTGAGCTAATCGGGGAAACGCGCAATTCTCCTACTT
CGCCAAGGGCAGGACAACCATTGCCGATGTATTGACCCCATAGACAGCTTCGTCGACGCCCGTCCCGGCCCCC
TTGGGCTTGCCGGACGGCTTATGTCATGATGGCGCCACCCTCGCAGGTTCAAGGCCGGCTTTCTTCCTCTATG
AACAAATCCCTTGCGCTGCTGACCGTCACGCTGCTGCTCGGCGGCTGCCAGTCACTTATCCACAAGACTCCCG
ATGGCACCCCGCCGGTGGAAGACACCGCGGTCGAGACCAAGGCCAAGCCGGAAAAGTACGGCTCCTTCAGCGA
GGACAGCCTGTATTCGCTGCTGGTGGCCGAACTGGCCGGGCAGCGCAACCGCTTCGACATCGCCCTGAGCAAC
TATGTGGTGCAGGCGCAGAAAACCCGCGACCCCGGGGTTTCCGAGCGCGCCTTCCGCATCGCCGAATACCTCG
GCGCCGACCAGGAAGCCCTCGACACCTCCCTGCTCTGGGCGCGCAGCGCGCCGGACAACCTCGATGCCCAACG
CGCCGCCGCGATCCAGTTGGCCCGCGCCGGGCGCTACGAGGAGTCCATGGTGTACATGGAGAAGGTCCTCAAC
GGCCAGGGCGACACGCACTTCGACTTCCTCGCCCTGTCTGCCGCGGAGACCGACCCGGATACCCGCGCCGGCC
TGCTGCAGAGCTTCGACCACCTGTTGAAGAAATACCCGAACAACGGCCAGTTGCTGTTCGGCAAGGCCCTGCT
GCTGCAACAGGACGGCCGCCCGGACGAAGCCCTGACCCTGCTCGAGGACAACTCCGCAAGCCGCCACGAAGTG
GCCCCCCTGCTGCTCCGCTCGCGCCTGTTGCAGAGCATGAAGCGCAGCGACGAGGCCCTGCCGCTGCTCAAGG
CCGGGATCAAGGAACACCCGGACGACAAGCGCGTGCGCCTCGCCTACGCGCGCCTGCTGGTGGAGCAGAACCG
CCTGGACGACGCCAAGGCCGAGTTCGCCGGACTGGTCCAGCAATTCCCCGACGACGACGACCTGCGTTTCTCC
CTGGCGCTGGTCTGCCTGGAAGCCCAGGCCTGGGACGAAGCCAGGATCTACCTGGAAGAACTGGTCGAGCGCG
ACAGCCACGTCGACGCCGCCCACTTCAACCTCGGCCGCCTCGCCGAGGAACAGAAGGACACCGCGCGTGCCCT
CGACGAGTACGCCCAGGTCGGCCCGGGCAATGACTTCCTCCCGGCGCAACTGCGCCAGACCGACGTCCTGCTC
AAGGCCGGTCGCGTCGACGAAGCCGCCCAGCGCCTGGACAAGGCGCGCAGCGAGCAACCCGACTACGCCATCC
AGCTGTACCTGATCGAAGCCGAGGCGCTGTCCAACAACGACCAGCAGGAAAAGGCCTGGCAGGCCATCCAGGA
GGGTCTGAAGCAGTACCCGGAGGACCTCAACCTGCTCTACACCCGCTCGATGCTGGCGGAGAAGCGCAACGAC
CTGGCGCAGATGGAAAAGGACCTGCGCTTCGTCATCGCCCGCGAGCCGGACAACGCCATGGCCCTCAACGCCC
TCGGCTACACCCTGGCCGACCGCACCACCCGCTACGGCGAGGCCCGCGAGCTGATCCTCAAGGCGCACAAGCT
GAACCCGGACGACCCGGCGATCCTCGACAGCATGGGCTGGATCAACTATCGCCAGGGCAAGCTGGCCGACGCC
GAGCGCTACCTGCGCCAGGCGCTGCAGCGCTACCCCGACCACGAGGTCGCCGCGCACCTGGGCGAAGTCCTCT
GGGCCCAGGGGCGCCAGGGCGACGCCCGGGCCATCTGGCGCGAATACCTCGACAAGCAGCCCGACAGCGACGT
GCTGCGCCGCACCATCAAGCGCCTGACCGGCGCCGAGACTCCTTGAAACCATGCGTCTACGTCTTTTCCTCGC
CGCCTCCGCGCTGGCCCTGCTCAGCGGCTGCGCCGGCCTGACCTCCCACGAAGCCCTGGAAGGCCAGGGCGAT
GCGCAGACCTGGAAAACCCACAAGCAGCAGCTCAGCGAGCTGGATGCCTGGCAGATCGACGGCAAGGTCGGCA
TCCGCGCCCCGCGCGACTCCGGCAGCGGCACCCTGTTCTGGCTGCAGCGCCAGGGCTACTACGACATCCGCCT
GTCCGGCCCGCTCGGCCGCGGCGCAGCACGCCTGACCGGGCGTGAAGGCGCGGTGAGCCTGGAAGTCGCCGGT
CAGGGCCGCTACCAGGCGGAGTCCCCGGAAGCACTGCTGGAAGAACAACTAGGCTGGCGCCTGCCGGTCTCGC
ACCTGCTCTGGTGGGTACGCGGCCTCCCGGCGCCGGACAGCAAGAGCCGCCTGACCCTCGACGCCGACAGCCG
CCTGGCGCGCCTGGAACAGGACGGCTGGCAGATCGAATACACCCGCTACGCCGAACAGAACGGCTACTGGCTA
CCCGAGCGCCTGAAGCTGCACGGCCAGGACCTCGACGTCACCCTGGTGATCAAGGACTGGCAGCCGCGCCAGC
TCGGCCGCTGA 
 
HemA Hypothetical protein lolB 
 
Forward primer         5’-CTTCAAGAATTCGTATTGACCCCATAGACAGCTTCG-3’ 
Reverse primer:  5'-GTGATTACGTAGTCAGCGCAAGGGATTTGTTCATA-3' 
 
Softberry analysis 
Promoter Pos:    235 LDF-  1.61 
 -10 box at pos.    220 TGTCATGAT Score    51 
 -35 box at pos.    200 TGGGCT    Score    -4 
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LysS sequence 
LOCUS       AE004091  1506 bp    DNA  
DEFINITION Lysyl-tRNA synthetase 
>gi|110645304:4140884-4142389  
GCTCGGCCAGCAGGTGCTCGCGGCGCTCGGTGAGCTGGACCTGGACATACTGCACGGCAAGCTCGACGATCCG
TTCCACCAGCGAGCCACGGGCGCCGGGGTCGTCGGCCAGCACCGCGGCCATCTCCTGGAGGTCGCCCTCCACG
CTGCTCCAGAACGCCGACAGCGCCTCTGCGTTGCGCTCGACGAAGAGGGCGAAGGTGTCGGTGATGAGATCGT
CGATGTCCTTGAAGTAGTAGGTGGTGGCCGACAACGGCACCTGGGCCTCGGCGGCCACCGCGCGGTGGCGCAC
GGCCCGTACGCCGTCGCGGACGATCAGGCGCATGGCGGCATCGAGAATCGCCTGGCGCCGCTGCTCGCTGCCC
TGGCGGCTGGCCTTGCGGCCCTGGTAACGAACGCTTTCGGCTACCGCGCTGGCGGCCTGCGCGGCGCTGTCTC
TGGGAGCTACTCGGGACACGGTGTTTCCTCCGCTCGCGGACGATGGGGCATTGTTCGGACTTTTTCGCGTGGA
ATCAATCGGCCGCTATCGGGGAAGCTCCGATCCCACCCGCACCTTCCGTGGTCAGCCGGCGGATCGGCGGCTA
TCGGCCCCTGGCCCGGCGGCCGGGACACCGCGCGGCCATGAAAAAACCGCCCGAAGGCGGCTTTTCCATGGAC
TGTTGCGGCGCTCAGGCCTGCGGGCGCATGTGCGGGAACAGGATCACGTCGCGGATCGACGGCGAGTTGGTCA
GCAGCATCACCAGGCGGTCGATGCCGATGCCTTCGCCGGCGGTCGGCGGCATGCCGTATTCCAGGGCATTGAT
GAAGTCGGCGTCGTAGTGCATCGCCTCGTCGTCGCCGGCGTCCTTCTCCTTGACCTGCAACATGAAGCGCTCG
GCCTGGTCCTCGGCGTCGTTCAGCTCGGAATAGGCATTGGCGATCTCGCGGCCGCCGATGAACAGCTCGAAGC
GGTCGGTGACGCTCGGGTCTTCGTCGTTGCGGCGGGCCAGCGGCGAAACCTCGAAGGGGTAGCGGGTGATGAA
GTGCGGCTGCTCCAGCTTGTGCTCCACCAGTTCCTCGAAAATCATCACCTGCAGCTTGCCCAGGCCTTCGTGG
CCGAGGACCTTGGCGCCGGCCTTCTTGGCGATGGCCCGCGCCTTCTCGACGTCGTTGAGGTCGGCGGCGGTGA
TCTCCGGGTTGTACTTGAGGATCGAATCGAACACCGACAGGCGCACGAACGGCTCGCCGAAGTGGAAGACCTT
GTCGCCGTAGGGCACGTCGGTGGTACCGAGTACCGACTGGGCCAGTTCGCGGAACAGTTCCTCGGTCAGGTCC
ATGTTGTCTTCGTAGTCGGCGTAGGCCTGGTAGAACTCGAGCATGGTGAACTCGGGGTTGTGCCGGGTCGAGA
CGCCTTCGTTACGGAAGTTGCGGTTGATCTCGAAGACCTTCTCGAAACCGCCGACCACCAGGCGCTTGAGGTA
CAGCTCCGGGGCGATGCGCAGGAACATGGCCATGTCCAGCGCGTTGTGATGGGTCTCGAACGGCTTGGCCGCG
GCGCCGCCGGGGATGGTCTGCAGCATCGGGGTCTCCACTTCGAGGAAACCGCGCTCGCTGAGGAAACGGCGGA
TGTGGGCGATGACCTGGGAACGCACGCGGAAGGTGTGGCGGGTTTCCTCGTTGACCATCAGGTCGACGTAGCG
CTGGCGGTAGCGCTGCTCGGTGTCGGTCAGGCCATGGTGCTTGTCCGGCAGCGGACGCAGCGACTTGGTCAGC
AGGCGCACGCTGGTCATGTCGACGTACAGGTCGCCCTTGCCCGAGCGGGCCAGCACGCCTTCGGCGCCGATGA
TGTCGCCCAGGTCCCAGGTCTTGATCTCGGCCAGGGTTTCTTCCGGCAGGGTCTTGCGGTTGACGTAGACCTG
CAGGCGCTCGCTGCTGTCCTGGAGGACGATGAAGGAACCGCGGTTGAGCATGATCCGACCGGCCACCTTGACC
GGGATCGCTGCGGCTTCCAGCTCTTCCTTGGTCTTGTCGGCGTACTGTTTCTGCAGGTCCGCGAAGTAGGCGT
CGCGGCGGAAGTCGTTGGGGAAGGCGATGGCCCGGGCTTCGCGCACGGCGGCAAGTTTTTCCTTGCGCTGGGC
GATCAGCTTGTTTTCTTCCTGTTGCAGTTCGTGCTGGTCGAGTTGTTGGTCGCTCAT 
 
 
Forward primer:  5’-CTTCAAGAATTCGCTGTCTCTGGGAGCTACTCG-3' 
Reverse primer: 5'-GTGATTACGTAGTCAGATAGCGGCCGATTGATTC-3' 
 
Softberry analysis 
Promoter Pos:    831 LDF-  0.47 
 -10 box at pos.    816 GGGCATTGT Score    27 
 -35 box at pos.    794 TTTCCT    Score    37 
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Spc sequence 
 
LOCUS       AE004091  1506 bp    DNA  
DEFINITION  spc ribosomal protein operon 
>gi|110227054: 4756935 to 4760468. 
TCAGTTACGGAACGGGAATTTGAAAGCACGCAGCAGGGCGCGACCTTCGTCATCCGTACGAGCGGTGGTGGTC
AGGGTGATGTCCAGGCCACGCAGCGCATCGATCTTGTCGTAATCGATTTCCGGGAAGATGATCTGCTCTTTCA
CGCCCATGCTGTAGTTGCCGCGACCATCGAAGGACTTGGCATTCAGGCCGCGGAAGTCACGCACGCGCGGCAG
GGAGATGGACAGCAGACGATCCAGGAACTCGTACATCCGGTCGCTACGCAGGGTGACCTTGACGCCGATCGGC
CAGCCTTCACGGATCTTGAAGCCTGCGATGGACTTACGAGCGTAAGTCACGACCGGCTTCTGACCAGTGATCT
TTTCCAGATCGGCTACGGCGTTCTCGATGATCTTCTTGTCACCGACCGCCTCGCCAAGACCCATGTTCAGGGT
GATTTTGGTAACGCGCGGAACTTCCATCACGTTCGCCAGCTGAAGCTCTTCTTTCAGCTTGGGCGCGATTTCC
TTCCGATAAATTTCTTTCAATCGTGCCATGGTGATCTACCTAGCAGCCTCAAGCCTGAACCGGTTTCTGGGTC
GACTTGAAGACACGAATTTTCTTACCGTCTTCTACCTTGAAGCCAACGCGGTCAGCCTTGCTGGTTTCAGTAT
TGAAGATGGCGACGTTGGAGACGTGCAGAGGCGCCTCCTTCTCGACGATACCGCCCTGTTGGCCGAGCATCGG
ATTGGGCTTGGTGTGGCGCTTGATCAGGTTCACCCCGCCGACGACCAGACGGTCGTCAGCGAGAACCTTCAGC
ACCTTGCCACGCTTGCCCTTGTCCTTGCCGGCAATGACGATTACTTCGTCGTCACGACGAATCTTTTGCATGA
CGGCTACTCCTTACAGCACTTCGGGGGCGAGCGAGACGATCTTCATGAACTTCTCGGTACGGAGTTCACGAGT
CACTGGCCCAAAGATACGGGTGCCGATCGGCTCCTGCTTGTTGTTCAGCAGGACGGCGGCGTTGCCGTCGAAG
CGGATGATGGAACCGTCGGTACGACGCACGCCGTGCTTGGTGCGAACGACCACGGCAGTCATGACCTGGCCCT
TCTTCACTTTGCCGCGCGGAATCGCTTCCTTGACGGTGACCTTGATGATGTCGCCGATGCCGGCGTAACGGCG
GTGGGAACCGCCGAGCACCTTGATGCACATCACACGACGCGCGCCGCTGTTGTCAGCGACATCGAGCATGGAT
TGAGTCTGAATCATATAATTTCTCCGACCCCTAGTCCTTAGACTTCCACCGCGCGTTCAACGATATCAACCAG
GGTCCAGGCCTTGGTCTTGGCCAGCGGACGGGTTTCGCGAATGGTGACCAGGTCACCAATGCGGCACTGATTG
GATTCGTCGTGTGCGTGCAGTTTGGTCGAACGCTTGACGTATTTGCCGTAGATCGGGTGCTTGACGCGACGCT
CGATCAGTACGGTGACGGTCTTGTCCATTTTGTCGCTGACGACGCGGCCGGTCAGCGTACGGACGGTTTTCTG
AGCTTCAGCCAT 
 
rplE rplX rplN rpsQ  
 
Forward primer:  5’-CTTCAAGAATTCGTAACGCGCGGAACTTCCATC-3' 
Reverse primer:  5'- CTCATTACGTAGTCAAGGTAGATCACCATGGCACGA -3' 
 
Softberry analysis 
Promoter Pos:   4976 LDF-  1.33 
 -10 box at pos.   4961 CGATAAATT Score    51 
 -35 box at pos.   4936 TTTCAG    Score    30 
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Tat sequence 
LOCUS       NC_002516      1488 bp    DNA     linear    
DEFINITION  Twin arginine translocase protein 
>gi|110645304:5706552-5708039 
GGCCGAGCGCGGCGTGGAGATCTTCTTCACCCAGGTGTTCCGCGACAGCTTTTTCCATGCCGACATGCACCCC
GGCAACATCTTCGTCAGCACCCGCGCGCCCTGGAGCCCGCAATACATCGCGGTGGACTGCGGCATCGTCGGCA
GCCTGACCGACGAGGACCAGGACTACCTGGCGCGCAACCTGATCGCCTTCTTCAAGCGCGACTACCGCAAGGT
CGCCCAACTGCATATCGACTCCGGCTGGGTACCGGCGGAAACCAAGGTCAACGACTTCGAGGCGGCGATCCGC
ACCGTCTGCGAACCGATCTTCGAGAAGCCGCTGAAGGACATCTCCTTCGGCCAGGTCCTGCTGCGCCTGTTCC
AGACCGCGCGCCGTTTCAACATGGAGATCCAGCCGCAACTGGTGTTGCTGCAGAAGACCCTGCTGAACATCGA
AGGCCTCGGCCGCCAGCTCTACCCGGAACTCGACCTGTGGGCCACCGCCCAGCCGTTCCTGGAGCGCTGGATG
CGCGAACGGGTCAGCCCGAAGCAGTTGCTGCGCAATTTCCAGCAACAGGTCGAGCAGGTGCCGCACCTGTCGC
AAATGGCCCGCGACACCCTCGAACGCCTGTCACAACCGCACGCCCACAATGCGCCGCCGCCGGAGTGGAAAGG
TTCCCGCCACGACTGGCTCGGGCGCCTGGTGGGCGCGGTGCTGCTGGTCGGCGCCGCCGAGGTCGGCCTGGGC
CAGCAGCTGGAAGCCTGGCCGGCGTGGGTGATGCTGGCCGGCGGGGTATTCCTGATCCTGCGCCGCTAGCGCC
GCGCACGGCCACTAGGCCCGCGCCGATAGCCAGTCGCGCTCCCGGCTGGCACACTACTCCCATTTCCGCCGGA
AACGCGCGCAACGTACCGGCAACGAACGTGGAAAGACCATGAAAGACTGGCTGGATGAGATTCACTGGAACGC
CGACGGCCTGGTCCCGGCGATCGCCCAGGATCACGAGACCGGGCGCGTGCTGATGATGGCCTGGATGAACCGC
GAGGCGCTGGCCCTGACCGCCAGCGAGAACCGTGCAATCTATTGGTCGCGTTCGCGTGGCAAGCTGTGGCGCA
AGGGCGAGGAGTCCGGGCACGTGCAGAAGCTGCACGAACTGCGTCTGGACTGCGACGCCGACGTGGTCATCCT
GATGGTCGAGCAGGTCGGCGGGATCGCCTGCCATACCGGCCGGGAAAGCTGTTTCTACCGCGTCTTCGAGAAC
GGCGCCTGGAAGACCGTCGATCCGGTGCTGAAGGACCCGGACGCTATCTACGAACACGCAGGACACCACCATG
AGTGACACCCTGACCCGCCTGGCGGCGGTGCTCGAGGAGCGCAAGAACGCCGCGCCCGACAGCTCCTACGTGG
CCAGTCTGTACCACAAAGGCCTGAACAAGATCCTGGAGAAGGTCGGCGAGGAGTCGGTGGAAACCATCATCGC
CGCCAAGGATGCCGCGGCCAGCGGCGACTGCCAGGACCTGATCTACGAAACCGCCGACCTCTGGTTCCACTCG
CTGGTGATGCTCTCGGCCCTCGGCCAGCATCCGCAAGCCGTGCTGGACGAACTGGAGCGCCGCTTCGGCCTTT
CCGGCCACGCCGAGAAAGCCGCCCGCCAACCATCGGCCTGAACCTACACATTGCGAGGAATACGACATGGGCA
TTTTTGACTGGAAACACTGGATCGTCATCCTGATCGTCGTGGTACTGGTGTTCGGCACCAAGCGCCTGAAGAA
CCTCGGTTCCGACGTCGGCGAAGCGATCAAGGGCTTCCGCAAGGCGGTGAACACCGAGGAAGACGACAAGAAG
GACCAGCCCGCCGCCCAGCCGGCCCAACCGCTGAACCAGCCGCACACCATCGACGCCCAGGCGCAGAAGGTCG
AAGAGCCGGCGCGCAAGGACTGACGGGTAGCCATCGATGTTCGGAATCAGCTTCAGCGAACTGTTGCTGGTCG
GGCTGGTCGCCCTGCTGGTGCTCGGCCCCGAGCGCCTGCCGGGCGCCGCACGTACCGCCGGCCTGTGGATCGG
CCGCCTGAAGCGCAGTTTCAATACCATCAAGCAGGAAGTGGAACGGGAAATCGGCGCGGACGAGATTCGCCGG
CAACTGCACAACGAGCACATCCTCTCGATGGAGCGCGAAGCGCAGAAGCTGCTGGCCCCGCTGACCGGCCAGA
ATCCCCCGCAGGAAACCCCGCCGCCGGCGGCCGAGAGCCCGGCGCCGAGCGTACCCACGCCGCCGCCGACCAG
CACGCCTGCGGTTCCGCCCGCGGACGCCGCGGCACCGCCGGCAGTCGCTGCCTCCACTCCCCCTTCGCCACCG
TCCGAGACGCCGCGTAATCCATGAGCGCCGATAAACCCGAGCAGCCTGAGCACGACCAGGAAATGCCCCTGGT
CTCGCACCTGACCGAACTGCGTACGCGCCTGCTGCGCAGCGTGGCGGCGATCTTCCTGATCTTCGCCGGCCTG
TTCTACTTCTCGCAGAAGATCTACACCCTGGTCTCCGAGCCGTTGCGCCGCTTCCTTCCGGAAGGCACCAGCA
TGATCGCCACCGACGTCGCCTCGCCGTTCCTCGCGCCGTTCAAGCTGACCATGGTGGTGGCGCTGTTCCTCGC
CATGCCGGTGATCCTCGCGCAGGTCTGGGGCTTCATCGCGCCCGGCCTGTACAAGCACGAGAAGCGCGTGGCG
CTGCCGCTGCTGGTGTCCAGCATCATCCTGTTCTACGCCGGGATGGCCTTCGCCTACTTCCTGGTGTTCCCGA
TGATCTTCCACTTCTTCGCCAGCGTGACGCCCGAGGGCGTGGCGATGATGACGGACATCAACAGCTACCTGGA
CTTCGTCCTGACTCTGTTCTTCGCCTTCGGCGTCGCCTTCGAGATCCCGGTGGCCACGGTGCTGCTGATCTGG
ATCGGAGTGGTCGACGTCGATTACCTGAAGAAGATCCGCCCGTACGTGATCATCGGCTGTTTCGTGGTCGGCA
TGGTCCTGACCCCGCCGGACATCTTCTCCCAGACCATGCTCGCGGTGCCGATGTGGCTGCTGTTCGAGATCGG
CCTGCTGTTCGGCCGCCTGGTACGCAAGCGCGGCGAGCATCCGGACGACCAACCGGCCAGCGACGGCGACCAG
CCTCCGGCCACCCGCCAGTGA 
 
UbiB HisI HisE tatA tatB tatC 
Forward primer  5’-CTTCAAGAATTCGGGGTATTCCTGATCCTGCGCCG-3' 
Reverse primer: 5'-GTGCATACGTAGTCAGGCGTTCCAGTGAATCTCATCCAG-3' 
 
Softberry analysis 
Promoter Pos:   2508 LDF-  1.09 
 -10 box at pos.   2493 TGGCACACT Score    42 
 -35 box at pos.   2473 TAGCCA    Score    24 
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Appendix 2: Promoter characterisation 
 
Table 7.1: Characterization of each of the genes (Price, Huang, Alm, & Arkin, 2005).  
Accession 
number 
Start 
position 
Stop 
position 
Strand Systematic 
name 
Gene 
name NCBI Description 
NP_250037.1 1461854 1460307 - PA1346  Arginine/lysine/ornithine 
decarboxylases 
NP_252390.1 4142389 4140884 - PA3700 lysS Lysyl-tRNA synthetase 
NP_252927.1 4754379 4753990 - PA4237 rplQ 50S ribosomal protein L17 
NP_252928.1 4755424 4754423 - PA4238 rpoA DNA-directed RNA polymerase, 
alpha subunit/40 kD subunit 
NP_252929.1 4756067 4755447 - PA4239 rpsD 30S ribosomal protein S4     
NP_252930.1 4756473 4756084 - PA4240 rpsK 30S ribosomal protein S11 
NP_252931.1 4756848 4756492 - PA4241 rpsM 30S ribosomal protein S13 
NP_252932.1 4757095 4756979 - PA4242 rpmJ 50S ribosomal protein L36 
NP_252933.1 4758452 4757124 - PA4243 secY preprotein translocase SecY 
NP_252934.1 4758887 4758453 - PA4244 rplO 50S ribosomal protein L15 
NP_252935.1 4759067 4758891 - PA4245 rpmD 50S ribosomal protein L30 
NP_252936.1 4759570 4759070 - PA4246 rpsE 30S ribosomal protein S5 
NP_252937.1 4759924 4759574 - PA4247 rplR 50S ribosomal protein L18 
NP_252938.1 4760468 4759935 - PA4248 rplF 50S ribosomal protein L6 
NP_252939.1 4760872 4760480 - PA4249 rpsH 30S ribosomal protein S8 
NP_252940.1 4761367 4761062 - PA4250 rpsN 30S ribosomal protein S14 
NP_252941.1 4761920 4761381 - PA4251 rplE 50S ribosomal protein L5 
NP_252942.1 4762254 4761940 - PA4252 rplX 50S ribosomal protein L24   
NP_252943.1 4762635 4762267 - PA4253 rplN 50S ribosomal protein L14 
NP_252944.1 4762925 4762659 - PA4254 rpsQ 30S ribosomal protein S17 
NP_252945.1 4763119 4762928 - PA4255 rpmC 50S ribosomal protein L29 
NP_252946.1 4763532 4763119 - PA4256 rplP 50S ribosomal protein L16 
NP_252947.1 4764230 4763544 - PA4257 rpsC 30S ribosomal protein S3 
NP_252948.1 4764575 4764243 - PA4258 rplV 50S ribosomal protein L22 
NP_252949.1 4764863 4764588 - PA4259 rpsS 30S ribosomal protein S19 
NP_252950.1 4765701 4764880 - PA4260 rplB 50S ribosomal protein L2 
NP_252951.1 4766012 4765713 - PA4261 rplW 50S ribosomal protein L23 
NP_252952.1 4766611 4766009 - PA4262 rplD 50S ribosomal protein L4 
NP_252953.1 4767260 4766625 - PA4263 rplC 50S ribosomal protein L3 
NP_252954.1 4767654 4767343 - PA4264 rpsJ 30S ribosomal protein S10 
NP_252955.1 4769004 4767811 - PA4265 tufA Translocation elongation factor Tu 
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NP_252956.1 4771155 4769035 - PA4266 fusA1 Translocation elongation factor G 
NP_252957.1 4771656 4771186 - PA4267 rpsG 30S ribosomal protein S7 
NP_252958.1 4772127 4771756 - PA4268 rpsL 30S ribosomal protein S12 
NP_252959.1 4776478 4772279 - PA4269 rpoC DNA-directed RNA polymerase, 
beta' subunit/160 kD subunit 
NP_252960.1 4780617 4776544 - PA4270 rpoB DNA-directed RNA polymerase, 
beta subunit/140 kD subunit 
NP_252961.1 4781207 4780839 - PA4271 rplL 50S ribosomal protein L7/L12 
NP_252962.1 4781786 4781286 - PA4272 rplJ 50S ribosomal protein L10 
NP_252963.1 4782680 4781985 - PA4273 rplA 50S ribosomal protein L1 
NP_252964.1 4783111 4782680 - PA4274 rplK 50S ribosomal protein L11 
NP_253357.1 5236774 5237391 + PA4668 lolB outer membrane lipoprotein LolB 
precursor 
NP_253755.1 5706552 5706800 + PA5068 tatA twin arginine translocase protein A 
NP_253756.1 5706814 5707239 + PA5069 tatB sec-independent translocase 
NP_253757.1 5707236 5708039 + PA5070 tatC transport protein TatC 
List of relevant genes with their start and stop positions, transcription strand, name and 
description are indicated. 
 
 
Table 7.2: Operon prediction (Price, Huang, Alm, & Arkin, 2005).  
SysName 1 SysName2 Name1 Name2 bOp pOp Sep 
PA1346 PA1347 
 
ldcC FALSE 0.121 84 
PA3699 PA3700 
 
lysS FALSE 0.065 212 
PA3700 PA3701 lysS prfB TRUE 0.773 181 
PA4236 PA4237 katA rplQ FALSE 0.011 282 
PA4237 PA4238 rplQ rpoA TRUE 0.92 44 
PA4238 PA4239 rpoA rpsD TRUE 0.599 23 
PA4239 PA4240 rpsD rpsK TRUE 0.977 17 
PA4240 PA4241 rpsK rpsM TRUE 0.996 19 
PA4241 PA4242 rpsM rpmJ TRUE 0.866 131 
PA4242 PA4243 rpmJ secY TRUE 0.662 29 
PA4243 PA4244 secY rplO TRUE 0.991 1 
PA4244 PA4245 rplO rpmD TRUE 0.999 4 
PA4245 PA4246 rpmD rpsE TRUE 0.999 3 
PA4246 PA4247 rpsE rplR TRUE 0.999 4 
PA4247 PA4248 rplR rplF TRUE 0.998 11 
PA4248 PA4249 rplF rpsH TRUE 0.998 12 
PA4249 PA4250 rpsH rpsN TRUE 0.871 190 
PA4250 PA4251 rpsN rplE TRUE 0.995 14 
PA4251 PA4252 rplE rplX TRUE 0.996 20 
PA4252 PA4253 rplX rplN TRUE 0.997 13 
PA4253 PA4254 rplN rpsQ TRUE 0.995 24 
PA4254 PA4255 rpsQ rpmC TRUE 0.999 3 
PA4255 PA4256 rpmC rplP TRUE 0.999 0 
PA4256 PA4257 rplP rpsC TRUE 0.998 12 
PA4257 PA4258 rpsC rplV TRUE 0.997 13 
PA4258 PA4259 rplV rpsS TRUE 0.997 13 
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PA4259 PA4260 rpsS rplB TRUE 0.996 17 
PA4260 PA4261 rplB rplW TRUE 0.998 12 
PA4261 PA4262 rplW rplD TRUE 1 -3 
PA4262 PA4263 rplD rplC TRUE 0.997 14 
PA4263 PA4264 rplC rpsJ TRUE 0.976 83 
PA4264 PA4265 rpsJ tufA TRUE 0.745 157 
PA4265 PA4266 tufA fusA1 TRUE 0.986 31 
PA4266 PA4267 fusA1 rpsG TRUE 0.946 31 
PA4267 PA4268 rpsG rpsL TRUE 0.979 100 
PA4268 PA4269 rpsL rpoC FALSE 0.331 152 
PA4269 PA4270 rpoC rpoB TRUE 0.991 66 
PA4270 PA4270.1 rpoB 
 
FALSE 0.065 151 
PA4667 PA4668 
 
lolB TRUE 0.95 5 
PA4668 PA4669 lolB ipk TRUE 0.972 2 
PA5065 PA5066 ubiB hisI FALSE 0.204 116 
PA5066 PA5067 hisI hisE TRUE 0.999 -7 
PA5067 PA5068 hisE tatA TRUE 0.638 26 
PA5068 PA5069 tatA tatB TRUE 0.976 14 
PA5069 PA5070 tatB tatC TRUE 0.997 -3 
PA5070 PA5071 tatC 
 
TRUE 0.949 -3 
Name 1 and 2 indicate the first and second genes in the pair. bOp refers to the prediction 
whether the pair lies in the same operon. pOp is the probability of the pair lying in the 
same operon. Values near 1 or 0 are confident predictions of being in the same operon 
or not, while values near 0.5 are low-confidence predictions. Sep indicates the distance 
between the two genes in the pair. 
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Appendix 3: Expected sizes of PCR products 
 
ldcC – 225 bases PCR product 
5’CTTCAAGAATTCGGGTTACGCGCGTGCCGGCAAGTCTCTACCCTGAGCCGACCGGCGGGGTTC
GCCCGCCTGCTGCTCGGGATCAACAATGTATAAAGACCTCAAATTTCCCGTCCTCATCGTCCATC
GCGACATCAAGGCCGACACCGTTGCCGGCGAACGCGTGCGGGGCATCGCCCACGAACTGGAGCAG
GACGGCTTCAGCATTCT TGACTACGTAATCAC-3’ 
 
lpp – 161 bases PCR product 
5’CTTCAAGAATTCGTATTGACCCCATAGACAGCTTCGTCGACGCCCGTCCCGGCCCCCTTGGGC
TTGCCGGACGGCTTATGTCATGATGGCGCCACCCTCGCAGGTTCAAGGCCGGCTTTCTTCCTCTA
TGAACAAATCCCTTGCGCTGACTACGTAATCAC-3’ 
 
lysS – 125bases PCR product 
5’CTTCAAGAATTCGCTGTCTCTGGGAGCTACTCGGGACACGGTGTTTCCTCCGCTCGCGGACGA
TGGGGCATTGTTCGGACTTTTTCGCGTGGAATCAATCGGCCGCTATCTGACTACGTAATCAC-3’ 
 
 
tat – 206 bases PCR product 
5’CTTCAAGAATTCGGGGTATTCCTGATCCTGCGCCGCTAGCGCCGCGCACGGCCACTAGGCCCG
CGCCGATAGCCAGTCGCGCTCCCGGCTGGCACACTACTCCCATTTCCGCCGGAAACGCGCGCAAC
GTACCGGCAACGAACGTGGAAAGACCATGAAAGACTGGCTGGATGAGATTCACTGGAACGCCGTG
ACCTACGTATGCAC-3’ 
 
 
spc – 134 bases PCR product 
5’CTTCAAGAATTCGTAACGCGCGGAACTTCCATCACGTTCGCCAGCTGAAGCTCTTCTTTCAGC
TTGGGCGCGATTTCCTTCCGATAAATTTCTTTCAATCGTGCCATGGTGATCTACCTTGACGTCGA
CATCAG-3’ 
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Appendix 4: Optimisation of PCR conditions 
and restriction of DNA 
 
 
 
 
 
 
 
 
 
 
 
 
___________________________________________________________ 
Figure 7.1: Agarose gel electrophoretic analysis of PCR reactions for Ptat. 
The reactions were performed at various magnesium chloride concentrations of 0.25mM 
(lanes 1-4) and 0.75mM (lanes 5-8). The reactions were also performed at various 
annealing temperatures of 53
o
C (lane 1, 5), 56
o
C (lane 2, 6), 58
o
C (lane 3, 7) and 60
o
C 
(lane 4, 8). 
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Figure 7.2: Agarose gel electrophoretic analysis of PCR reactions for Ptat 
and Plpp. PCR reactions for Ptat and Plpp are represented in lanes 1-8 and 9-24 
respectively. The reactions were performed at various magnesium chloride 
concentrations of 0.25mM (lanes 9-12), 0.75mM (lanes 13-16), 1mM (lanes 1-4, 17-20) 
and 1.5mM (lanes 5-8, 21-24). The reactions were also performed at various annealing 
temperatures of 53
o
C (lane 1, 5), 56
o
C (lane 2, 6), 58
o
C (lane 3, 7) and 60
o
C (lane 4, 8) 
for Ptat, and 48
o
C (lane 9, 13, 17, 21), 50
o
C (lane 10, 14, 18, 22), 52
o
C (lane 11, 15, 19, 
23) and 54
o
C (lane 12, 16, 20, 24) respectively for Plpp.  
 
 
 
 
 
 
 
 
___________________________________________________________ 
Figure 7.3: Agarose gel electrophoretic analysis of PCR reactions for PldcC. 
The reactions were performed at various magnesium chloride concentrations of 0.75mM 
(lanes 1-4), 1mM (lanes 5-8) and 1.5mM (lanes 9-12). The reactions were also performed 
at various annealing temperatures of 50
o
C (lane 1, 5, 9, 13), 52
o
C (lane 2, 6, 10, 14), 
54
o
C (lane 3, 7, 11, 15) and 56
o
C (lane 4, 8, 12, 16). 
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Figure 7.4: Agarose gel electrophoretic analysis of PCR reactions for PldcC. 
The reactions were performed at magnesium chloride concentrations of 0.75mM (lanes 
1-3), 1mM (lanes 4-6) and 1.5mM (lanes 7);and annealing temperatures of 50
o
C (lane 1, 
4, 7), 52
o
C (lane 2, 5) and 54
o
C (lane 3, 6). 
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Figure 7.5: Agarose gel electrophoretic analysis of PCR reactions for Ptat. 
The reactions were performed at various magnesium chloride concentrations of 1mM 
(lanes 1- 10) and 1.5mM (lanes 11- 20). The reactions were also performed at various 
annealing temperatures of 53
o
C (lane 1, 11), 54
o
C (lane 2, 12), 56
o
C (lane 3, 13), 58
o
C 
(lane 4, 14), 60
o
C (lane 5, 15), 62
o
C (lane 6, 16), 64
o
C (lane 7, 17), 66
o
C (lane 8, 18), 
68
o
C (lane 9, 19) and 70
o
C (lane 10, 20). 
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Figure 7.6: Agarose gel electrophoretic analysis of PCR reactions for Pspc. 
The reactions were performed at various magnesium chloride concentrations of 0.75mM 
(lanes 1-5), 1mM (lanes 6-10) and 1.5mM (lanes 11-15). The reactions were also 
performed at various annealing temperatures of 50
o
C (lane 1, 6, 11), 52
o
C (lane 2, 7, 12), 
54
o
C (lane 3, 8, 13), 56
o
C (lane 4, 9, 14) and 58
o
C (lane 5, 10, 15). 
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Figure 7.7: Agarose gel electrophoretic analysis of PCR reactions for PlysS. 
The reactions were performed at various magnesium chloride concentrations and 
annealing temperatures. Gel A represents reactions performed using magnesium 
chloride concentrations of 0.75mM (lanes 1-5), 1mM (lanes 6-10) and 1.5mM (lanes 11-
15), and annealing temperatures of 50
o
C (lane 1, 6, 11), 52
o
C (lane 2, 7, 12), 54
o
C (lane 
3, 8, 13), 56
o
C (lane 4, 9, 14) and 58
o
C (lane 5, 10, 15). Gel B represents reactions 
performed using magnesium chloride concentrations of 0.75mM (lanes 1-5), 1mM (lanes 
6-10) and 1.5mM (lanes 11-15), and annealing temperatures of 56
o
C (lane 1, 6, 11), 
58
o
C (lane 2, 7, 12), 60
o
C (lane 3, 8, 13), 62
o
C (lane 4, 9, 14) and 64
o
C (lane 5, 10, 15). 
Gel C represents reactions performed using magnesium chloride concentrations of 1mM 
(lanes 1-5) at various annealing temperatures of 62
o
C (lane 1), 64
o
C (lane 2), 66
o
C (lane 
3), 68
o
C (lane 4) and 70
o
C (lane 5). Gel D represents reactions performed using 
magnesium chloride concentrations of 1mM (lanes 1-5) at various annealing 
temperatures of 68
o
C (lane 1), 70
o
C (lane 2), 72
o
C (lane 3) and 74
o
C (lane 4). Gel E 
represents reactions performed using magnesium chloride concentrations of 0.75mM 
(lanes 1-4) and 1.5mM (lanes 5-8), and annealing temperatures of 66
o
C (lane 1, 5), 68
o
C 
(lane 2, 6), 70
o
C (lane 3, 7) and 72
o
C (lane 4, 8). 
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Figure 7.8: Agarose gel electrophoretic analysis for restriction of plasmids 
pBR322 and pSB417. Undigested and digested plasmid pBR322 are represented in 
lanes 1 and 2 respectively. Undigested and digested plasmid pSB417 are represented in 
lanes 3 and 4 respectively. 
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Figure 7.9: Agarose gel electrophoretic analysis for restriction of plasmids 
pBR322, pSB417 and pBR322-lux. Plasmid pSB417 digested with SalI and PstI in 
two separate reactions are represented in lane 1 and 2 respectively. Double digestion of 
plasmid pBR322-lux with SalI and PstI is represented in lanes 3. Undigested plasmid 
pBR322-lux is represented in lane 4. Plasmid pSB417 digested with EcoRI and BamHI in 
a double digest is represented in lane 5 while plasmid pBR322 digested in the same 
manner is represented in lane 6. Restriction digests were performed for 30 minutes. 
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Figure 7.10: Agarose gel electrophoretic analysis for restriction of plasmid 
pSB417. Figure A: Undigested plasmid pSB417 is represented in lane 2 and 5. Plasmid 
pSB417 digested with SalI is represented in lane 2 and subsequently digested with PstI 
is represented in lane 3. Plasmid pSB417 digested with PstI is represented in lane 4. 
Figure B: A double digest of plasmid pSB417 with SalI and XbaI is represented in lane 1. 
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Figure 7.11: Agarose gel electrophoretic analysis for restriction of the 
promoterless plasmid pBR322-lux. Double digest of the plasmid with EcoRI and 
BamHI is represented in lanes 1 and 2. Undigested plasmid is represented in lane 3. 
Plasmid digested with SnaBI is represented in lane 1 of figure B. 
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Figure 7.12: Confirmative agarose gel electrophoretic analysis for 
restriction of the promoterless plasmid pBR322-lux. A: Undigested plasmid is 
represented in lane 1 and 3. Plasmid digested with SnaBI and EcoRI is represented in 
lane 2 and 4 respectively. B: Undigested plasmid represented in lane 1. Successive 
digestions of plasmid with SnaBI first and then EcoRI is represented in lanes 2 and 3 
respectively. C: Undigested plasmid is represented in lane 1. Double digest of the 
plasmid with EcoRI and SnaBI is represented in lane 2. 
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Appendix 5: Expected DNA sequence of 
promoterless pME-lux 
 
cctctcaggcgccgctggtgccgctggttggacgccaagggtgaatccgcctcgataccctgattactcgcttcctgcgccctctcaggcgg
cgataggggactggtaaaacggggattgcccagacgcctcccccgccccttcaggggcacaaatgcggccccaacggggccacgtag
tggtgcgttttttgcgtttccacccttttcttccttttcccttttaaaccttttaggacgtctacaggccacgtaatccgtggcctgtagagtttaaaaag
ggacggatttgttgccattaagggacggatttgttgttaagaagggacggatttgttgttgtaaagggacggatttgttgtattgtgggacgcag
atacagtgtccccttatacacaaggaatgtcgaacgtggcctcacccccaatggtttacaaaagcaatgccctggtcgaggccgcgtatcg
cctcagtgttcaggaacagcggatcgttctggcctgtattagccaggtgaagaggagcgagcctgtcaccgatgaagtgatgtattcagtg
acggcggaggacatagcgacgatggcgggtgtccctatcgaatcttcctacaaccagctcaaagaagcggccctgcgcctgaaacggc
gggaagtccggttaacccaagagcccaatggcaaggggaaaagaccgagtgtgatgattaccggctgggtgcaaacaatcatctaccg
ggagggtgagggccgtgtagaactcaggttcaccaaagacatgctgccgtacctgacggaactcaccaaacagttcaccaaatacgcct
tggctgacgtggccaagatggacagcacccacgcgatcaggctttacgagctgctcatgcaatgggacagcatcggccagcgcgaaat
agaaattgaccagctgcgaaagtggtttcaactggaaggccggtatccctcgatcaaggacttcaagttgcgagtgcttgatccagccgtg
acgcagatcaacgagcacagcccgctacaggtggagtgggcgcagcgaaagaccgggcgcaaggtcacacatctgttgttcagttttg
gaccgaagaagcccgccaaggcggtgggtaaggccccagcgaagcgcaaggccgggaagatttcagatgctgagatcgcgaaaca
ggctcgccctggtgagacatgggaagcggcccgcgctcgactaacccagatgccgctggatctggcctagaggccgtggccaccacgg
cccggcctgcctttcaggctgcgcaactgttgggaagggcgatcggtgcgggcctcttcgctattacgccagctggcgaaagggggatgtg
ctgcaaggcgattaagttgggtaacgccagggttttcccagtcacgacgttgtaaaacgacggccagtgaattgtccattttagcctccttag
ctcctgaaaatctcgtcgaagctcggcggatttgtcctactcaagcttggctgcaggtcgacgGATCCGTCGACCTGCAGGTC
ATCAACTATCAAACGCTTCGGTTAAGCTTAAAGCACACCCTTTCTGCGTCCTCGTATTGACGCG
ACGTAAAATTTCAACGAGCACGCCGGGATACTTACCATATTCTCTGCTAATTATCCCGACATCA
TCGGTAACAATAAATGCTGGATAACTGGTTGCTGACGCATCCATATAACTCATCAACCCCGGC
GTTCCATCAGGTACAGGTTTCAACGTTTCAGGATCAAGCGCTCGCGCATATACCCACGGCGG
AACATGTTTACGCTGCATTTCATCCTCAAAGAAACAAGTGTTGAGTTCAACTTGATTAAATATAT
CTCGGATCTGACTAATATCACTGAGATTGAAAGTATCAAATAAAAGATGATTGAAATCATCACG
TTTCAGAGATTCTTTTTCGTAACTTTTCCAGCCGCCTCCGGTTATGATATAAAGGCTTTTATCTC
CAGAAAATGAGATTTTTTTATCTTTCATATAATGGCAGAGTAAATAAATAAAGTATGGCGAACCA
ATAAGACAAAGATCTTTCCCTTGATTTTTTATTCGTTCAAGACTATTCAATGTTTTAACAAAATCT
ATTCGTTCTTCTGTTACGGTAAATGTCGTAGGATATAACAATTCCACCAAACTCATAACATATTT
AAACCAAATATTATGAGCATTAAATCTATCTGGTCCCAAATTGACTAATTCTATTTGATGATCAA
ACCAACTACCAACATATTTCATGCCATAACTCACAGAGCCTAAGAGTCTCTCAATACTTAATCT
GTCACGCGCCACCTGACTTTTTAAACCATTCGTGCCGCTACTGGTAAACCAACTTTCAATCTCG
TTTTCCTGAGAAGTTAATAAGCGAGTAAACTTAAAAACCGATGTTGGGAATACAGGTATGTCAT
CAATTTCCGTAATATTGTCATCTACTTTGTGTGCCTGACAGTAGTGACGATATTCTCGACAATG
TTTATAATGATTACGAAATGCATCAAGCACAAGTTTCTTTCTGATTTTTTCCTGCTCGTCGTAAG
ACCACACTAATGGATCGCTCGAAAAAATCAAATCATCAATTTCTGAGCTTGCTGTAATTTCTTGT
TTATCAACATATGAAGTCATACCTGTTTTACTCCTCAAGATAATATTAGAAAGTATGGCAGCACT
GCTGTCATACTCTTTTATACCCTTCATCTTTCAAGCTGCTGCTTTGTTGGCTGCTTTCACTCACC
CCAGTCACATAGTTATCTATGCTCCTGGGGATTCGTTCACTTGCCGCCTCGCTGCAACTCGAA
ATCTATTAGGTATATTCCATGTGGTACTTCTTAATATTATCATCAACAATATTGATTACATTTTTT
TGGCTCATCAAATCATTCATTGGTTCAAAGGACAGCAATACACTTTTCGCACCACACTTTTCAA
TTGCCAACTTAGCCGCAGTTATACACTCCGTATAATTTCCGACAGCGTTTTCTGCAATTATTTCT
TCAAGTTTATTTTCGAAATTTTCATTAGGGTGCATTTCAAGAACATAATCACTAATAAATGCACG
CGTCTCTTGTTTAGCTTTATTACTATCTTCGTTATAGTTAACTAATATCATTAACTGATGGTCTAT
CTCTGATAGGTCAACGTCATATTTATCCGCAACGGCTTTATATCTTTCAGCATATTCATATCTAA
CATCATTAGAATCATCCCACTTAAAGATGAGAGGAATACCTTTTTTGGCCGCCCACTCAACAAT
ATGATGACTGGTTGCTGTTACATATTTCCGAGGTCCGCCTGGCGTATAAGCATGGGGATTTAC
AGATATTTTAGGGAAGCTATAAAAATCGTTATCTGGATTACAATAGCCTGTTGTTAAAGCATCG
TTAATGATTTCATAACACTCTTCAAATAGTTGCTGTTGATATTCAACCGGGCGATTAAAAAAATG
CATTTCATCTTTTTTTTCGCAATCACTAAACCCTAAAATAAATCTCCCTTCACTTAACTGATCCAA
TAAGCAAGCTTCCTCCGCTATGGCGACAGGATGATGAGTTGTAATGATGTGATTTAATGAACC
AATTTTAATTTTCTCTGTTAAACCGAGCAGAAAACCAGAAACAGTCAGAGGAGCGCCGACAAC
ACCATTATCTGAAAAATGATTTTCATACACTAAAATCTGTTCAAAATTCAACTTATCAACATACTC
CGTTATTTCCTGCATGCGAACTATACTTTGTTCTTGAACAGTTGTTGAATTGATGAAGTTAAGG
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AAGAACAATCCAAATTTCATTTCTTTCTCCTTAGCTAATATAATAGCGAACGTTGTTTTTCTTTAA
GAAATGGCATGACATCAGACTGGAAGAGCTTCATGGAAGCAATAATTTCGTCTACTGTTCCATT
AGCTTCAAATCCACAACAAATATTTGATATTCCTGTAGCATCAATGTCTTTTTGAATTATGTCAA
TACATTCCTGCGGCGTTCCCACGGGATTGATTTCGTAACTGTAATCAATACGGCGATTAGTATC
TTTATGTCCTTTTAATACAAAGTCACGCCACTGCCCTTTATTGAAATCATAACCTCTTGTTTGGT
CTGAATCATCAAAAATAGTCGTAGCATTCACATAAGAATCATACCAATGCCCCAGAAATTTCCG
GCAAATCTCTTTCGCTTTAATTGAGTCATGATCTACAGATGTTATATATGATAAGCAATGGTCGA
TATTATGAATATCGTGCCCATATTCTTGAGCCACTTCATTATAAAGCTCAAGTTGTGCTTTCTTT
TCGTTAGTATTTATAATCCAACTTAATATCATCGGTAGGCCAAATTGAGCAGCCCACTCAGTCG
TCGAAGCTGATTCAGCCACCACATAAACCGGTGCGCCACCTCTGCTATACGCCGCGGGGTTT
ACTTTTACCTTATGGAACTTGATATGTTCATTATCAGCTTCCATATATCCCTCTGTCATGCCATT
CTTTATCAGCCCGTACCAGCATTCCGCTAAGGCGCGACTGTTATTCATATCTGTGCCGAATAC
GCGAAAGTCCTTGTTGTAAAGCCCTCGGCAAATACCAAACCGAAATCGTCCTTTTGACATTTGA
TCCAATAAATTCACATCTTCAAGTTGGCGTACTGGATGGGCTGTGGGAAGAACAATAGCGGCA
GTTCCTACATTCAATTTTTTAGTCGCGCCAAGTAAATATGCAGCAGCGACATAAGGGTTACCAA
GCAAACCAAACTCCGTGAAATGATGCTCCAGTAACCATACGGTATCAAAACCACACTCCTCAG
AGATGCGACCTAATTTAACCAAACGTTTCATTACCTCTGTTTGAGAAAATTGGGGAGGTTGGTA
TGTAAGCAAAAAGTTTCCAAATTTCATAGAGAGTCCTTATATTGCTATTTGAGTGATAGAATATC
TCAATAGATTTTAAGACAGAGAAATTGCTTGATTTTCAATCTCAATTCTCATTCGGCGTTCATTG
ACTGTCGCAATAGTTAAATGTTCAAATGACGGTTCAGTAATATCAACATCAATATCCAGATGAT
CATTATCCATCGCGATAGCGGCTTTCGTAACCGATTGATAAAAATTGCGCAGGACCACTAAATT
TTCACTCAAGTCATGCGAACTTCCTAACAAAGAATATATCTTGCATCGATTACTACGAATATTTG
ATAACAATGTGATAACTTCATCTTGCTTGACCCAATTATCGTTATTTGCAGTAAAAGCAATAAAC
GGTATATCAAGATACATCATGTTATTAATTGTAGAAGCTAAATCTTCCCAACCAAAATCAAGACA
ATCTCTCGCAAAGACTTCAGCACCCAATTTATGGCCTTCAAAATCTAGATTATCCGGCAATTCA
TTAATGGGTAGACTGAGATAATCAAACCCTAAAGCTCTTTCAAGAGAATATCTTAAGTTAACAA
CACCGACTGCGGTGATTAAAAACGAAGCATTGATTTCAGATAGGCTTGCATAAGCTATCCGCG
CAGATAAGCTTGAAGCCAACATACCGAAGTTATTTATTTTTCGTGTAGTTAACCAATCAACCAC
TGCTAACAAGCTCTGCTTTCCTATAGACATTGTAAATTCATCAATTGTCCCTGAACTCAATCCAA
CGTGGTGAAGCGAATCATAGCGGATCACATGAAATCCATTCCGCGATAAATATTCCGCCAGAC
CAGCAAAATGATCCATCCTGCGGGCAAAACCAGACGCAATAATAATGGCATTCTTTCTCTTTG
GGCTGTTTTCTTCTGGCAGCGTTTCCCAAACATGAATTTTTTTATTTCCTTCAACACAAATAACG
TGGTCGATGGTTTTATATTTTGATTCATTTTCCATACTTTTACCTATTATGGGACAAATACAAGG
AACTTATCTTCTTCCAGGAATCGAGTCTGTTCTATTTCAACCGCAACATCCTTAGCCGTATAGT
TAGATGGCCTTTCATGAGAAATATATGTCACTAATCGTTGCAACGGTCTCATTCCGTCATGAGA
TCCACCAACTCGAAATATGTTATTCATTCCTGCTTCTACAATCCTTTCCGCACCTTTTAATGCTA
ACGCATCTCGATATTTAAATGATGACTCCCAAGGAAAAATAGATATGGTTTGCGTCTTATTTTTT
TGAACATAAGGCAATATTTGCTCAATATTATCGACGTGATGAAGGTACACACATCTGCCAAGTG
GTTGATTAAATTCCACACCTGCATTTGACTCAATAATCATCCAACGTTGATGAATATCCACCTCT
ACTTTTAATCCAGCAAACAAGCTTTCTTTTTGAACTAAAGAATAGGCCGCCTTTTCATCAAAATC
TTTTTTGGCATTCGGTAATATATGCGCATATAGATTAAGTTTTTCTATCAACGCTAACTTAAATT
CCTCATAATGATTTCCCATGTAATATATGTTTTGGGCAGAAAAACAAGCTCGCTGATCGTAAAA
ACAAACATCATGAGCCGCACCTGTCGCTGCGGACGTCAAATCAACAGGATTATCGATAATGCA
AAGACTCTTTTTAGAACCAAATTTAATCACATCAGCATAAGATGGCGCATGCTCTACCGCCCAA
TTAATCGCATCTGGCCCTCCCCAAGCGACAATAACATCCGCATGTCGCATAATTTCTTTTGCGA
GTGATGTATCACCTTGGTGGGGCCAATATATAACAGATAAAGAGCGCGTTATCGGATGATTAG
GGTCTACATCAATAAAACTTAACGCTAATGCATTAGCGGTAAAAGGATCGGTTGACGATGTTTT
TATAATACACTGATTCTTAGTTAAAATTGCGCGTAATATAGACATGATCCCAGATAATGGAACAT
TACCTGCCAACAGATGTACAGATTTACCTTTCGGAAAAGCCCGAACATAACTTTCATCCTGAGG
TAGCCATTCATCCATGATATGGCGAGAACCAAGTTCATTTTCTACAACATCATAAAGGCCGCCT
TTAGAACATAAAATCATAGATATCCAATTGGCCTCTAGCTTAGCCATTTCTTCTGAATATCCCAT
ATATTTTTTTAAGTCACGAATGTATGTCCTGCGTCTTGAGTATTCTTCATTTTTCCATCTTTGCC
CTACCGTATAGAGAAAATTGACAATGTTATGCAACCGTAATTCGTTATTTCCATTACAATCAATA
ATGTTTTTTACATGAGAGTCATTCAATATTGGCAGGTAAACACTATTATCACCAAAATTAATGGA
TTGCACTAAATCATCACTTTCGGGAAAGATTTCAACCTGGCCGTTAATAATGAATGAAATTTTTT
TAGTCATACGTATCCTCCAAGCCTGaattcctggcagtttatggcgggcgtcctgcccgccaccctccgggccgttgcttcg
caacgttcaaatccgctcccggcggatttgtcctactcaggacagcgttcaccgacaaacaacagataaaacgaaaggcccagtctttcg
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actgagcctttcgttttatttgatgcctggggcttcctcgctcactgactcgctgcgctcggtcgttcggctgcggcgagcggtatcagctcactc
aaaggcggtaatacggttatccacagaatcaggggataacgcaggaaagaacatgtgagcaaaaggccagcaaaaggccaggaac
cgtaaaaaggccgcgttgctggcgtttttccataggctccgcccccctgacgagcatcacaaaaatcgacgctcaagtcagaggtggcga
aacccgacaggactataaagataccaggcgtttccccctggaagctccctcgtgcgctctcctgttccgaccctgccgcttaccggatacct
gtccgcctttctcccttcgggaagcgtggcgctttctcatagctcacgctgtaggtatctcagttcggtgtaggtcgttcgctccaagctgggctg
tgtgcacgaaccccccgttcagcccgaccgctgcgccttatccggtaactatcgtcttgagtccaacccggtaagacacgacttatcgccac
tggcagcagccactggtaacaggattagcagagcgaggtatgtaggcggtgctacagagttcttgaagtggtggcctaactacggctaca
ctagaaggacagtatttggtatctgcgctctgctgaagccagttaccttcggaaaaagagttggtagctcttgatccggcaaacaaaccacc
gctggtagcggtggtttttttgtttgcaagcagcagattacgcgcagaaaaaaaggatctcaagaagatcctttgatcttttctacggggtctga
cgctcagtggaacgaaaactcacgttaagggattttggtcatgagattatcaaaaaggatcttcacctagatccttttaaattaaaaatgaagt
tttaaatcaatctaaagtatatatgagtaaacttggtctgacagttaccaatgcttaatcagtgaggcacctatctcagcgatctgtctatttcgtt
catccatagttgcctgactccccgtcgtgtagataactacgatacgggagggcttaccatctggccccagtgctgcaatgataccgcgaga
cccacgctcaccggctccagatttatcagcaataaaccagccagccggaagggccgagcgcagaagtggtcctgcaactttatccgcct
ccatccagtctattaattgttgccgggaagctagagtaagtagttcgccagttaatagtttgcgcaacgttgttgccattgctacaggcatcgtg
gtgtcacgctcgtcgtttggtatggcttcattcagctccggttcccaacgatcaaggcgagttacatgatcccccatgttgtgcaaaaaagcgg
ttagctccttcggtcctccgatcgttgtcagaagtaagttggccgcagtgttatcactcatggttatggcagcactgcataattctcttactgtcat
gccatccgtaagatgcttttctgtgactggtgagtcgaattggccgcggcgttgtgacaatttaccgaacaactccgcggccgggaagccg
atctcggcttgaacgaattgttaggtggcggtacttgggtcgatatcaaagtgcatcacttcttcccgtatgcccaactttgtatagagagccac
tgcgggatcgtcaccgtaatctgcttgcacgtagatcacataagcaccaagcgcgttggcctcatgcttgaggagattgatgagcgcggtg
gcaatgccctgcctccggtgctcgccggagactgcgagatcatagatatagatctcactacgcggctgctcaaacctgggcagaacgtaa
gccgcgagagcgccaacaaccgcttcttggtcgaaggcagcaagcgcgatgaatgtcttactacggagcaagttcccgaggtaatcgg
agtccggctgatgttgggagtaggtggctacgtctccgaactcacgaccgaaaagatcaagagcagcccgcatggatttgacttggtcag
ggccgagcctacatgtgcgaatgatgcccatacttgagccacctaactttgttttagggcgactgccctgctgcgtaacatcgttgctgctgcg
taacatcgttgctgctccataacatcaaacatcgacccacggcgtaacgcgcttgctgcttggatgcccgaggcatagactgtacaaaaaa
acagtcataacaagccatgaaaaccgccactgcgccgttaccaccgctgcgttcggtcaaggttctggaccagttgcgtgagcgcatacg
ctacttgcattacagtttacgaaccgaacaggcttatgtcaattcg 
 
Replication protein 
LacZ  gene  RBS for LacZ gene 
Multiple cloning site (pUCP24); EcoRI-SmaI-BamHI-SalI-PstI-HindIII 
rrnB terminator 
Gentamicin resistance gene  RBS for gentamicin resistance gene 
 
Upper case: Lux cassette 
Lower case: pME4510 plasmid 
 
LuxE  LuxB  LuxA LuxD LuxC 
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Appendix 6: DNA sequencing of constructs in 
E. coli. 
Promoterless pME-lux sequence (EcoRI and SnaBI junction) 
AnGaaTtGAatgTTatGCaCCGTAaTTCGTTATTTCCATTACAATCAATAATGTTTTTTACATGAgannccnnnnnann
ngGCAGGTAAACACTATTATCACCAAAATTAATGGATTGCACTAAATCATCACCTTCGGGAAAGATTTCAACC
TGGCCGTTAATAATGAATGAAATTTTTTTAGTCATACGTATCCTCCAAGCCTGAATTCCTGGCAGTTTATGG
CGGGCGTCCTGCCCGCCACCCTCCGGGCCGTTGCTTCGCAACGTTCAAATCCGCTCCCGGCGGATTTGT
CCTACTCAGGAGAGCGTTCACCGACAAACAACAGATAAAACGAAAGGCCCAGTCTTTCGACTGAGCCTTTC
GTTTTATTTGATGCCTGGGGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCG
GTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGT
GAGCAAAAGGCCAGCAAAAGG 
 
Promoterless pME-lux sequence (BamHI junction) 
tncgGaAntTGTCCTACTCaggCTTGGGCTGCAgGTCGAcgGATCcgTCGACCTGCAgGcCccnnnnnannnaaACG
CtTCGGTTAAGCtTAAAGCACACcCTTTCTGcGTCCTcgTATTGACGCGACGTAAAATTTCAACGAGCACGCC
GGGATACTTACCATATTCTCTGCTAATTATCCCGACATCATCGGTAACAATAAATGCTGGATAACTGGTTGC
TGACGCATCCATATAACTCATCAACCCCGGCGTTCCATCAGGTACAGGTTTCAACGTTTCAGGATCAAGCG
CTCGCGCATATACCCACGGCGGAACATGTTTACGCTGCATTTCATCCTCAAAGAAACAAGTGTTGAGTTCA
ACTTGATTAAATATATCTCGGATCTGACTAATATCACTGAGATTGAAAGTATCAAATAAAAGATGATTGAAAT
CATCACGTTTCAGAGATTCTTTTTCGTAACTTTTCCAGCCGCCTCCGGTTATGATATAAAGGCTTTTATCTCC
AGAAAATGAGATTTTTTTATCTTTCATATAATGGCAGAGTAAATAAATAAAGTATGGCGAACCAATAAGACAA
AGATCTTTCCCTTGATTTTTTATTCGTTCAAGACTATTCAATgTTTTTAanaaAATCTATTcggttcTTCTgntacgggt
AAATGTCGnaaggATATAA 
 
Spc3-pME-lux sequence (EcoRI and SnaBI junction) 
GanTtGaATGTTatgCaCCGTAaTTCGTTATTTCcaTTACAATCAATAATGTTTTTTACAtgnanncCCnnnnnnaannn
ggCAGGTAAACACTATTATCACCAAAATTAATggaTTGCACTAAATCATCACCTTCGGGAAAGATTTCAACCT
GGCCGTTAATAATGAATGAAATTTTTTTAGTCATACGTAGTCAGGTAGATCACCATGGCACGATTGAAAGAA
ATTTATCGGAAGGAAATCGCGCCCAAGCTGAAAGAAGAGCTTCAGCTGGCGAACGTGATGGAAGTTCCGC
GCGTTACGAATTCCTGGCAGTTTATGGCGGGCGTCCTGCCCGCCACCCTCCGGGCCGTTGCTTCGCAAC
GTTCAAATCCGCTCCCGGCGGATTTGTCCTACTCAGGAGAGCGTTCACCGACAAACAACAGATAAAACGAA
AGGCCCAGTCTTTCGACTGAGCCTTTCGTTTTATTTGATGCCTGGGGCTTCCTCGCTCACTGACTCGCTGC
GCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATC
AGGGGATAACGCAGG 
 
Spc5-pME-lux sequence (EcoRI and SnaBI junction) 
TgaatgTTnngcaCCGTAaTTCGTTATTtCCATTACAATCAATAATGTTTTTTACATGAGngccnnnnnnaaannngCAG
GTAAACACTATTATCACCAAAATTAATggaTTGCACTAAATCATCACCTTCGGGAAAGATTTCAACCTGGCCG
TTAATAATGAATGAAATTTTTTTAGTCATACGTAGTCAGGTAGATCACCATGGCACGATTGAAAGAAATTTAT
CGGAAGGAAATCGCGCCCAAGCTGAAAGAAGAGCTTCAGCTGGCGAACGTGATGGAAGTTCCGCGCGTT
ACGAATTCCTGGCAGTTTATGGCGGGCGTCCTGCCCGCCACCCTCCGGGCCGTTGCTTCGCAACGTTCAA
ATCCGCTCCCGGCGGATTTGTCCTACTCAGGAGAGCGTTCACCGACAAACAACAGATAAAACGAAAGGCC
CAGTCTTTCGACTGAGCCTTTCGTTTTATTTGATGCCTGGGGCTTCCTCGCTCACTGACTCGCTGCGCTCG
GTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGG
GATAACGCaggAAAGA 
 
Spc9-pME-lux sequence (EcoRI and SnaBI junction) 
CnngtTaTGCaCcgTAaTTCGTTATTtCCATTACAATCAATAATGTTTTTTACATGagagCCCnnnnnnaaanngGCAG
GTAAACACTATTATCACCAAAATTAATggaTTGCACTAAATCATCACCTTCGGGAAAGATTTCAACCTGGCCG
TTAATAATGAATGAAATTTTTTTAGTCATACGTAGTCAAGGTAGATCACCATGGCACGATTGAAAGAAATTTA
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TCGGAAGGAAATCGCGCCCAAGCTGAAAGAAGAGCTTCAGCTGGCGAACGTGATGGAAGTTCCGCGCGTT
ACGAATTCCTGGCAGTTTATGGCGGGCGTCCTGCCCGCCACCCTCCGGGCCGTTGCTTCGCAACGTTCAA
ATCCGCTCCCGGCGGATTTGTCCTACTCAGGAGAGCGTTCACCGACAAACAACAGATAAAACGAAAGGCC
CAGTCTTTCGACTGAGCCTTTCGTTTTATTTGATGCCTGGGGCTTCCTCGCTCACTGACTCGCTGCGCTCG
GTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATAnggTTATCCACAGAATCAGGGG
GATAACGcagGAAAG 
LdcC8-pME-lux sequence (EcoRI and SnaBI junction) 
GaatGaCatgTTatGCaCCGTAaTTCGTTATTTCCATTACAATCAATAATGTTTTTTACATGagancCCnnnnnnnnnn
ngCAGGTAAACACtatTATCACCAAAATTAATggaTTGCACTAAATCATCACCTTCGGGAAAGATTTCAACCTG
GCCGTTAATAATGAATGAAATTTTTTTAGTCATACGTAGTCAAGAGAATGCTGAAGCCGTCCTGCTCCAGCT
CGTGGGCGATGCCCCGCACGCGTTCGCCGGCAACGGTGTCGGCCTTGATGTCGCGATGGACGATGAGGA
CGGGAAATTTGAGGTCTTTATACATTGTTGATCCCGAGCAGCAGGCGGGCGAACCCCGCCGGTGGGCTCA
GGGTAGAGAGTTGCCGGCACGCGCGTAACCCGAATTCCTGGCAGTTTATGGCGGGCGTCCTGCCCGCCA
CCCTCCGGGCCGTTGCTTCGCAACGTTCAAATCCGCTCCCGGCGGATTTGTCCTACTCAGGAGAGCGTTC
ACCGACAAACAACAGATAAAACGAAAGGCCCAGTCTTTCGACTGAGCCTTTCGTTTTATTTGATGCCTGGG
GCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGG
CGGTAATA 
 
LdcC4b-pME-lux sequence (EcoRI and SnaBI junction) 
GanTtGAatgntTGCaCCGTAaTTCGTTATTTCcaTTACAATCAATAATGTTTTTTACATGAganncnnnnnnannnGG
CAGGTAAACACTAtTATCACCAAAATTAATGGATTGCACTAAATCATCACCTTCGGGAAAGATTTCAACCTGG
CCGTTAATAATGAATGAAATTTTTTTAGTCATACGTAGTCAAGAGAATGCTGAAGCCGTCCTGCTCCAGCTC
GTGGGCGATGCCCCGCACGCGTTCGCCGGCAACGGTGTCGGCCTTGATGTCGCGATGGACGATGAGGAC
GGGAAATTTGAGGTCTTTATACATTGTTGATCCCGAGCAGCAGGCGGGCGAACCCCGCCGGTGGGCTCAG
GGTAGAGAGTTGCCGGCACGCGCGTAACCCGAATTCCTGGCAGTTTATGGCGGGCGTCCTGCCCGCCAC
CCTCCGGGCCGTTGCTTCGCAACGTTCAAATCCGCTCCCGGCGGATTTGTCCTACTCAGGAGAGCGTTCA
CCGACAAACAACAGATAAAACGAAAGGCCCAGTCTTTCGACTGAGCCTTTCGTTTTATTTGATGCCTGGGG
CTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGC
GGTAATA 
 
Lys2-pME-lux sequence (EcoRI and SnaBI junction) 
TtGCaccgTatTCGnttTTCATTacaTCAATAATGTTTTttnATGAgannccnnnnnannngGCAGGTAAACACTATTATCA
CCAAAATTAATgGATTGCACTAAATCATCACCTTCGGGAAAGATTtCAACCTGGCCGTTAATAATGAATGAAA
TTTTTTTAGTCATACGTAGTCAGATAGCGGCCGATTGATTCCACGCGAAAAAGCCCGAACAATGCCCCATC
GTCCGCGAGCGGAGGAAACACCGTGCCCCGAGTAGCTCCCAGAGACAGCGAATTCCTGGCAGTTTATGG
CGGGCGTCCTGCCCGCCACCCTCCGGGCCGTTGCTTCGCAACGTTCAAATCCGCTCCCGGCGGATTTGT
CCTACTCAGGAGAGCGTTCACCGACAAACAACAGATAAAACGAAAGGCCCAGTCTTTCGACTGAGCCTTTC
GTTTTATTTGATGCCTGGGGCtTCCTCGCTCaCTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCG
GtATCAGCTCACTcnaAGGCGGTa 
 
Lys3-pME-lux sequence (EcoRI and SnaBI junction) 
ATtnnCaTGTtaTggCACCGTAaTTCGTTATTTCcATTACAATCAATAATGTTTTTTACATGagnncncnnnnnnaannt
gGCAGGTAAACACTAtTATCACCAAAATTAATggaTTGCACTAAATCATCACCTTCGGGAAAGATTTCAACCTG
GCCGTTAATAATGAATGAAATTTTTTTAGTCATACGTAGTCAGATAGCGGCCGATTGATTCCACGCGAAAAA
GCCCGAACAATGCCCCATCGTCCGCGAGCGGAGGAAACACCGTGCCCCGAGTAGCTCCCAGAGACAGCG
AATTCCTGGCAGTTTATGGCGGGCGTCCTGCCCGCCACCCTCCGGGCCGTTGCTTCGCAACGTTCAAATC
CGCTCCCGGCGGATTTGTCCTACTCAGGAGAGCGTTCACCGACAAACAACAGATAAAACGAAAGGCCCAG
TCTTTCGACTGAGCCTTTCGTTTTATTTGATGCCTGGGGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTC
GTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATA
ACGCAGGAAAGAA 
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Lys6-pME-lux sequence (EcoRI and SnaBI junction) 
GgaatGAaTgnttGCaCCGTAaTTCGTTATTTCCATTACAATCAATAATGTTTTTTACATGAGagCCCnnnnnnaann
gGCAGGTAAACACTATTATCACCAAAATTAATGGATTGCACTAAATCATCACCTTCGGGAAAGATTTCAACC
TGGCCGTTAATAATGAATGAAATTTTTTTAGTCATACGTAGTCAGATAGCGGCCGATTGATTCCACGCGAAA
AAGCCCGAACAATGCCCCATCGTCCGCGAGCGGAGGAAACACCGTGCCCCGAGTAGCTCCCAGAGACAG
CGAATTCCTGGCAGTTTATGGCGGGCGTCCTGCCCGCCACCCTCCGGGCCGTTGCTTCGCAACGTTCAAA
TCCGCTCCCGGCGGATTTGTCCTACTCAGGAGAGCGTTCACCGACAAACAACAGATAAAACGAAAGGCCC
AGTCTTTCGACTGAGCCTTTCGTTTTATTTGATGCCTGGGGCTTCCTCGCTCACTGACTCGCTGCGCTCGG
TCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGA
TAACGCAGGAAAGA 
 
Lpp4-pME-lux sequence (EcoRI and SnaBI junction) 
GgnaTtGAaTGtttGCaCCGTaATTCGTTATTtCCATTACAATCAATAATGTTTTTTACATGAGagcccnnnnnnaannn
GCAGGTAAACACTATTATCACCAAAATTAATGGATTGCACTAAATCATCACCTTCGGGAAAGATTTCAACCT
GGCCGTTAATAATGAATGAAATTTTTTTAGTCATACGTAGTCAGCGCAAGGGATTTGTTCATAGAGGAAGAA
AGCCGGCCTTGAACCTGCGAGGGTGGCGTCATCATGACATAAGCCGTCCGGCAAGCCCAAGGGGGCCGG
GACGGGGCGTCGACGAAGCTGTCTATGGGGTCAATACGAATTCCTGGCAGTTTATGGCGGGCGTCCTGC
CCGCCACCCTCCGGGCCGTTGCTTCGCAACGTTCAAATCCGCTCCCGGCGGATTTGTCCTACTCAGGAGA
GCGTTCACCGACAAACAACAGATAAAACGAAAGGCCCAGTCTTTCGACTGAGCCTTTCGTTTTATTTGATG
CCTGGGGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCAC
TCAAAGGCGGTAATA 
 
Lpp8-pME-lux sequence (EcoRI and SnaBI junction) 
GGnaTtGaCaTGtTatGCaCCGTAaTTCGTTATTTCcaTTACAATCAATAATGTTTTTTACATGagcnnncnnnnnaann
gGCAGGtAAACACTAttaTCACCAAAATTAATgGATTGCACTAAATCATCACCTTCGGGAAAGATTTCAACCTG
GCCGTTAATAATGAATGAAATTTTTTTAGTCATACGTAGTCAGCGCAAGGGATTTGTTCATAGAGGAAGAAA
GCCGGCCTTGAACCTGCGAGGGTGGCGTCATCATGACATAAGCCGTCCGGCAAGCCCAAGGGGGCCGG
GACGGGGCGTCGACGAAGCTGTCTATGGGGTCAATACGAATTCCTGGCAGTTTATGGCGGGCGTCCTGC
CCGCCACCCTCCGGGCCGTTGCTTCGCAACGTTCAAATCCGCTCCCGGCGGATTTGTCCTACTCAGGAGA
GCGTTCACCGACAAACAACAGATAAAACGAAAGGCCCAGTCTTTCGACTGAGCCTTTCGTTTTATTTGATG
CCTGGGGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCAC
TCAAAGGCGGTAATAC 
 
Tat9-pME-lux sequence (EcoRI and SnaBI junction) 
AnGnaTtGaaTgttaTGCaCCGTaATTCGTTATTTCCATTACAATCAATAATGTTTTTTACATGanancnnnnnnnnnnn
nngCAGGTAAACACTATTAtCACCAAAATTAATggaTTGCACTAAATCATCACCTTCGGGAAAGATTTCAACCT
GGCCGTTAATAATGAATGAAATTTTTTTAGTCATACGTAGTCAGGCGTTCCAGTGAATCTCATCCAGCCAGT
CTTTCATGGTCTTTCCACGTTCGTTGCCGGTGCGTTGCCCGCGTTTCCGGCGGAAATAGGGGTAGTGTGC
CAGCCGTGGACGCGACTGGCTATCGGCGCAGGATCAGGAATACCCCGAATTCCTGGCAGTTTATGGCGG
GCGTCCTGCCCGCCACCCTCCGGGCCGTTGCTTCGCAACGTTCAAATCCGCTCCCGGCGGATTTGTCCTA
CTCAGGAGAGCGTTCACCGACAAACAACAGATAAAACGAAAGGCCCAGTCTTTCGACTGAGCCTTTCGTTT
TATTTGATGCCTGGGGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTAT
CAGCTCACTCAAAG 
 
Tat12-pME-lux sequence (EcoRI and SnaBI junction) 
TnntTatGCaccggTAATTCGTTATTTCCaTTACAATCAATAAtggTTTTTTACATGAgngcCcnnnnnnaannnngCAGG
TAAACACTAtTATCACCAAAATTAATgncATTGCACTAAATCATCACCTTCGGGAAAGATTTCAACCTGGCCGT
TAATAATGAATGAAATTTTTTTAGTCATACGTAGTCAGGCGTTCCAGTGAATCTCATCCAGGTGCATACGTA
GTCAGGCGTTCCAGTGAATCTCATCCAGCCAGTCTTTCATGGTCTTTCCACGTTCGTTGCCGGTGCGTTGC
CCGCGTTTCCGGCGGAAATAGGGGTAGTGTGCCAGCCGTGGACGCGACTGGCTATCGGCGCAGGATCAG
GAATACCCCGAATTCCTGGCAGTTTATGGCGGGCGTCCTGCCCGCCACCCTCCGGGCCGTTGCTTCGCAA
CGTTCAAATCCGCTCCCGGCGGATTTGTCCTACTCAGGAGAGCGTTCACCGACAAACAACAGATAAAACGA
AAGGCCCAGTCTTTCGACTGAGCCTTTCGTTTTATTTGATGCCTGGGGCTTCCTCGCTCACTGACTCGCTG
CGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAAT
CAGGGG 
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Appendix 7: Sequences of all plasmids in P. 
aeruginosa 
 
pME-lux plasmid 
CCTCTCAGGCGCCGCTGGTGCCGCTGGTTGGACGCCAAGGGTGAATCCGCCTCGATACCCTGATTACTCGCTTCCTGCGCCCTCTCAGGCGGCGATAGGGGACTGGTAAAACGGGGATTGCCCAGACGCCTCCCCCGCCCC
TTCAGGGGCACAAATGCGGCCCCAACGGGGCCACGTAGTGGTGCGTTTTTTGCGTTTCCACCCTTTTCTTCCTTTTCCCTTTTAAACCTTTTAGGACGTCTACAGGCCACGTAATCCGTGGCCTGTAGAGTTTAAAAAGGGAC
GGATTTGTTGCCATTAAGGGACGGATTTGTTGTTAAGAAGGGACGGATTTGTTGTTGTAAAGGGACGGATTTGTTGTATTGTGGGACGCAGATACAGTGTCCCCTTATACACAAGGAATGTCGAACGTGGCCTCACCCCCA
ATGGTTTACAAAAGCAATGCCCTGGTCGAGGCCGCGTATCGCCTCAGTGTTCAGGAACAGCGGATCGTTCTGGCCTGTATTAGCCAGGTGAAGAGGAGCGAGCCTGTCACCGATGAAGTGATGTATTCAGTGACGGCGGA
GGACATAGCGACGATGGCGGGTGTCCCTATCGAATCTTCCTACAACCAGCTCAAAGAAGCGGCCCTGCGCCTGAAACGGCGGGAAGTCCGGTTAACCCAAGAGCCCAATGGCAAGGGGAAAAGACCGAGTGTGATGATT
ACCGGCTGGGTGCAAACAATCATCTACCGGGAGGGTGAGGGCCGTGTAGAACTCAGGTTCACCAAAGACATGCTGCCGTACCTGACGGAACTCACCAAACAGTTCACCAAATACGCCTTGGCTGACGTGGCCAAGATGGA
CAGCACCCACGCGATCAGGCTTTACGAGCTGCTCATGCAATGGGACAGCATCGGCCAGCGCGAAATAGAAATTGACCAGCTGCGAAAGTGGTTTCAACTGGAAGGCCGGTATCCCTCGATCAAGGACTTCAAGTTGCGAG
TGCTTGATCCAGCCGTGACGCAGATCAACGAGCACAGCCCGCTACAGGTGGAGTGGGCGCAGCGAAAGACCGGGCGCAAGGTCACACATCTGTTGTTCAGTTTTGGACCGAAGAAGCCCGCCAAGGCGGTGGGTAAGG
CCCCAGCGAAGCGCAAGGCCGGGAAGATTTCAGATGCTGAGATCGCGAAACAGGCTCGCCCTGGTGAGACATGGGAAGCGGCCCGCGCTCGACTAACCCAGATGCCGCTGGATCTGGCCTAGAGGCCGTGGCCACCAC
GGCCCGGCCTGCCTTTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACG
ACGTTGTAAAACGACGGCCAGTGAATTGTCCATTTTAGCCTCCTTAGCTCCTGAAAATCTCGTCGAAGCTCGGCGGATTTGTCCTACTCAAGCTTGGCTGCAGGTCGACGGATCCGTCGACCTGCAGGTCATCAACTATCAA
ACGCTTCGGTTAAGCTTAAAGCACACCCTTTCTGCGTCCTCGTATTGACGCGACGTAAAATTTCAACGAGCACGCCGGGATACTTACCATATTCTCTGCTAATTATCCCGACATCATCGGTAACAATAAATGCTGGATAACTG
GTTGCTGACGCATCCATATAACTCATCAACCCCGGCGTTCCATCAGGTACAGGTTTCAACGTTTCAGGATCAAGCGCTCGCGCATATACCCACGGCGGAACATGTTTACGCTGCATTTCATCCTCAAAGAAACAAGTGTTGA
GTTCAACTTGATTAAATATATCTCGGATCTGACTAATATCACTGAGATTGAAAGTATCAAATAAAAGATGATTGAAATCATCACGTTTCAGAGATTCTTTTTCGTAACTTTTCCAGCCGCCTCCGGTTATGATATAAAGGCTTT
TATCTCCAGAAAATGAGATTTTTTTATCTTTCATATAATGGCAGAGTAAATAAATAAAGTATGGCGAACCAATAAGACAAAGATCTTTCCCTTGATTTTTTATTCGTTCAAGACTATTCAATGTTTTAACAAAATCTATTCGTTC
TTCTGTTACGGTAAATGTCGTAGGATATAACAATTCCACCAAACTCATAACATATTTAAACCAAATATTATGAGCATTAAATCTATCTGGTCCCAAATTGACTAATTCTATTTGATGATCAAACCAACTACCAACATATTTCATG
CCATAACTCACAGAGCCTAAGAGTCTCTCAATACTTAATCTGTCACGCGCCACCTGACTTTTTAAACCATTCGTGCCGCTACTGGTAAACCAACTTTCAATCTCGTTTTCCTGAGAAGTTAATAAGCGAGTAAACTTAAAAACC
GATGTTGGGAATACAGGTATGTCATCAATTTCCGTAATATTGTCATCTACTTTGTGTGCCTGACAGTAGTGACGATATTCTCGACAATGTTTATAATGATTACGAAATGCATCAAGCACAAGTTTCTTTCTGATTTTTTCCTGC
TCGTCGTAAGACCACACTAATGGATCGCTCGAAAAAATCAAATCATCAATTTCTGAGCTTGCTGTAATTTCTTGTTTATCAACATATGAAGTCATACCTGTTTTACTCCTCAAGATAATATTAGAAAGTATGGCAGCACTGCTG
TCATACTCTTTTATACCCTTCATCTTTCAAGCTGCTGCTTTGTTGGCTGCTTTCACTCACCCCAGTCACATAGTTATCTATGCTCCTGGGGATTCGTTCACTTGCCGCCTCGCTGCAACTCGAAATCTATTAGGTATATTCCATGT
GGTACTTCTTAATATTATCATCAACAATATTGATTACATTTTTTTGGCTCATCAAATCATTCATTGGTTCAAAGGACAGCAATACACTTTTCGCACCACACTTTTCAATTGCCAACTTAGCCGCAGTTATACACTCCGTATAATTT
CCGACAGCGTTTTCTGCAATTATTTCTTCAAGTTTATTTTCGAAATTTTCATTAGGGTGCATTTCAAGAACATAATCACTAATAAATGCACGCGTCTCTTGTTTAGCTTTATTACTATCTTCGTTATAGTTAACTAATATCATTAA
CTGATGGTCTATCTCTGATAGGTCAACGTCATATTTATCCGCAACGGCTTTATATCTTTCAGCATATTCATATCTAACATCATTAGAATCATCCCACTTAAAGATGAGAGGAATACCTTTTTTGGCCGCCCACTCAACAATATG
ATGACTGGTTGCTGTTACATATTTCCGAGGTCCGCCTGGCGTATAAGCATGGGGATTTACAGATATTTTAGGGAAGCTATAAAAATCGTTATCTGGATTACAATAGCCTGTTGTTAAAGCATCGTTAATGATTTCATAACACT
CTTCAAATAGTTGCTGTTGATATTCAACCGGGCGATTAAAAAAATGCATTTCATCTTTTTTTTCGCAATCACTAAACCCTAAAATAAATCTCCCTTCACTTAACTGATCCAATAAGCAAGCTTCCTCCGCTATGGCGACAGGAT
GATGAGTTGTAATGATGTGATTTAATGAACCAATTTTAATTTTCTCTGTTAAACCGAGCAGAAAACCAGAAACAGTCAGAGGAGCGCCGACAACACCATTATCTGAAAAATGATTTTCATACACTAAAATCTGTTCAAAATTC
AACTTATCAACATACTCCGTTATTTCCTGCATGCGAACTATACTTTGTTCTTGAACAGTTGTTGAATTGATGAAGTTAAGGAAGAACAATCCAAATTTCATTTCTTTCTCCTTAGCTAATATAATAGCGAACGTTGTTTTTCTTTA
AGAAATGGCATGACATCAGACTGGAAGAGCTTCATGGAAGCAATAATTTCGTCTACTGTTCCATTAGCTTCAAATCCACAACAAATATTTGATATTCCTGTAGCATCAATGTCTTTTTGAATTATGTCAATACATTCCTGCGGC
GTTCCCACGGGATTGATTTCGTAACTGTAATCAATACGGCGATTAGTATCTTTATGTCCTTTTAATACAAAGTCACGCCACTGCCCTTTATTGAAATCATAACCTCTTGTTTGGTCTGAATCATCAAAAATAGTCGTAGCATTCA
CATAAGAATCATACCAATGCCCCAGAAATTTCCGGCAAATCTCTTTCGCTTTAATTGAGTCATGATCTACAGATGTTATATATGATAAGCAATGGTCGATATTATGAATATCGTGCCCATATTCTTGAGCCACTTCATTATAAA
GCTCAAGTTGTGCTTTCTTTTCGTTAGTATTTATAATCCAACTTAATATCATCGGTAGGCCAAATTGAGCAGCCCACTCAGTCGTCGAAGCTGATTCAGCCACCACATAAACCGGTGCGCCACCTCTGCTATACGCCGCGGGG
TTTACTTTTACCTTATGGAACTTGATATGTTCATTATCAGCTTCCATATATCCCTCTGTCATGCCATTCTTTATCAGCCCGTACCAGCATTCCGCTAAGGCGCGACTGTTATTCATATCTGTGCCGAATACGCGAAAGTCCTTGTT
GTAAAGCCCTCGGCAAATACCAAACCGAAATCGTCCTTTTGACATTTGATCCAATAAATTCACATCTTCAAGTTGGCGTACTGGATGGGCTGTGGGAAGAACAATAGCGGCAGTTCCTACATTCAATTTTTTAGTCGCGCCA
AGTAAATATGCAGCAGCGACATAAGGGTTACCAAGCAAACCAAACTCCGTGAAATGATGCTCCAGTAACCATACGGTATCAAAACCACACTCCTCAGAGATGCGACCTAATTTAACCAAACGTTTCATTACCTCTGTTTGAG
AAAATTGGGGAGGTTGGTATGTAAGCAAAAAGTTTCCAAATTTCATAGAGAGTCCTTATATTGCTATTTGAGTGATAGAATATCTCAATAGATTTTAAGACAGAGAAATTGCTTGATTTTCAATCTCAATTCTCATTCGGCGT
TCATTGACTGTCGCAATAGTTAAATGTTCAAATGACGGTTCAGTAATATCAACATCAATATCCAGATGATCATTATCCATCGCGATAGCGGCTTTCGTAACCGATTGATAAAAATTGCGCAGGACCACTAAATTTTCACTCAA
GTCATGCGAACTTCCTAACAAAGAATATATCTTGCATCGATTACTACGAATATTTGATAACAATGTGATAACTTCATCTTGCTTGACCCAATTATCGTTATTTGCAGTAAAAGCAATAAACGGTATATCAAGATACATCATGTT
ATTAATTGTAGAAGCTAAATCTTCCCAACCAAAATCAAGACAATCTCTCGCAAAGACTTCAGCACCCAATTTATGGCCTTCAAAATCTAGATTATCCGGCAATTCATTAATGGGTAGACTGAGATAATCAAACCCTAAAGCTC
TTTCAAGAGAATATCTTAAGTTAACAACACCGACTGCGGTGATTAAAAACGAAGCATTGATTTCAGATAGGCTTGCATAAGCTATCCGCGCAGATAAGCTTGAAGCCAACATACCGAAGTTATTTATTTTTCGTGTAGTTAAC
CAATCAACCACTGCTAACAAGCTCTGCTTTCCTATAGACATTGTAAATTCATCAATTGTCCCTGAACTCAATCCAACGTGGTGAAGCGAATCATAGCGGATCACATGAAATCCATTCCGCGATAAATATTCCGCCAGACCAGC
AAAATGATCCATCCTGCGGGCAAAACCAGACGCAATAATAATGGCATTCTTTCTCTTTGGGCTGTTTTCTTCTGGCAGCGTTTCCCAAACATGAATTTTTTTATTTCCTTCAACACAAATAACGTGGTCGATGGTTTTATATTTT
GATTCATTTTCCATACTTTTACCTATTATGGGACAAATACAAGGAACTTATCTTCTTCCAGGAATCGAGTCTGTTCTATTTCAACCGCAACATCCTTAGCCGTATAGTTAGATGGCCTTTCATGAGAAATATATGTCACTAATCG
TTGCAACGGTCTCATTCCGTCATGAGATCCACCAACTCGAAATATGTTATTCATTCCTGCTTCTACAATCCTTTCCGCACCTTTTAATGCTAACGCATCTCGATATTTAAATGATGACTCCCAAGGAAAAATAGATATGGTTTGC
GTCTTATTTTTTTGAACATAAGGCAATATTTGCTCAATATTATCGACGTGATGAAGGTACACACATCTGCCAAGTGGTTGATTAAATTCCACACCTGCATTTGACTCAATAATCATCCAACGTTGATGAATATCCACCTCTACTT
TTAATCCAGCAAACAAGCTTTCTTTTTGAACTAAAGAATAGGCCGCCTTTTCATCAAAATCTTTTTTGGCATTCGGTAATATATGCGCATATAGATTAAGTTTTTCTATCAACGCTAACTTAAATTCCTCATAATGATTTCCCAT
GTAATATATGTTTTGGGCAGAAAAACAAGCTCGCTGATCGTAAAAACAAACATCATGAGCCGCACCTGTCGCTGCGGACGTCAAATCAACAGGATTATCGATAATGCAAAGACTCTTTTTAGAACCAAATTTAATCACATCA
GCATAAGATGGCGCATGCTCTACCGCCCAATTAATCGCATCTGGCCCTCCCCAAGCGACAATAACATCCGCATGTCGCATAATTTCTTTTGCGAGTGATGTATCACCTTGGTGGGGCCAATATATAACAGATAAAGAGCGCG
TTATCGGATGATTAGGGTCTACATCAATAAAACTTAACGCTAATGCATTAGCGGTAAAAGGATCGGTTGACGATGTTTTTATAATACACTGATTCTTAGTTAAAATTGCGCGTAATATAGACATGATCCCAGATAATGGAAC
ATTACCTGCCAACAGATGTACAGATTTACCTTTCGGAAAAGCCCGAACATAACTTTCATCCTGAGGTAGCCATTCATCCATGATATGGCGAGAACCAAGTTCATTTTCTACAACATCATAAAGGCCGCCTTTAGAACATAAAA
TCATAGATATCCAATTGGCCTCTAGCTTAGCCATTTCTTCTGAATATCCCATATATTTTTTTAAGTCACGAATGTATGTCCTGCGTCTTGAGTATTCTTCATTTTTCCATCTTTGCCCTACCGTATAGAGAAAATTGACAATGTTA
TGCAACCGTAATTCGTTATTTCCATTACAATCAATAATGTTTTTTACATGAGAGTCATTCAATATTGGCAGGTAAACACTATTATCACCAAAATTAATGGATTGCACTAAATCATCACTTTCGGGAAAGATTTCAACCTGGCCG
TTAATAATGAATGAAATTTTTTTAGTCATACGTATCCTCCAAGCCTGAATTCCTGGCAGTTTATGGCGGGCGTCCTGCCCGCCACCCTCCGGGCCGTTGCTTCGCAACGTTCAAATCCGCTCCCGGCGGATTTGTCCTACTCA
GGACAGCGTTCACCGACAAACAACAGATAAAACGAAAGGCCCAGTCTTTCGACTGAGCCTTTCGTTTTATTTGATGCCTGGGGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCT
CACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTG
ACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTT
TCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTC
TTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTA
TTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAA
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAG
TATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTG
GCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCC
GGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATC
CCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTG
TGACTGGTGAGTCGAATTGGCCGCGGCGTTGTGACAATTTACCGAACAACTCCGCGGCCGGGAAGCCGATCTCGGCTTGAACGAATTGTTAGGTGGCGGTACTTGGGTCGATATCAAAGTGCATCACTTCTTCCCGTATGC
CCAACTTTGTATAGAGAGCCACTGCGGGATCGTCACCGTAATCTGCTTGCACGTAGATCACATAAGCACCAAGCGCGTTGGCCTCATGCTTGAGGAGATTGATGAGCGCGGTGGCAATGCCCTGCCTCCGGTGCTCGCCGG
AGACTGCGAGATCATAGATATAGATCTCACTACGCGGCTGCTCAAACCTGGGCAGAACGTAAGCCGCGAGAGCGCCAACAACCGCTTCTTGGTCGAAGGCAGCAAGCGCGATGAATGTCTTACTACGGAGCAAGTTCCCG
AGGTAATCGGAGTCCGGCTGATGTTGGGAGTAGGTGGCTACGTCTCCGAACTCACGACCGAAAAGATCAAGAGCAGCCCGCATGGATTTGACTTGGTCAGGGCCGAGCCTACATGTGCGAATGATGCCCATACTTGAGCC
ACCTAACTTTGTTTTAGGGCGACTGCCCTGCTGCGTAACATCGTTGCTGCTGCGTAACATCGTTGCTGCTCCATAACATCAAACATCGACCCACGGCGTAACGCGCTTGCTGCTTGGATGCCCGAGGCATAGACTGTACAAA
AAAACAGTCATAACAAGCCATGAAAACCGCCACTGCGCCGTTACCACCGCTGCGTTCGGTCAAGGTTCTGGACCAGTTGCGTGAGCGCATACGCTACTTGCATTACAGTTTACGAACCGAACAGGCTTATGTCAATTCG 
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LdcC-pME-lux plasmid 
 
CCTCTCAGGCGCCGCTGGTGCCGCTGGTTGGACGCCAAGGGTGAATCCGCCTCGATACCCTGATTACTCGCTTCCTGCGCCCTCTCAGGCGGCGATAGGGGACTGGTAAAACGGGGATTGCCCAGACGCCTCCCCCGCCCC
TTCAGGGGCACAAATGCGGCCCCAACGGGGCCACGTAGTGGTGCGTTTTTTGCGTTTCCACCCTTTTCTTCCTTTTCCCTTTTAAACCTTTTAGGACGTCTACAGGCCACGTAATCCGTGGCCTGTAGAGTTTAAAAAGGGAC
GGATTTGTTGCCATTAAGGGACGGATTTGTTGTTAAGAAGGGACGGATTTGTTGTTGTAAAGGGACGGATTTGTTGTATTGTGGGACGCAGATACAGTGTCCCCTTATACACAAGGAATGTCGAACGTGGCCTCACCCCCA
ATGGTTTACAAAAGCAATGCCCTGGTCGAGGCCGCGTATCGCCTCAGTGTTCAGGAACAGCGGATCGTTCTGGCCTGTATTAGCCAGGTGAAGAGGAGCGAGCCTGTCACCGATGAAGTGATGTATTCAGTGACGGCGGA
GGACATAGCGACGATGGCGGGTGTCCCTATCGAATCTTCCTACAACCAGCTCAAAGAAGCGGCCCTGCGCCTGAAACGGCGGGAAGTCCGGTTAACCCAAGAGCCCAATGGCAAGGGGAAAAGACCGAGTGTGATGATT
ACCGGCTGGGTGCAAACAATCATCTACCGGGAGGGTGAGGGCCGTGTAGAACTCAGGTTCACCAAAGACATGCTGCCGTACCTGACGGAACTCACCAAACAGTTCACCAAATACGCCTTGGCTGACGTGGCCAAGATGGA
CAGCACCCACGCGATCAGGCTTTACGAGCTGCTCATGCAATGGGACAGCATCGGCCAGCGCGAAATAGAAATTGACCAGCTGCGAAAGTGGTTTCAACTGGAAGGCCGGTATCCCTCGATCAAGGACTTCAAGTTGCGAG
TGCTTGATCCAGCCGTGACGCAGATCAACGAGCACAGCCCGCTACAGGTGGAGTGGGCGCAGCGAAAGACCGGGCGCAAGGTCACACATCTGTTGTTCAGTTTTGGACCGAAGAAGCCCGCCAAGGCGGTGGGTAAGG
CCCCAGCGAAGCGCAAGGCCGGGAAGATTTCAGATGCTGAGATCGCGAAACAGGCTCGCCCTGGTGAGACATGGGAAGCGGCCCGCGCTCGACTAACCCAGATGCCGCTGGATCTGGCCTAGAGGCCGTGGCCACCAC
GGCCCGGCCTGCCTTTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACG
ACGTTGTAAAACGACGGCCAGTGAATTGTCCATTTTAGCCTCCTTAGCTCCTGAAAATCTCGTCGAAGCTCGGCGGATTTGTCCTACTCAAGCTTGGCTGCAGGTCGACGGATCCGTCGACCTGCAGGTCATCAACTATCAA
ACGCTTCGGTTAAGCTTAAAGCACACCCTTTCTGCGTCCTCGTATTGACGCGACGTAAAATTTCAACGAGCACGCCGGGATACTTACCATATTCTCTGCTAATTATCCCGACATCATCGGTAACAATAAATGCTGGATAACTG
GTTGCTGACGCATCCATATAACTCATCAACCCCGGCGTTCCATCAGGTACAGGTTTCAACGTTTCAGGATCAAGCGCTCGCGCATATACCCACGGCGGAACATGTTTACGCTGCATTTCATCCTCAAAGAAACAAGTGTTGA
GTTCAACTTGATTAAATATATCTCGGATCTGACTAATATCACTGAGATTGAAAGTATCAAATAAAAGATGATTGAAATCATCACGTTTCAGAGATTCTTTTTCGTAACTTTTCCAGCCGCCTCCGGTTATGATATAAAGGCTTT
TATCTCCAGAAAATGAGATTTTTTTATCTTTCATATAATGGCAGAGTAAATAAATAAAGTATGGCGAACCAATAAGACAAAGATCTTTCCCTTGATTTTTTATTCGTTCAAGACTATTCAATGTTTTAACAAAATCTATTCGTTC
TTCTGTTACGGTAAATGTCGTAGGATATAACAATTCCACCAAACTCATAACATATTTAAACCAAATATTATGAGCATTAAATCTATCTGGTCCCAAATTGACTAATTCTATTTGATGATCAAACCAACTACCAACATATTTCATG
CCATAACTCACAGAGCCTAAGAGTCTCTCAATACTTAATCTGTCACGCGCCACCTGACTTTTTAAACCATTCGTGCCGCTACTGGTAAACCAACTTTCAATCTCGTTTTCCTGAGAAGTTAATAAGCGAGTAAACTTAAAAACC
GATGTTGGGAATACAGGTATGTCATCAATTTCCGTAATATTGTCATCTACTTTGTGTGCCTGACAGTAGTGACGATATTCTCGACAATGTTTATAATGATTACGAAATGCATCAAGCACAAGTTTCTTTCTGATTTTTTCCTGC
TCGTCGTAAGACCACACTAATGGATCGCTCGAAAAAATCAAATCATCAATTTCTGAGCTTGCTGTAATTTCTTGTTTATCAACATATGAAGTCATACCTGTTTTACTCCTCAAGATAATATTAGAAAGTATGGCAGCACTGCTG
TCATACTCTTTTATACCCTTCATCTTTCAAGCTGCTGCTTTGTTGGCTGCTTTCACTCACCCCAGTCACATAGTTATCTATGCTCCTGGGGATTCGTTCACTTGCCGCCTCGCTGCAACTCGAAATCTATTAGGTATATTCCATGT
GGTACTTCTTAATATTATCATCAACAATATTGATTACATTTTTTTGGCTCATCAAATCATTCATTGGTTCAAAGGACAGCAATACACTTTTCGCACCACACTTTTCAATTGCCAACTTAGCCGCAGTTATACACTCCGTATAATTT
CCGACAGCGTTTTCTGCAATTATTTCTTCAAGTTTATTTTCGAAATTTTCATTAGGGTGCATTTCAAGAACATAATCACTAATAAATGCACGCGTCTCTTGTTTAGCTTTATTACTATCTTCGTTATAGTTAACTAATATCATTAA
CTGATGGTCTATCTCTGATAGGTCAACGTCATATTTATCCGCAACGGCTTTATATCTTTCAGCATATTCATATCTAACATCATTAGAATCATCCCACTTAAAGATGAGAGGAATACCTTTTTTGGCCGCCCACTCAACAATATG
ATGACTGGTTGCTGTTACATATTTCCGAGGTCCGCCTGGCGTATAAGCATGGGGATTTACAGATATTTTAGGGAAGCTATAAAAATCGTTATCTGGATTACAATAGCCTGTTGTTAAAGCATCGTTAATGATTTCATAACACT
CTTCAAATAGTTGCTGTTGATATTCAACCGGGCGATTAAAAAAATGCATTTCATCTTTTTTTTCGCAATCACTAAACCCTAAAATAAATCTCCCTTCACTTAACTGATCCAATAAGCAAGCTTCCTCCGCTATGGCGACAGGAT
GATGAGTTGTAATGATGTGATTTAATGAACCAATTTTAATTTTCTCTGTTAAACCGAGCAGAAAACCAGAAACAGTCAGAGGAGCGCCGACAACACCATTATCTGAAAAATGATTTTCATACACTAAAATCTGTTCAAAATTC
AACTTATCAACATACTCCGTTATTTCCTGCATGCGAACTATACTTTGTTCTTGAACAGTTGTTGAATTGATGAAGTTAAGGAAGAACAATCCAAATTTCATTTCTTTCTCCTTAGCTAATATAATAGCGAACGTTGTTTTTCTTTA
AGAAATGGCATGACATCAGACTGGAAGAGCTTCATGGAAGCAATAATTTCGTCTACTGTTCCATTAGCTTCAAATCCACAACAAATATTTGATATTCCTGTAGCATCAATGTCTTTTTGAATTATGTCAATACATTCCTGCGGC
GTTCCCACGGGATTGATTTCGTAACTGTAATCAATACGGCGATTAGTATCTTTATGTCCTTTTAATACAAAGTCACGCCACTGCCCTTTATTGAAATCATAACCTCTTGTTTGGTCTGAATCATCAAAAATAGTCGTAGCATTCA
CATAAGAATCATACCAATGCCCCAGAAATTTCCGGCAAATCTCTTTCGCTTTAATTGAGTCATGATCTACAGATGTTATATATGATAAGCAATGGTCGATATTATGAATATCGTGCCCATATTCTTGAGCCACTTCATTATAAA
GCTCAAGTTGTGCTTTCTTTTCGTTAGTATTTATAATCCAACTTAATATCATCGGTAGGCCAAATTGAGCAGCCCACTCAGTCGTCGAAGCTGATTCAGCCACCACATAAACCGGTGCGCCACCTCTGCTATACGCCGCGGGG
TTTACTTTTACCTTATGGAACTTGATATGTTCATTATCAGCTTCCATATATCCCTCTGTCATGCCATTCTTTATCAGCCCGTACCAGCATTCCGCTAAGGCGCGACTGTTATTCATATCTGTGCCGAATACGCGAAAGTCCTTGTT
GTAAAGCCCTCGGCAAATACCAAACCGAAATCGTCCTTTTGACATTTGATCCAATAAATTCACATCTTCAAGTTGGCGTACTGGATGGGCTGTGGGAAGAACAATAGCGGCAGTTCCTACATTCAATTTTTTAGTCGCGCCA
AGTAAATATGCAGCAGCGACATAAGGGTTACCAAGCAAACCAAACTCCGTGAAATGATGCTCCAGTAACCATACGGTATCAAAACCACACTCCTCAGAGATGCGACCTAATTTAACCAAACGTTTCATTACCTCTGTTTGAG
AAAATTGGGGAGGTTGGTATGTAAGCAAAAAGTTTCCAAATTTCATAGAGAGTCCTTATATTGCTATTTGAGTGATAGAATATCTCAATAGATTTTAAGACAGAGAAATTGCTTGATTTTCAATCTCAATTCTCATTCGGCGT
TCATTGACTGTCGCAATAGTTAAATGTTCAAATGACGGTTCAGTAATATCAACATCAATATCCAGATGATCATTATCCATCGCGATAGCGGCTTTCGTAACCGATTGATAAAAATTGCGCAGGACCACTAAATTTTCACTCAA
GTCATGCGAACTTCCTAACAAAGAATATATCTTGCATCGATTACTACGAATATTTGATAACAATGTGATAACTTCATCTTGCTTGACCCAATTATCGTTATTTGCAGTAAAAGCAATAAACGGTATATCAAGATACATCATGTT
ATTAATTGTAGAAGCTAAATCTTCCCAACCAAAATCAAGACAATCTCTCGCAAAGACTTCAGCACCCAATTTATGGCCTTCAAAATCTAGATTATCCGGCAATTCATTAATGGGTAGACTGAGATAATCAAACCCTAAAGCTC
TTTCAAGAGAATATCTTAAGTTAACAACACCGACTGCGGTGATTAAAAACGAAGCATTGATTTCAGATAGGCTTGCATAAGCTATCCGCGCAGATAAGCTTGAAGCCAACATACCGAAGTTATTTATTTTTCGTGTAGTTAAC
CAATCAACCACTGCTAACAAGCTCTGCTTTCCTATAGACATTGTAAATTCATCAATTGTCCCTGAACTCAATCCAACGTGGTGAAGCGAATCATAGCGGATCACATGAAATCCATTCCGCGATAAATATTCCGCCAGACCAGC
AAAATGATCCATCCTGCGGGCAAAACCAGACGCAATAATAATGGCATTCTTTCTCTTTGGGCTGTTTTCTTCTGGCAGCGTTTCCCAAACATGAATTTTTTTATTTCCTTCAACACAAATAACGTGGTCGATGGTTTTATATTTT
GATTCATTTTCCATACTTTTACCTATTATGGGACAAATACAAGGAACTTATCTTCTTCCAGGAATCGAGTCTGTTCTATTTCAACCGCAACATCCTTAGCCGTATAGTTAGATGGCCTTTCATGAGAAATATATGTCACTAATCG
TTGCAACGGTCTCATTCCGTCATGAGATCCACCAACTCGAAATATGTTATTCATTCCTGCTTCTACAATCCTTTCCGCACCTTTTAATGCTAACGCATCTCGATATTTAAATGATGACTCCCAAGGAAAAATAGATATGGTTTGC
GTCTTATTTTTTTGAACATAAGGCAATATTTGCTCAATATTATCGACGTGATGAAGGTACACACATCTGCCAAGTGGTTGATTAAATTCCACACCTGCATTTGACTCAATAATCATCCAACGTTGATGAATATCCACCTCTACTT
TTAATCCAGCAAACAAGCTTTCTTTTTGAACTAAAGAATAGGCCGCCTTTTCATCAAAATCTTTTTTGGCATTCGGTAATATATGCGCATATAGATTAAGTTTTTCTATCAACGCTAACTTAAATTCCTCATAATGATTTCCCAT
GTAATATATGTTTTGGGCAGAAAAACAAGCTCGCTGATCGTAAAAACAAACATCATGAGCCGCACCTGTCGCTGCGGACGTCAAATCAACAGGATTATCGATAATGCAAAGACTCTTTTTAGAACCAAATTTAATCACATCA
GCATAAGATGGCGCATGCTCTACCGCCCAATTAATCGCATCTGGCCCTCCCCAAGCGACAATAACATCCGCATGTCGCATAATTTCTTTTGCGAGTGATGTATCACCTTGGTGGGGCCAATATATAACAGATAAAGAGCGCG
TTATCGGATGATTAGGGTCTACATCAATAAAACTTAACGCTAATGCATTAGCGGTAAAAGGATCGGTTGACGATGTTTTTATAATACACTGATTCTTAGTTAAAATTGCGCGTAATATAGACATGATCCCAGATAATGGAAC
ATTACCTGCCAACAGATGTACAGATTTACCTTTCGGAAAAGCCCGAACATAACTTTCATCCTGAGGTAGCCATTCATCCATGATATGGCGAGAACCAAGTTCATTTTCTACAACATCATAAAGGCCGCCTTTAGAACATAAAA
TCATAGATATCCAATTGGCCTCTAGCTTAGCCATTTCTTCTGAATATCCCATATATTTTTTTAAGTCACGAATGTATGTCCTGCGTCTTGAGTATTCTTCATTTTTCCATCTTTGCCCTACCGTATAGAGAAAATTGACAATGTTA
TGCAACCGTAATTCGTTATTTCCATTACAATCAATAATGTTTTTTACATGAGAGTCATTCAATATTGGCAGGTAAACACTATTATCACCAAAATTAATGGATTGCACTAAATCATCACTTTCGGGAAAGATTTCAACCTGGCCG
TTAATAATGAATGAAATTTTTTTAGTCATACGTAGTCAAGAGAATGCTGAAGCCGTCCTGCTCCAGCTCGTGGGCGATGCCCCGCACGCGTTCGCCGGCAACGGTGTCGGCCTTGATGT
CGCGATGGACGATGAGGACGGGAAATTTGAGGTCTTTATACATTGTTGATCCCGAGCAGCAGGCGGGCGAACCCCGCCGGTGGGCTCAGGGTAGAGAGTTGCCGGCACGCG
CGTAACCCGAATTCCTGGCAGTTTATGGCGGGCGTCCTGCCCGCCACCCTCCGGGCCGTTGCTTCGCAACGTTCAAATCCGCTCCCGGCGGATTTGTCCTACTCAGGACAGCGTTCACCGACAAACAACAGATAAAACG
AAAGGCCCAGTCTTTCGACTGAGCCTTTCGTTTTATTTGATGCCTGGGGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAAT
CAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAG
GTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCT
CACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCC
ACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCT
TCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACG
CTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAA
TGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCAC
GCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATA
GTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTC
GGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTCGAATTGGCCGCGGCGTTGTG
ACAATTTACCGAACAACTCCGCGGCCGGGAAGCCGATCTCGGCTTGAACGAATTGTTAGGTGGCGGTACTTGGGTCGATATCAAAGTGCATCACTTCTTCCCGTATGCCCAACTTTGTATAGAGAGCCACTGCGGGATCGT
CACCGTAATCTGCTTGCACGTAGATCACATAAGCACCAAGCGCGTTGGCCTCATGCTTGAGGAGATTGATGAGCGCGGTGGCAATGCCCTGCCTCCGGTGCTCGCCGGAGACTGCGAGATCATAGATATAGATCTCACTAC
GCGGCTGCTCAAACCTGGGCAGAACGTAAGCCGCGAGAGCGCCAACAACCGCTTCTTGGTCGAAGGCAGCAAGCGCGATGAATGTCTTACTACGGAGCAAGTTCCCGAGGTAATCGGAGTCCGGCTGATGTTGGGAGTA
GGTGGCTACGTCTCCGAACTCACGACCGAAAAGATCAAGAGCAGCCCGCATGGATTTGACTTGGTCAGGGCCGAGCCTACATGTGCGAATGATGCCCATACTTGAGCCACCTAACTTTGTTTTAGGGCGACTGCCCTGCTG
CGTAACATCGTTGCTGCTGCGTAACATCGTTGCTGCTCCATAACATCAAACATCGACCCACGGCGTAACGCGCTTGCTGCTTGGATGCCCGAGGCATAGACTGTACAAAAAAACAGTCATAACAAGCCATGAAAACCGCCA
CTGCGCCGTTACCACCGCTGCGTTCGGTCAAGGTTCTGGACCAGTTGCGTGAGCGCATACGCTACTTGCATTACAGTTTACGAACCGAACAGGCTTATGTCAATTCG 
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CCTCTCAGGCGCCGCTGGTGCCGCTGGTTGGACGCCAAGGGTGAATCCGCCTCGATACCCTGATTACTCGCTTCCTGCGCCCTCTCAGGCGGCGATAGGGGACTGGTAAAACGGGGATTGCCCAGACGCCTCCCCCGCCCC
TTCAGGGGCACAAATGCGGCCCCAACGGGGCCACGTAGTGGTGCGTTTTTTGCGTTTCCACCCTTTTCTTCCTTTTCCCTTTTAAACCTTTTAGGACGTCTACAGGCCACGTAATCCGTGGCCTGTAGAGTTTAAAAAGGGAC
GGATTTGTTGCCATTAAGGGACGGATTTGTTGTTAAGAAGGGACGGATTTGTTGTTGTAAAGGGACGGATTTGTTGTATTGTGGGACGCAGATACAGTGTCCCCTTATACACAAGGAATGTCGAACGTGGCCTCACCCCCA
ATGGTTTACAAAAGCAATGCCCTGGTCGAGGCCGCGTATCGCCTCAGTGTTCAGGAACAGCGGATCGTTCTGGCCTGTATTAGCCAGGTGAAGAGGAGCGAGCCTGTCACCGATGAAGTGATGTATTCAGTGACGGCGGA
GGACATAGCGACGATGGCGGGTGTCCCTATCGAATCTTCCTACAACCAGCTCAAAGAAGCGGCCCTGCGCCTGAAACGGCGGGAAGTCCGGTTAACCCAAGAGCCCAATGGCAAGGGGAAAAGACCGAGTGTGATGATT
ACCGGCTGGGTGCAAACAATCATCTACCGGGAGGGTGAGGGCCGTGTAGAACTCAGGTTCACCAAAGACATGCTGCCGTACCTGACGGAACTCACCAAACAGTTCACCAAATACGCCTTGGCTGACGTGGCCAAGATGGA
CAGCACCCACGCGATCAGGCTTTACGAGCTGCTCATGCAATGGGACAGCATCGGCCAGCGCGAAATAGAAATTGACCAGCTGCGAAAGTGGTTTCAACTGGAAGGCCGGTATCCCTCGATCAAGGACTTCAAGTTGCGAG
TGCTTGATCCAGCCGTGACGCAGATCAACGAGCACAGCCCGCTACAGGTGGAGTGGGCGCAGCGAAAGACCGGGCGCAAGGTCACACATCTGTTGTTCAGTTTTGGACCGAAGAAGCCCGCCAAGGCGGTGGGTAAGG
CCCCAGCGAAGCGCAAGGCCGGGAAGATTTCAGATGCTGAGATCGCGAAACAGGCTCGCCCTGGTGAGACATGGGAAGCGGCCCGCGCTCGACTAACCCAGATGCCGCTGGATCTGGCCTAGAGGCCGTGGCCACCAC
GGCCCGGCCTGCCTTTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACG
ACGTTGTAAAACGACGGCCAGTGAATTGTCCATTTTAGCCTCCTTAGCTCCTGAAAATCTCGTCGAAGCTCGGCGGATTTGTCCTACTCAAGCTTGGCTGCAGGTCGACGGATCCGTCGACCTGCAGGTCATCAACTATCAA
ACGCTTCGGTTAAGCTTAAAGCACACCCTTTCTGCGTCCTCGTATTGACGCGACGTAAAATTTCAACGAGCACGCCGGGATACTTACCATATTCTCTGCTAATTATCCCGACATCATCGGTAACAATAAATGCTGGATAACTG
GTTGCTGACGCATCCATATAACTCATCAACCCCGGCGTTCCATCAGGTACAGGTTTCAACGTTTCAGGATCAAGCGCTCGCGCATATACCCACGGCGGAACATGTTTACGCTGCATTTCATCCTCAAAGAAACAAGTGTTGA
GTTCAACTTGATTAAATATATCTCGGATCTGACTAATATCACTGAGATTGAAAGTATCAAATAAAAGATGATTGAAATCATCACGTTTCAGAGATTCTTTTTCGTAACTTTTCCAGCCGCCTCCGGTTATGATATAAAGGCTTT
TATCTCCAGAAAATGAGATTTTTTTATCTTTCATATAATGGCAGAGTAAATAAATAAAGTATGGCGAACCAATAAGACAAAGATCTTTCCCTTGATTTTTTATTCGTTCAAGACTATTCAATGTTTTAACAAAATCTATTCGTTC
TTCTGTTACGGTAAATGTCGTAGGATATAACAATTCCACCAAACTCATAACATATTTAAACCAAATATTATGAGCATTAAATCTATCTGGTCCCAAATTGACTAATTCTATTTGATGATCAAACCAACTACCAACATATTTCATG
CCATAACTCACAGAGCCTAAGAGTCTCTCAATACTTAATCTGTCACGCGCCACCTGACTTTTTAAACCATTCGTGCCGCTACTGGTAAACCAACTTTCAATCTCGTTTTCCTGAGAAGTTAATAAGCGAGTAAACTTAAAAACC
GATGTTGGGAATACAGGTATGTCATCAATTTCCGTAATATTGTCATCTACTTTGTGTGCCTGACAGTAGTGACGATATTCTCGACAATGTTTATAATGATTACGAAATGCATCAAGCACAAGTTTCTTTCTGATTTTTTCCTGC
TCGTCGTAAGACCACACTAATGGATCGCTCGAAAAAATCAAATCATCAATTTCTGAGCTTGCTGTAATTTCTTGTTTATCAACATATGAAGTCATACCTGTTTTACTCCTCAAGATAATATTAGAAAGTATGGCAGCACTGCTG
TCATACTCTTTTATACCCTTCATCTTTCAAGCTGCTGCTTTGTTGGCTGCTTTCACTCACCCCAGTCACATAGTTATCTATGCTCCTGGGGATTCGTTCACTTGCCGCCTCGCTGCAACTCGAAATCTATTAGGTATATTCCATGT
GGTACTTCTTAATATTATCATCAACAATATTGATTACATTTTTTTGGCTCATCAAATCATTCATTGGTTCAAAGGACAGCAATACACTTTTCGCACCACACTTTTCAATTGCCAACTTAGCCGCAGTTATACACTCCGTATAATTT
CCGACAGCGTTTTCTGCAATTATTTCTTCAAGTTTATTTTCGAAATTTTCATTAGGGTGCATTTCAAGAACATAATCACTAATAAATGCACGCGTCTCTTGTTTAGCTTTATTACTATCTTCGTTATAGTTAACTAATATCATTAA
CTGATGGTCTATCTCTGATAGGTCAACGTCATATTTATCCGCAACGGCTTTATATCTTTCAGCATATTCATATCTAACATCATTAGAATCATCCCACTTAAAGATGAGAGGAATACCTTTTTTGGCCGCCCACTCAACAATATG
ATGACTGGTTGCTGTTACATATTTCCGAGGTCCGCCTGGCGTATAAGCATGGGGATTTACAGATATTTTAGGGAAGCTATAAAAATCGTTATCTGGATTACAATAGCCTGTTGTTAAAGCATCGTTAATGATTTCATAACACT
CTTCAAATAGTTGCTGTTGATATTCAACCGGGCGATTAAAAAAATGCATTTCATCTTTTTTTTCGCAATCACTAAACCCTAAAATAAATCTCCCTTCACTTAACTGATCCAATAAGCAAGCTTCCTCCGCTATGGCGACAGGAT
GATGAGTTGTAATGATGTGATTTAATGAACCAATTTTAATTTTCTCTGTTAAACCGAGCAGAAAACCAGAAACAGTCAGAGGAGCGCCGACAACACCATTATCTGAAAAATGATTTTCATACACTAAAATCTGTTCAAAATTC
AACTTATCAACATACTCCGTTATTTCCTGCATGCGAACTATACTTTGTTCTTGAACAGTTGTTGAATTGATGAAGTTAAGGAAGAACAATCCAAATTTCATTTCTTTCTCCTTAGCTAATATAATAGCGAACGTTGTTTTTCTTTA
AGAAATGGCATGACATCAGACTGGAAGAGCTTCATGGAAGCAATAATTTCGTCTACTGTTCCATTAGCTTCAAATCCACAACAAATATTTGATATTCCTGTAGCATCAATGTCTTTTTGAATTATGTCAATACATTCCTGCGGC
GTTCCCACGGGATTGATTTCGTAACTGTAATCAATACGGCGATTAGTATCTTTATGTCCTTTTAATACAAAGTCACGCCACTGCCCTTTATTGAAATCATAACCTCTTGTTTGGTCTGAATCATCAAAAATAGTCGTAGCATTCA
CATAAGAATCATACCAATGCCCCAGAAATTTCCGGCAAATCTCTTTCGCTTTAATTGAGTCATGATCTACAGATGTTATATATGATAAGCAATGGTCGATATTATGAATATCGTGCCCATATTCTTGAGCCACTTCATTATAAA
GCTCAAGTTGTGCTTTCTTTTCGTTAGTATTTATAATCCAACTTAATATCATCGGTAGGCCAAATTGAGCAGCCCACTCAGTCGTCGAAGCTGATTCAGCCACCACATAAACCGGTGCGCCACCTCTGCTATACGCCGCGGGG
TTTACTTTTACCTTATGGAACTTGATATGTTCATTATCAGCTTCCATATATCCCTCTGTCATGCCATTCTTTATCAGCCCGTACCAGCATTCCGCTAAGGCGCGACTGTTATTCATATCTGTGCCGAATACGCGAAAGTCCTTGTT
GTAAAGCCCTCGGCAAATACCAAACCGAAATCGTCCTTTTGACATTTGATCCAATAAATTCACATCTTCAAGTTGGCGTACTGGATGGGCTGTGGGAAGAACAATAGCGGCAGTTCCTACATTCAATTTTTTAGTCGCGCCA
AGTAAATATGCAGCAGCGACATAAGGGTTACCAAGCAAACCAAACTCCGTGAAATGATGCTCCAGTAACCATACGGTATCAAAACCACACTCCTCAGAGATGCGACCTAATTTAACCAAACGTTTCATTACCTCTGTTTGAG
AAAATTGGGGAGGTTGGTATGTAAGCAAAAAGTTTCCAAATTTCATAGAGAGTCCTTATATTGCTATTTGAGTGATAGAATATCTCAATAGATTTTAAGACAGAGAAATTGCTTGATTTTCAATCTCAATTCTCATTCGGCGT
TCATTGACTGTCGCAATAGTTAAATGTTCAAATGACGGTTCAGTAATATCAACATCAATATCCAGATGATCATTATCCATCGCGATAGCGGCTTTCGTAACCGATTGATAAAAATTGCGCAGGACCACTAAATTTTCACTCAA
GTCATGCGAACTTCCTAACAAAGAATATATCTTGCATCGATTACTACGAATATTTGATAACAATGTGATAACTTCATCTTGCTTGACCCAATTATCGTTATTTGCAGTAAAAGCAATAAACGGTATATCAAGATACATCATGTT
ATTAATTGTAGAAGCTAAATCTTCCCAACCAAAATCAAGACAATCTCTCGCAAAGACTTCAGCACCCAATTTATGGCCTTCAAAATCTAGATTATCCGGCAATTCATTAATGGGTAGACTGAGATAATCAAACCCTAAAGCTC
TTTCAAGAGAATATCTTAAGTTAACAACACCGACTGCGGTGATTAAAAACGAAGCATTGATTTCAGATAGGCTTGCATAAGCTATCCGCGCAGATAAGCTTGAAGCCAACATACCGAAGTTATTTATTTTTCGTGTAGTTAAC
CAATCAACCACTGCTAACAAGCTCTGCTTTCCTATAGACATTGTAAATTCATCAATTGTCCCTGAACTCAATCCAACGTGGTGAAGCGAATCATAGCGGATCACATGAAATCCATTCCGCGATAAATATTCCGCCAGACCAGC
AAAATGATCCATCCTGCGGGCAAAACCAGACGCAATAATAATGGCATTCTTTCTCTTTGGGCTGTTTTCTTCTGGCAGCGTTTCCCAAACATGAATTTTTTTATTTCCTTCAACACAAATAACGTGGTCGATGGTTTTATATTTT
GATTCATTTTCCATACTTTTACCTATTATGGGACAAATACAAGGAACTTATCTTCTTCCAGGAATCGAGTCTGTTCTATTTCAACCGCAACATCCTTAGCCGTATAGTTAGATGGCCTTTCATGAGAAATATATGTCACTAATCG
TTGCAACGGTCTCATTCCGTCATGAGATCCACCAACTCGAAATATGTTATTCATTCCTGCTTCTACAATCCTTTCCGCACCTTTTAATGCTAACGCATCTCGATATTTAAATGATGACTCCCAAGGAAAAATAGATATGGTTTGC
GTCTTATTTTTTTGAACATAAGGCAATATTTGCTCAATATTATCGACGTGATGAAGGTACACACATCTGCCAAGTGGTTGATTAAATTCCACACCTGCATTTGACTCAATAATCATCCAACGTTGATGAATATCCACCTCTACTT
TTAATCCAGCAAACAAGCTTTCTTTTTGAACTAAAGAATAGGCCGCCTTTTCATCAAAATCTTTTTTGGCATTCGGTAATATATGCGCATATAGATTAAGTTTTTCTATCAACGCTAACTTAAATTCCTCATAATGATTTCCCAT
GTAATATATGTTTTGGGCAGAAAAACAAGCTCGCTGATCGTAAAAACAAACATCATGAGCCGCACCTGTCGCTGCGGACGTCAAATCAACAGGATTATCGATAATGCAAAGACTCTTTTTAGAACCAAATTTAATCACATCA
GCATAAGATGGCGCATGCTCTACCGCCCAATTAATCGCATCTGGCCCTCCCCAAGCGACAATAACATCCGCATGTCGCATAATTTCTTTTGCGAGTGATGTATCACCTTGGTGGGGCCAATATATAACAGATAAAGAGCGCG
TTATCGGATGATTAGGGTCTACATCAATAAAACTTAACGCTAATGCATTAGCGGTAAAAGGATCGGTTGACGATGTTTTTATAATACACTGATTCTTAGTTAAAATTGCGCGTAATATAGACATGATCCCAGATAATGGAAC
ATTACCTGCCAACAGATGTACAGATTTACCTTTCGGAAAAGCCCGAACATAACTTTCATCCTGAGGTAGCCATTCATCCATGATATGGCGAGAACCAAGTTCATTTTCTACAACATCATAAAGGCCGCCTTTAGAACATAAAA
TCATAGATATCCAATTGGCCTCTAGCTTAGCCATTTCTTCTGAATATCCCATATATTTTTTTAAGTCACGAATGTATGTCCTGCGTCTTGAGTATTCTTCATTTTTCCATCTTTGCCCTACCGTATAGAGAAAATTGACAATGTTA
TGCAACCGTAATTCGTTATTTCCATTACAATCAATAATGTTTTTTACATGAGAGTCATTCAATATTGGCAGGTAAACACTATTATCACCAAAATTAATGGATTGCACTAAATCATCACTTTCGGGAAAGATTTCAACCTGGCCG
TTAATAATGAATGAAATTTTTTTAGTCATACGTAGTCAGGTAGATCACCATGGCACGATTGAAAGAAATTTATCGGAAGGAAATCGCGCCCAAGCTGAAAGAAGAGCTTCAGCTGGCGAA
CGTGATGGAAGTTCCGCGCGTTACGAATTCCTGGCAGTTTATGGCGGGCGTCCTGCCCGCCACCCTCCGGGCCGTTGCTTCGCAACGTTCAAATCCGCTCCCGGCGGATTTGTCCTACTCAGGACAGCGTTCACCG
ACAAACAACAGATAAAACGAAAGGCCCAGTCTTTCGACTGAGCCTTTCGTTTTATTTGATGCCTGGGGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTA
ATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAA
ATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAG
CGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCG
GTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGC
TCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGAT
CTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAA
CTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCA
ATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTA
AGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAA
AAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTCGA
ATTGGCCGCGGCGTTGTGACAATTTACCGAACAACTCCGCGGCCGGGAAGCCGATCTCGGCTTGAACGAATTGTTAGGTGGCGGTACTTGGGTCGATATCAAAGTGCATCACTTCTTCCCGTATGCCCAACTTTGTATAGA
GAGCCACTGCGGGATCGTCACCGTAATCTGCTTGCACGTAGATCACATAAGCACCAAGCGCGTTGGCCTCATGCTTGAGGAGATTGATGAGCGCGGTGGCAATGCCCTGCCTCCGGTGCTCGCCGGAGACTGCGAGATCA
TAGATATAGATCTCACTACGCGGCTGCTCAAACCTGGGCAGAACGTAAGCCGCGAGAGCGCCAACAACCGCTTCTTGGTCGAAGGCAGCAAGCGCGATGAATGTCTTACTACGGAGCAAGTTCCCGAGGTAATCGGAGTC
CGGCTGATGTTGGGAGTAGGTGGCTACGTCTCCGAACTCACGACCGAAAAGATCAAGAGCAGCCCGCATGGATTTGACTTGGTCAGGGCCGAGCCTACATGTGCGAATGATGCCCATACTTGAGCCACCTAACTTTGTTTT
AGGGCGACTGCCCTGCTGCGTAACATCGTTGCTGCTGCGTAACATCGTTGCTGCTCCATAACATCAAACATCGACCCACGGCGTAACGCGCTTGCTGCTTGGATGCCCGAGGCATAGACTGTACAAAAAAACAGTCATAAC
AAGCCATGAAAACCGCCACTGCGCCGTTACCACCGCTGCGTTCGGTCAAGGTTCTGGACCAGTTGCGTGAGCGCATACGCTACTTGCATTACAGTTTACGAACCGAACAGGCTTATGTCAATTCG 
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CCTCTCAGGCGCCGCTGGTGCCGCTGGTTGGACGCCAAGGGTGAATCCGCCTCGATACCCTGATTACTCGCTTCCTGCGCCCTCTCAGGCGGCGATAGGGGACTGGTAAAACGGGGATTGCCCAGACGCCTCCCCCGCCCC
TTCAGGGGCACAAATGCGGCCCCAACGGGGCCACGTAGTGGTGCGTTTTTTGCGTTTCCACCCTTTTCTTCCTTTTCCCTTTTAAACCTTTTAGGACGTCTACAGGCCACGTAATCCGTGGCCTGTAGAGTTTAAAAAGGGAC
GGATTTGTTGCCATTAAGGGACGGATTTGTTGTTAAGAAGGGACGGATTTGTTGTTGTAAAGGGACGGATTTGTTGTATTGTGGGACGCAGATACAGTGTCCCCTTATACACAAGGAATGTCGAACGTGGCCTCACCCCCA
ATGGTTTACAAAAGCAATGCCCTGGTCGAGGCCGCGTATCGCCTCAGTGTTCAGGAACAGCGGATCGTTCTGGCCTGTATTAGCCAGGTGAAGAGGAGCGAGCCTGTCACCGATGAAGTGATGTATTCAGTGACGGCGGA
GGACATAGCGACGATGGCGGGTGTCCCTATCGAATCTTCCTACAACCAGCTCAAAGAAGCGGCCCTGCGCCTGAAACGGCGGGAAGTCCGGTTAACCCAAGAGCCCAATGGCAAGGGGAAAAGACCGAGTGTGATGATT
ACCGGCTGGGTGCAAACAATCATCTACCGGGAGGGTGAGGGCCGTGTAGAACTCAGGTTCACCAAAGACATGCTGCCGTACCTGACGGAACTCACCAAACAGTTCACCAAATACGCCTTGGCTGACGTGGCCAAGATGGA
CAGCACCCACGCGATCAGGCTTTACGAGCTGCTCATGCAATGGGACAGCATCGGCCAGCGCGAAATAGAAATTGACCAGCTGCGAAAGTGGTTTCAACTGGAAGGCCGGTATCCCTCGATCAAGGACTTCAAGTTGCGAG
TGCTTGATCCAGCCGTGACGCAGATCAACGAGCACAGCCCGCTACAGGTGGAGTGGGCGCAGCGAAAGACCGGGCGCAAGGTCACACATCTGTTGTTCAGTTTTGGACCGAAGAAGCCCGCCAAGGCGGTGGGTAAGG
CCCCAGCGAAGCGCAAGGCCGGGAAGATTTCAGATGCTGAGATCGCGAAACAGGCTCGCCCTGGTGAGACATGGGAAGCGGCCCGCGCTCGACTAACCCAGATGCCGCTGGATCTGGCCTAGAGGCCGTGGCCACCAC
GGCCCGGCCTGCCTTTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACG
ACGTTGTAAAACGACGGCCAGTGAATTGTCCATTTTAGCCTCCTTAGCTCCTGAAAATCTCGTCGAAGCTCGGCGGATTTGTCCTACTCAAGCTTGGCTGCAGGTCGACGGATCCGTCGACCTGCAGGTCATCAACTATCAA
ACGCTTCGGTTAAGCTTAAAGCACACCCTTTCTGCGTCCTCGTATTGACGCGACGTAAAATTTCAACGAGCACGCCGGGATACTTACCATATTCTCTGCTAATTATCCCGACATCATCGGTAACAATAAATGCTGGATAACTG
GTTGCTGACGCATCCATATAACTCATCAACCCCGGCGTTCCATCAGGTACAGGTTTCAACGTTTCAGGATCAAGCGCTCGCGCATATACCCACGGCGGAACATGTTTACGCTGCATTTCATCCTCAAAGAAACAAGTGTTGA
GTTCAACTTGATTAAATATATCTCGGATCTGACTAATATCACTGAGATTGAAAGTATCAAATAAAAGATGATTGAAATCATCACGTTTCAGAGATTCTTTTTCGTAACTTTTCCAGCCGCCTCCGGTTATGATATAAAGGCTTT
TATCTCCAGAAAATGAGATTTTTTTATCTTTCATATAATGGCAGAGTAAATAAATAAAGTATGGCGAACCAATAAGACAAAGATCTTTCCCTTGATTTTTTATTCGTTCAAGACTATTCAATGTTTTAACAAAATCTATTCGTTC
TTCTGTTACGGTAAATGTCGTAGGATATAACAATTCCACCAAACTCATAACATATTTAAACCAAATATTATGAGCATTAAATCTATCTGGTCCCAAATTGACTAATTCTATTTGATGATCAAACCAACTACCAACATATTTCATG
CCATAACTCACAGAGCCTAAGAGTCTCTCAATACTTAATCTGTCACGCGCCACCTGACTTTTTAAACCATTCGTGCCGCTACTGGTAAACCAACTTTCAATCTCGTTTTCCTGAGAAGTTAATAAGCGAGTAAACTTAAAAACC
GATGTTGGGAATACAGGTATGTCATCAATTTCCGTAATATTGTCATCTACTTTGTGTGCCTGACAGTAGTGACGATATTCTCGACAATGTTTATAATGATTACGAAATGCATCAAGCACAAGTTTCTTTCTGATTTTTTCCTGC
TCGTCGTAAGACCACACTAATGGATCGCTCGAAAAAATCAAATCATCAATTTCTGAGCTTGCTGTAATTTCTTGTTTATCAACATATGAAGTCATACCTGTTTTACTCCTCAAGATAATATTAGAAAGTATGGCAGCACTGCTG
TCATACTCTTTTATACCCTTCATCTTTCAAGCTGCTGCTTTGTTGGCTGCTTTCACTCACCCCAGTCACATAGTTATCTATGCTCCTGGGGATTCGTTCACTTGCCGCCTCGCTGCAACTCGAAATCTATTAGGTATATTCCATGT
GGTACTTCTTAATATTATCATCAACAATATTGATTACATTTTTTTGGCTCATCAAATCATTCATTGGTTCAAAGGACAGCAATACACTTTTCGCACCACACTTTTCAATTGCCAACTTAGCCGCAGTTATACACTCCGTATAATTT
CCGACAGCGTTTTCTGCAATTATTTCTTCAAGTTTATTTTCGAAATTTTCATTAGGGTGCATTTCAAGAACATAATCACTAATAAATGCACGCGTCTCTTGTTTAGCTTTATTACTATCTTCGTTATAGTTAACTAATATCATTAA
CTGATGGTCTATCTCTGATAGGTCAACGTCATATTTATCCGCAACGGCTTTATATCTTTCAGCATATTCATATCTAACATCATTAGAATCATCCCACTTAAAGATGAGAGGAATACCTTTTTTGGCCGCCCACTCAACAATATG
ATGACTGGTTGCTGTTACATATTTCCGAGGTCCGCCTGGCGTATAAGCATGGGGATTTACAGATATTTTAGGGAAGCTATAAAAATCGTTATCTGGATTACAATAGCCTGTTGTTAAAGCATCGTTAATGATTTCATAACACT
CTTCAAATAGTTGCTGTTGATATTCAACCGGGCGATTAAAAAAATGCATTTCATCTTTTTTTTCGCAATCACTAAACCCTAAAATAAATCTCCCTTCACTTAACTGATCCAATAAGCAAGCTTCCTCCGCTATGGCGACAGGAT
GATGAGTTGTAATGATGTGATTTAATGAACCAATTTTAATTTTCTCTGTTAAACCGAGCAGAAAACCAGAAACAGTCAGAGGAGCGCCGACAACACCATTATCTGAAAAATGATTTTCATACACTAAAATCTGTTCAAAATTC
AACTTATCAACATACTCCGTTATTTCCTGCATGCGAACTATACTTTGTTCTTGAACAGTTGTTGAATTGATGAAGTTAAGGAAGAACAATCCAAATTTCATTTCTTTCTCCTTAGCTAATATAATAGCGAACGTTGTTTTTCTTTA
AGAAATGGCATGACATCAGACTGGAAGAGCTTCATGGAAGCAATAATTTCGTCTACTGTTCCATTAGCTTCAAATCCACAACAAATATTTGATATTCCTGTAGCATCAATGTCTTTTTGAATTATGTCAATACATTCCTGCGGC
GTTCCCACGGGATTGATTTCGTAACTGTAATCAATACGGCGATTAGTATCTTTATGTCCTTTTAATACAAAGTCACGCCACTGCCCTTTATTGAAATCATAACCTCTTGTTTGGTCTGAATCATCAAAAATAGTCGTAGCATTCA
CATAAGAATCATACCAATGCCCCAGAAATTTCCGGCAAATCTCTTTCGCTTTAATTGAGTCATGATCTACAGATGTTATATATGATAAGCAATGGTCGATATTATGAATATCGTGCCCATATTCTTGAGCCACTTCATTATAAA
GCTCAAGTTGTGCTTTCTTTTCGTTAGTATTTATAATCCAACTTAATATCATCGGTAGGCCAAATTGAGCAGCCCACTCAGTCGTCGAAGCTGATTCAGCCACCACATAAACCGGTGCGCCACCTCTGCTATACGCCGCGGGG
TTTACTTTTACCTTATGGAACTTGATATGTTCATTATCAGCTTCCATATATCCCTCTGTCATGCCATTCTTTATCAGCCCGTACCAGCATTCCGCTAAGGCGCGACTGTTATTCATATCTGTGCCGAATACGCGAAAGTCCTTGTT
GTAAAGCCCTCGGCAAATACCAAACCGAAATCGTCCTTTTGACATTTGATCCAATAAATTCACATCTTCAAGTTGGCGTACTGGATGGGCTGTGGGAAGAACAATAGCGGCAGTTCCTACATTCAATTTTTTAGTCGCGCCA
AGTAAATATGCAGCAGCGACATAAGGGTTACCAAGCAAACCAAACTCCGTGAAATGATGCTCCAGTAACCATACGGTATCAAAACCACACTCCTCAGAGATGCGACCTAATTTAACCAAACGTTTCATTACCTCTGTTTGAG
AAAATTGGGGAGGTTGGTATGTAAGCAAAAAGTTTCCAAATTTCATAGAGAGTCCTTATATTGCTATTTGAGTGATAGAATATCTCAATAGATTTTAAGACAGAGAAATTGCTTGATTTTCAATCTCAATTCTCATTCGGCGT
TCATTGACTGTCGCAATAGTTAAATGTTCAAATGACGGTTCAGTAATATCAACATCAATATCCAGATGATCATTATCCATCGCGATAGCGGCTTTCGTAACCGATTGATAAAAATTGCGCAGGACCACTAAATTTTCACTCAA
GTCATGCGAACTTCCTAACAAAGAATATATCTTGCATCGATTACTACGAATATTTGATAACAATGTGATAACTTCATCTTGCTTGACCCAATTATCGTTATTTGCAGTAAAAGCAATAAACGGTATATCAAGATACATCATGTT
ATTAATTGTAGAAGCTAAATCTTCCCAACCAAAATCAAGACAATCTCTCGCAAAGACTTCAGCACCCAATTTATGGCCTTCAAAATCTAGATTATCCGGCAATTCATTAATGGGTAGACTGAGATAATCAAACCCTAAAGCTC
TTTCAAGAGAATATCTTAAGTTAACAACACCGACTGCGGTGATTAAAAACGAAGCATTGATTTCAGATAGGCTTGCATAAGCTATCCGCGCAGATAAGCTTGAAGCCAACATACCGAAGTTATTTATTTTTCGTGTAGTTAAC
CAATCAACCACTGCTAACAAGCTCTGCTTTCCTATAGACATTGTAAATTCATCAATTGTCCCTGAACTCAATCCAACGTGGTGAAGCGAATCATAGCGGATCACATGAAATCCATTCCGCGATAAATATTCCGCCAGACCAGC
AAAATGATCCATCCTGCGGGCAAAACCAGACGCAATAATAATGGCATTCTTTCTCTTTGGGCTGTTTTCTTCTGGCAGCGTTTCCCAAACATGAATTTTTTTATTTCCTTCAACACAAATAACGTGGTCGATGGTTTTATATTTT
GATTCATTTTCCATACTTTTACCTATTATGGGACAAATACAAGGAACTTATCTTCTTCCAGGAATCGAGTCTGTTCTATTTCAACCGCAACATCCTTAGCCGTATAGTTAGATGGCCTTTCATGAGAAATATATGTCACTAATCG
TTGCAACGGTCTCATTCCGTCATGAGATCCACCAACTCGAAATATGTTATTCATTCCTGCTTCTACAATCCTTTCCGCACCTTTTAATGCTAACGCATCTCGATATTTAAATGATGACTCCCAAGGAAAAATAGATATGGTTTGC
GTCTTATTTTTTTGAACATAAGGCAATATTTGCTCAATATTATCGACGTGATGAAGGTACACACATCTGCCAAGTGGTTGATTAAATTCCACACCTGCATTTGACTCAATAATCATCCAACGTTGATGAATATCCACCTCTACTT
TTAATCCAGCAAACAAGCTTTCTTTTTGAACTAAAGAATAGGCCGCCTTTTCATCAAAATCTTTTTTGGCATTCGGTAATATATGCGCATATAGATTAAGTTTTTCTATCAACGCTAACTTAAATTCCTCATAATGATTTCCCAT
GTAATATATGTTTTGGGCAGAAAAACAAGCTCGCTGATCGTAAAAACAAACATCATGAGCCGCACCTGTCGCTGCGGACGTCAAATCAACAGGATTATCGATAATGCAAAGACTCTTTTTAGAACCAAATTTAATCACATCA
GCATAAGATGGCGCATGCTCTACCGCCCAATTAATCGCATCTGGCCCTCCCCAAGCGACAATAACATCCGCATGTCGCATAATTTCTTTTGCGAGTGATGTATCACCTTGGTGGGGCCAATATATAACAGATAAAGAGCGCG
TTATCGGATGATTAGGGTCTACATCAATAAAACTTAACGCTAATGCATTAGCGGTAAAAGGATCGGTTGACGATGTTTTTATAATACACTGATTCTTAGTTAAAATTGCGCGTAATATAGACATGATCCCAGATAATGGAAC
ATTACCTGCCAACAGATGTACAGATTTACCTTTCGGAAAAGCCCGAACATAACTTTCATCCTGAGGTAGCCATTCATCCATGATATGGCGAGAACCAAGTTCATTTTCTACAACATCATAAAGGCCGCCTTTAGAACATAAAA
TCATAGATATCCAATTGGCCTCTAGCTTAGCCATTTCTTCTGAATATCCCATATATTTTTTTAAGTCACGAATGTATGTCCTGCGTCTTGAGTATTCTTCATTTTTCCATCTTTGCCCTACCGTATAGAGAAAATTGACAATGTTA
TGCAACCGTAATTCGTTATTTCCATTACAATCAATAATGTTTTTTACATGAGAGTCATTCAATATTGGCAGGTAAACACTATTATCACCAAAATTAATGGATTGCACTAAATCATCACTTTCGGGAAAGATTTCAACCTGGCCG
TTAATAATGAATGAAATTTTTTTAGTCATACGTAGTCAGATAGCGGCCGATTGATTCCACGCGAAAAAGCCCGAACAATGCCCCATCGTCCGCGAGCGGAGGAAACACCGTGCCCCGAG
TAGCTCCCAGAGACAGCGAATTCCTGGCAGTTTATGGCGGGCGTCCTGCCCGCCACCCTCCGGGCCGTTGCTTCGCAACGTTCAAATCCGCTCCCGGCGGATTTGTCCTACTCAGGACAGCGTTCACCGACAAACAA
CAGATAAAACGAAAGGCCCAGTCTTTCGACTGAGCCTTTCGTTTTATTTGATGCCTGGGGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTT
ATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGC
TCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGC
TTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACAC
GACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAA
GCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACG
GGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTG
ACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCG
CGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCG
CCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGG
TTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTCGAATTGGCCG
CGGCGTTGTGACAATTTACCGAACAACTCCGCGGCCGGGAAGCCGATCTCGGCTTGAACGAATTGTTAGGTGGCGGTACTTGGGTCGATATCAAAGTGCATCACTTCTTCCCGTATGCCCAACTTTGTATAGAGAGCCACT
GCGGGATCGTCACCGTAATCTGCTTGCACGTAGATCACATAAGCACCAAGCGCGTTGGCCTCATGCTTGAGGAGATTGATGAGCGCGGTGGCAATGCCCTGCCTCCGGTGCTCGCCGGAGACTGCGAGATCATAGATATA
GATCTCACTACGCGGCTGCTCAAACCTGGGCAGAACGTAAGCCGCGAGAGCGCCAACAACCGCTTCTTGGTCGAAGGCAGCAAGCGCGATGAATGTCTTACTACGGAGCAAGTTCCCGAGGTAATCGGAGTCCGGCTGAT
GTTGGGAGTAGGTGGCTACGTCTCCGAACTCACGACCGAAAAGATCAAGAGCAGCCCGCATGGATTTGACTTGGTCAGGGCCGAGCCTACATGTGCGAATGATGCCCATACTTGAGCCACCTAACTTTGTTTTAGGGCGA
CTGCCCTGCTGCGTAACATCGTTGCTGCTGCGTAACATCGTTGCTGCTCCATAACATCAAACATCGACCCACGGCGTAACGCGCTTGCTGCTTGGATGCCCGAGGCATAGACTGTACAAAAAAACAGTCATAACAAGCCATG
AAAACCGCCACTGCGCCGTTACCACCGCTGCGTTCGGTCAAGGTTCTGGACCAGTTGCGTGAGCGCATACGCTACTTGCATTACAGTTTACGAACCGAACAGGCTTATGTCAATTCG 
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CCTCTCAGGCGCCGCTGGTGCCGCTGGTTGGACGCCAAGGGTGAATCCGCCTCGATACCCTGATTACTCGCTTCCTGCGCCCTCTCAGGCGGCGATAGGGGACTGGTAAAACGGGGATTGCCCAGACGCCTCCCCCGCCCC
TTCAGGGGCACAAATGCGGCCCCAACGGGGCCACGTAGTGGTGCGTTTTTTGCGTTTCCACCCTTTTCTTCCTTTTCCCTTTTAAACCTTTTAGGACGTCTACAGGCCACGTAATCCGTGGCCTGTAGAGTTTAAAAAGGGAC
GGATTTGTTGCCATTAAGGGACGGATTTGTTGTTAAGAAGGGACGGATTTGTTGTTGTAAAGGGACGGATTTGTTGTATTGTGGGACGCAGATACAGTGTCCCCTTATACACAAGGAATGTCGAACGTGGCCTCACCCCCA
ATGGTTTACAAAAGCAATGCCCTGGTCGAGGCCGCGTATCGCCTCAGTGTTCAGGAACAGCGGATCGTTCTGGCCTGTATTAGCCAGGTGAAGAGGAGCGAGCCTGTCACCGATGAAGTGATGTATTCAGTGACGGCGGA
GGACATAGCGACGATGGCGGGTGTCCCTATCGAATCTTCCTACAACCAGCTCAAAGAAGCGGCCCTGCGCCTGAAACGGCGGGAAGTCCGGTTAACCCAAGAGCCCAATGGCAAGGGGAAAAGACCGAGTGTGATGATT
ACCGGCTGGGTGCAAACAATCATCTACCGGGAGGGTGAGGGCCGTGTAGAACTCAGGTTCACCAAAGACATGCTGCCGTACCTGACGGAACTCACCAAACAGTTCACCAAATACGCCTTGGCTGACGTGGCCAAGATGGA
CAGCACCCACGCGATCAGGCTTTACGAGCTGCTCATGCAATGGGACAGCATCGGCCAGCGCGAAATAGAAATTGACCAGCTGCGAAAGTGGTTTCAACTGGAAGGCCGGTATCCCTCGATCAAGGACTTCAAGTTGCGAG
TGCTTGATCCAGCCGTGACGCAGATCAACGAGCACAGCCCGCTACAGGTGGAGTGGGCGCAGCGAAAGACCGGGCGCAAGGTCACACATCTGTTGTTCAGTTTTGGACCGAAGAAGCCCGCCAAGGCGGTGGGTAAGG
CCCCAGCGAAGCGCAAGGCCGGGAAGATTTCAGATGCTGAGATCGCGAAACAGGCTCGCCCTGGTGAGACATGGGAAGCGGCCCGCGCTCGACTAACCCAGATGCCGCTGGATCTGGCCTAGAGGCCGTGGCCACCAC
GGCCCGGCCTGCCTTTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACG
ACGTTGTAAAACGACGGCCAGTGAATTGTCCATTTTAGCCTCCTTAGCTCCTGAAAATCTCGTCGAAGCTCGGCGGATTTGTCCTACTCAAGCTTGGCTGCAGGTCGACGGATCCGTCGACCTGCAGGTCATCAACTATCAA
ACGCTTCGGTTAAGCTTAAAGCACACCCTTTCTGCGTCCTCGTATTGACGCGACGTAAAATTTCAACGAGCACGCCGGGATACTTACCATATTCTCTGCTAATTATCCCGACATCATCGGTAACAATAAATGCTGGATAACTG
GTTGCTGACGCATCCATATAACTCATCAACCCCGGCGTTCCATCAGGTACAGGTTTCAACGTTTCAGGATCAAGCGCTCGCGCATATACCCACGGCGGAACATGTTTACGCTGCATTTCATCCTCAAAGAAACAAGTGTTGA
GTTCAACTTGATTAAATATATCTCGGATCTGACTAATATCACTGAGATTGAAAGTATCAAATAAAAGATGATTGAAATCATCACGTTTCAGAGATTCTTTTTCGTAACTTTTCCAGCCGCCTCCGGTTATGATATAAAGGCTTT
TATCTCCAGAAAATGAGATTTTTTTATCTTTCATATAATGGCAGAGTAAATAAATAAAGTATGGCGAACCAATAAGACAAAGATCTTTCCCTTGATTTTTTATTCGTTCAAGACTATTCAATGTTTTAACAAAATCTATTCGTTC
TTCTGTTACGGTAAATGTCGTAGGATATAACAATTCCACCAAACTCATAACATATTTAAACCAAATATTATGAGCATTAAATCTATCTGGTCCCAAATTGACTAATTCTATTTGATGATCAAACCAACTACCAACATATTTCATG
CCATAACTCACAGAGCCTAAGAGTCTCTCAATACTTAATCTGTCACGCGCCACCTGACTTTTTAAACCATTCGTGCCGCTACTGGTAAACCAACTTTCAATCTCGTTTTCCTGAGAAGTTAATAAGCGAGTAAACTTAAAAACC
GATGTTGGGAATACAGGTATGTCATCAATTTCCGTAATATTGTCATCTACTTTGTGTGCCTGACAGTAGTGACGATATTCTCGACAATGTTTATAATGATTACGAAATGCATCAAGCACAAGTTTCTTTCTGATTTTTTCCTGC
TCGTCGTAAGACCACACTAATGGATCGCTCGAAAAAATCAAATCATCAATTTCTGAGCTTGCTGTAATTTCTTGTTTATCAACATATGAAGTCATACCTGTTTTACTCCTCAAGATAATATTAGAAAGTATGGCAGCACTGCTG
TCATACTCTTTTATACCCTTCATCTTTCAAGCTGCTGCTTTGTTGGCTGCTTTCACTCACCCCAGTCACATAGTTATCTATGCTCCTGGGGATTCGTTCACTTGCCGCCTCGCTGCAACTCGAAATCTATTAGGTATATTCCATGT
GGTACTTCTTAATATTATCATCAACAATATTGATTACATTTTTTTGGCTCATCAAATCATTCATTGGTTCAAAGGACAGCAATACACTTTTCGCACCACACTTTTCAATTGCCAACTTAGCCGCAGTTATACACTCCGTATAATTT
CCGACAGCGTTTTCTGCAATTATTTCTTCAAGTTTATTTTCGAAATTTTCATTAGGGTGCATTTCAAGAACATAATCACTAATAAATGCACGCGTCTCTTGTTTAGCTTTATTACTATCTTCGTTATAGTTAACTAATATCATTAA
CTGATGGTCTATCTCTGATAGGTCAACGTCATATTTATCCGCAACGGCTTTATATCTTTCAGCATATTCATATCTAACATCATTAGAATCATCCCACTTAAAGATGAGAGGAATACCTTTTTTGGCCGCCCACTCAACAATATG
ATGACTGGTTGCTGTTACATATTTCCGAGGTCCGCCTGGCGTATAAGCATGGGGATTTACAGATATTTTAGGGAAGCTATAAAAATCGTTATCTGGATTACAATAGCCTGTTGTTAAAGCATCGTTAATGATTTCATAACACT
CTTCAAATAGTTGCTGTTGATATTCAACCGGGCGATTAAAAAAATGCATTTCATCTTTTTTTTCGCAATCACTAAACCCTAAAATAAATCTCCCTTCACTTAACTGATCCAATAAGCAAGCTTCCTCCGCTATGGCGACAGGAT
GATGAGTTGTAATGATGTGATTTAATGAACCAATTTTAATTTTCTCTGTTAAACCGAGCAGAAAACCAGAAACAGTCAGAGGAGCGCCGACAACACCATTATCTGAAAAATGATTTTCATACACTAAAATCTGTTCAAAATTC
AACTTATCAACATACTCCGTTATTTCCTGCATGCGAACTATACTTTGTTCTTGAACAGTTGTTGAATTGATGAAGTTAAGGAAGAACAATCCAAATTTCATTTCTTTCTCCTTAGCTAATATAATAGCGAACGTTGTTTTTCTTTA
AGAAATGGCATGACATCAGACTGGAAGAGCTTCATGGAAGCAATAATTTCGTCTACTGTTCCATTAGCTTCAAATCCACAACAAATATTTGATATTCCTGTAGCATCAATGTCTTTTTGAATTATGTCAATACATTCCTGCGGC
GTTCCCACGGGATTGATTTCGTAACTGTAATCAATACGGCGATTAGTATCTTTATGTCCTTTTAATACAAAGTCACGCCACTGCCCTTTATTGAAATCATAACCTCTTGTTTGGTCTGAATCATCAAAAATAGTCGTAGCATTCA
CATAAGAATCATACCAATGCCCCAGAAATTTCCGGCAAATCTCTTTCGCTTTAATTGAGTCATGATCTACAGATGTTATATATGATAAGCAATGGTCGATATTATGAATATCGTGCCCATATTCTTGAGCCACTTCATTATAAA
GCTCAAGTTGTGCTTTCTTTTCGTTAGTATTTATAATCCAACTTAATATCATCGGTAGGCCAAATTGAGCAGCCCACTCAGTCGTCGAAGCTGATTCAGCCACCACATAAACCGGTGCGCCACCTCTGCTATACGCCGCGGGG
TTTACTTTTACCTTATGGAACTTGATATGTTCATTATCAGCTTCCATATATCCCTCTGTCATGCCATTCTTTATCAGCCCGTACCAGCATTCCGCTAAGGCGCGACTGTTATTCATATCTGTGCCGAATACGCGAAAGTCCTTGTT
GTAAAGCCCTCGGCAAATACCAAACCGAAATCGTCCTTTTGACATTTGATCCAATAAATTCACATCTTCAAGTTGGCGTACTGGATGGGCTGTGGGAAGAACAATAGCGGCAGTTCCTACATTCAATTTTTTAGTCGCGCCA
AGTAAATATGCAGCAGCGACATAAGGGTTACCAAGCAAACCAAACTCCGTGAAATGATGCTCCAGTAACCATACGGTATCAAAACCACACTCCTCAGAGATGCGACCTAATTTAACCAAACGTTTCATTACCTCTGTTTGAG
AAAATTGGGGAGGTTGGTATGTAAGCAAAAAGTTTCCAAATTTCATAGAGAGTCCTTATATTGCTATTTGAGTGATAGAATATCTCAATAGATTTTAAGACAGAGAAATTGCTTGATTTTCAATCTCAATTCTCATTCGGCGT
TCATTGACTGTCGCAATAGTTAAATGTTCAAATGACGGTTCAGTAATATCAACATCAATATCCAGATGATCATTATCCATCGCGATAGCGGCTTTCGTAACCGATTGATAAAAATTGCGCAGGACCACTAAATTTTCACTCAA
GTCATGCGAACTTCCTAACAAAGAATATATCTTGCATCGATTACTACGAATATTTGATAACAATGTGATAACTTCATCTTGCTTGACCCAATTATCGTTATTTGCAGTAAAAGCAATAAACGGTATATCAAGATACATCATGTT
ATTAATTGTAGAAGCTAAATCTTCCCAACCAAAATCAAGACAATCTCTCGCAAAGACTTCAGCACCCAATTTATGGCCTTCAAAATCTAGATTATCCGGCAATTCATTAATGGGTAGACTGAGATAATCAAACCCTAAAGCTC
TTTCAAGAGAATATCTTAAGTTAACAACACCGACTGCGGTGATTAAAAACGAAGCATTGATTTCAGATAGGCTTGCATAAGCTATCCGCGCAGATAAGCTTGAAGCCAACATACCGAAGTTATTTATTTTTCGTGTAGTTAAC
CAATCAACCACTGCTAACAAGCTCTGCTTTCCTATAGACATTGTAAATTCATCAATTGTCCCTGAACTCAATCCAACGTGGTGAAGCGAATCATAGCGGATCACATGAAATCCATTCCGCGATAAATATTCCGCCAGACCAGC
AAAATGATCCATCCTGCGGGCAAAACCAGACGCAATAATAATGGCATTCTTTCTCTTTGGGCTGTTTTCTTCTGGCAGCGTTTCCCAAACATGAATTTTTTTATTTCCTTCAACACAAATAACGTGGTCGATGGTTTTATATTTT
GATTCATTTTCCATACTTTTACCTATTATGGGACAAATACAAGGAACTTATCTTCTTCCAGGAATCGAGTCTGTTCTATTTCAACCGCAACATCCTTAGCCGTATAGTTAGATGGCCTTTCATGAGAAATATATGTCACTAATCG
TTGCAACGGTCTCATTCCGTCATGAGATCCACCAACTCGAAATATGTTATTCATTCCTGCTTCTACAATCCTTTCCGCACCTTTTAATGCTAACGCATCTCGATATTTAAATGATGACTCCCAAGGAAAAATAGATATGGTTTGC
GTCTTATTTTTTTGAACATAAGGCAATATTTGCTCAATATTATCGACGTGATGAAGGTACACACATCTGCCAAGTGGTTGATTAAATTCCACACCTGCATTTGACTCAATAATCATCCAACGTTGATGAATATCCACCTCTACTT
TTAATCCAGCAAACAAGCTTTCTTTTTGAACTAAAGAATAGGCCGCCTTTTCATCAAAATCTTTTTTGGCATTCGGTAATATATGCGCATATAGATTAAGTTTTTCTATCAACGCTAACTTAAATTCCTCATAATGATTTCCCAT
GTAATATATGTTTTGGGCAGAAAAACAAGCTCGCTGATCGTAAAAACAAACATCATGAGCCGCACCTGTCGCTGCGGACGTCAAATCAACAGGATTATCGATAATGCAAAGACTCTTTTTAGAACCAAATTTAATCACATCA
GCATAAGATGGCGCATGCTCTACCGCCCAATTAATCGCATCTGGCCCTCCCCAAGCGACAATAACATCCGCATGTCGCATAATTTCTTTTGCGAGTGATGTATCACCTTGGTGGGGCCAATATATAACAGATAAAGAGCGCG
TTATCGGATGATTAGGGTCTACATCAATAAAACTTAACGCTAATGCATTAGCGGTAAAAGGATCGGTTGACGATGTTTTTATAATACACTGATTCTTAGTTAAAATTGCGCGTAATATAGACATGATCCCAGATAATGGAAC
ATTACCTGCCAACAGATGTACAGATTTACCTTTCGGAAAAGCCCGAACATAACTTTCATCCTGAGGTAGCCATTCATCCATGATATGGCGAGAACCAAGTTCATTTTCTACAACATCATAAAGGCCGCCTTTAGAACATAAAA
TCATAGATATCCAATTGGCCTCTAGCTTAGCCATTTCTTCTGAATATCCCATATATTTTTTTAAGTCACGAATGTATGTCCTGCGTCTTGAGTATTCTTCATTTTTCCATCTTTGCCCTACCGTATAGAGAAAATTGACAATGTTA
TGCAACCGTAATTCGTTATTTCCATTACAATCAATAATGTTTTTTACATGAGAGTCATTCAATATTGGCAGGTAAACACTATTATCACCAAAATTAATGGATTGCACTAAATCATCACTTTCGGGAAAGATTTCAACCTGGCCG
TTAATAATGAATGAAATTTTTTTAGTCATACGTAGTCAGATAGCGGCCGATTGATTCCACGCGAAAAAGCCCGAACAATGCCCCATCGTCCGCGAGCGGAGGAAACACCGTGCCCCGAG
TAGCTCCCAGAGACAGCGAATTCCTGGCAGTTTATGGCGGGCGTCCTGCCCGCCACCCTCCGGGCCGTTGCTTCGCAACGTTCAAATCCGCTCCCGGCGGATTTGTCCTACTCAGGACAGCGTTCACCGACAAACAA
CAGATAAAACGAAAGGCCCAGTCTTTCGACTGAGCCTTTCGTTTTATTTGATGCCTGGGGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTT
ATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGC
TCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGC
TTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACAC
GACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAA
GCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACG
GGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTG
ACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCG
CGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCG
CCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGG
TTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTCGAATTGGCCG
CGGCGTTGTGACAATTTACCGAACAACTCCGCGGCCGGGAAGCCGATCTCGGCTTGAACGAATTGTTAGGTGGCGGTACTTGGGTCGATATCAAAGTGCATCACTTCTTCCCGTATGCCCAACTTTGTATAGAGAGCCACT
GCGGGATCGTCACCGTAATCTGCTTGCACGTAGATCACATAAGCACCAAGCGCGTTGGCCTCATGCTTGAGGAGATTGATGAGCGCGGTGGCAATGCCCTGCCTCCGGTGCTCGCCGGAGACTGCGAGATCATAGATATA
GATCTCACTACGCGGCTGCTCAAACCTGGGCAGAACGTAAGCCGCGAGAGCGCCAACAACCGCTTCTTGGTCGAAGGCAGCAAGCGCGATGAATGTCTTACTACGGAGCAAGTTCCCGAGGTAATCGGAGTCCGGCTGAT
GTTGGGAGTAGGTGGCTACGTCTCCGAACTCACGACCGAAAAGATCAAGAGCAGCCCGCATGGATTTGACTTGGTCAGGGCCGAGCCTACATGTGCGAATGATGCCCATACTTGAGCCACCTAACTTTGTTTTAGGGCGA
CTGCCCTGCTGCGTAACATCGTTGCTGCTGCGTAACATCGTTGCTGCTCCATAACATCAAACATCGACCCACGGCGTAACGCGCTTGCTGCTTGGATGCCCGAGGCATAGACTGTACAAAAAAACAGTCATAACAAGCCATG
AAAACCGCCACTGCGCCGTTACCACCGCTGCGTTCGGTCAAGGTTCTGGACCAGTTGCGTGAGCGCATACGCTACTTGCATTACAGTTTACGAACCGAACAGGCTTATGTCAATTCG 
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CCTCTCAGGCGCCGCTGGTGCCGCTGGTTGGACGCCAAGGGTGAATCCGCCTCGATACCCTGATTACTCGCTTCCTGCGCCCTCTCAGGCGGCGATAGGGGACTGGTAAAACGGGGATTGCCCAGACGCCTCCCCCGCCCC
TTCAGGGGCACAAATGCGGCCCCAACGGGGCCACGTAGTGGTGCGTTTTTTGCGTTTCCACCCTTTTCTTCCTTTTCCCTTTTAAACCTTTTAGGACGTCTACAGGCCACGTAATCCGTGGCCTGTAGAGTTTAAAAAGGGAC
GGATTTGTTGCCATTAAGGGACGGATTTGTTGTTAAGAAGGGACGGATTTGTTGTTGTAAAGGGACGGATTTGTTGTATTGTGGGACGCAGATACAGTGTCCCCTTATACACAAGGAATGTCGAACGTGGCCTCACCCCCA
ATGGTTTACAAAAGCAATGCCCTGGTCGAGGCCGCGTATCGCCTCAGTGTTCAGGAACAGCGGATCGTTCTGGCCTGTATTAGCCAGGTGAAGAGGAGCGAGCCTGTCACCGATGAAGTGATGTATTCAGTGACGGCGGA
GGACATAGCGACGATGGCGGGTGTCCCTATCGAATCTTCCTACAACCAGCTCAAAGAAGCGGCCCTGCGCCTGAAACGGCGGGAAGTCCGGTTAACCCAAGAGCCCAATGGCAAGGGGAAAAGACCGAGTGTGATGATT
ACCGGCTGGGTGCAAACAATCATCTACCGGGAGGGTGAGGGCCGTGTAGAACTCAGGTTCACCAAAGACATGCTGCCGTACCTGACGGAACTCACCAAACAGTTCACCAAATACGCCTTGGCTGACGTGGCCAAGATGGA
CAGCACCCACGCGATCAGGCTTTACGAGCTGCTCATGCAATGGGACAGCATCGGCCAGCGCGAAATAGAAATTGACCAGCTGCGAAAGTGGTTTCAACTGGAAGGCCGGTATCCCTCGATCAAGGACTTCAAGTTGCGAG
TGCTTGATCCAGCCGTGACGCAGATCAACGAGCACAGCCCGCTACAGGTGGAGTGGGCGCAGCGAAAGACCGGGCGCAAGGTCACACATCTGTTGTTCAGTTTTGGACCGAAGAAGCCCGCCAAGGCGGTGGGTAAGG
CCCCAGCGAAGCGCAAGGCCGGGAAGATTTCAGATGCTGAGATCGCGAAACAGGCTCGCCCTGGTGAGACATGGGAAGCGGCCCGCGCTCGACTAACCCAGATGCCGCTGGATCTGGCCTAGAGGCCGTGGCCACCAC
GGCCCGGCCTGCCTTTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACG
ACGTTGTAAAACGACGGCCAGTGAATTGTCCATTTTAGCCTCCTTAGCTCCTGAAAATCTCGTCGAAGCTCGGCGGATTTGTCCTACTCAAGCTTGGCTGCAGGTCGACGGATCCGTCGACCTGCAGGTCATCAACTATCAA
ACGCTTCGGTTAAGCTTAAAGCACACCCTTTCTGCGTCCTCGTATTGACGCGACGTAAAATTTCAACGAGCACGCCGGGATACTTACCATATTCTCTGCTAATTATCCCGACATCATCGGTAACAATAAATGCTGGATAACTG
GTTGCTGACGCATCCATATAACTCATCAACCCCGGCGTTCCATCAGGTACAGGTTTCAACGTTTCAGGATCAAGCGCTCGCGCATATACCCACGGCGGAACATGTTTACGCTGCATTTCATCCTCAAAGAAACAAGTGTTGA
GTTCAACTTGATTAAATATATCTCGGATCTGACTAATATCACTGAGATTGAAAGTATCAAATAAAAGATGATTGAAATCATCACGTTTCAGAGATTCTTTTTCGTAACTTTTCCAGCCGCCTCCGGTTATGATATAAAGGCTTT
TATCTCCAGAAAATGAGATTTTTTTATCTTTCATATAATGGCAGAGTAAATAAATAAAGTATGGCGAACCAATAAGACAAAGATCTTTCCCTTGATTTTTTATTCGTTCAAGACTATTCAATGTTTTAACAAAATCTATTCGTTC
TTCTGTTACGGTAAATGTCGTAGGATATAACAATTCCACCAAACTCATAACATATTTAAACCAAATATTATGAGCATTAAATCTATCTGGTCCCAAATTGACTAATTCTATTTGATGATCAAACCAACTACCAACATATTTCATG
CCATAACTCACAGAGCCTAAGAGTCTCTCAATACTTAATCTGTCACGCGCCACCTGACTTTTTAAACCATTCGTGCCGCTACTGGTAAACCAACTTTCAATCTCGTTTTCCTGAGAAGTTAATAAGCGAGTAAACTTAAAAACC
GATGTTGGGAATACAGGTATGTCATCAATTTCCGTAATATTGTCATCTACTTTGTGTGCCTGACAGTAGTGACGATATTCTCGACAATGTTTATAATGATTACGAAATGCATCAAGCACAAGTTTCTTTCTGATTTTTTCCTGC
TCGTCGTAAGACCACACTAATGGATCGCTCGAAAAAATCAAATCATCAATTTCTGAGCTTGCTGTAATTTCTTGTTTATCAACATATGAAGTCATACCTGTTTTACTCCTCAAGATAATATTAGAAAGTATGGCAGCACTGCTG
TCATACTCTTTTATACCCTTCATCTTTCAAGCTGCTGCTTTGTTGGCTGCTTTCACTCACCCCAGTCACATAGTTATCTATGCTCCTGGGGATTCGTTCACTTGCCGCCTCGCTGCAACTCGAAATCTATTAGGTATATTCCATGT
GGTACTTCTTAATATTATCATCAACAATATTGATTACATTTTTTTGGCTCATCAAATCATTCATTGGTTCAAAGGACAGCAATACACTTTTCGCACCACACTTTTCAATTGCCAACTTAGCCGCAGTTATACACTCCGTATAATTT
CCGACAGCGTTTTCTGCAATTATTTCTTCAAGTTTATTTTCGAAATTTTCATTAGGGTGCATTTCAAGAACATAATCACTAATAAATGCACGCGTCTCTTGTTTAGCTTTATTACTATCTTCGTTATAGTTAACTAATATCATTAA
CTGATGGTCTATCTCTGATAGGTCAACGTCATATTTATCCGCAACGGCTTTATATCTTTCAGCATATTCATATCTAACATCATTAGAATCATCCCACTTAAAGATGAGAGGAATACCTTTTTTGGCCGCCCACTCAACAATATG
ATGACTGGTTGCTGTTACATATTTCCGAGGTCCGCCTGGCGTATAAGCATGGGGATTTACAGATATTTTAGGGAAGCTATAAAAATCGTTATCTGGATTACAATAGCCTGTTGTTAAAGCATCGTTAATGATTTCATAACACT
CTTCAAATAGTTGCTGTTGATATTCAACCGGGCGATTAAAAAAATGCATTTCATCTTTTTTTTCGCAATCACTAAACCCTAAAATAAATCTCCCTTCACTTAACTGATCCAATAAGCAAGCTTCCTCCGCTATGGCGACAGGAT
GATGAGTTGTAATGATGTGATTTAATGAACCAATTTTAATTTTCTCTGTTAAACCGAGCAGAAAACCAGAAACAGTCAGAGGAGCGCCGACAACACCATTATCTGAAAAATGATTTTCATACACTAAAATCTGTTCAAAATTC
AACTTATCAACATACTCCGTTATTTCCTGCATGCGAACTATACTTTGTTCTTGAACAGTTGTTGAATTGATGAAGTTAAGGAAGAACAATCCAAATTTCATTTCTTTCTCCTTAGCTAATATAATAGCGAACGTTGTTTTTCTTTA
AGAAATGGCATGACATCAGACTGGAAGAGCTTCATGGAAGCAATAATTTCGTCTACTGTTCCATTAGCTTCAAATCCACAACAAATATTTGATATTCCTGTAGCATCAATGTCTTTTTGAATTATGTCAATACATTCCTGCGGC
GTTCCCACGGGATTGATTTCGTAACTGTAATCAATACGGCGATTAGTATCTTTATGTCCTTTTAATACAAAGTCACGCCACTGCCCTTTATTGAAATCATAACCTCTTGTTTGGTCTGAATCATCAAAAATAGTCGTAGCATTCA
CATAAGAATCATACCAATGCCCCAGAAATTTCCGGCAAATCTCTTTCGCTTTAATTGAGTCATGATCTACAGATGTTATATATGATAAGCAATGGTCGATATTATGAATATCGTGCCCATATTCTTGAGCCACTTCATTATAAA
GCTCAAGTTGTGCTTTCTTTTCGTTAGTATTTATAATCCAACTTAATATCATCGGTAGGCCAAATTGAGCAGCCCACTCAGTCGTCGAAGCTGATTCAGCCACCACATAAACCGGTGCGCCACCTCTGCTATACGCCGCGGGG
TTTACTTTTACCTTATGGAACTTGATATGTTCATTATCAGCTTCCATATATCCCTCTGTCATGCCATTCTTTATCAGCCCGTACCAGCATTCCGCTAAGGCGCGACTGTTATTCATATCTGTGCCGAATACGCGAAAGTCCTTGTT
GTAAAGCCCTCGGCAAATACCAAACCGAAATCGTCCTTTTGACATTTGATCCAATAAATTCACATCTTCAAGTTGGCGTACTGGATGGGCTGTGGGAAGAACAATAGCGGCAGTTCCTACATTCAATTTTTTAGTCGCGCCA
AGTAAATATGCAGCAGCGACATAAGGGTTACCAAGCAAACCAAACTCCGTGAAATGATGCTCCAGTAACCATACGGTATCAAAACCACACTCCTCAGAGATGCGACCTAATTTAACCAAACGTTTCATTACCTCTGTTTGAG
AAAATTGGGGAGGTTGGTATGTAAGCAAAAAGTTTCCAAATTTCATAGAGAGTCCTTATATTGCTATTTGAGTGATAGAATATCTCAATAGATTTTAAGACAGAGAAATTGCTTGATTTTCAATCTCAATTCTCATTCGGCGT
TCATTGACTGTCGCAATAGTTAAATGTTCAAATGACGGTTCAGTAATATCAACATCAATATCCAGATGATCATTATCCATCGCGATAGCGGCTTTCGTAACCGATTGATAAAAATTGCGCAGGACCACTAAATTTTCACTCAA
GTCATGCGAACTTCCTAACAAAGAATATATCTTGCATCGATTACTACGAATATTTGATAACAATGTGATAACTTCATCTTGCTTGACCCAATTATCGTTATTTGCAGTAAAAGCAATAAACGGTATATCAAGATACATCATGTT
ATTAATTGTAGAAGCTAAATCTTCCCAACCAAAATCAAGACAATCTCTCGCAAAGACTTCAGCACCCAATTTATGGCCTTCAAAATCTAGATTATCCGGCAATTCATTAATGGGTAGACTGAGATAATCAAACCCTAAAGCTC
TTTCAAGAGAATATCTTAAGTTAACAACACCGACTGCGGTGATTAAAAACGAAGCATTGATTTCAGATAGGCTTGCATAAGCTATCCGCGCAGATAAGCTTGAAGCCAACATACCGAAGTTATTTATTTTTCGTGTAGTTAAC
CAATCAACCACTGCTAACAAGCTCTGCTTTCCTATAGACATTGTAAATTCATCAATTGTCCCTGAACTCAATCCAACGTGGTGAAGCGAATCATAGCGGATCACATGAAATCCATTCCGCGATAAATATTCCGCCAGACCAGC
AAAATGATCCATCCTGCGGGCAAAACCAGACGCAATAATAATGGCATTCTTTCTCTTTGGGCTGTTTTCTTCTGGCAGCGTTTCCCAAACATGAATTTTTTTATTTCCTTCAACACAAATAACGTGGTCGATGGTTTTATATTTT
GATTCATTTTCCATACTTTTACCTATTATGGGACAAATACAAGGAACTTATCTTCTTCCAGGAATCGAGTCTGTTCTATTTCAACCGCAACATCCTTAGCCGTATAGTTAGATGGCCTTTCATGAGAAATATATGTCACTAATCG
TTGCAACGGTCTCATTCCGTCATGAGATCCACCAACTCGAAATATGTTATTCATTCCTGCTTCTACAATCCTTTCCGCACCTTTTAATGCTAACGCATCTCGATATTTAAATGATGACTCCCAAGGAAAAATAGATATGGTTTGC
GTCTTATTTTTTTGAACATAAGGCAATATTTGCTCAATATTATCGACGTGATGAAGGTACACACATCTGCCAAGTGGTTGATTAAATTCCACACCTGCATTTGACTCAATAATCATCCAACGTTGATGAATATCCACCTCTACTT
TTAATCCAGCAAACAAGCTTTCTTTTTGAACTAAAGAATAGGCCGCCTTTTCATCAAAATCTTTTTTGGCATTCGGTAATATATGCGCATATAGATTAAGTTTTTCTATCAACGCTAACTTAAATTCCTCATAATGATTTCCCAT
GTAATATATGTTTTGGGCAGAAAAACAAGCTCGCTGATCGTAAAAACAAACATCATGAGCCGCACCTGTCGCTGCGGACGTCAAATCAACAGGATTATCGATAATGCAAAGACTCTTTTTAGAACCAAATTTAATCACATCA
GCATAAGATGGCGCATGCTCTACCGCCCAATTAATCGCATCTGGCCCTCCCCAAGCGACAATAACATCCGCATGTCGCATAATTTCTTTTGCGAGTGATGTATCACCTTGGTGGGGCCAATATATAACAGATAAAGAGCGCG
TTATCGGATGATTAGGGTCTACATCAATAAAACTTAACGCTAATGCATTAGCGGTAAAAGGATCGGTTGACGATGTTTTTATAATACACTGATTCTTAGTTAAAATTGCGCGTAATATAGACATGATCCCAGATAATGGAAC
ATTACCTGCCAACAGATGTACAGATTTACCTTTCGGAAAAGCCCGAACATAACTTTCATCCTGAGGTAGCCATTCATCCATGATATGGCGAGAACCAAGTTCATTTTCTACAACATCATAAAGGCCGCCTTTAGAACATAAAA
TCATAGATATCCAATTGGCCTCTAGCTTAGCCATTTCTTCTGAATATCCCATATATTTTTTTAAGTCACGAATGTATGTCCTGCGTCTTGAGTATTCTTCATTTTTCCATCTTTGCCCTACCGTATAGAGAAAATTGACAATGTTA
TGCAACCGTAATTCGTTATTTCCATTACAATCAATAATGTTTTTTACATGAGAGTCATTCAATATTGGCAGGTAAACACTATTATCACCAAAATTAATGGATTGCACTAAATCATCACTTTCGGGAAAGATTTCAACCTGGCCG
TTAATAATGAATGAAATTTTTTTAGTCATACGTAGTCAGCGCAAGGGATTTGTTCATAGAGGAAGAAAGCCGGCCTTGAACCTGCGAGGGTGGCGTCATCATGACATAAGCCGTCCGGCA
AGCCCAAGGGGGCCGGGACGGGGCGTCGACGAAGCTGTCTATGGGGTCAATACGAATTCCTGGCAGTTTATGGCGGGCGTCCTGCCCGCCACCCTCCGGGCCGTTGCTTCGCAACGTTCAAATCCG
CTCCCGGCGGATTTGTCCTACTCAGGACAGCGTTCACCGACAAACAACAGATAAAACGAAAGGCCCAGTCTTTCGACTGAGCCTTTCGTTTTATTTGATGCCTGGGGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTC
GGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGT
TTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCC
GCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCT
GCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAAC
TACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATT
ACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAA
AATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTA
CGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCC
TCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCA
ACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCA
TGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTCGAATTGGCCGCGGCGTTGTGACAATTTACCGAACAACTCCGCGGCCGGGAAGCCGATCTCGGCTTGAACGAATTGTTAGGTGGCGGTACTTGGGTCGATATCAA
AGTGCATCACTTCTTCCCGTATGCCCAACTTTGTATAGAGAGCCACTGCGGGATCGTCACCGTAATCTGCTTGCACGTAGATCACATAAGCACCAAGCGCGTTGGCCTCATGCTTGAGGAGATTGATGAGCGCGGTGGCAA
TGCCCTGCCTCCGGTGCTCGCCGGAGACTGCGAGATCATAGATATAGATCTCACTACGCGGCTGCTCAAACCTGGGCAGAACGTAAGCCGCGAGAGCGCCAACAACCGCTTCTTGGTCGAAGGCAGCAAGCGCGATGAAT
GTCTTACTACGGAGCAAGTTCCCGAGGTAATCGGAGTCCGGCTGATGTTGGGAGTAGGTGGCTACGTCTCCGAACTCACGACCGAAAAGATCAAGAGCAGCCCGCATGGATTTGACTTGGTCAGGGCCGAGCCTACATGT
GCGAATGATGCCCATACTTGAGCCACCTAACTTTGTTTTAGGGCGACTGCCCTGCTGCGTAACATCGTTGCTGCTGCGTAACATCGTTGCTGCTCCATAACATCAAACATCGACCCACGGCGTAACGCGCTTGCTGCTTGGAT
GCCCGAGGCATAGACTGTACAAAAAAACAGTCATAACAAGCCATGAAAACCGCCACTGCGCCGTTACCACCGCTGCGTTCGGTCAAGGTTCTGGACCAGTTGCGTGAGCGCATACGCTACTTGCATTACAGTTTACGAACC
GAACAGGCTTATGTCAATTCG 
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CCTCTCAGGCGCCGCTGGTGCCGCTGGTTGGACGCCAAGGGTGAATCCGCCTCGATACCCTGATTACTCGCTTCCTGCGCCCTCTCAGGCGGCGATAGGGGACTGGTAAAACGGGGATTGCCCAGACGCCTCCCCCGCCCC
TTCAGGGGCACAAATGCGGCCCCAACGGGGCCACGTAGTGGTGCGTTTTTTGCGTTTCCACCCTTTTCTTCCTTTTCCCTTTTAAACCTTTTAGGACGTCTACAGGCCACGTAATCCGTGGCCTGTAGAGTTTAAAAAGGGAC
GGATTTGTTGCCATTAAGGGACGGATTTGTTGTTAAGAAGGGACGGATTTGTTGTTGTAAAGGGACGGATTTGTTGTATTGTGGGACGCAGATACAGTGTCCCCTTATACACAAGGAATGTCGAACGTGGCCTCACCCCCA
ATGGTTTACAAAAGCAATGCCCTGGTCGAGGCCGCGTATCGCCTCAGTGTTCAGGAACAGCGGATCGTTCTGGCCTGTATTAGCCAGGTGAAGAGGAGCGAGCCTGTCACCGATGAAGTGATGTATTCAGTGACGGCGGA
GGACATAGCGACGATGGCGGGTGTCCCTATCGAATCTTCCTACAACCAGCTCAAAGAAGCGGCCCTGCGCCTGAAACGGCGGGAAGTCCGGTTAACCCAAGAGCCCAATGGCAAGGGGAAAAGACCGAGTGTGATGATT
ACCGGCTGGGTGCAAACAATCATCTACCGGGAGGGTGAGGGCCGTGTAGAACTCAGGTTCACCAAAGACATGCTGCCGTACCTGACGGAACTCACCAAACAGTTCACCAAATACGCCTTGGCTGACGTGGCCAAGATGGA
CAGCACCCACGCGATCAGGCTTTACGAGCTGCTCATGCAATGGGACAGCATCGGCCAGCGCGAAATAGAAATTGACCAGCTGCGAAAGTGGTTTCAACTGGAAGGCCGGTATCCCTCGATCAAGGACTTCAAGTTGCGAG
TGCTTGATCCAGCCGTGACGCAGATCAACGAGCACAGCCCGCTACAGGTGGAGTGGGCGCAGCGAAAGACCGGGCGCAAGGTCACACATCTGTTGTTCAGTTTTGGACCGAAGAAGCCCGCCAAGGCGGTGGGTAAGG
CCCCAGCGAAGCGCAAGGCCGGGAAGATTTCAGATGCTGAGATCGCGAAACAGGCTCGCCCTGGTGAGACATGGGAAGCGGCCCGCGCTCGACTAACCCAGATGCCGCTGGATCTGGCCTAGAGGCCGTGGCCACCAC
GGCCCGGCCTGCCTTTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACG
ACGTTGTAAAACGACGGCCAGTGAATTGTCCATTTTAGCCTCCTTAGCTCCTGAAAATCTCGTCGAAGCTCGGCGGATTTGTCCTACTCAAGCTTGGCTGCAGGTCGACGGATCCGTCGACCTGCAGGTCATCAACTATCAA
ACGCTTCGGTTAAGCTTAAAGCACACCCTTTCTGCGTCCTCGTATTGACGCGACGTAAAATTTCAACGAGCACGCCGGGATACTTACCATATTCTCTGCTAATTATCCCGACATCATCGGTAACAATAAATGCTGGATAACTG
GTTGCTGACGCATCCATATAACTCATCAACCCCGGCGTTCCATCAGGTACAGGTTTCAACGTTTCAGGATCAAGCGCTCGCGCATATACCCACGGCGGAACATGTTTACGCTGCATTTCATCCTCAAAGAAACAAGTGTTGA
GTTCAACTTGATTAAATATATCTCGGATCTGACTAATATCACTGAGATTGAAAGTATCAAATAAAAGATGATTGAAATCATCACGTTTCAGAGATTCTTTTTCGTAACTTTTCCAGCCGCCTCCGGTTATGATATAAAGGCTTT
TATCTCCAGAAAATGAGATTTTTTTATCTTTCATATAATGGCAGAGTAAATAAATAAAGTATGGCGAACCAATAAGACAAAGATCTTTCCCTTGATTTTTTATTCGTTCAAGACTATTCAATGTTTTAACAAAATCTATTCGTTC
TTCTGTTACGGTAAATGTCGTAGGATATAACAATTCCACCAAACTCATAACATATTTAAACCAAATATTATGAGCATTAAATCTATCTGGTCCCAAATTGACTAATTCTATTTGATGATCAAACCAACTACCAACATATTTCATG
CCATAACTCACAGAGCCTAAGAGTCTCTCAATACTTAATCTGTCACGCGCCACCTGACTTTTTAAACCATTCGTGCCGCTACTGGTAAACCAACTTTCAATCTCGTTTTCCTGAGAAGTTAATAAGCGAGTAAACTTAAAAACC
GATGTTGGGAATACAGGTATGTCATCAATTTCCGTAATATTGTCATCTACTTTGTGTGCCTGACAGTAGTGACGATATTCTCGACAATGTTTATAATGATTACGAAATGCATCAAGCACAAGTTTCTTTCTGATTTTTTCCTGC
TCGTCGTAAGACCACACTAATGGATCGCTCGAAAAAATCAAATCATCAATTTCTGAGCTTGCTGTAATTTCTTGTTTATCAACATATGAAGTCATACCTGTTTTACTCCTCAAGATAATATTAGAAAGTATGGCAGCACTGCTG
TCATACTCTTTTATACCCTTCATCTTTCAAGCTGCTGCTTTGTTGGCTGCTTTCACTCACCCCAGTCACATAGTTATCTATGCTCCTGGGGATTCGTTCACTTGCCGCCTCGCTGCAACTCGAAATCTATTAGGTATATTCCATGT
GGTACTTCTTAATATTATCATCAACAATATTGATTACATTTTTTTGGCTCATCAAATCATTCATTGGTTCAAAGGACAGCAATACACTTTTCGCACCACACTTTTCAATTGCCAACTTAGCCGCAGTTATACACTCCGTATAATTT
CCGACAGCGTTTTCTGCAATTATTTCTTCAAGTTTATTTTCGAAATTTTCATTAGGGTGCATTTCAAGAACATAATCACTAATAAATGCACGCGTCTCTTGTTTAGCTTTATTACTATCTTCGTTATAGTTAACTAATATCATTAA
CTGATGGTCTATCTCTGATAGGTCAACGTCATATTTATCCGCAACGGCTTTATATCTTTCAGCATATTCATATCTAACATCATTAGAATCATCCCACTTAAAGATGAGAGGAATACCTTTTTTGGCCGCCCACTCAACAATATG
ATGACTGGTTGCTGTTACATATTTCCGAGGTCCGCCTGGCGTATAAGCATGGGGATTTACAGATATTTTAGGGAAGCTATAAAAATCGTTATCTGGATTACAATAGCCTGTTGTTAAAGCATCGTTAATGATTTCATAACACT
CTTCAAATAGTTGCTGTTGATATTCAACCGGGCGATTAAAAAAATGCATTTCATCTTTTTTTTCGCAATCACTAAACCCTAAAATAAATCTCCCTTCACTTAACTGATCCAATAAGCAAGCTTCCTCCGCTATGGCGACAGGAT
GATGAGTTGTAATGATGTGATTTAATGAACCAATTTTAATTTTCTCTGTTAAACCGAGCAGAAAACCAGAAACAGTCAGAGGAGCGCCGACAACACCATTATCTGAAAAATGATTTTCATACACTAAAATCTGTTCAAAATTC
AACTTATCAACATACTCCGTTATTTCCTGCATGCGAACTATACTTTGTTCTTGAACAGTTGTTGAATTGATGAAGTTAAGGAAGAACAATCCAAATTTCATTTCTTTCTCCTTAGCTAATATAATAGCGAACGTTGTTTTTCTTTA
AGAAATGGCATGACATCAGACTGGAAGAGCTTCATGGAAGCAATAATTTCGTCTACTGTTCCATTAGCTTCAAATCCACAACAAATATTTGATATTCCTGTAGCATCAATGTCTTTTTGAATTATGTCAATACATTCCTGCGGC
GTTCCCACGGGATTGATTTCGTAACTGTAATCAATACGGCGATTAGTATCTTTATGTCCTTTTAATACAAAGTCACGCCACTGCCCTTTATTGAAATCATAACCTCTTGTTTGGTCTGAATCATCAAAAATAGTCGTAGCATTCA
CATAAGAATCATACCAATGCCCCAGAAATTTCCGGCAAATCTCTTTCGCTTTAATTGAGTCATGATCTACAGATGTTATATATGATAAGCAATGGTCGATATTATGAATATCGTGCCCATATTCTTGAGCCACTTCATTATAAA
GCTCAAGTTGTGCTTTCTTTTCGTTAGTATTTATAATCCAACTTAATATCATCGGTAGGCCAAATTGAGCAGCCCACTCAGTCGTCGAAGCTGATTCAGCCACCACATAAACCGGTGCGCCACCTCTGCTATACGCCGCGGGG
TTTACTTTTACCTTATGGAACTTGATATGTTCATTATCAGCTTCCATATATCCCTCTGTCATGCCATTCTTTATCAGCCCGTACCAGCATTCCGCTAAGGCGCGACTGTTATTCATATCTGTGCCGAATACGCGAAAGTCCTTGTT
GTAAAGCCCTCGGCAAATACCAAACCGAAATCGTCCTTTTGACATTTGATCCAATAAATTCACATCTTCAAGTTGGCGTACTGGATGGGCTGTGGGAAGAACAATAGCGGCAGTTCCTACATTCAATTTTTTAGTCGCGCCA
AGTAAATATGCAGCAGCGACATAAGGGTTACCAAGCAAACCAAACTCCGTGAAATGATGCTCCAGTAACCATACGGTATCAAAACCACACTCCTCAGAGATGCGACCTAATTTAACCAAACGTTTCATTACCTCTGTTTGAG
AAAATTGGGGAGGTTGGTATGTAAGCAAAAAGTTTCCAAATTTCATAGAGAGTCCTTATATTGCTATTTGAGTGATAGAATATCTCAATAGATTTTAAGACAGAGAAATTGCTTGATTTTCAATCTCAATTCTCATTCGGCGT
TCATTGACTGTCGCAATAGTTAAATGTTCAAATGACGGTTCAGTAATATCAACATCAATATCCAGATGATCATTATCCATCGCGATAGCGGCTTTCGTAACCGATTGATAAAAATTGCGCAGGACCACTAAATTTTCACTCAA
GTCATGCGAACTTCCTAACAAAGAATATATCTTGCATCGATTACTACGAATATTTGATAACAATGTGATAACTTCATCTTGCTTGACCCAATTATCGTTATTTGCAGTAAAAGCAATAAACGGTATATCAAGATACATCATGTT
ATTAATTGTAGAAGCTAAATCTTCCCAACCAAAATCAAGACAATCTCTCGCAAAGACTTCAGCACCCAATTTATGGCCTTCAAAATCTAGATTATCCGGCAATTCATTAATGGGTAGACTGAGATAATCAAACCCTAAAGCTC
TTTCAAGAGAATATCTTAAGTTAACAACACCGACTGCGGTGATTAAAAACGAAGCATTGATTTCAGATAGGCTTGCATAAGCTATCCGCGCAGATAAGCTTGAAGCCAACATACCGAAGTTATTTATTTTTCGTGTAGTTAAC
CAATCAACCACTGCTAACAAGCTCTGCTTTCCTATAGACATTGTAAATTCATCAATTGTCCCTGAACTCAATCCAACGTGGTGAAGCGAATCATAGCGGATCACATGAAATCCATTCCGCGATAAATATTCCGCCAGACCAGC
AAAATGATCCATCCTGCGGGCAAAACCAGACGCAATAATAATGGCATTCTTTCTCTTTGGGCTGTTTTCTTCTGGCAGCGTTTCCCAAACATGAATTTTTTTATTTCCTTCAACACAAATAACGTGGTCGATGGTTTTATATTTT
GATTCATTTTCCATACTTTTACCTATTATGGGACAAATACAAGGAACTTATCTTCTTCCAGGAATCGAGTCTGTTCTATTTCAACCGCAACATCCTTAGCCGTATAGTTAGATGGCCTTTCATGAGAAATATATGTCACTAATCG
TTGCAACGGTCTCATTCCGTCATGAGATCCACCAACTCGAAATATGTTATTCATTCCTGCTTCTACAATCCTTTCCGCACCTTTTAATGCTAACGCATCTCGATATTTAAATGATGACTCCCAAGGAAAAATAGATATGGTTTGC
GTCTTATTTTTTTGAACATAAGGCAATATTTGCTCAATATTATCGACGTGATGAAGGTACACACATCTGCCAAGTGGTTGATTAAATTCCACACCTGCATTTGACTCAATAATCATCCAACGTTGATGAATATCCACCTCTACTT
TTAATCCAGCAAACAAGCTTTCTTTTTGAACTAAAGAATAGGCCGCCTTTTCATCAAAATCTTTTTTGGCATTCGGTAATATATGCGCATATAGATTAAGTTTTTCTATCAACGCTAACTTAAATTCCTCATAATGATTTCCCAT
GTAATATATGTTTTGGGCAGAAAAACAAGCTCGCTGATCGTAAAAACAAACATCATGAGCCGCACCTGTCGCTGCGGACGTCAAATCAACAGGATTATCGATAATGCAAAGACTCTTTTTAGAACCAAATTTAATCACATCA
GCATAAGATGGCGCATGCTCTACCGCCCAATTAATCGCATCTGGCCCTCCCCAAGCGACAATAACATCCGCATGTCGCATAATTTCTTTTGCGAGTGATGTATCACCTTGGTGGGGCCAATATATAACAGATAAAGAGCGCG
TTATCGGATGATTAGGGTCTACATCAATAAAACTTAACGCTAATGCATTAGCGGTAAAAGGATCGGTTGACGATGTTTTTATAATACACTGATTCTTAGTTAAAATTGCGCGTAATATAGACATGATCCCAGATAATGGAAC
ATTACCTGCCAACAGATGTACAGATTTACCTTTCGGAAAAGCCCGAACATAACTTTCATCCTGAGGTAGCCATTCATCCATGATATGGCGAGAACCAAGTTCATTTTCTACAACATCATAAAGGCCGCCTTTAGAACATAAAA
TCATAGATATCCAATTGGCCTCTAGCTTAGCCATTTCTTCTGAATATCCCATATATTTTTTTAAGTCACGAATGTATGTCCTGCGTCTTGAGTATTCTTCATTTTTCCATCTTTGCCCTACCGTATAGAGAAAATTGACAATGTTA
TGCAACCGTAATTCGTTATTTCCATTACAATCAATAATGTTTTTTACATGAGAGTCATTCAATATTGGCAGGTAAACACTATTATCACCAAAATTAATGGATTGCACTAAATCATCACTTTCGGGAAAGATTTCAACCTGGCCG
TTAATAATGAATGAAATTTTTTTAGTCATACGTAGTCAGCGCAAGGGATTTGTTCATAGAGGAAGAAAGCCGGCCTTGAACCTGCGAGGGTGGCGTCATCATGACATAAGCCGTCCGGCA
AGCCCAAGGGGGCCGGGACGGGGCGTCGACGAAGCTGTCTATGGGGTCAATACGAATTCCTGGCAGTTTATGGCGGGCGTCCTGCCCGCCACCCTCCGGGCCGTTGCTTCGCAACGTTCAAATCCG
CTCCCGGCGGATTTGTCCTACTCAGGACAGCGTTCACCGACAAACAACAGATAAAACGAAAGGCCCAGTCTTTCGACTGAGCCTTTCGTTTTATTTGATGCCTGGGGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTC
GGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGT
TTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCC
GCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCT
GCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAAC
TACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATT
ACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAA
AATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTA
CGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCC
TCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCA
ACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCA
TGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTCGAATTGGCCGCGGCGTTGTGACAATTTACCGAACAACTCCGCGGCCGGGAAGCCGATCTCGGCTTGAACGAATTGTTAGGTGGCGGTACTTGGGTCGATATCAA
AGTGCATCACTTCTTCCCGTATGCCCAACTTTGTATAGAGAGCCACTGCGGGATCGTCACCGTAATCTGCTTGCACGTAGATCACATAAGCACCAAGCGCGTTGGCCTCATGCTTGAGGAGATTGATGAGCGCGGTGGCAA
TGCCCTGCCTCCGGTGCTCGCCGGAGACTGCGAGATCATAGATATAGATCTCACTACGCGGCTGCTCAAACCTGGGCAGAACGTAAGCCGCGAGAGCGCCAACAACCGCTTCTTGGTCGAAGGCAGCAAGCGCGATGAAT
GTCTTACTACGGAGCAAGTTCCCGAGGTAATCGGAGTCCGGCTGATGTTGGGAGTAGGTGGCTACGTCTCCGAACTCACGACCGAAAAGATCAAGAGCAGCCCGCATGGATTTGACTTGGTCAGGGCCGAGCCTACATGT
GCGAATGATGCCCATACTTGAGCCACCTAACTTTGTTTTAGGGCGACTGCCCTGCTGCGTAACATCGTTGCTGCTGCGTAACATCGTTGCTGCTCCATAACATCAAACATCGACCCACGGCGTAACGCGCTTGCTGCTTGGAT
GCCCGAGGCATAGACTGTACAAAAAAACAGTCATAACAAGCCATGAAAACCGCCACTGCGCCGTTACCACCGCTGCGTTCGGTCAAGGTTCTGGACCAGTTGCGTGAGCGCATACGCTACTTGCATTACAGTTTACGAACC
GAACAGGCTTATGTCAATTCG 
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CCTCTCAGGCGCCGCTGGTGCCGCTGGTTGGACGCCAAGGGTGAATCCGCCTCGATACCCTGATTACTCGCTTCCTGCGCCCTCTCAGGCGGCGATAGGGGACTGGTAAAACGGGGATTGCCCAGACGCCTCCCCCGCCCC
TTCAGGGGCACAAATGCGGCCCCAACGGGGCCACGTAGTGGTGCGTTTTTTGCGTTTCCACCCTTTTCTTCCTTTTCCCTTTTAAACCTTTTAGGACGTCTACAGGCCACGTAATCCGTGGCCTGTAGAGTTTAAAAAGGGAC
GGATTTGTTGCCATTAAGGGACGGATTTGTTGTTAAGAAGGGACGGATTTGTTGTTGTAAAGGGACGGATTTGTTGTATTGTGGGACGCAGATACAGTGTCCCCTTATACACAAGGAATGTCGAACGTGGCCTCACCCCCA
ATGGTTTACAAAAGCAATGCCCTGGTCGAGGCCGCGTATCGCCTCAGTGTTCAGGAACAGCGGATCGTTCTGGCCTGTATTAGCCAGGTGAAGAGGAGCGAGCCTGTCACCGATGAAGTGATGTATTCAGTGACGGCGGA
GGACATAGCGACGATGGCGGGTGTCCCTATCGAATCTTCCTACAACCAGCTCAAAGAAGCGGCCCTGCGCCTGAAACGGCGGGAAGTCCGGTTAACCCAAGAGCCCAATGGCAAGGGGAAAAGACCGAGTGTGATGATT
ACCGGCTGGGTGCAAACAATCATCTACCGGGAGGGTGAGGGCCGTGTAGAACTCAGGTTCACCAAAGACATGCTGCCGTACCTGACGGAACTCACCAAACAGTTCACCAAATACGCCTTGGCTGACGTGGCCAAGATGGA
CAGCACCCACGCGATCAGGCTTTACGAGCTGCTCATGCAATGGGACAGCATCGGCCAGCGCGAAATAGAAATTGACCAGCTGCGAAAGTGGTTTCAACTGGAAGGCCGGTATCCCTCGATCAAGGACTTCAAGTTGCGAG
TGCTTGATCCAGCCGTGACGCAGATCAACGAGCACAGCCCGCTACAGGTGGAGTGGGCGCAGCGAAAGACCGGGCGCAAGGTCACACATCTGTTGTTCAGTTTTGGACCGAAGAAGCCCGCCAAGGCGGTGGGTAAGG
CCCCAGCGAAGCGCAAGGCCGGGAAGATTTCAGATGCTGAGATCGCGAAACAGGCTCGCCCTGGTGAGACATGGGAAGCGGCCCGCGCTCGACTAACCCAGATGCCGCTGGATCTGGCCTAGAGGCCGTGGCCACCAC
GGCCCGGCCTGCCTTTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACG
ACGTTGTAAAACGACGGCCAGTGAATTGTCCATTTTAGCCTCCTTAGCTCCTGAAAATCTCGTCGAAGCTCGGCGGATTTGTCCTACTCAAGCTTGGCTGCAGGTCGACGGATCCGTCGACCTGCAGGTCATCAACTATCAA
ACGCTTCGGTTAAGCTTAAAGCACACCCTTTCTGCGTCCTCGTATTGACGCGACGTAAAATTTCAACGAGCACGCCGGGATACTTACCATATTCTCTGCTAATTATCCCGACATCATCGGTAACAATAAATGCTGGATAACTG
GTTGCTGACGCATCCATATAACTCATCAACCCCGGCGTTCCATCAGGTACAGGTTTCAACGTTTCAGGATCAAGCGCTCGCGCATATACCCACGGCGGAACATGTTTACGCTGCATTTCATCCTCAAAGAAACAAGTGTTGA
GTTCAACTTGATTAAATATATCTCGGATCTGACTAATATCACTGAGATTGAAAGTATCAAATAAAAGATGATTGAAATCATCACGTTTCAGAGATTCTTTTTCGTAACTTTTCCAGCCGCCTCCGGTTATGATATAAAGGCTTT
TATCTCCAGAAAATGAGATTTTTTTATCTTTCATATAATGGCAGAGTAAATAAATAAAGTATGGCGAACCAATAAGACAAAGATCTTTCCCTTGATTTTTTATTCGTTCAAGACTATTCAATGTTTTAACAAAATCTATTCGTTC
TTCTGTTACGGTAAATGTCGTAGGATATAACAATTCCACCAAACTCATAACATATTTAAACCAAATATTATGAGCATTAAATCTATCTGGTCCCAAATTGACTAATTCTATTTGATGATCAAACCAACTACCAACATATTTCATG
CCATAACTCACAGAGCCTAAGAGTCTCTCAATACTTAATCTGTCACGCGCCACCTGACTTTTTAAACCATTCGTGCCGCTACTGGTAAACCAACTTTCAATCTCGTTTTCCTGAGAAGTTAATAAGCGAGTAAACTTAAAAACC
GATGTTGGGAATACAGGTATGTCATCAATTTCCGTAATATTGTCATCTACTTTGTGTGCCTGACAGTAGTGACGATATTCTCGACAATGTTTATAATGATTACGAAATGCATCAAGCACAAGTTTCTTTCTGATTTTTTCCTGC
TCGTCGTAAGACCACACTAATGGATCGCTCGAAAAAATCAAATCATCAATTTCTGAGCTTGCTGTAATTTCTTGTTTATCAACATATGAAGTCATACCTGTTTTACTCCTCAAGATAATATTAGAAAGTATGGCAGCACTGCTG
TCATACTCTTTTATACCCTTCATCTTTCAAGCTGCTGCTTTGTTGGCTGCTTTCACTCACCCCAGTCACATAGTTATCTATGCTCCTGGGGATTCGTTCACTTGCCGCCTCGCTGCAACTCGAAATCTATTAGGTATATTCCATGT
GGTACTTCTTAATATTATCATCAACAATATTGATTACATTTTTTTGGCTCATCAAATCATTCATTGGTTCAAAGGACAGCAATACACTTTTCGCACCACACTTTTCAATTGCCAACTTAGCCGCAGTTATACACTCCGTATAATTT
CCGACAGCGTTTTCTGCAATTATTTCTTCAAGTTTATTTTCGAAATTTTCATTAGGGTGCATTTCAAGAACATAATCACTAATAAATGCACGCGTCTCTTGTTTAGCTTTATTACTATCTTCGTTATAGTTAACTAATATCATTAA
CTGATGGTCTATCTCTGATAGGTCAACGTCATATTTATCCGCAACGGCTTTATATCTTTCAGCATATTCATATCTAACATCATTAGAATCATCCCACTTAAAGATGAGAGGAATACCTTTTTTGGCCGCCCACTCAACAATATG
ATGACTGGTTGCTGTTACATATTTCCGAGGTCCGCCTGGCGTATAAGCATGGGGATTTACAGATATTTTAGGGAAGCTATAAAAATCGTTATCTGGATTACAATAGCCTGTTGTTAAAGCATCGTTAATGATTTCATAACACT
CTTCAAATAGTTGCTGTTGATATTCAACCGGGCGATTAAAAAAATGCATTTCATCTTTTTTTTCGCAATCACTAAACCCTAAAATAAATCTCCCTTCACTTAACTGATCCAATAAGCAAGCTTCCTCCGCTATGGCGACAGGAT
GATGAGTTGTAATGATGTGATTTAATGAACCAATTTTAATTTTCTCTGTTAAACCGAGCAGAAAACCAGAAACAGTCAGAGGAGCGCCGACAACACCATTATCTGAAAAATGATTTTCATACACTAAAATCTGTTCAAAATTC
AACTTATCAACATACTCCGTTATTTCCTGCATGCGAACTATACTTTGTTCTTGAACAGTTGTTGAATTGATGAAGTTAAGGAAGAACAATCCAAATTTCATTTCTTTCTCCTTAGCTAATATAATAGCGAACGTTGTTTTTCTTTA
AGAAATGGCATGACATCAGACTGGAAGAGCTTCATGGAAGCAATAATTTCGTCTACTGTTCCATTAGCTTCAAATCCACAACAAATATTTGATATTCCTGTAGCATCAATGTCTTTTTGAATTATGTCAATACATTCCTGCGGC
GTTCCCACGGGATTGATTTCGTAACTGTAATCAATACGGCGATTAGTATCTTTATGTCCTTTTAATACAAAGTCACGCCACTGCCCTTTATTGAAATCATAACCTCTTGTTTGGTCTGAATCATCAAAAATAGTCGTAGCATTCA
CATAAGAATCATACCAATGCCCCAGAAATTTCCGGCAAATCTCTTTCGCTTTAATTGAGTCATGATCTACAGATGTTATATATGATAAGCAATGGTCGATATTATGAATATCGTGCCCATATTCTTGAGCCACTTCATTATAAA
GCTCAAGTTGTGCTTTCTTTTCGTTAGTATTTATAATCCAACTTAATATCATCGGTAGGCCAAATTGAGCAGCCCACTCAGTCGTCGAAGCTGATTCAGCCACCACATAAACCGGTGCGCCACCTCTGCTATACGCCGCGGGG
TTTACTTTTACCTTATGGAACTTGATATGTTCATTATCAGCTTCCATATATCCCTCTGTCATGCCATTCTTTATCAGCCCGTACCAGCATTCCGCTAAGGCGCGACTGTTATTCATATCTGTGCCGAATACGCGAAAGTCCTTGTT
GTAAAGCCCTCGGCAAATACCAAACCGAAATCGTCCTTTTGACATTTGATCCAATAAATTCACATCTTCAAGTTGGCGTACTGGATGGGCTGTGGGAAGAACAATAGCGGCAGTTCCTACATTCAATTTTTTAGTCGCGCCA
AGTAAATATGCAGCAGCGACATAAGGGTTACCAAGCAAACCAAACTCCGTGAAATGATGCTCCAGTAACCATACGGTATCAAAACCACACTCCTCAGAGATGCGACCTAATTTAACCAAACGTTTCATTACCTCTGTTTGAG
AAAATTGGGGAGGTTGGTATGTAAGCAAAAAGTTTCCAAATTTCATAGAGAGTCCTTATATTGCTATTTGAGTGATAGAATATCTCAATAGATTTTAAGACAGAGAAATTGCTTGATTTTCAATCTCAATTCTCATTCGGCGT
TCATTGACTGTCGCAATAGTTAAATGTTCAAATGACGGTTCAGTAATATCAACATCAATATCCAGATGATCATTATCCATCGCGATAGCGGCTTTCGTAACCGATTGATAAAAATTGCGCAGGACCACTAAATTTTCACTCAA
GTCATGCGAACTTCCTAACAAAGAATATATCTTGCATCGATTACTACGAATATTTGATAACAATGTGATAACTTCATCTTGCTTGACCCAATTATCGTTATTTGCAGTAAAAGCAATAAACGGTATATCAAGATACATCATGTT
ATTAATTGTAGAAGCTAAATCTTCCCAACCAAAATCAAGACAATCTCTCGCAAAGACTTCAGCACCCAATTTATGGCCTTCAAAATCTAGATTATCCGGCAATTCATTAATGGGTAGACTGAGATAATCAAACCCTAAAGCTC
TTTCAAGAGAATATCTTAAGTTAACAACACCGACTGCGGTGATTAAAAACGAAGCATTGATTTCAGATAGGCTTGCATAAGCTATCCGCGCAGATAAGCTTGAAGCCAACATACCGAAGTTATTTATTTTTCGTGTAGTTAAC
CAATCAACCACTGCTAACAAGCTCTGCTTTCCTATAGACATTGTAAATTCATCAATTGTCCCTGAACTCAATCCAACGTGGTGAAGCGAATCATAGCGGATCACATGAAATCCATTCCGCGATAAATATTCCGCCAGACCAGC
AAAATGATCCATCCTGCGGGCAAAACCAGACGCAATAATAATGGCATTCTTTCTCTTTGGGCTGTTTTCTTCTGGCAGCGTTTCCCAAACATGAATTTTTTTATTTCCTTCAACACAAATAACGTGGTCGATGGTTTTATATTTT
GATTCATTTTCCATACTTTTACCTATTATGGGACAAATACAAGGAACTTATCTTCTTCCAGGAATCGAGTCTGTTCTATTTCAACCGCAACATCCTTAGCCGTATAGTTAGATGGCCTTTCATGAGAAATATATGTCACTAATCG
TTGCAACGGTCTCATTCCGTCATGAGATCCACCAACTCGAAATATGTTATTCATTCCTGCTTCTACAATCCTTTCCGCACCTTTTAATGCTAACGCATCTCGATATTTAAATGATGACTCCCAAGGAAAAATAGATATGGTTTGC
GTCTTATTTTTTTGAACATAAGGCAATATTTGCTCAATATTATCGACGTGATGAAGGTACACACATCTGCCAAGTGGTTGATTAAATTCCACACCTGCATTTGACTCAATAATCATCCAACGTTGATGAATATCCACCTCTACTT
TTAATCCAGCAAACAAGCTTTCTTTTTGAACTAAAGAATAGGCCGCCTTTTCATCAAAATCTTTTTTGGCATTCGGTAATATATGCGCATATAGATTAAGTTTTTCTATCAACGCTAACTTAAATTCCTCATAATGATTTCCCAT
GTAATATATGTTTTGGGCAGAAAAACAAGCTCGCTGATCGTAAAAACAAACATCATGAGCCGCACCTGTCGCTGCGGACGTCAAATCAACAGGATTATCGATAATGCAAAGACTCTTTTTAGAACCAAATTTAATCACATCA
GCATAAGATGGCGCATGCTCTACCGCCCAATTAATCGCATCTGGCCCTCCCCAAGCGACAATAACATCCGCATGTCGCATAATTTCTTTTGCGAGTGATGTATCACCTTGGTGGGGCCAATATATAACAGATAAAGAGCGCG
TTATCGGATGATTAGGGTCTACATCAATAAAACTTAACGCTAATGCATTAGCGGTAAAAGGATCGGTTGACGATGTTTTTATAATACACTGATTCTTAGTTAAAATTGCGCGTAATATAGACATGATCCCAGATAATGGAAC
ATTACCTGCCAACAGATGTACAGATTTACCTTTCGGAAAAGCCCGAACATAACTTTCATCCTGAGGTAGCCATTCATCCATGATATGGCGAGAACCAAGTTCATTTTCTACAACATCATAAAGGCCGCCTTTAGAACATAAAA
TCATAGATATCCAATTGGCCTCTAGCTTAGCCATTTCTTCTGAATATCCCATATATTTTTTTAAGTCACGAATGTATGTCCTGCGTCTTGAGTATTCTTCATTTTTCCATCTTTGCCCTACCGTATAGAGAAAATTGACAATGTTA
TGCAACCGTAATTCGTTATTTCCATTACAATCAATAATGTTTTTTACATGAGAGTCATTCAATATTGGCAGGTAAACACTATTATCACCAAAATTAATGGATTGCACTAAATCATCACTTTCGGGAAAGATTTCAACCTGGCCG
TTAATAATGAATGAAATTTTTTTAGTCATACGTAGTCAGGCGTTCCAGTGAATCTCATCCAGCCAGTCTTTCATGGTCTTTCCACGTTCGTTGCCGGTGCGTTGCCCGCGTTTCCGGCGGA
AATAGGGGTAGTGTGCCAGCCGTGGACGCGACTGGCTATCGGCGCAGGATCAGGAATACCCCGAATTCCTGGCAGTTTATGGCGGGCGTCCTGCCCGCCACCCTCCGGGCCGTTGCTTCGCAAC
GTTCAAATCCGCTCCCGGCGGATTTGTCCTACTCAGGACAGCGTTCACCGACAAACAACAGATAAAACGAAAGGCCCAGTCTTTCGACTGAGCCTTTCGTTTTATTTGATGCCTGGGGCTTCCTCGCTCACTGACTCGCTGCG
CTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGC
GTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTT
CCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCA
GCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGT
GGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCA
AGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCC
TTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCG
TGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCA
ACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAG
CTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAAT
TCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTCGAATTGGCCGCGGCGTTGTGACAATTTACCGAACAACTCCGCGGCCGGGAAGCCGATCTCGGCTTGAACGAATTGTTAGGTGGCGGTACTTG
GGTCGATATCAAAGTGCATCACTTCTTCCCGTATGCCCAACTTTGTATAGAGAGCCACTGCGGGATCGTCACCGTAATCTGCTTGCACGTAGATCACATAAGCACCAAGCGCGTTGGCCTCATGCTTGAGGAGATTGATGAG
CGCGGTGGCAATGCCCTGCCTCCGGTGCTCGCCGGAGACTGCGAGATCATAGATATAGATCTCACTACGCGGCTGCTCAAACCTGGGCAGAACGTAAGCCGCGAGAGCGCCAACAACCGCTTCTTGGTCGAAGGCAGCAA
GCGCGATGAATGTCTTACTACGGAGCAAGTTCCCGAGGTAATCGGAGTCCGGCTGATGTTGGGAGTAGGTGGCTACGTCTCCGAACTCACGACCGAAAAGATCAAGAGCAGCCCGCATGGATTTGACTTGGTCAGGGCC
GAGCCTACATGTGCGAATGATGCCCATACTTGAGCCACCTAACTTTGTTTTAGGGCGACTGCCCTGCTGCGTAACATCGTTGCTGCTGCGTAACATCGTTGCTGCTCCATAACATCAAACATCGACCCACGGCGTAACGCGC
TTGCTGCTTGGATGCCCGAGGCATAGACTGTACAAAAAAACAGTCATAACAAGCCATGAAAACCGCCACTGCGCCGTTACCACCGCTGCGTTCGGTCAAGGTTCTGGACCAGTTGCGTGAGCGCATACGCTACTTGCATTA
CAGTTTACGAACCGAACAGGCTTATGTCAATTCG 
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CCTCTCAGGCGCCGCTGGTGCCGCTGGTTGGACGCCAAGGGTGAATCCGCCTCGATACCCTGATTACTCGCTTCCTGCGCCCTCTCAGGCGGCGATAGGGGACTGGTAAAACGGGGATTGCCCAGACGCCTCCCCCGCCCC
TTCAGGGGCACAAATGCGGCCCCAACGGGGCCACGTAGTGGTGCGTTTTTTGCGTTTCCACCCTTTTCTTCCTTTTCCCTTTTAAACCTTTTAGGACGTCTACAGGCCACGTAATCCGTGGCCTGTAGAGTTTAAAAAGGGAC
GGATTTGTTGCCATTAAGGGACGGATTTGTTGTTAAGAAGGGACGGATTTGTTGTTGTAAAGGGACGGATTTGTTGTATTGTGGGACGCAGATACAGTGTCCCCTTATACACAAGGAATGTCGAACGTGGCCTCACCCCCA
ATGGTTTACAAAAGCAATGCCCTGGTCGAGGCCGCGTATCGCCTCAGTGTTCAGGAACAGCGGATCGTTCTGGCCTGTATTAGCCAGGTGAAGAGGAGCGAGCCTGTCACCGATGAAGTGATGTATTCAGTGACGGCGGA
GGACATAGCGACGATGGCGGGTGTCCCTATCGAATCTTCCTACAACCAGCTCAAAGAAGCGGCCCTGCGCCTGAAACGGCGGGAAGTCCGGTTAACCCAAGAGCCCAATGGCAAGGGGAAAAGACCGAGTGTGATGATT
ACCGGCTGGGTGCAAACAATCATCTACCGGGAGGGTGAGGGCCGTGTAGAACTCAGGTTCACCAAAGACATGCTGCCGTACCTGACGGAACTCACCAAACAGTTCACCAAATACGCCTTGGCTGACGTGGCCAAGATGGA
CAGCACCCACGCGATCAGGCTTTACGAGCTGCTCATGCAATGGGACAGCATCGGCCAGCGCGAAATAGAAATTGACCAGCTGCGAAAGTGGTTTCAACTGGAAGGCCGGTATCCCTCGATCAAGGACTTCAAGTTGCGAG
TGCTTGATCCAGCCGTGACGCAGATCAACGAGCACAGCCCGCTACAGGTGGAGTGGGCGCAGCGAAAGACCGGGCGCAAGGTCACACATCTGTTGTTCAGTTTTGGACCGAAGAAGCCCGCCAAGGCGGTGGGTAAGG
CCCCAGCGAAGCGCAAGGCCGGGAAGATTTCAGATGCTGAGATCGCGAAACAGGCTCGCCCTGGTGAGACATGGGAAGCGGCCCGCGCTCGACTAACCCAGATGCCGCTGGATCTGGCCTAGAGGCCGTGGCCACCAC
GGCCCGGCCTGCCTTTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACG
ACGTTGTAAAACGACGGCCAGTGAATTGTCCATTTTAGCCTCCTTAGCTCCTGAAAATCTCGTCGAAGCTCGGCGGATTTGTCCTACTCAAGCTTGGCTGCAGGTCGACGGATCCGTCGACCTGCAGGTCATCAACTATCAA
ACGCTTCGGTTAAGCTTAAAGCACACCCTTTCTGCGTCCTCGTATTGACGCGACGTAAAATTTCAACGAGCACGCCGGGATACTTACCATATTCTCTGCTAATTATCCCGACATCATCGGTAACAATAAATGCTGGATAACTG
GTTGCTGACGCATCCATATAACTCATCAACCCCGGCGTTCCATCAGGTACAGGTTTCAACGTTTCAGGATCAAGCGCTCGCGCATATACCCACGGCGGAACATGTTTACGCTGCATTTCATCCTCAAAGAAACAAGTGTTGA
GTTCAACTTGATTAAATATATCTCGGATCTGACTAATATCACTGAGATTGAAAGTATCAAATAAAAGATGATTGAAATCATCACGTTTCAGAGATTCTTTTTCGTAACTTTTCCAGCCGCCTCCGGTTATGATATAAAGGCTTT
TATCTCCAGAAAATGAGATTTTTTTATCTTTCATATAATGGCAGAGTAAATAAATAAAGTATGGCGAACCAATAAGACAAAGATCTTTCCCTTGATTTTTTATTCGTTCAAGACTATTCAATGTTTTAACAAAATCTATTCGTTC
TTCTGTTACGGTAAATGTCGTAGGATATAACAATTCCACCAAACTCATAACATATTTAAACCAAATATTATGAGCATTAAATCTATCTGGTCCCAAATTGACTAATTCTATTTGATGATCAAACCAACTACCAACATATTTCATG
CCATAACTCACAGAGCCTAAGAGTCTCTCAATACTTAATCTGTCACGCGCCACCTGACTTTTTAAACCATTCGTGCCGCTACTGGTAAACCAACTTTCAATCTCGTTTTCCTGAGAAGTTAATAAGCGAGTAAACTTAAAAACC
GATGTTGGGAATACAGGTATGTCATCAATTTCCGTAATATTGTCATCTACTTTGTGTGCCTGACAGTAGTGACGATATTCTCGACAATGTTTATAATGATTACGAAATGCATCAAGCACAAGTTTCTTTCTGATTTTTTCCTGC
TCGTCGTAAGACCACACTAATGGATCGCTCGAAAAAATCAAATCATCAATTTCTGAGCTTGCTGTAATTTCTTGTTTATCAACATATGAAGTCATACCTGTTTTACTCCTCAAGATAATATTAGAAAGTATGGCAGCACTGCTG
TCATACTCTTTTATACCCTTCATCTTTCAAGCTGCTGCTTTGTTGGCTGCTTTCACTCACCCCAGTCACATAGTTATCTATGCTCCTGGGGATTCGTTCACTTGCCGCCTCGCTGCAACTCGAAATCTATTAGGTATATTCCATGT
GGTACTTCTTAATATTATCATCAACAATATTGATTACATTTTTTTGGCTCATCAAATCATTCATTGGTTCAAAGGACAGCAATACACTTTTCGCACCACACTTTTCAATTGCCAACTTAGCCGCAGTTATACACTCCGTATAATTT
CCGACAGCGTTTTCTGCAATTATTTCTTCAAGTTTATTTTCGAAATTTTCATTAGGGTGCATTTCAAGAACATAATCACTAATAAATGCACGCGTCTCTTGTTTAGCTTTATTACTATCTTCGTTATAGTTAACTAATATCATTAA
CTGATGGTCTATCTCTGATAGGTCAACGTCATATTTATCCGCAACGGCTTTATATCTTTCAGCATATTCATATCTAACATCATTAGAATCATCCCACTTAAAGATGAGAGGAATACCTTTTTTGGCCGCCCACTCAACAATATG
ATGACTGGTTGCTGTTACATATTTCCGAGGTCCGCCTGGCGTATAAGCATGGGGATTTACAGATATTTTAGGGAAGCTATAAAAATCGTTATCTGGATTACAATAGCCTGTTGTTAAAGCATCGTTAATGATTTCATAACACT
CTTCAAATAGTTGCTGTTGATATTCAACCGGGCGATTAAAAAAATGCATTTCATCTTTTTTTTCGCAATCACTAAACCCTAAAATAAATCTCCCTTCACTTAACTGATCCAATAAGCAAGCTTCCTCCGCTATGGCGACAGGAT
GATGAGTTGTAATGATGTGATTTAATGAACCAATTTTAATTTTCTCTGTTAAACCGAGCAGAAAACCAGAAACAGTCAGAGGAGCGCCGACAACACCATTATCTGAAAAATGATTTTCATACACTAAAATCTGTTCAAAATTC
AACTTATCAACATACTCCGTTATTTCCTGCATGCGAACTATACTTTGTTCTTGAACAGTTGTTGAATTGATGAAGTTAAGGAAGAACAATCCAAATTTCATTTCTTTCTCCTTAGCTAATATAATAGCGAACGTTGTTTTTCTTTA
AGAAATGGCATGACATCAGACTGGAAGAGCTTCATGGAAGCAATAATTTCGTCTACTGTTCCATTAGCTTCAAATCCACAACAAATATTTGATATTCCTGTAGCATCAATGTCTTTTTGAATTATGTCAATACATTCCTGCGGC
GTTCCCACGGGATTGATTTCGTAACTGTAATCAATACGGCGATTAGTATCTTTATGTCCTTTTAATACAAAGTCACGCCACTGCCCTTTATTGAAATCATAACCTCTTGTTTGGTCTGAATCATCAAAAATAGTCGTAGCATTCA
CATAAGAATCATACCAATGCCCCAGAAATTTCCGGCAAATCTCTTTCGCTTTAATTGAGTCATGATCTACAGATGTTATATATGATAAGCAATGGTCGATATTATGAATATCGTGCCCATATTCTTGAGCCACTTCATTATAAA
GCTCAAGTTGTGCTTTCTTTTCGTTAGTATTTATAATCCAACTTAATATCATCGGTAGGCCAAATTGAGCAGCCCACTCAGTCGTCGAAGCTGATTCAGCCACCACATAAACCGGTGCGCCACCTCTGCTATACGCCGCGGGG
TTTACTTTTACCTTATGGAACTTGATATGTTCATTATCAGCTTCCATATATCCCTCTGTCATGCCATTCTTTATCAGCCCGTACCAGCATTCCGCTAAGGCGCGACTGTTATTCATATCTGTGCCGAATACGCGAAAGTCCTTGTT
GTAAAGCCCTCGGCAAATACCAAACCGAAATCGTCCTTTTGACATTTGATCCAATAAATTCACATCTTCAAGTTGGCGTACTGGATGGGCTGTGGGAAGAACAATAGCGGCAGTTCCTACATTCAATTTTTTAGTCGCGCCA
AGTAAATATGCAGCAGCGACATAAGGGTTACCAAGCAAACCAAACTCCGTGAAATGATGCTCCAGTAACCATACGGTATCAAAACCACACTCCTCAGAGATGCGACCTAATTTAACCAAACGTTTCATTACCTCTGTTTGAG
AAAATTGGGGAGGTTGGTATGTAAGCAAAAAGTTTCCAAATTTCATAGAGAGTCCTTATATTGCTATTTGAGTGATAGAATATCTCAATAGATTTTAAGACAGAGAAATTGCTTGATTTTCAATCTCAATTCTCATTCGGCGT
TCATTGACTGTCGCAATAGTTAAATGTTCAAATGACGGTTCAGTAATATCAACATCAATATCCAGATGATCATTATCCATCGCGATAGCGGCTTTCGTAACCGATTGATAAAAATTGCGCAGGACCACTAAATTTTCACTCAA
GTCATGCGAACTTCCTAACAAAGAATATATCTTGCATCGATTACTACGAATATTTGATAACAATGTGATAACTTCATCTTGCTTGACCCAATTATCGTTATTTGCAGTAAAAGCAATAAACGGTATATCAAGATACATCATGTT
ATTAATTGTAGAAGCTAAATCTTCCCAACCAAAATCAAGACAATCTCTCGCAAAGACTTCAGCACCCAATTTATGGCCTTCAAAATCTAGATTATCCGGCAATTCATTAATGGGTAGACTGAGATAATCAAACCCTAAAGCTC
TTTCAAGAGAATATCTTAAGTTAACAACACCGACTGCGGTGATTAAAAACGAAGCATTGATTTCAGATAGGCTTGCATAAGCTATCCGCGCAGATAAGCTTGAAGCCAACATACCGAAGTTATTTATTTTTCGTGTAGTTAAC
CAATCAACCACTGCTAACAAGCTCTGCTTTCCTATAGACATTGTAAATTCATCAATTGTCCCTGAACTCAATCCAACGTGGTGAAGCGAATCATAGCGGATCACATGAAATCCATTCCGCGATAAATATTCCGCCAGACCAGC
AAAATGATCCATCCTGCGGGCAAAACCAGACGCAATAATAATGGCATTCTTTCTCTTTGGGCTGTTTTCTTCTGGCAGCGTTTCCCAAACATGAATTTTTTTATTTCCTTCAACACAAATAACGTGGTCGATGGTTTTATATTTT
GATTCATTTTCCATACTTTTTACCTATTATGGGACAAATACAAGGAACTTATCTTCTTCCAGGAATCGAGTCTGTTCTATTTCAACCGCAACATCCTTAGCCGTATAGTTAGATGGCCTTTCATGAGAAATATATGTCACTAATC
GTTGCAACGGTCTCATTCCGTCATGAGATCCACCAACTCGAAATATGTTATTCATTCCTGCTTCTACAATCCTTTCCGCACCTTTTAATGCTAACGCATCTCGATATTTAAATGATGACTCCCAAGGAAAAATAGATATGGTTT
GCGTCTTATTTTTTTGAACATAAGGCAATATTTGCTCAATATTATCGACGTGATGAAGGTACACACATCTGCCAAGTGGTTGATTAAATTCCACACCTGCATTTGACTCAATAATCATCCAACGTTGATGAATATCCACCTCTA
CTTTTAATCCAGCAAACAAGCTTTCTTTTTGAACTAAAGAATAGGCCGCCTTTTCATCAAAATCTTTTTTGGCATTCGGTAATATATGCGCATATAGATTAAGTTTTTCTATCAACGCTAACTTAAATTCCTCATAATGATTTCCC
ATGTAATATATGTTTTGGGCAGAAAAACAAGCTCGCTGATCGTAAAAACAAACATCATGAGCCGCACCTGTCGCTGCGGACGTCAAATCAACAGGATTATCGATAATGCAAAGACTCTTTTTAGAACCAAATTTAATCACAT
CAGCATAAGATGGCGCATGCTCTACCGCCCAATTAATCGCATCTGGCCCTCCCCAAGCGACAATAACATCCGCATGTCGCATAATTTCTTTTGCGAGTGATGTATCACCTTGGTGGGGCCAATATATAACAGATAAAGAGCG
CGTTATCGGATGATTAGGGTCTACATCAATAAAACTTAACGCTAATGCATTAGCGGTAAAAGGATCGGTTGACGATGTTTTTATAATACACTGATTCTTAGTTAAAATTGCGCGTAATATAGACATGATCCCAGATAATGGA
ACATTACCTGCCAACAGATGTACAGATTTACCTTTCGGAAAAGCCCGAACATAACTTTCATCCTGAGGTAGCCATTCATCCATGATATGGCGAGAACCAAGTTCATTTTCTACAACATCATAAAGGCCGCCTTTAGAACATAA
AATCATAGATATCCAATTGGCCTCTAGCTTAGCCATTTCTTCTGAATATCCCATATATTTTTTTAAGTCACGAATGTATGTCCTGCGTCTTGAGTATTCTTCATTTTTCCATCTTTGCCCTACCGTATAGAGAAAATTGACAATGT
TATGCAACCGTAATTCGTTATTTCCATTACAATCAATAATGTTTTTTACATGAGAGTCATTCAATATTGGCAGGTAAACACTATTATCACCAAAATTAATGGATTGCACTAAATCATCACTTTCGGGAAAGATTTCAACCTGGC
CGTTAATAATGAATGAAATTTTTTTAGTCATACGTAGTCAGGCGTTCCAGTGAATCTCATCCAGCCAGTCTTTCATGGTCTTTCCACGTTCGTTGCCGGTGCGTTGCCCGCGTTTCCGGCG
GAAATAGGGGTAGTGTGCCAGCCGTGGACGCGACTGGCTATCGGCGCAGGATCAGGAATACCCCGAATTCCTGGCAGTTTATGGCGGGCGTCCTGCCCGCCACCCTCCGGGCCGTTGCTTCGCA
ACGTTCAAATCCGCTCCCGGCGGATTTGTCCTACTCAGGACAGCGTTCACCGACAAACAACAGATAAAACGAAAGGCCCAGTCTTTCGACTGAGCCTTTCGTTTTATTTGATGCCTGGGGCTTCCTCGCTCACTGACTCGCTG
CGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCC
GCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCT
GTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGT
TCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAA
GTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTG
CAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGAT
CCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGT
CGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTG
CAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTC
AGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATA
ATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTCGAATTGGCCGCGGCGTTGTGACAATTTACCGAACAACTCCGCGGCCGGGAAGCCGATCTCGGCTTGAACGAATTGTTAGGTGGCGGTACT
TGGGTCGATATCAAAGTGCATCACTTCTTCCCGTATGCCCAACTTTGTATAGAGAGCCACTGCGGGATCGTCACCGTAATCTGCTTGCACGTAGATCACATAAGCACCAAGCGCGTTGGCCTCATGCTTGAGGAGATTGATG
AGCGCGGTGGCAATGCCCTGCCTCCGGTGCTCGCCGGAGACTGCGAGATCATAGATATAGATCTCACTACGCGGCTGCTCAAACCTGGGCAGAACGTAAGCCGCGAGAGCGCCAACAACCGCTTCTTGGTCGAAGGCAG
CAAGCGCGATGAATGTCTTACTACGGAGCAAGTTCCCGAGGTAATCGGAGTCCGGCTGATGTTGGGAGTAGGTGGCTACGTCTCCGAACTCACGACCGAAAAGATCAAGAGCAGCCCGCATGGATTTGACTTGGTCAGG
GCCGAGCCTACATGTGCGAATGATGCCCATACTTGAGCCACCTAACTTTGTTTTAGGGCGACTGCCCTGCTGCGTAACATCGTTGCTGCTGCGTAACATCGTTGCTGCTCCATAACATCAAACATCGACCCACGGCGTAACG
CGCTTGCTGCTTGGATGCCCGAGGCATAGACTGTACAAAAAAACAGTCATAACAAGCCATGAAAACCGCCACTGCGCCGTTACCACCGCTGCGTTCGGTCAAGGTTCTGGACCAGTTGCGTGAGCGCATACGCTACTTGCA
TTACAGTTTACGAACCGAACAGGCTTATGTCAATTCG 
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CCTCTCAGGCGCCGCTGGTGCCGCTGGTTGGACGCCAAGGGTGAATCCGCCTCGATACCCTGATTACTCGCTTCCTGCGCCCTCTCAGGCGGCGATAGGGGACTGGTAAAACGGGGATTGCCCAGACGCCTCCCCCGCCCC
TTCAGGGGCACAAATGCGGCCCCAACGGGGCCACGTAGTGGTGCGTTTTTTGCGTTTCCACCCTTTTCTTCCTTTTCCCTTTTAAACCTTTTAGGACGTCTACAGGCCACGTAATCCGTGGCCTGTAGAGTTTAAAAAGGGAC
GGATTTGTTGCCATTAAGGGACGGATTTGTTGTTAAGAAGGGACGGATTTGTTGTTGTAAAGGGACGGATTTGTTGTATTGTGGGACGCAGATACAGTGTCCCCTTATACACAAGGAATGTCGAACGTGGCCTCACCCCCA
ATGGTTTACAAAAGCAATGCCCTGGTCGAGGCCGCGTATCGCCTCAGTGTTCAGGAACAGCGGATCGTTCTGGCCTGTATTAGCCAGGTGAAGAGGAGCGAGCCTGTCACCGATGAAGTGATGTATTCAGTGACGGCGGA
GGACATAGCGACGATGGCGGGTGTCCCTATCGAATCTTCCTACAACCAGCTCAAAGAAGCGGCCCTGCGCCTGAAACGGCGGGAAGTCCGGTTAACCCAAGAGCCCAATGGCAAGGGGAAAAGACCGAGTGTGATGATT
ACCGGCTGGGTGCAAACAATCATCTACCGGGAGGGTGAGGGCCGTGTAGAACTCAGGTTCACCAAAGACATGCTGCCGTACCTGACGGAACTCACCAAACAGTTCACCAAATACGCCTTGGCTGACGTGGCCAAGATGGA
CAGCACCCACGCGATCAGGCTTTACGAGCTGCTCATGCAATGGGACAGCATCGGCCAGCGCGAAATAGAAATTGACCAGCTGCGAAAGTGGTTTCAACTGGAAGGCCGGTATCCCTCGATCAAGGACTTCAAGTTGCGAG
TGCTTGATCCAGCCGTGACGCAGATCAACGAGCACAGCCCGCTACAGGTGGAGTGGGCGCAGCGAAAGACCGGGCGCAAGGTCACACATCTGTTGTTCAGTTTTGGACCGAAGAAGCCCGCCAAGGCGGTGGGTAAGG
CCCCAGCGAAGCGCAAGGCCGGGAAGATTTCAGATGCTGAGATCGCGAAACAGGCTCGCCCTGGTGAGACATGGGAAGCGGCCCGCGCTCGACTAACCCAGATGCCGCTGGATCTGGCCTAGAGGCCGTGGCCACCAC
GGCCCGGCCTGCCTTTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACG
ACGTTGTAAAACGACGGCCAGTGAATTGTCCATTTTAGCCTCCTTAGCTCCTGAAAATCTCGTCGAAGCTCGGCGGATTTGTCCTACTCAAGCTTGGCTGCAGGTCGACGGATCCGTCGACCTGCAGGTCATCAACTATCAA
ACGCTTCGGTTAAGCTTAAAGCACACCCTTTCTGCGTCCTCGTATTGACGCGACGTAAAATTTCAACGAGCACGCCGGGATACTTACCATATTCTCTGCTAATTATCCCGACATCATCGGTAACAATAAATGCTGGATAACTG
GTTGCTGACGCATCCATATAACTCATCAACCCCGGCGTTCCATCAGGTACAGGTTTCAACGTTTCAGGATCAAGCGCTCGCGCATATACCCACGGCGGAACATGTTTACGCTGCATTTCATCCTCAAAGAAACAAGTGTTGA
GTTCAACTTGATTAAATATATCTCGGATCTGACTAATATCACTGAGATTGAAAGTATCAAATAAAAGATGATTGAAATCATCACGTTTCAGAGATTCTTTTTCGTAACTTTTCCAGCCGCCTCCGGTTATGATATAAAGGCTTT
TATCTCCAGAAAATGAGATTTTTTTATCTTTCATATAATGGCAGAGTAAATAAATAAAGTATGGCGAACCAATAAGACAAAGATCTTTCCCTTGATTTTTTATTCGTTCAAGACTATTCAATGTTTTAACAAAATCTATTCGTTC
TTCTGTTACGGTAAATGTCGTAGGATATAACAATTCCACCAAACTCATAACATATTTAAACCAAATATTATGAGCATTAAATCTATCTGGTCCCAAATTGACTAATTCTATTTGATGATCAAACCAACTACCAACATATTTCATG
CCATAACTCACAGAGCCTAAGAGTCTCTCAATACTTAATCTGTCACGCGCCACCTGACTTTTTAAACCATTCGTGCCGCTACTGGTAAACCAACTTTCAATCTCGTTTTCCTGAGAAGTTAATAAGCGAGTAAACTTAAAAACC
GATGTTGGGAATACAGGTATGTCATCAATTTCCGTAATATTGTCATCTACTTTGTGTGCCTGACAGTAGTGACGATATTCTCGACAATGTTTATAATGATTACGAAATGCATCAAGCACAAGTTTCTTTCTGATTTTTTCCTGC
TCGTCGTAAGACCACACTAATGGATCGCTCGAAAAAATCAAATCATCAATTTCTGAGCTTGCTGTAATTTCTTGTTTATCAACATATGAAGTCATACCTGTTTTACTCCTCAAGATAATATTAGAAAGTATGGCAGCACTGCTG
TCATACTCTTTTATACCCTTCATCTTTCAAGCTGCTGCTTTGTTGGCTGCTTTCACTCACCCCAGTCACATAGTTATCTATGCTCCTGGGGATTCGTTCACTTGCCGCCTCGCTGCAACTCGAAATCTATTAGGTATATTCCATGT
GGTACTTCTTAATATTATCATCAACAATATTGATTACATTTTTTTGGCTCATCAAATCATTCATTGGTTCAAAGGACAGCAATACACTTTTCGCACCACACTTTTCAATTGCCAACTTAGCCGCAGTTATACACTCCGTATAATTT
CCGACAGCGTTTTCTGCAATTATTTCTTCAAGTTTATTTTCGAAATTTTCATTAGGGTGCATTTCAAGAACATAATCACTAATAAATGCACGCGTCTCTTGTTTAGCTTTATTACTATCTTCGTTATAGTTAACTAATATCATTAA
CTGATGGTCTATCTCTGATAGGTCAACGTCATATTTATCCGCAACGGCTTTATATCTTTCAGCATATTCATATCTAACATCATTAGAATCATCCCACTTAAAGATGAGAGGAATACCTTTTTTGGCCGCCCACTCAACAATATG
ATGACTGGTTGCTGTTACATATTTCCGAGGTCCGCCTGGCGTATAAGCATGGGGATTTACAGATATTTTAGGGAAGCTATAAAAATCGTTATCTGGATTACAATAGCCTGTTGTTAAAGCATCGTTAATGATTTCATAACACT
CTTCAAATAGTTGCTGTTGATATTCAACCGGGCGATTAAAAAAATGCATTTCATCTTTTTTTTCGCAATCACTAAACCCTAAAATAAATCTCCCTTCACTTAACTGATCCAATAAGCAAGCTTCCTCCGCTATGGCGACAGGAT
GATGAGTTGTAATGATGTGATTTAATGAACCAATTTTAATTTTCTCTGTTAAACCGAGCAGAAAACCAGAAACAGTCAGAGGAGCGCCGACAACACCATTATCTGAAAAATGATTTTCATACACTAAAATCTGTTCAAAATTC
AACTTATCAACATACTCCGTTATTTCCTGCATGCGAACTATACTTTGTTCTTGAACAGTTGTTGAATTGATGAAGTTAAGGAAGAACAATCCAAATTTCATTTCTTTCTCCTTAGCTAATATAATAGCGAACGTTGTTTTTCTTTA
AGAAATGGCATGACATCAGACTGGAAGAGCTTCATGGAAGCAATAATTTCGTCTACTGTTCCATTAGCTTCAAATCCACAACAAATATTTGATATTCCTGTAGCATCAATGTCTTTTTGAATTATGTCAATACATTCCTGCGGC
GTTCCCACGGGATTGATTTCGTAACTGTAATCAATACGGCGATTAGTATCTTTATGTCCTTTTAATACAAAGTCACGCCACTGCCCTTTATTGAAATCATAACCTCTTGTTTGGTCTGAATCATCAAAAATAGTCGTAGCATTCA
CATAAGAATCATACCAATGCCCCAGAAATTTCCGGCAAATCTCTTTCGCTTTAATTGAGTCATGATCTACAGATGTTATATATGATAAGCAATGGTCGATATTATGAATATCGTGCCCATATTCTTGAGCCACTTCATTATAAA
GCTCAAGTTGTGCTTTCTTTTCGTTAGTATTTATAATCCAACTTAATATCATCGGTAGGCCAAATTGAGCAGCCCACTCAGTCGTCGAAGCTGATTCAGCCACCACATAAACCGGTGCGCCACCTCTGCTATACGCCGCGGGG
TTTACTTTTACCTTATGGAACTTGATATGTTCATTATCAGCTTCCATATATCCCTCTGTCATGCCATTCTTTATCAGCCCGTACCAGCATTCCGCTAAGGCGCGACTGTTATTCATATCTGTGCCGAATACGCGAAAGTCCTTGTT
GTAAAGCCCTCGGCAAATACCAAACCGAAATCGTCCTTTTGACATTTGATCCAATAAATTCACATCTTCAAGTTGGCGTACTGGATGGGCTGTGGGAAGAACAATAGCGGCAGTTCCTACATTCAATTTTTTAGTCGCGCCA
AGTAAATATGCAGCAGCGACATAAGGGTTACCAAGCAAACCAAACTCCGTGAAATGATGCTCCAGTAACCATACGGTATCAAAACCACACTCCTCAGAGATGCGACCTAATTTAACCAAACGTTTCATTACCTCTGTTTGAG
AAAATTGGGGAGGTTGGTATGTAAGCAAAAAGTTTCCAAATTTCATAGAGAGTCCTTATATTGCTATTTGAGTGATAGAATATCTCAATAGATTTTAAGACAGAGAAATTGCTTGATTTTCAATCTCAATTCTCATTCGGCGT
TCATTGACTGTCGCAATAGTTAAATGTTCAAATGACGGTTCAGTAATATCAACATCAATATCCAGATGATCATTATCCATCGCGATAGCGGCTTTCGTAACCGATTGATAAAAATTGCGCAGGACCACTAAATTTTCACTCAA
GTCATGCGAACTTCCTAACAAAGAATATATCTTGCATCGATTACTACGAATATTTGATAACAATGTGATAACTTCATCTTGCTTGACCCAATTATCGTTATTTGCAGTAAAAGCAATAAACGGTATATCAAGATACATCATGTT
ATTAATTGTAGAAGCTAAATCTTCCCAACCAAAATCAAGACAATCTCTCGCAAAGACTTCAGCACCCAATTTATGGCCTTCAAAATCTAGATTATCCGGCAATTCATTAATGGGTAGACTGAGATAATCAAACCCTAAAGCTC
TTTCAAGAGAATATCTTAAGTTAACAACACCGACTGCGGTGATTAAAAACGAAGCATTGATTTCAGATAGGCTTGCATAAGCTATCCGCGCAGATAAGCTTGAAGCCAACATACCGAAGTTATTTATTTTTCGTGTAGTTAAC
CAATCAACCACTGCTAACAAGCTCTGCTTTCCTATAGACATTGTAAATTCATCAATTGTCCCTGAACTCAATCCAACGTGGTGAAGCGAATCATAGCGGATCACATGAAATCCATTCCGCGATAAATATTCCGCCAGACCAGC
AAAATGATCCATCCTGCGGGCAAAACCAGACGCAATAATAATGGCATTCTTTCTCTTTGGGCTGTTTTCTTCTGGCAGCGTTTCCCAAACATGAATTTTTTTATTTCCTTCAACACAAATAACGTGGTCGATGGTTTTATATTTT
GATTCATTTTCCATACTTTTACCTATTATGGGACAAATACAAGGAACTTATCTTCTTCCAGGAATCGAGTCTGTTCTATTTCAACCGCAACATCCTTAGCCGTATAGTTAGATGGCCTTTCATGAGAAATATATGTCACTAATCG
TTGCAACGGTCTCATTCCGTCATGAGATCCACCAACTCGAAATATGTTATTCATTCCTGCTTCTACAATCCTTTCCGCACCTTTTAATGCTAACGCATCTCGATATTTAAATGATGACTCCCAAGGAAAAATAGATATGGTTTGC
GTCTTATTTTTTTGAACATAAGGCAATATTTGCTCAATATTATCGACGTGATGAAGGTACACACATCTGCCAAGTGGTTGATTAAATTCCACACCTGCATTTGACTCAATAATCATCCAACGTTGATGAATATCCACCTCTACTT
TTAATCCAGCAAACAAGCTTTCTTTTTGAACTAAAGAATAGGCCGCCTTTTCATCAAAATCTTTTTTGGCATTCGGTAATATATGCGCATATAGATTAAGTTTTTCTATCAACGCTAACTTAAATTCCTCATAATGATTTCCCAT
GTAATATATGTTTTGGGCAGAAAAACAAGCTCGCTGATCGTAAAAACAAACATCATGAGCCGCACCTGTCGCTGCGGACGTCAAATCAACAGGATTATCGATAATGCAAAGACTCTTTTTAGAACCAAATTTAATCACATCA
GCATAAGATGGCGCATGCTCTACCGCCCAATTAATCGCATCTGGCCCTCCCCAAGCGACAATAACATCCGCATGTCGCATAATTTCTTTTGCGAGTGATGTATCACCTTGGTGGGGCCAATATATAACAGATAAAGAGCGCG
TTATCGGATGATTAGGGTCTACATCAATAAAACTTAACGCTAATGCATTAGCGGTAAAAGGATCGGTTGACGATGTTTTTATAATACACTGATTCTTAGTTAAAATTGCGCGTAATATAGACATGATCCCAGATAATGGAAC
ATTACCTGCCAACAGATGTACAGATTTACCTTTCGGAAAAGCCCGAACATAACTTTCATCCTGAGGTAGCCATTCATCCATGATATGGCGAGAACCAAGTTCATTTTCTACAACATCATAAAGGCCGCCTTTAGAACATAAAA
TCATAGATATCCAATTGGCCTCTAGCTTAGCCATTTCTTCTGAATATCCCATATATTTTTTTAAGTCACGAATGTATGTCCTGCGTCTTGAGTATTCTTCATTTTTCCATCTTTGCCCTACCGTATAGAGAAAATTGACAATGTTA
TGCAACCGTAATTCGTTATTTCCATTACAATCAATAATGTTTTTTACATGAGAGTCATTCAATATTGGCAGGTAAACACTATTATCACCAAAATTAATGGATTGCACTAAATCATCACTTTCGGGAAAGATTTCAACCTGGCCG
TTAATAATGAATGAAATTTTTTTAGTCATACGTAGTCAGGCGTTCCAGTGAATCTCATCCAGCCAGTCTTTCATGGTCTTTCCACGTTCGTTGCCGGTGCGTTGCCCGCGTTTCCGGCGGA
AATAGGGGTAGTGTGCCAGCCGTGGACGCGACTGGCTATCGGCGCAGGATCAGGAATACCCCGAATTCCTGGCAGTTTATGGCGGGCGTCCTGCCCGCCACCCTCCGGGCCGTTGCTTCGCAAC
GTTCAAATCCGCTCCCGGCGGATTTGTCCTACTCAGGACAGCGTTCACCGACAAACAACAGATAAAACGAAAGGCCCAGTCTTTCGACTGAGCCTTTCGTTTTATTTGATGCCTGGGGCTTCCTCGCTCACTGACTCGCTGCG
CTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGC
GTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTT
CCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCA
GCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGT
GGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCA
AGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCC
TTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCG
TGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCA
ACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAG
CTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAAT
TCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTCGAATTGGCCGCGGCGTTGTGACAATTTACCGAACAACTCCGCGGCCGGGAAGCCGATCTCGGCTTGAACGAATTGTTAGGTGGCGGTACTTG
GGTCGATATCAAAGTGCATCACTTCTTCCCGTATGCCCAACTTTGTATAGAGAGCCACTGCGGGATCGTCACCGTAATCTGCTTGCACGTAGATCACATAAGCACCAAGCGCGTTGGCCTCATGCTTGAGGAGATTGATGAG
CGCGGTGGCAATGCCCTGCCTCCGGTGCTCGCCGGAGACTGCGAGATCATAGATATAGATCTCACTACGCGGCTGCTCAAACCTGGGCAGAACGTAAGCCGCGAGAGCGCCAACAACCGCTTCTTGGTCGAAGGCAGCAA
GCGCGATGAATGTCTTACTACGGAGCAAGTTCCCGAGGTAATCGGAGTCCGGCTGATGTTGGGAGTAGGTGGCTACGTCTCCGAACTCACGACCGAAAAGATCAAGAGCAGCCCGCATGGATTTGACTTGGTCAGGGCC
GAGCCTACATGTGCGAATGATGCCCATACTTGAGCCACCTAACTTTGTTTTAGGGCGACTGCCCTGCTGCGTAACATCGTTGCTGCTGCGTAACATCGTTGCTGCTCCATAACATCAAACATCGACCCACGGCGTAACGCGC
TTGCTGCTTGGATGCCCGAGGCATAGACTGTACAAAAAAACAGTCATAACAAGCCATGAAAACCGCCACTGCGCCGTTACCACCGCTGCGTTCGGTCAAGGTTCTGGACCAGTTGCGTGAGCGCATACGCTACTTGCATTA
CAGTTTACGAACCGAACAGGCTTATGTCAATTCG 
 
TACGTA – SnaBI site  GAATTC – EcoRI site  Bases switched with 
each other  
C converted to T C converted to G G converted to A T converted to 
C Addition of T 
-35 Promoter sequence -10 Promoter sequence  
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Appendix 8: Validation 
Normality and constant variance test 
LysR25 
Nonlinear Regression  Equation: f = a/(1+exp(-(x-x0)*b)) 
 
R  Rsqr  Adj Rsqr  Standard Error of Estimate 
0.9943 0.9886 0.9828  0.2163  
 
  Coefficient Std. Error t P  
a 9.2401 2.0090 4.5993 0.0100  
b 0.3609 0.0752 4.8011 0.0086  
x0 6.2140 1.3208 4.7047 0.0093  
 
Statistical Tests: 
Normality Test (Shapiro-Wilk)   Passed (P = 0.3696) 
W Statistic= 0.9061 Significance Level = 0.0500 
Constant Variance Test  Passed (P = 0.4383) 
 
LysG25 
Nonlinear Regression   Equation: f = a/(1+exp(-(x-x0)*b)) 
 
R  Rsqr  Adj Rsqr  Standard Error of Estimate 
0.9877 0.9756 0.9634  0.2805  
 
  Coefficient Std. Error t P  
a 7.4474 1.5832 4.7041 0.0093  
b 0.3962 0.1110 3.5707 0.0234  
x0 5.0918 1.2321 4.1327 0.0145  
 
Statistical Tests: 
Normality Test (Shapiro-Wilk)   Passed (P = 0.1281) 
W Statistic= 0.8520 Significance Level = 0.0500 
Constant Variance Test  Passed (P = 0.7810) 
 
TatH5 
Nonlinear Regression   Equation: f = a/(1+exp(-(x-x0)*b)) 
 
R  Rsqr  Adj Rsqr  Standard Error of Estimate 
0.9930 0.9860 0.9790  0.2396  
 
  Coefficient Std. Error t P  
a 8.8295 1.9052 4.6344 0.0098  
b 0.3787 0.0842 4.4976 0.0108  
x0 5.9787 1.2699 4.7082 0.0093  
 
Statistical Tests: 
Normality Test (Shapiro-Wilk)   Passed (P = 0.2942) 
W Statistic= 0.8936 Significance Level = 0.0500 
Constant Variance Test  Passed (P = 0.0956) 
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TatH9 
Nonlinear Regression   Equation: f = a/(1+exp(-(x-x0)*b)) 
 
R  Rsqr  Adj Rsqr  Standard Error of Estimate 
0.9881 0.9764 0.9646  0.2585  
 
  Coefficient Std. Error t P  
a 7.9098 2.4671 3.2062 0.0327  
b 0.3459 0.1063 3.2545 0.0312  
x0 6.1210 1.9728 3.1027 0.0361  
 
Statistical Tests: 
Normality Test (Shapiro-Wilk)   Passed (P = 0.2802) 
W Statistic= 0.8911 Significance Level = 0.0500 
Constant Variance Test  Passed (P = 0.1815) 
 
TatH14 
Nonlinear Regression   Equation: f = a/(1+exp(-(x-x0)*b)) 
 
R  Rsqr  Adj Rsqr  Standard Error of Estimate 
0.9927 0.9854 0.9781  0.2208  
 
  Coefficient Std. Error t P  
a 7.0357 0.9006 7.8125 0.0014  
b 0.4403 0.0881 4.9974 0.0075  
x0 5.0301 0.6890 7.3004 0.0019  
 
Statistical Tests: 
Normality Test (Shapiro-Wilk)   Passed (P = 0.2213) 
W Statistic= 0.8788 Significance Level = 0.0500 
Constant Variance Test  Passed (P = 0.1815) 
 
LppR3 
Nonlinear Regression   Equation: f = a/(1+exp(-(x-x0)*b)) 
 
R  Rsqr  Adj Rsqr  Standard Error of Estimate 
0.9865 0.9731 0.9597  0.2802  
 
  Coefficient Std. Error t P  
a 16.8952 26.1381 0.6464 0.5532  
b 0.2332 0.1091 2.1386 0.0992  
x0 10.8524 11.1828 0.9705 0.3868  
 
Statistical Tests: 
Normality Test (Shapiro-Wilk)   Passed (P = 0.2759) 
W Statistic= 0.8902 Significance Level = 0.0500 
Constant Variance Test  Passed (P = 0.6019) 
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LppR4 
Nonlinear Regression   Equation: f = a/(1+exp(-(x-x0)*b)) 
 
R  Rsqr  Adj Rsqr  Standard Error of Estimate 
0.9914 0.9828 0.9742  0.2351  
 
  Coefficient Std. Error t P  
a 7.0263 0.9868 7.1204 0.0021  
b 0.4307 0.0948 4.5454 0.0105  
x0 4.4543 0.7677 5.8021 0.0044  
 
Statistical Tests: 
Normality Test (Shapiro-Wilk)   Passed (P = 0.3443) 
W Statistic= 0.9022 Significance Level = 0.0500 
Constant Variance Test  Passed (P = 0.3884) 
 
LdcC 
Nonlinear Regression   Equation: f = a/(1+exp(-(x-x0)*b)) 
 
R  Rsqr  Adj Rsqr  Standard Error of Estimate 
0.9835 0.9673 0.9510  0.2820  
 
  Coefficient Std. Error t P  
a 15.6450 27.1065 0.5772 0.5948  
b 0.2274 0.1198 1.8987 0.1304  
x0 11.3584 12.8547 0.8836 0.4268  
 
Statistical Tests: 
Normality Test (Shapiro-Wilk)   Passed (P = 0.3543) 
W Statistic= 0.9038 Significance Level = 0.0500 
Constant Variance Test  Passed (P = 0.8429) 
 
Spc 
Nonlinear Regression   Equation: f = a/(1+exp(-(x-x0)*b)) 
 
R  Rsqr  Adj Rsqr  Standard Error of Estimate 
0.9791 0.9586 0.9380  0.2907  
 
  Coefficient Std. Error t P  
a 8.8611 6.7855 1.3059 0.2616  
b 0.2703 0.1356 1.9939 0.1169  
x0 7.5251 5.6853 1.3236 0.2562  
 
Statistical Tests: 
Normality Test (Shapiro-Wilk)   Passed (P = 0.2417) 
W Statistic= 0.8833 Significance Level = 0.0500 
Constant Variance Test  Passed (P = 0.7200) 
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Table 7.3: Plasmid copy number 
Strain 
Plasmid 
size (bp) 
Concentration of genomic DNA ( g/mL) Concentration of plasmid DNA ( g/mL) Plasmid copy number 
  
6hrs 24 hrs 7 days 14 days 21 days 28 days 6hrs 24 hrs 7 days 14 days 21 days 28 days 6hrs 24 hrs 7 days 14 days 21 days 28 days 
WT 0 27.59 112.61 119.97 105.71 107.34 107.69 
            
pME4510 4017 21.87 101.05 110.33 116.39 112.92 114.93 1.70 5.44 5.93 6.20 5.91 6.14 121.8 84.5 84.3 83.5 82.1 83.8 
pMElux 9844 8.28 37.00 33.58 32.74 31.75 35.32 1.31 3.12 2.49 2.78 2.54 2.88 101.0 53.9 47.4 54.4 51.1 52.2 
ldcC 9934 9.74 32.25 29.19 30.64 32.23 30.11 1.52 2.45 2.31 2.52 2.60 2.49 99.1 48.2 50.3 52.1 51.2 52.3 
spc 9934 8.95 33.06 32.98 32.76 31.12 30.89 1.35 2.76 2.40 2.33 2.48 2.49 95.6 52.9 46.2 45.1 50.5 51.1 
lys R25 9943 8.12 34.58 32.09 31.05 32.86 26.79 1.27 2.48 2.03 2.47 2.32 2.33 99.3 45.5 40.1 50.5 44.7 55.2 
lys G25 9968 9.17 34.04 29.29 30.32 31.49 32.31 1.38 2.53 2.30 2.49 2.45 2.62 95.5 47.0 49.6 51.9 49.2 51.2 
lpp R3 9968 9.35 38.80 27.72 30.07 32.78 31.72 1.40 2.52 1.93 2.24 2.55 2.43 94.6 41.1 44.0 47.2 49.1 48.3 
lpp R4 10014 9.88 35.86 27.17 28.04 30.70 33.35 1.53 2.66 2.01 2.35 2.31 2.58 97.6 46.7 46.5 52.7 47.4 48.6 
tat H5 10014 5.90 34.97 28.31 27.78 28.30 33.33 0.88 2.72 1.89 1.93 2.00 2.49 93.7 48.9 42.0 43.8 44.4 47.0 
tat H9 10014 9.42 35.68 27.20 28.65 30.08 32.07 1.45 2.55 1.86 2.27 2.42 2.39 96.8 44.9 42.9 49.9 50.7 46.9 
tat H14 10032 8.34 35.68 29.88 31.66 29.47 32.17 1.29 2.74 2.22 2.39 2.28 2.30 97.0 48.3 46.6 47.4 48.7 44.9 
Size of genome in each case is 6300000bp. 
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Table 7.4: Relationship between time and plasmid copy number for all plasmid-bearing strains. 
    N Correlation Sig. 
Pair 1 Time & pME4510_PCN 6 -.539 .270 
Pair 2 Time & pMElux_PCN 6 -.503 .309 
Pair 3 Time & ldcC_PCN 6 -.453 .366 
Pair 4 Time & spc_PCN 6 -.493 .321 
Pair 5 Time & lysR25_PCN 6 -.354 .492 
Pair 6 Time & lysG25_PCN 6 -.463 .356 
Pair 7 Time & lppR3_PCN 6 -.391 .443 
Pair 8 Time & lppR4_PCN 6 -.483 .332 
Pair 9 Time & tatH5_PCN 6 -.515 .296 
Pair 10 Time & tatH9_PCN 6 -.433 .391 
Pair 11 Time & tatH14_PCN 6 -.532 .277 
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Appendix 9: Bacterial growth and gene 
expression 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
___________________________________________________________ 
Figure 7.13: Comparisons of bioluminescence (RLU), colony forming units 
(CFU), live fluorescence (RFU) and total RFU at various time points. Time in 
hours is represented on X-axis of all graphs.     CFU,     RLU,     Live RFU and      Total 
RFU. A: ldcC, B: spc, C: tat, D: lpp. 
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Appendix 10: Preservative efficacy testing 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
________________________________________________________________________ 
Figure 7.14: BKC efficacy test for all strains. Relationship between relative 
bioluminescence (A-D), colony forming units (E-H) and relative fluorescence (I) against 
time for all strains challenged with 0.02% (A, E), 0.01% (B, F), 0.005% (C, G) and 
0.0025% (D, H, I) BKC. 
  WT 
  pME4510 
  pME-lux 
  ldcC 
  spc 
  lysR25 
  lysG25 
  lppR3 
  lppR4 
  tatH5 
  tatH9 
  tatH14 
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Table 7.5: Correlations between RLU, CFU and RFU for all strains challenged with 
various concentrations of BKC. 
 BKC Conc  WT pME4510 pMElux ldcC spc lysR25 lysG25 lppR3 lppR4 tatH5 tatH9 tatH14 
CFU:RLU 0.02% Correl -.444 .431 .027 .949** .156 .344 -.917** -.110 .524 -.575 .753 -.300 
  Sig .318 .334 .955 .001 .738 .450 .004 .815 .228 .177 .051 .514 
 0.01% Correl -.070 -.257 -.189 -.320 .525 .652 .534 .090 .187 -.087 -.083 .051 
  Sig .881 .578 .685 .484 .226 .113 .217 .847 .687 .854 .860 .914 
 0.005% Correl .640 -.102 .467 -.025 -.093 .805* .781* .457 -.182 .632 .575 .691 
  Sig .122 .828 .291 .957 .842 .029 .038 .303 .696 .128 .177 .086 
 0.0025% Correl -.045 .422 -.228 .549 .427 .907** .945** .906** .901** .959** .901** .957** 
  Sig .924 .346 .623 .202 .339 .005 .001 .005 .006 .001 .006 .001 
 0.00125% Correl .221 .547 -.018 .247 -.011 .995** .999** .997** .997** .993** .962** .998** 
  Sig .633 .204 .969 .593 .981 .000 .000 .000 .000 .000 .001 .000 
 0.0006% Correl -.577 -.582 -.306 .999** .998** 1.000** 1.000** .999** 1.000** 1.000** 1.000** 1.000** 
  Sig .175 .171 .504 .000 .000 .000 .000 .000 .000 .000 .000 .000 
 0.0003% Correl .361 .395 .392 .985** .989** .962** .990** .998** .986** .968** .992** .997** 
  Sig .427 .380 .385 .000 .000 .001 .000 .000 .000 .000 .000 .000 
 0.0000% Correl .072 .159 -.098 .401 .118 .368 .452 .387 .382 .635 .380 .485 
  Sig .878 .734 .835 .373 .801 .416 .309 .391 .398 .125 .401 .270 
               
RLU:RFU 0.02% Correl             
  Sig             
 0.01% Correl             
  Sig             
 0.005% Correl             
  Sig             
 0.0025% Correl -.077 .354 -.313 .550 .428 .908** .945** .906** .902** .959** .901** .957** 
  Sig .869 .436 .494 .201 .338 .005 .001 .005 .005 .001 .006 .001 
 0.00125% Correl .316 .552 .033 .250 -.009 .995** .999** .997** .998** .994** .962** .998** 
  Sig .490 .199 .943 .589 .985 .000 .000 .000 .000 .000 .001 .000 
 0.0006% Correl -.390 -.512 -.206 .976** .967** .864* .943** .933** .933** .976** .974** .926** 
  Sig .387 .240 .657 .000 .000 .012 .001 .002 .002 .000 .000 .003 
 0.0003% Correl .351 .379 .401 .976** .984** .933** .918** .995** .974** .991** .982** .998** 
  Sig .439 .402 .372 .000 .000 .002 .004 .000 .000 .000 .000 .000 
 0.0000% Correl .040 .215 -.221 -.042 -.035 -.114 .457 .083 -.090 .625 .399 -.179 
  Sig .932 .644 .633 .929 .940 .807 .303 .860 .847 .133 .376 .700 
               
CFU:RFU 0.02% Correl             
  Sig             
 0.01% Correl             
  Sig             
 0.005% Correl             
  Sig             
 0.0025% Correl .988** .993** .987** 1.000** 1.000** 1.000** 1.000** 1.000** 1.000** 1.000** 1.000** 1.000** 
  Sig .000 .000 .000 .000 .000 .000 .000 .000 .000 .000 .000 .000 
 0.00125% Correl .989** .996** .986** 1.000** 1.000** 1.000** 1.000** 1.000** 1.000** 1.000** 1.000** 1.000** 
  Sig .000 .000 .000 .000 .000 .000 .000 .000 .000 .000 .000 .000 
 0.0006% Correl .891** .932** .848* .967** .953** .854* .936** .920** .922** .973** .974** .921** 
  Sig .007 .002 .016 .000 .001 .015 .002 .003 .003 .000 .000 .003 
 0.0003% Correl .999** .999** .999** .999** .996** .987** .965** .998** .997** .931** .957** .994** 
  Sig .000 .000 .000 .000 .000 .000 .000 .000 .000 .002 .001 .000 
 0.0000% Correl .982** .961** .856* .386 .934** .514 .992** .911** .808* .953** .977** .747 
  Sig .000 .001 .014 .393 .002 .238 .000 .004 .028 .001 .000 .053 
*. Correlation is significant at the 0.05 level (2-tailed). 
**. Correlation is significant at the 0.01 level (2-tailed). 
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Table 7.6: Correlations between RLU, CFU and RFU for strains challenged with 
various concentrations of BA. 
 BA Conc  WT pME4510 pMElux ldcC spc lysR25 lppR4 tatH5 
CFU:RLU 2% Correl    .798
* 
.815
* 
.950
** 
.818
* 
.793
* 
  Sig    .031 .025 .001 .025 .034 
 1% Correl    .955
** 
.923
** 
.988
** 
.981
** 
.989
** 
  Sig    .001 .003 .000 .000 .000 
 0.5% Correl    .992
** 
1.000
** 
.990
** 
.990
** 
.993
** 
  Sig    .000 .000 .000 .000 .000 
 0.25% Correl    .997
** 
.991
** 
.984
** 
.991
** 
.994
** 
  Sig    .000 .000 .000 .000 .000 
 0.125% Correl    .780
* 
.874
* 
.777
* 
.856
* 
.898
** 
  Sig    .039 .010 .040 .014 .006 
 0.06% Correl    .891
** 
.765
* 
.959
** 
.918
** 
.923
** 
  Sig    .007 .045 .001 .004 .003 
           
RLU:RFU 2% Correl    .799
* 
.818
* 
.952
** 
.826
* 
.798
* 
  Sig    .031 .025 .001 .022 .031 
 1% Correl    .960
** 
.931
** 
.989
** 
.995
** 
.996
** 
  Sig    .001 .002 .000 .000 .000 
 0.5% Correl    .998
** 
.999
** 
.990
** 
.997
** 
.997
** 
  Sig    .000 .000 .000 .000 .000 
 0.25% Correl    .985
** 
.978
** 
.985
** 
.992
** 
.994
** 
  Sig    .000 .000 .000 .000 .000 
 0.125% Correl    .770
* 
.896
** 
.804
* 
.826
* 
.905
** 
  Sig    .043 .006 .029 .022 .005 
 0.06% Correl         
  Sig         
           
CFU:RFU 2% Correl .948
** 
.998
** 
.998
** 
.999
** 
1.000
** 
1.000
** 
1.000
** 
1.000
** 
  Sig .001 .000 .000 .000 .000 .000 .000 .000 
 1% Correl .954
** 
.925
** 
.909
** 
.999
** 
.992
** 
.989
** 
.989
** 
.992
** 
  Sig .001 .003 .005 .000 .000 .000 .000 .000 
 0.5% Correl .998
** 
.976
** 
.998
** 
.998
** 
1.000
** 
.999
** 
.998
** 
.998
** 
  Sig .000 .000 .000 .000 .000 .000 .000 .000 
 0.25% Correl .982
** 
.975
** 
.985
** 
.991
** 
.995
** 
.998
** 
.999
** 
.998
** 
  Sig .000 .000 .000 .000 .000 .000 .000 .000 
 0.125% Correl .998
** 
.992
** 
.999
** 
1.000
** 
.999
** 
.998
** 
.998
** 
1.000
** 
  Sig .000 .000 .000 .000 .000 .000 .000 .000 
 0.06% Correl         
  Sig         
*. Correlation is significant at the 0.05 level (2-tailed). 
**. Correlation is significant at the 0.01 level (2-tailed). 
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Table 7.7: Log unit reductions of RLU and CFU for all strains at various BKC 
concentrations 
0.02% BKC 
  CFU CFU CFU CFU CFU CFU CFU   RLU RLU RLU RLU RLU RLU RLU 
  0 6 24 168 336 504 672   0 6 24 168 336 504 672 
WT 2.59 6.51 - - - - -                 
pME4510 2.29 6.11 - - - - -                 
pMElux 3.57 6.48 - - - - -                 
ldcC 3.49 6.60 - - - - -   3.65 - - - - - - 
spc 3.39 6.57 - - - - -   3.68 - - - - - - 
lys R25 3.28 6.42 - - - - -   4.57 - - - - - - 
lys G25 3.24 6.47 - - - - -   4.49 - - - - - - 
lpp R3 3.41 6.56 - - - - -   4.34 - - - - - - 
lpp R4 3.36 6.48 - - - - -   4.42 - - - - - - 
tat H5 3.34 6.42 - - - - -   4.27 - - - - - - 
tat H9 3.40 6.40 - - - - -   4.43 - - - - - - 
tat H14 3.32 6.40 - - - - -   4.38 - - - - - - 
                0.01% BKC 
  CFU CFU CFU CFU CFU CFU CFU   RLU RLU RLU RLU RLU RLU RLU 
  0 6 24 168 336 504 672   0 6 24 168 336 504 672 
WT 2.03 6.51 - - - - -                 
pME4510 1.67 6.11 - - - - -                 
pMElux 3.22 6.48 - - - - -                 
ldcC 2.75 6.60 - - - - -   3.65 - - - - - - 
spc 2.76 6.57 - - - - -   3.68 - - - - - - 
lys R25 2.72 6.42 - - - - -   4.57 - - - - - - 
lys G25 2.79 6.47 - - - - -   4.49 - - - - - - 
lpp R3 3.00 6.56 - - - - -   4.34 - - - - - - 
lpp R4 2.86 6.48 - - - - -   4.42 - - - - - - 
tat H5 2.71 6.42 - - - - -   4.27 - - - - - - 
tat H9 2.74 6.40 - - - - -   4.43 - - - - - - 
tat H14 2.78 6.40 - - - - -   4.38 - - - - - - 
                0.005% BKC 
  CFU CFU CFU CFU CFU CFU CFU   RLU RLU RLU RLU RLU RLU RLU 
  0 6 24 168 336 504 672   0 6 24 168 336 504 672 
WT 1.60 6.51 - - - - -                 
pME4510 1.43 6.11 - - - - -                 
pMElux 3.57 6.48 - - - - -                 
ldcC 1.99 6.60 - - - - -   3.65 - - - - - - 
spc 1.79 6.57 - - - - -   3.68 - - - - - - 
lys R25 1.79 6.42 - - - - -   2.96 - - - - - - 
lys G25 1.84 6.47 - - - - -   3.29 - - - - - - 
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lpp R3 1.88 6.56 - - - - -   4.34 - - - - - - 
lpp R4 1.76 6.48 - - - - -   4.42 - - - - - - 
tat H5 1.67 6.42 - - - - -   4.27 - - - - - - 
tat H9 1.71 6.40 - - - - -   4.43 - - - - - - 
tat H14 1.64 6.40 - - - - -   4.38 - - - - - - 
                0.0025% BKC 
  CFU CFU CFU CFU CFU CFU CFU   RLU RLU RLU RLU RLU RLU RLU 
  0 6 24 168 336 504 672                 
WT 1.55 6.51 - - - - -                 
pME4510 1.31 6.11 - - - - -                 
pMElux 3.22 6.48 - - - - -                 
ldcC 0.46 6.60 - - - - -   3.65 - - - - - - 
spc 0.18 6.57 - - - - -   3.68 - - - - - - 
lys R25 0.26 6.42 - - - - -   2.28 4.57 - - - - - 
lys G25 0.23 6.47 - - - - -   2.28 4.49 - - - - - 
lpp R3 0.23 6.56 - - - - -   4.34 4.34 - - - - - 
lpp R4 0.18 6.48 - - - - -   2.48 4.42 - - - - - 
tat H5 0.08 6.42 - - - - -   4.27 4.27 - - - - - 
tat H9 0.09 6.40 - - - - -   4.43 4.43 - - - - - 
tat H14 0.10 6.40 - - - - -   4.38 4.38 - - - - - 
                0.00125% BKC 
  CFU CFU CFU CFU CFU CFU CFU   RLU RLU RLU RLU RLU RLU RLU 
  0 6 24 168 336 504 672   0 6 24 168 336 504 672 
WT 1.51 6.51 - - - - -                 
pME4510 1.24 6.11 - - - - -                 
pMElux 2.73 6.48 - - - - -                 
ldcC 0.24 6.60 - - - - -   3.65 - - - - - - 
spc 0.16 6.57 - - - - -   3.68 - - - - - - 
lys R25 0.25 6.42 - - - - -   1.56 4.57 - - - - - 
lys G25 0.13 6.47 - - - - -   1.17 4.49 - - - - - 
lpp R3 0.22 6.56 - - - - -   1.29 4.34 - - - - - 
lpp R4 0.14 6.48 - - - - -   1.30 4.42 - - - - - 
tat H5 -0.02 6.42 - - - - -   1.70 4.27 - - - - - 
tat H9 0.04 6.40 - - - - -   1.72 4.43 - - - - - 
tat H14 0.03 6.40 - - - - -   2.19 4.38 - - - - - 
                0.000625% BKC 
  CFU CFU CFU CFU CFU CFU CFU   RLU RLU RLU RLU RLU RLU RLU 
  0 6 24 168 336 504 672                 
WT 1.21 6.51 - - - - -                 
pME4510 0.78 6.11 - - - - -                 
pMElux 2.68 6.48 - - - - -                 
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ldcC 0.24 2.32 3.30 6.60 - - -   0.45 3.65 - - - - - 
spc 0.13 2.29 3.03 6.57 - - -   0.78 3.68 - - - - - 
lys R25 0.04 2.35 3.06 6.42 - - -   0.88 2.83 4.57 - - - - 
lys G25 0.06 2.30 2.83 6.47 - - -   0.85 2.88 4.49 - - - - 
lpp R3 0.11 2.48 3.41 6.56 - - -   0.67 2.36 4.34 - - - - 
lpp R4 0.11 2.34 3.11 6.48 - - -   0.78 2.51 4.42 - - - - 
tat H5 -0.04 2.18 3.02 6.42 - - -   0.53 4.27 4.27 - - - - 
tat H9 0.02 2.29 2.96 6.40 - - -   0.73 4.43 4.43 - - - - 
tat H14 0.00 2.31 2.89 6.40 - - -   0.90 4.38 4.38 - - - - 
                0.0003125% BKC 
  CFU CFU CFU CFU CFU CFU CFU   RLU RLU RLU RLU RLU RLU RLU 
  0 6 24 168 336 504 672   0 6 24 168 336 504 672 
WT 0.93 6.51 - - - - -                 
pME4510 0.76 6.11 - - - - -                 
pMElux 0.90 6.48 - - - - -                 
ldcC 0.16 1.39 1.54 3.59 6.60 - -   0.16 0.82 3.65 - - - - 
spc 0.10 0.82 1.14 3.09 6.57 - -   0.28 0.85 3.68 - - - - 
lys R25 0.03 0.39 0.87 2.76 3.72 - -   0.64 1.51 2.66 4.57 - - - 
lys G25 0.01 0.36 1.41 2.99 6.47 - -   0.77 1.48 2.56 4.49 - - - 
lpp R3 0.06 0.64 1.35 3.48 6.56 - -   0.55 1.13 3.39 4.34 - - - 
lpp R4 0.03 0.40 1.11 3.12 6.48 - -   0.54 1.28 2.36 4.42 - - - 
tat H5 -0.06 0.70 1.21 3.20 6.42 - -   0.31 1.35 2.50 4.27 - - - 
tat H9 -0.01 0.24 0.71 2.83 3.86 - -   0.64 1.46 2.36 4.43 - - - 
tat H14 0.01 0.52 0.91 3.36 3.77 - -   0.69 1.38 2.88 4.38 - - - 
                0% BKC 
  CFU CFU CFU CFU CFU CFU CFU   RLU RLU RLU RLU RLU RLU RLU 
  0 6 24 168 336 504 672   0 6 24 168 336 504 672 
WT 0.00 -0.13 -0.24 -0.19 -0.19 -0.10 -0.18                 
pME4510 0.00 -0.46 -0.54 -0.52 -0.62 -0.68 -0.63                 
pMElux 0.00 -0.10 0.15 0.16 -0.08 -0.07 0.00                 
ldcC 0.00 0.50 0.56 0.43 0.57 0.55 0.27   0.00 0.03 0.06 0.69 0.40 0.88 0.59 
spc 0.00 0.24 0.45 0.25 0.51 0.46 0.00   0.00 0.03 0.05 0.43 0.58 0.73 0.96 
lys R25 0.00 0.27 0.31 0.26 0.48 0.16 0.24   0.00 0.01 0.02 0.61 0.65 0.78 0.64 
lys G25 0.00 0.18 0.47 0.38 0.36 0.12 0.35   0.00 0.03 0.09 0.50 0.44 0.50 0.40 
lpp R3 0.00 0.57 0.83 0.78 0.44 0.48 0.26   0.00 0.07 0.09 0.35 0.43 0.54 0.36 
lpp R4 0.00 0.29 0.48 0.48 0.08 0.47 0.31   0.00 0.03 0.07 0.33 0.27 0.28 0.18 
tat H5 0.00 0.03 0.26 0.60 -0.02 0.28 0.34   0.00 0.04 0.07 0.46 0.41 0.50 0.29 
tat H9 0.00 0.27 0.39 0.67 0.40 0.21 0.25   0.00 0.07 0.11 0.43 0.41 0.41 0.29 
tat H14 0.00 0.38 0.81 0.74 0.40 0.35 0.33   0.00 0.02 0.04 0.37 0.38 0.43 0.28 
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Table 7.8: Log unit reductions of RLU and CFU for all strains at various BA 
concentrations. 
2% BA 
  CFU CFU CFU CFU CFU CFU CFU   RLU RLU RLU RLU RLU RLU RLU 
  0 6 24 168 336 504 672  0 6 24 168 336 504 672 
WT 2.04 6.51 - - - - -                
pME4510 2.88 6.11 - - - - -                
pMElux 3.24 6.32 - - - - -                
ldcC 0.21 6.60 - - - - -   1.25 3.65 - - - - - 
spc 0.14 6.57 - - - - -   1.26 3.68 - - - - - 
lys R25 0.03 6.42 - - - - -   1.70 4.57 - - - - - 
lpp R4 0.13 6.48 - - - - -   1.86 4.42 - - - - - 
tat H5 0.08 6.42 - - - - -   1.99 4.27 - - - - - 
                
1% BA 
  CFU CFU CFU CFU CFU CFU CFU   RLU RLU RLU RLU RLU RLU RLU 
  0 6 24 168 336 504 672  0 6 24 168 336 504 672 
WT 0.27 6.51 - - - - -                
pME4510 0.03 6.11 - - - - -                
pMElux 0.19 6.32 - - - - -                
ldcC 0.18 0.49 0.87 6.60 - - -   0.61 1.35 3.65 - - - - 
spc 0.13 0.57 0.86 6.57 - - -   0.85 3.68 3.68 - - - - 
lys R25 -0.03 0.38 0.68 6.42 - - -   1.07 1.67 2.30 4.57 - - - 
lpp R4 0.05 0.44 0.72 6.48 - - -   0.90 1.48 2.42 4.42 - - - 
tat H5 -0.02 0.36 0.65 6.42 - - -   0.79 1.28 1.97 4.27 - - - 
                
0.5% BA 
  CFU CFU CFU CFU CFU CFU CFU   RLU RLU RLU RLU RLU RLU RLU 
  0 6 24 168 336 504 672  0 6 24 168 336 504 672 
WT 0.30 0.85 1.48 6.51 - - -                
pME4510 0.11 0.36 0.56 6.11 - - -                
pMElux 0.25 0.61 1.01 6.32 - - -                
ldcC 0.13 0.71 1.37 6.60 - - -   0.26 0.67 1.50 2.00 2.81 2.88 3.18 
spc 0.10 0.68 1.35 6.57 - - -   0.32 0.93 1.54 2.15 3.21 2.98 3.38 
lys R25 -0.10 0.53 1.21 6.42 - - -   0.33 0.79 1.09 2.28 2.28 2.30 2.28 
lpp R4 -0.03 0.57 1.19 6.48 - - -   0.26 0.67 1.22 2.40 2.27 2.25 2.35 
tat H5 -0.05 0.53 1.24 6.42 - - -   0.04 0.48 0.93 2.01 2.03 2.10 2.19 
                
0.25% BA 
  CFU CFU CFU CFU CFU CFU CFU   RLU RLU RLU RLU RLU RLU RLU 
  0 6 24 168 336 504 672  0 6 24 168 336 504 672 
WT 0.49 0.53 0.76 0.86 2.37 2.39 2.41               
pME4510 0.11 0.12 0.35 0.41 1.29 1.29 1.26               
pMElux 0.18 0.31 0.50 0.71 1.40 1.45 1.51               
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ldcC 0.13 0.53 1.20 1.56 1.83 1.79 1.72  -0.12 0.31 0.82 0.86 1.02 0.93 0.95 
spc 0.10 0.40 1.22 1.39 1.76 1.84 1.67  0.09 0.46 1.04 1.04 1.33 1.16 1.01 
lys R25 -0.11 0.38 1.01 1.34 1.51 1.51 1.47  0.06 0.52 0.64 0.64 0.78 0.67 0.68 
lpp R4 -0.01 0.46 1.04 1.30 1.59 1.53 1.42  -0.10 0.37 0.60 0.60 0.79 0.67 0.67 
tat H5 -0.05 0.30 0.99 1.30 1.48 1.63 1.61  -0.29 0.01 0.33 0.31 0.47 0.39 0.55 
                
0.125% BA 
  CFU CFU CFU CFU CFU CFU CFU   RLU RLU RLU RLU RLU RLU RLU 
  0 6 24 168 336 504 672  0 6 24 168 336 504 672 
WT 0.25 0.48 0.49 1.33 1.27 1.13 1.00               
pME4510 -0.15 -0.07 0.03 1.16 0.96 0.99 1.03               
pMElux 0.13 0.27 0.29 1.46 1.37 1.35 1.36               
ldcC 0.16 0.25 0.29 1.95 2.01 2.03 1.83  -0.04 0.33 1.08 1.24 1.20 1.13 1.32 
spc 0.14 0.17 0.38 1.86 2.01 2.25 1.86  0.21 0.45 1.94 2.22 2.24 2.15 2.21 
lys R25 -0.12 -0.05 0.01 1.53 1.81 1.96 1.55  0.02 0.38 0.77 0.79 0.93 0.91 1.01 
lpp R4 -0.05 0.07 0.17 1.89 1.96 1.93 1.68  0.08 0.41 0.71 0.70 0.92 0.92 1.03 
tat H5 -0.13 0.00 0.14 1.76 1.81 1.79 1.58  -0.11 0.13 0.55 0.54 0.71 0.74 0.89 
                
0.0625% BA 
  CFU CFU CFU CFU CFU CFU CFU   RLU RLU RLU RLU RLU RLU RLU 
  0 6 24 168 336 504 672  0 6 24 168 336 504 672 
WT 0.51 0.46 0.42 0.27 0.22 0.10 0.09               
pME4510 -0.07 -0.15 -0.19 0.10 0.09 -0.17 -0.19               
pMElux 0.15 0.18 -0.26 -0.25 0.31 0.22 -0.12               
ldcC 0.13 0.15 0.03 -0.05 0.14 0.11 0.06  -0.19 -0.08 -0.29 -0.31 -0.13 -0.13 -0.17 
spc 0.20 0.18 -0.04 -0.06 0.25 0.17 0.04  0.00 0.05 -0.13 -0.16 -0.09 -0.08 -0.10 
lys R25 0.10 0.01 -0.25 -0.26 -0.05 -0.11 -0.08  -0.02 0.02 -0.17 -0.19 -0.05 -0.07 -0.08 
lpp R4 -0.08 0.06 -0.23 -0.19 -0.01 -0.03 -0.09  0.02 0.13 -0.14 -0.08 -0.02 0.02 0.03 
tat H5 0.00 0.09 -0.20 -0.24 0.00 -0.05 -0.13  -0.16 -0.14 -0.25 -0.28 -0.18 -0.16 -0.27 
                
0% BA 
  CFU CFU CFU CFU CFU CFU CFU   RLU RLU RLU RLU RLU RLU RLU 
  0 6 24 168 336 504 672  0 6 24 168 336 504 672 
WT 0 -0.13 -0.24 -0.19 -0.19 -0.10 -0.18               
pME4510 0 -0.46 -0.54 -0.52 -0.62 -0.68 -0.63               
pMElux 0 0.00 -0.01 0.00 -0.23 -0.22 -0.15               
ldcC 0 0.50 0.56 0.43 0.57 0.55 0.27  0.00 0.03 0.06 0.69 0.40 0.88 0.59 
spc 0 0.24 0.45 0.25 0.51 0.46 0.00  0.00 0.03 0.05 0.43 0.58 0.73 0.96 
lys R25 0 0.27 0.31 0.26 0.48 0.16 0.24  0.00 0.01 0.02 0.61 0.65 0.78 0.64 
lpp R4 0 0.29 0.48 0.48 0.08 0.47 0.31  0.00 0.03 0.07 0.33 0.27 0.28 0.18 
tat H5 0 0.03 0.26 0.60 -0.02 0.28 0.34  0.00 0.04 0.07 0.46 0.41 0.50 0.29 
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Table 7.9: Equivalence between bioluminescence and plate count method. 
  Significance values for BKC concentrations Significance values for BA concentrations 
Strain 0 0.02% 0.01% 0.005% 0.0025% 0.00125% 0.0006% 0.0003% 2% 1% 0.50% 0.25% 0.13% 0.06% 
ldcC 0.000 0.277 0.419 0.447 0.454 0.454 0.447 0.379 0.454 0.128 0.250 0.142 0.040 0.000 
spc 0.000 0.291 0.424 0.449 0.454 0.454 0.448 0.265 0.454 0.155 0.250 0.121 0.047 0.000 
lys R25 0.000 0.408 0.403 0.450 0.454 0.455 0.451 0.158 0.454 0.149 0.270 0.168 0.041 0.000 
lys G25 0.000 0.363 0.426 0.448 0.454 0.455 0.45 0.199 nd nd nd nd nd nd 
lpp R3 0.001 0.293 0.389 0.447 0.454 0.455 0.452 0.254 nd nd nd nd nd nd 
lpp R4 0.000 0.283 0.379 0.448 0.454 0.455 0.45 0.185 0.454 0.140 0.257 0.145 0.048 0.000 
tat H5 0.000 0.331 0.387 0.447 0.454 0.454 0.45 0.298 0.454 0.137 0.260 0.133 0.051 0.000 
tat H9 0.000 0.334 0.384 0.446 0.454 0.454 0.45 0.122 nd nd nd nd nd nd 
tat H14 0.000 0.341 0.372 0.449 0.454 0.454 0.45 0.2 nd nd nd nd nd nd 
ANOVA (Significance level P<0.05). Values greater than 0.05 indicate no significant difference between both methods (highlighted in green). nd 
– not determined 
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